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ABSTRACT 
 
Many small molecules targeted for synthesis in the laboratory are inherently 
modular in their construction. Harnessing this modularity towards a unified strategy for 
the synthesis of these compounds, this dissertation describes an approach to small 
molecule making based on the iterative cross-coupling (ICC) of bifunctional haloboronic 
acid building blocks. Realizing a general ICC approach in the context of small molecule 
synthesis required the discovery of a ligand with the capacity to attenuate the reactivity of 
boronic acids under Suzuki-Miyaura cross-coupling (SMC) conditions and then liberate 
this masked reactivity under mild conditions. Towards this end, N-methyliminodiacetic 
acid (MIDA) was discovered to be such a ligand, enabling an approach by which the 
reactivity of boronic acids is modulated via rehybridization of the boron center. Further, 
MIDA boronates, which result from the condensation of MIDA with boronic acids, were 
found to possess a number of enabling properties. Specifically, MIDA boronates are 
uniformly stable to SiO2 chromatography and to storage under ambient air at room 
temperature. MIDA boronates were also found to be compatible with a broad range of 
common reagents and reaction conditions, enabling an approach by which relatively 
simple MIDA boronates can be elaborated through multiple-step organic synthesis en 
route to structurally complex boronate building blocks. Through a process of rate-
controlled in situ release of boronic acids from the corresponding MIDA boronates, 
MIDA boronates were found to serve as generally effective surrogates for otherwise 
unstable boronic acids in high-yielding Suzuki-Miyaura cross-coupling reactions with 
deactivated aryl chlorides. Enabled by these collective discoveries, and towards the goal 
of a simple and accessible approach to small molecule synthesis, a machine with the 
capacity to perform fully automated ICC syntheses was developed and was employed in 
the syntheses of several natural products. 
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CHAPTER 1 
INTRODUCTION 
 
Eric P. Gillis and Martin D. Burke 
 
 In contrast to the efficiency with which peptides and oligonucleotides can be 
prepared in the laboratory, the process of small molecule synthesis remains a relatively 
complex, un-systematized, and inflexible process that is practiced almost exclusively by 
highly trained specialists. However, like peptides and oligonucleotides, most small 
molecules are modular in their construction. This dissertation began with the hypothesis 
that the inherent modularity in small molecules remains largely underutilized, and that a 
unified strategy for the construction of these compounds through the iterative coupling of 
bifunctional building blocks might be possible. As a basis for this idea, this chapter 
introduces pioneering studies that have expanded the use of iterative coupling in organic 
synthesis. Attention is focused on the use of palladium-catalyzed cross-coupling in these 
iterative processes, with a specific interest in the use of the Suzuki-Miyaura cross-
coupling (SMC) as the primary C-C bond forming reaction. Further, a mechanistic 
framework is discussed for the proposal that sp3-hybridized boronates might serve as 
protected-boronic acid equivalents in the SMC reaction. 
 
 
 
Adapted from Gillis, E. P.; Burke, M. D. Aldrichimica Acta 2009, 42, 17-27. 
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1-1 THE PROSPECT OF A GENERAL APPROACH TO SMALL MOLECULE 
SYNTHESIS 
Many organic molecules are inherently modular in their constitution. With respect 
to the molecules found in living systems, this modularity is a direct consequence of the 
fact that nearly all biosynthetic systems are based on the iterative coupling of bifunctional 
building blocks. For example, polypeptides are built from amino acids, oligonucleotides 
are derived from nucleotide monomers, and oligosaccharides are stitched together from 
individual sugar units. Interestingly, most small-molecule natural products are similarly 
constructed by the iterative coupling of bifunctional building blocks: e.g., polyketides 
from malonyl-CoA or methylmalonyl-CoA units, nonribosomal peptides from amino 
acids, polyterpenes from isopentenyl pyrophosphate or dimethylallyl pyrophosphate, and 
fatty acids from malonyl-CoA. Similarly, many synthetic pharmaceuticals are also highly 
modular because they are constructed by using different reactions to assemble collections 
of small building blocks, typically cyclic and heterocyclic fragments and their associated 
appendages. Thus, modularity is a remarkably general feature of many of the molecules 
that are targeted for synthesis in the laboratory. 
 
Automated solid-phase peptide synthesis 
 Despite the common modularity inherent to small molecules, the strategies 
utilized for making polypeptides, oligonucleotides, and oligosaccharides are very 
different from those typically used to prepare small molecules. Specifically, all of the 
former classes of compounds are almost always constructed via iterative coupling of 
suitably protected forms of their constituent monomers. 1  In this regard, solid-phase 
peptide synthesis (SPPS) represents a pinnacle in synthetic strategy in terms of efficiency, 
simplicity and modularity. 
 Shown in Scheme 1.1 is the general, modern approach to peptide synthesis. A key 
principal of this approach is the use of a bifunctional building block (an amino acid) in 
which, crucial to avoiding unwanted oligomerization, one of the functional groups is 
masked with a protecting group. Although the first peptide, glycyl-glycine, was 
synthesized in 1901 by Emil Fischer,2 it was not until 1932 that the first protecting group 
with the capacity to reversibly attenuate the reactivity of nitrogen, the carbobenzoxy 
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group, was introduced by Max Bergmann.3 With a suitably protected building block, the 
peptide bond-forming reaction can proceed with high selectivity. Following the bond-
forming step, the protecting group is removed to expose the reactive amine terminus 
which is available to undergo a subsequent round of peptide coupling. In each iteration a 
different amino acid can be introduced, thus the process is highly flexible and modular. In 
1963 Bruce Merrifield introduced the concept of solid-phase synthesis, whereby one of 
the termini of a peptide would be bound to a solid resin particle. 4  This advance 
introduced a simple, robust and importantly, general method for the purification of 
peptides. In fact, only two years after this report the first automated SPPS instrument was 
disclosed.5 Certainly the simplicity of the approach and the generality of the coupling, 
deprotection and purification conditions contributed to the rapid translation of SPPS to an 
automated platform. In fact, the first automated synthesis of a peptide, the nine-amino 
acid peptide bradykinin, was executed using only 80 steps encoded onto a stepping-
drum.5a,6 The development of an automated, iterative approach to peptide synthesis has 
had a dramatic impact on the use of peptides in science.1a Similar automated iterative 
strategies have also been developed for oligonucleotides, and to a lesser extent 
oligosaccharides.1b,1c Importantly, the advanced development of such automation has 
made it possible for even non-chemists to routinely prepare these types of compounds for 
a wide range of applications. 
 
 
Scheme 1.1. The paradigm of modern peptide synthesis is based on the coupling of bifunctional building 
blocks (amino acids) in which the required functional groups are preinstalled in the correct oxidation state 
and with the desired stereochemical relationships. In order to avoid undesired oligomerization, one of the 
functionalities must be chemically masked during the coupling step. Following the coupling, the masking 
group is removed and the cycle can be repeated, in theory, a limitless number of times. In each iteration a 
different amino acid can be introduced, thus the process is highly flexible and modular. 
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Automated solid-phase synthesis of organic polymers via iterative cross-coupling 
 In stark contrast to the efficiency with which peptides and oligonucleotides can be 
prepared in the laboratory, in small molecule synthesis it is typical for a synthetic chemist 
to develop a unique, customized strategy for each small molecule that is targeted for 
preparation. As a result, the synthesis of small molecules remains a relatively complex, 
un-systematized, and inflexible process that is practiced almost exclusively by highly 
trained specialists. In terms of conceptualizing a more direct approach to small molecule 
synthesis, the pioneering work of Moore and co-workers on the development of the first 
automated, iterative cross-coupling (ICC) approach towards polymer synthesis represents 
a very important advance. 7,8 
 The first iterative protocol for Pd-mediated cross-coupling was reported by Moore 
and co-workers in 1992,7 and two years later this methodology was transferred to an 
automated platform.8 The methodology described by these authors was based on an 
iterative cycle of Sonogashira cross-coupling reactions9 utilizing bifunctional building 
blocks containing both an acetylene and an aryl iodide functionality (in either reactive or 
masked forms). Two distinct protecting-group strategies were employed in 
complementary approaches, such that either the acetylene (Scheme 1.2A) or the aryl 
iodide (Scheme 1.2B) functionalities could be masked. Because of the complementarities 
of these two approaches the products could be utilized in a converging synthesis.7 In one 
case, a trimethylsilyl moiety bound to the acetylene unit prevented the alkyne from 
undergoing transmetallation to Pd (Scheme 1.2A).10a Following a selective coupling with 
the free acetylene of another compound, the silyl group was removed under the action of 
K2CO3 in methanol allowing the iterative cycle to be repeated.10 Alternatively, the 
diethyltriazene group was used as a masking group, serving as a latent aryl iodide.11 In 
this approach, following a selective coupling the aryl iodide functionality was introduced 
by treating the diethyltriazene group with MeI in a pressurized bomb at 110 °C (Scheme 
1.2B). 
 5
 
Scheme 1.2. Moore and co-workers reported two complementary approaches to the iterative synthesis of 
organic polymers. Both approaches utilize a bifunctional building block in iterative Sonogashira coupling, 
and differ in which functionality is masked: the terminal acetylene (A) or the aryl iodide (B). 
 
 To enable an automated approach similar to that employed by Merrifield,1a Moore 
and co-workers devised a chemical linker by which the coupled product would be bound 
to the solid-phase through a triazene linkage (Scheme 1.3).8 Cleavage of the desired 
product from the solid support was accomplished by treating the resin with MeI at 110 °C 
to generate the corresponding aryl iodide, similar to the method described for the 
solution-phase approach. Through this approach a polymer 32 units in length was 
synthesized. This methodology has played a major role in promoting the synthesis and 
study of a wide range of phenylacetylyne oligomers that possess interesting functions. 
 
K2CO3, MeOH
Sonogashira coupling
deprotection
I
H SiMe3
SiMe3
MeOSiMe3
= aryl
= Polymer
N N
Et
N
H  
Scheme 1.3. Automated iterative Sonogashira coupling was made possible through the development of a 
triazene-based linker for the solid-phase. Through this automated approach a polymer 32 units in length 
was synthesized. 
 
Other iterative cross-coupling approaches 
 An ICC approach to the synthesis of polyenes has been developed by Zeng and 
Negishi (Scheme 1.4).12 In this approach a bromo enyne is employed as a bifunctional 
building block, where the alkyne serves as a latent E-alkenyl zirconacene group. 13 
Alkenyl zirconacenes can be utilized as cross-coupling partners in a multi-metal 
catalyzed process in which the organic group appended to Zr is transmetallated to Al, 
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then Zn, and finally Pd.13,14 In the iterative cycle, following selective cross-coupling the 
trimethylsilyl group is removed under the action of K2CO3 in methanol to expose the 
terminal alkyne,10a which is then utilized in a subsequent hydrozirconation reaction with 
Schwartz’s reagent15 to introduce the E-alkenyl zirconacene group. As a demonstration of 
the utility of this approach Zeng and Negishi applied this ICC method to the synthesis of 
four polyene fragments which constitute portions of the natural products mycoticin A and 
B, roseofungin, surgumycin, RK-397, roflamycoin, dermostatin A and B and 
amphotericin B.12 Although this approach was successful in the synthesis of several all-
trans polyenes, the scope of this ICC method is limited to certain classes of polyenes and 
substrates that are compatible with the required hydrozirconation reaction. 
 
 
Scheme 1.4. Zeng and Negishi reported an ICC approach in which bromo enynes serve as bifunctional 
building blocks. The alkyne functionality serves as a latent E-alkenyl zirconacene group. Through multi-
metal catalysis the organozirconacene group undergoes cross-coupling with alkenyl bromides. Following 
the coupling reaction the trimethylsilyl group is removed under the action of K2CO3 in methanol and the 
resulting terminal alkyne is utilized in a hydrozirconation reaction with Schwartz’s reagent to install the E-
alkenyl zirconacene group. 
 
Lynchpin systems 
 A compound containing two functional groups, both of which could react under 
the same reaction manifold, but which can be distinguished with a high degree of 
chemical selectivity, can be referred to as a “lynchpin” reagent. The boron-tin reagents 
developed by Coleman for polyene synthesis16 are good examples of these types of 
reagents (Scheme 1.5). While either terminus of linchpin 1.1 could cross-coupling with 
1.2 under palladium catalysis, the absence of base in the first coupling step allows 
complete differentiation of the boron and tin functionalities, and ensures that only the 
stannane terminus of 1.1 undergoes transmetallation. Since both 1.2 and 1.3 react under 
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the same reaction manifold (oxidative addition to palladium), an efficient reaction 
sequence could still be expected if, alternatively, 1.3 was employed in the first coupling 
and 1.1 was used the second coupling. In a related example, the organic group transferred 
by lynchpin 1.4 is asymmetric (Scheme 1.6).17 If halide 1.6 was used in the first coupling 
and halide 1.5 was used in the second coupling, a different product would be expected. 
Thus, this approach is well suited towards the synthesis of libraries of compounds since 
multiple products can be obtained simply by reordering the steps in which the same 
reagents are used. 
 
Scheme 1.5. Reagent 1.1 is an example of a lynchpin reagent because both the stannane and borane 
functionalities are reactive under the same manifold (Pd-catalyzed cross-coupling) but their reactivity can 
be differentiated with a high degree of selectivity. 
 
 
Scheme 1.6. Asymmetric lynchpin reagents such as 1.4 are versatile building blocks since a simple 
reordering of the coupling steps with 1.5 and 1.6 can be expected to afford a different final product. 
 
 Lynchpins with termini containing the same metal can be differentiated by 
selective activation. 18  In an approach demonstrated by Denmark and co-workers 19 
(Scheme 1.7), treatment of lynchpin 1.7 with TMSOK results in the selective activation 
of the silanol moiety,20 allowing the first coupling to proceed with high selectivity. A 
second coupling follows in which the dimethylheterocyclic silane 21  is activated by 
fluoride.22  
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Scheme 1.7. The cross-coupling of 1.7 demonstrates the use of a lynchpin in which the termini are 
differentiated via selective activation. 
 
 Lynchpin reagents can also exploit the difference in rates of oxidative addition 
between halides/pseudo-halides. Aryl iodides, bromides and triflates can be engaged in 
Suzuki-Miyaura cross-coupling (SMC) reactions under standard conditions using 
traditional palladium catalysts such as Pd(PPh3)4, Pd2dba3, Pd(OAc)2 and PdCl2(dppf). 
On the other hand, aryl chlorides are typically unreactive under these conditions but can 
be cross-coupled using palladium catalysts supported by sterically bulky and/or electron-
rich phosphine or N-heterocyclic carbene ligands. 23 , 24  This difference in reactivity 
allowed Hii and coworkers to employ chlorobromoarenes as lynchpin reagents in the 
synthesis of many triaryl compounds (Scheme 1.8).25 Recently the first cross-coupling 
reactions involving oxidative addition to an aryl acetate C-O bond were reported.26,27 
Critical to this advance was the identification of nickel catalysts capable of undergoing 
selective oxidative addition into this C-O bond; palladium catalysts capable of this 
reactivity have not yet been discovered. Capitalizing on the difference in capabilities of 
palladium and nickel catalysts to insert into aryl acetate C-O bonds, Garg and co-workers 
demonstrated that bromopivalate 1.10 can serve as a lynchpin reagent where the first and 
second couplings are differentiated by the identity of the catalytic metal (Scheme 1.9).26 
Although many important molecules lend themselves to a synthesis approach based on 
lynchpin reagents, the lynchpin approach cannot be used as an iterative coupling strategy 
that can be turned over a theoretically limitless number of times. 
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Scheme 1.8. The difference in reactivity of a C-Br and C-Cl bond towards oxidative addition was exploited 
by Hii and coworkers in the synthesis of several triaryl compounds. 
 
 
Scheme 1.9. Garg and coworkers demonstrated that the identity of the catalytic metal (Pd or Ni) used in a 
SMC reaction can be used to differentiate the functionality of a lynchpin reagent.  
 
 Iterative coupling is herein distinguished from the use of lynchpin reagents in the 
fact that with this approach, in theory, a limitless number of iterations are possible. 
Instead of employing an approach in which the termini of a building block are 
differentiated by selective activation, in iterative coupling the termini of a bifunctional 
building block are differentiated by chemically masking one of the two functionalities in 
order to render it unreactive. When the proper masking group is employed the 
differentiation potential can be expected to remain very high regardless of the identity of 
the building block. Following the coupling of the building blocks, in a separate chemical 
step the masking group is removed to expose the otherwise latent functionality. Because 
the conditions of the unmasking step are orthogonal to the conditions of the coupling step, 
in theory the reaction conditions used in the first coupling step will remain applicable to 
any of the following coupling steps. That is, unlike coupling reactions which employ 
lynchpin reagents, in iterative coupling the conditions used to promote the coupling of 
each new building block can, in theory, be identical. The scope of substrates which are 
amenable to an iterative synthesis approach is determined by the generality of the 
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coupling reaction, the availability of building blocks, the mildness of the coupling and 
deprotection steps, and the stability of the chemical intermediates and products. 
 
The potential for a general approach to small molecule synthesis 
 This dissertation began with the hypothesis that the inherent modularity in small 
molecules remains largely underutilized, and that a unified strategy for the construction 
of these compounds through the iterative coupling of bifunctional building blocks might 
be possible. In the idealized form of this “iterative cross-coupling” (ICC) approach, 
building blocks having all of the required functional groups preinstalled in the correct 
oxidation states and with the desired stereochemical relationships would be iteratively 
united using only stereospecific cross-coupling reactions (Scheme 1.10). Towards this 
end, the Suzuki-Miyaura cross-coupling (SMC) reaction28 between an organohalide and a 
boronic acid represents an efficient, functional group tolerant, stereospecific, and 
increasingly general method for C–C bond formation in complex molecule synthesis,29 
and thus was selected as the principal reaction on which to base the ICC platform. Our 
envisioned ICC approach was based on the use of bifunctional building blocks containing 
both of the functionalities that are reactive under SMC conditions: a halide and a boronic 
acid. In order to avoid undesired random oligomerization, realizing this ICC approach 
required the discovery of a means to reversibly attenuate the reactivity of either the halide 
or the boronic acid under SMC conditions. 
 
 
Scheme 1.10. Similar to the approach used in the iterative synthesis of peptides, we envisioned an iterative 
strategy for the synthesis of small molecules. This strategy would be based on the iterative cross-coupling 
(ICC) of bifunctional haloboronic acids via the Suzuki-Miyaura reaction. Realizing this approach required 
the discovery of a ligand with the capacity to reversibly attenuate the reactivity of a boronic acid. 
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 In order to realize the ICC approach in the context of complex small molecule 
synthesis, it was critical to achieve boronic acid or halide unmasking under mild 
conditions that would be compatible with sensitive building blocks. Although there are 
methods for generating halides and pseudo-halides from functional groups that are inert 
to SMC conditions, this approach was less preferred because the conditions used in these 
transformations are relatively harsh and/or the reactions are limited in generality. 30 
Alternatively, the reactivity of a boronic acid can be modulated by exchanging the OH 
groups on boron for other chemical moieties.31 Further, the reactivity of boron towards 
ligand substitution is a general and well studied phenomenon.32 However, at the onset of 
our work there were no reports of a ligand for boronic acids with the capacity to attenuate 
reactivity under SMC conditions and be cleaved to liberate a reactive boronic acid under 
conditions mild enough to be generally compatible with complex molecule synthesis. 
 Boronic acids and boronic esters are preferred reagents for cross-coupling 
reactions due to the low toxicity of boranes and their associated byproducts,31 the 
relatively good stability of boronic acids/esters versus organomagnesium 33  and 
organozinc reagents34 and the relatively mild conditions required to activate boranes 
towards cross-coupling.22 However, some boronic acids/esters are inherently unstable to 
storage and/or the conditions of the SMC reaction. With the goal of maximizing the 
generality of the ICC approach, it would be desirable that even these unstable reagents 
could be utilized efficiently in a SMC reaction. A ligand with the capacity to attenuate the 
reactivity of boron under SMC conditions might also possess the capacity to attenuate the 
reactivity of the borane towards oxidation and protodeboronation processes. In this case, 
these “protected” boranes might serve as easily stored and handled surrogates for 
otherwise unstable boronic acids. 35  Achieving this surrogate therefore constituted a 
second goal. 
 Another important factor in the generality of the ICC approach is the efficiency 
with which complex building blocks can be accessed. The synthesis of complex boronic 
acids is generally limited by the incompatibility of common reagents with this functional 
group35 and/or the problematic isolation of complex boranes in multistep synthesis.31,36 
Further, many of the methods used for installing boron suffer from limited functional 
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group compatibility.31 Therefore, a third goal in the development of ICC would be to 
discover a more efficient approach to accessing complex boronic acids. 
 As our ultimate objective, we hoped that discoveries made in the development of 
the ICC approach might allow this process to be translated to an automated platform. 
Realizing the goal of automated iterative cross-coupling would be more readily achieved 
if the chemical steps involved in the ICC approach remained general and technically 
simple. Additionally, realizing an automated ICC approach would require the 
development of an automated synthesis machine which might require additional chemical, 
engineering and software development. 
 
1-2 THE TRANSMETALLATION STEP OF THE SUZUKI-MIYAURA CROSS-
COUPLING REACTION 
 To enable our vision of a general ICC approach to small molecule synthesis we 
would need to discover a ligand for boronic acids with the capacity to reversibly attenuate 
the reactivity of boron under SMC reaction conditions. As a framework for developing a 
hypothesis on how such a ligand might function, it is instructive to consider the 
mechanism of the SMC reaction,28 and specifically the mechanism of the transmetallation 
step. The catalytic cycle of the SMC reaction can most simply be understood as a series 
of three general steps: oxidative addition, transmetallation and reductive elimination 
(Scheme 1.11). In the first step, a Pd(0) species undergoes oxidative addition with the C-
X bond of an organo-halide or organo-pseudo-halide (OTf, OMs, OTs)37 to furnish a 
Pd(II) intermediate containing as anionic ligands the halide/pseudo-halide and the organic 
group originally appended to the halide/pseudo-halide. The rate of oxidative addition is 
affected by the identity of the halide/pseudo-halide, and follows the general trend: I > 
OTf > Br >> Cl and OTf > OTs ~ OMs, although there are exceptions to this trend.38 
Additionally, the rate of oxidative addition is generally faster for electron-deficient 
organo-halides/pseudo-halides than for electron-rich organo-halide/pseudo-halides.  
 Following oxidative addition, an activated organoborane species undergoes 
transmetallation with the Pd(II) species. There are several mechanistic pathways that are 
possible for the transmetallation step, and the specifics of these mechanisms will be 
discussed below. Regardless of the details of this step, the overall effect is that the halide 
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on Pd(II) is replaced by the organic group originally bonded to boron. In the final step the 
two organic ligands on Pd(II), in cis-relationship, undergo a reductive elimination process 
in which the product is formed and a Pd(0) species is regenerated, thereby allowing the 
catalytic cycle to turnover. Oxidative addition, transmetallation and reductive elimination, 
are typically faster for aryl and vinyl organic groups (containing terminal sp2-hybridized 
carbons) than for alkyl groups (containing terminal sp3-hybridized carbons), and this 
phenomenon has an effect on the substrate scope of the SMC reaction and in cross-
coupling reactions in general. Byproducts from the SMC catalytic cycle are a 
halide/pseudo-halide salt and a borane, typically boric acid, both of which are generally 
non-toxic. 
 
 
Scheme 1.11 The catalytic cycle of the SMC reaction involves three steps: oxidative addition, 
transmetallation, and reductive elimination. 
 
The transmetallation step of the SMC mechanism is complex and, relative to 
oxidative addition and reductive elimination, remains poorly understood. Current data 
suggest that transmetallation between Pd(II) and a boronic acid/ester proceeds via either 
of two mechanistic pathways (Scheme 1.12).28, 39,40,41,42 As an exception, it is known that 
tetraphenylborate salts undergo transmetallation without added base.28a Additionally, 
anionic triol-complexed boronates undergo transmetallation with Pd(II) without added 
base.43,44 In pathway A (Scheme 1.12), an electronically activated boron “ate” complex is 
formed via the coordination of hydroxide or alkoxide with a neutral boronic acid.28 
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Displacement of the halide of the Pd(II) intermediate is proposed to occur via an SE2 
mechanism leading to transition state C (Scheme 1.12).45 Although the formation of a 
boron “ate” complex is supported by numerous experimental observations,28 and most 
recently by the isolation and characterization of discrete boron “ate” complexes,46 direct 
experimental evidence for this mechanism has remained elusive.  
 
 
Scheme 1.12. Transmetallation between Pd(II) and a boronic acid is proposed to proceed via either of two 
mechanistic pathways. 
 
In pathway B (Scheme 1.12), an oxygen atom on a ligand bound to Pd(II) is 
proposed to coordinate to a neutral boron species via donation of oxygen lone pair 
electron density into the boron p-orbital. In support of this mechanism, boronic esters 
have been demonstrated to undergo transmetalation to an (alkoxo)palladium(II) 
intermediate without added base, whereas transmetalation to a (chloro)palladium(II) 
intermediate under the same conditions did not occur (Scheme 1.13).47 Further, a boronic 
acid has been shown to undergo transmetalation with a (hydroxo)palladium(II) 
intermediate in the absence of base (Scheme 1.14).40 Recent DFT calculations support a 
mechanistic pathway from a (hydroxo)palladium(II) intermediate to transition state C 
(Scheme 1.12).45 In this study a pathway from a (bromo)palladium(II) intermediate to a 
(hydroxo)palladium(II) intermediate was not located. However, the formation of a 
(hydroxo)palladium(II) intermediate under mock catalytic conditions (Pd(PPh3)4:PhBr 
1:49) has been observed by Matos and Soderquist.39 With regard to our goal of 
attenuating boronic acid reactivity, the most important lesson derived from these studies 
is that both pathways A and B necessitate a vacant and Lewis-acidic p-orbital on boron 
(Scheme 1.12). 
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Scheme 1.13. Transmetalation of a boronic ester to a (chloro)palladium(II) intermediate does not proceed, 
while transmetalation of a boronic ester to an (alkoxo)palladium(II) intermediate occurs without added 
base.47 
 
 
Scheme 1.14. Transmetalation of a boronic acid to a (hydroxo)palladium(II) intermediate occurs in the 
absence of base.40 
 
 
1-3 ATTENUATING THE REACTIVITY OF BORONIC ACIDS VIA REDUCTION 
OF THE LEWIS ACIDITY OF THE BORON P-ORBITAL 
 Bidentate ligands that contain strongly electron-donating heteroatoms bonded to 
boron are known to attenuate the cross-coupling of organoboron compounds.39,40 This is 
presumably due to conjugation of the lone pair electron density on the heteroatoms of 
these ligands to the empty p-orbital on boron, which in turn reduces the Lewis acidity of 
the boron center. In the first example that harnesses this effect, Soderquist and co-
workers demonstrated a large difference in reactivity between a 9-BBN borane and an 
oxo-9-BBN borane, with the latter possessing an electron-donating heteroatom (Scheme 
1.15).39 Also harnessing this effect, a few examples of selective cross-coupling of 
bifunctional building blocks possessing both a halide and a boron-containing functional 
group have been reported. Deng, Mayeux, and Cai achieved the selective cross-coupling 
of an aryl iodide with an aryl boronic acid in the presence of an aryl pinacol boronic ester 
(Scheme 1.16), 48  and Hohn and Pietruszka reported the selective coupling of a 
cyclopropyl iodide with a boronic acid in the presence of a boronic ester (Scheme 
1.17.).49 Contemporaneous with our studies, Suginome and co-workers introduced the 
1,8-diaminonapthalene (dan) ligand as a protecting group for boronic acids 50  and 
demonstrated its use in the iterative synthesis of a collection of polyarene compounds 
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(Scheme 1.8).50a Similar to the ICC approach discussed herein, the Suginome approach 
utilizes bifunctional haloboronic acid building blocks in which the reactivity of the boron 
functionality is masked via complexation with a ligand, in this case 1,8-
diaminonapthalene. However, due to the strong boron-heteroatom bonds of these and 
related boronic esters, hydrolysis these bonds typically requires relatively harsh 
conditions which may be incompatible with complex small molecule synthesis. For 
example, the 1,8-diaminonapthalene ligand is typically cleaved upon treating at room 
temperature with aqueous 5 M HCl for 5 hours or aqueous 2 M  H2SO4 for 10-27 
hours.50a-b Cleavage of the pinacol ligand typically requires acid and/or an oxidant such 
as NaIO4.51,52 
 
Bhexyl Bbutyl
O
+
1.0 eq.1.0 eq.
Br
Pd(PPh3)4
NaOH, THF
butylhexyl +
86% yield 0% yield
0.8 eq.
Bbutyl Bhexyl
O
+
1.0 eq.1.0 eq.
Br
Pd(PPh3)4
NaOH, THF
hexylbutyl +
84% yield 0% yield
0.8 eq.
(A)
(B)
 
Scheme 1.15. (A) A 9-BBN borane was found to be much more reactive than a related oxo-9-BBN borane 
under SMC conditions. (B) It was demonstrated that difference in the organic group on boron does not 
account for this difference in reactivity. 
 
 
Scheme 1.16. Deng and co-workers have described a selective SMC reaction between an aryl boronic acid 
and an aryl iodide in the presence of a pinacol boronic.  
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Scheme 1.17. Hohn and Pietruszka have reported a selective SMC reaction between a cyclopropyl iodide 
and a boronic acid that occurs selectively in the presence of a sterically encumbered boronic ester.  
 
 
Scheme 1.18. Contemporaneous with our studies, Suginome and co-workers reported an ICC approach 
utilizing bifunctional haloboronic acids in which the reactivity of the boron functionality is reversibly 
attenuated via complexation with 1,8-diaminonapthalene (dan). The conditions required to remove the dan 
ligand from boron are relatively harsh and to date this methodology has only been applied in the synthesis 
of robust polyarene and polystyrene products. 
  
1-4 ATTENUATING THE REACTIVITY OF BORONIC ACIDS VIA 
PYRAMIDALIZATION AT THE BORON CENTER 
 The work described herein was based on the hypothesis that boronic acid 
reactivity could alternatively be attenuated by rehybridization of a boron center from sp2 
to sp3 via complexation with a heteroatomic, tridentate ligand. In theory, an sp3-
hybridized boronate complex lacking a p-orbital on boron would be unreactive under 
SMC conditions. Importantly, it was known that the boron-heteroatom bonds in such 
complexes are weaker that those found in their sp2-hybridized counterparts. For example, 
the E(B-O) of the complex NH3•Me2BOH is estimated to be 11 kcal/mol weaker than in 
that of Me2BOH.53 Thus, we reasoned that it might be possible to cleave the ligand to 
regenerate the boronic acid under mild conditions. 
 In order to test our hypothesis, we would need to be able to access a stable, sp3-
hybridized boronate. Fortunately, the synthesis and characterization of sp3-hybridized 
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organoboronates has been a rich area of study32 and there was a significant amount of 
precedent to inform our endeavors in the synthesis of boronate complexes. A particularly 
intriguing report by Mancilla, Contreras and Wrackmeyer described boronates derived 
from the condensation of boronic acids with the ligand N-methyliminodiacetic acid 
(MIDA) (Scheme 1.19).54 In this report 1H-NMR studies were performed that indicated 
that these complexes are sp3 hybridized and quite stable.54 To us, this unique structure 
raised intriguing questions as to its potential lack of reactivity under SMC conditions. 
However, reports on the reactivity of these interesting boronate compounds were limited 
to descriptions detailing the derivatization of the ligand itself.55 Most studies in this area 
had been directed towards the synthesis and characterization of new derivatives of these 
boronates for potential applications in boron-neutron capture therapy to treat brain tumors 
and melanomas.55,56 Therefore, the chemistry of this class of stable, neutral boronate 
species remained largely unexplored. 
 
 
Scheme 1.19. Studies by Mancilla, Contreras and Wrackmeyer demonstrated that condensation of boronic 
acids with N-methyliminodiacetic acid (MIDA) affords isolable boronate complexes that are sp3-hybridized 
at the boron center. 
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CHAPTER 2 
ITERATIVE CROSS-COUPLING WITH B-PROTECTED HALOBORONIC ACID 
BUILDING BLOCKS 
 
Eric P. Gillis, Steven G. Ballmer, and Martin D. Burke 
 
 Realizing a general iterative cross-coupling (ICC) approach to the synthesis of 
complex small molecules required the discovery of a ligand with the capacity to attenuate 
the reactivity of boronic acids under Suzuki-Miyaura cross-coupling (SMC) conditions 
and then liberate this masked reactivity under mild conditions. This chapter describes the 
study and selection of a ligand with such a capacity, N-methyliminodiacetic acid (MIDA). 
It was found that condensation of MIDA with boronic acids affords sp3-hybridized MIDA 
boronate esters which are crystalline solids that are generally stable to SiO2 
chromatography and storage under ambient air at room temperature. Further, and 
irrespective of the organic group appended to boron, it was found that MIDA boronates 
are inert to the conditions of anhydrous SMC reactions, yet are converted to the 
corresponding boronic acid using mild aqueous base. The applicability of ICC to 
complex molecule synthesis was tested in the first total synthesis of the natural product 
ratanhine. Subsequent studies indicate that the ICC methodology is applicable to multi-
gram scale synthesis. Steven G. Ballmer contributed to the work presented in this chapter 
by performing the experiments described in Scheme 2.11. 
 
Adapted from Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2007, 129, 6716-6717; Gillis, E.; Burke, M. D. 
J. Am. Chem. Soc. 2008, 130, 14084-14085; and Ballmer, S. G.; Gillis, E. P.; Burke, M. D. Org. Synth. 
2009, 86, 344-359.  
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2-1 BACKGROUND 
 When I joined Professor Martin Burke’s research group during my first year at the 
University of Illinois, Champaign-Urbana in August 2005, he suggested that I investigate 
the potential of using the ligand N-methyliminodiacetic acid (MIDA) (2.1a, Figure 2.1) to 
attenuate the reactivity of boronic acids under Suzuki-Miyaura cross-coupling (SMC) 
conditions. Pioneering studies by Mancilla, Contreras and Wrackmeyer 1  had 
demonstrated that this ligand, when condensed with boronic acids under Dean-Stark 
dehydration conditions, forms an isolable boron-containing complex (Figure 2.1). 2 
Further, it was shown through variable-temperature 1H-NMR studies that these 
complexes are sp3 hybridized with a B-N bond strength of >20 kcal/mol.1 Despite 
numerous reports on the synthesis of derivatives of these boronates,3 the reactivity of this 
class of borane remained unknown. In fact, very little was known about the reactivity of 
neutral sp3-hybridized boronates in general other than reactions involved in the formation 
and solvolysis of these compounds.2 Therefore, boronates based on the MIDA ligand and 
its derivatives appeared to present a foundation on which to test our two hypotheses: that 
neutral sp3-hybridized boronates will not undergo transmetallation with Pd(II), and that 
regenerating the boronic acid from an sp3-hybridized boronate will be possible under 
mild conditions. 
 
Figure 2.1. Studies by Mancilla, Contreras and Wrackmeyer demonstrated that condensation of boronic 
acids with N-methyliminodiacetic acid (MIDA) affords isolable boronate complexes that are sp3-hybridized 
at the boron center. 
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2-2 DISCOVERY THAT MIDA ATTENUATES THE REACTIVITY OF BORONIC 
ACIDS 
 To test the hypothesis that sp3-hybridized boronate esters would be inert to cross-
coupling we prepared a collection of boronate esters and evaluated their reactivity under 
SMC conditions. As a first step towards accessing a diverse collection of boronate esters, 
a collection of tridentate ligands representing a variety of structural motifs was gathered 
(Figure 2.2). Ligands 2.1a, 2.1b, 2.1f, and 2.1g were purchased from commercial sources, 
ligands 2.1c, 2.1d, 2.1e, and 2.1h were prepared by the general route shown in Scheme 
2.1,4 and ligand 2.1i5 was prepared in three steps from 2-chloroanisole (Scheme 2.2). 
Next, ligands 2.1a–2.1i were condensed under Dean-Stark conditions with p-tolylboronic 
acid (2.2) to afford boronates 2.3a–2.3i (Scheme 2.3).1,5 Remarkably, boronates 2.3a, 
2.3c, 2.3d and 2.3h were all completely stable to standard SiO2 chromatography. To the 
best of our knowledge, the stability of this class of boronate to SiO2 was previously 
unknown.1,3 Complexation of 2.2 with 2.1e was not successful, likely due to the weak 
Lewis-basic character of the aniline nitrogen. All of the boronates accessed in Scheme 
2.3 were found to have good solubility in THF with the exceptions of 2.3b, which did not 
fully dissolve even in DMF at a 0.05 M concentration. 
 
 
Figure 2.2. A collection of trivalent ligands for boron. 
 
Scheme 2.1. A general route to iminodiacetic acid derivatives. Treatment with BaCl2 results in the selective 
precipitation of the tridentate ligand as the barium chelate. Hydrolysis of the chelate with H2SO4 affords the 
water soluble product which is readily separated from the water-insoluble BaSO4 byproduct. 
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Scheme 2.2. Synthesis of a diphenolamine ligand for boron. 
 
 
Scheme 2.3. sp3-hybridized boronates were prepared via Dean-Stark condensation of p-tolylboronic acid 
with ligands 2.1a–2.1i. 
 
 To test the hypothesis that boron pyramidalization will inhibit cross-coupling, one 
equivalent of boronate 2.3a and one equivalent of boronic acid 2.4 were allowed to react 
with a limiting quantity of p-bromobenzaldehyde (2.5) under anhydrous 6  SMC 
conditions7 (Table 2.1). In this experiment a 24:1.0 ratio of biaryls 2.6 and 2.7 was 
observed, consistent with strong preferential reactivity with the sp2-hybridized boronic 
acid 2.4 (entry 1). The control experiment with 2.2 yielded a 1.0:1.0 mixture of products 
(entry 2). Sterically bulky N-alkyl substitution was tolerated but not significantly 
advantageous (entries 3 and 4). Interestingly, diethanolamine adduct 2.3f, for which 
related structures have been shown to be sp3-hybridized but also less conformationally 
rigid than their iminodiacetic acid counterparts,8 demonstrated no selectivity (entry 5). 
When the SMC experiment was repeated employing 2.3f and 2.4, but in the absence of 
2.5, 1H-NMR analysis of the final reaction solution demonstrated no change in 
composition of 2.3f, indicating that the reactivity of 2.3f is not due to cleavage of the 
diethanolamine ligand under SMC conditions. Proline-derived boronate 2.3h 
demonstrated similar reactivity to 2.3a (entry 6). Boronate 2.3i showed low selectivity 
possibly due to the low basicity of the aniline nitrogen (entry 7). In a related study, 1-
butenyl boronic acid was complexed with ligands 2.1a–2.1g, and the resulting boronates 
were evaluated in a SMC competition experiment similar to that described in Table 2.1. 
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Specifically, in each case one equivalent of the boronate and one equivalent of E-
propenyl boronic acid were allowed to react with a limiting one equivalent of β-
bromostyrene under SMC conditions employing Pd(OAc)2:John-Phos and K3PO4 in THF 
at room temperature for 12 hours. In all cases the results obtained in this study were 
similar to those described in Table 2.1. Prior to these studies, to the best of our 
knowledge, this type of reactivity attenuation with neutral, sp3-hybridized boronate esters 
was unknown. Owing to the structural simplicity and commercial availability of MIDA, 
the attractive physical properties of MIDA boronates, and the effectiveness of the ligand 
to attenuate the reactivity of boronic acids, the MIDA ligand was selected for further 
studies.9,10 
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Table 2.1 
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2-3 MECHANISTIC UNDERPINNINGS OF MIDA BORONATE REACTIVITY 
 To gain understanding on the dramatic difference in reactivity for the structurally 
related MIDA (2.3a) and N-methyldiethanolamine (2.3f)  adducts, we carried out single 
crystal X-ray analysis on the related boronates 2.8a and 2.8b11 which revealed no major 
differences in bond lengths, bond angles, or tetrahedral character12 at the boron centers 
(Table 2.2). In contrast, and consistent with studies of related complexes,1,8,13 variable 
temperature 1H-NMR analysis of a solution of 2.8b in d6-DSMO revealed coalescence of 
the diastereotopic methylene protons of the diethanolamine backbone upon heating from 
23 °C to 60 °C (Figure 2.3A); the same experiment with MIDA boronate 2.8a indicated 
no coalescence, even upon heating to 150 °C (Figure 2.3B). These data are consistent 
with the conclusion that the N→B bond in 2.8b is dynamic which renders the boron p-
orbital and nitrogen lone-pair susceptible to reactivity, whereas for boronate 2.3a these 
potentially reactive sites are kinetically inaccessible even at high temperature. 
Table 2.2. 
Bond  
distance (Å) 
2.8a 2.8b 
B1-N1 1.667 1.688 
B1-O1 1.476 1.442 
B1-O2 1.475 1.467 
B1-C6 1.578 1.590 
   
Bond angle (o) 2.8a 2.8b 
C6-B1-N1 114.7 115.0 
C6-B1-O1 115.1 112.4 
C6-B1-O2 113.4 112.4 
N1-B1-O1 100.8 101.1 
N1-B1-O2 101.9 100.1 
O1-B1-O2 109.5 114.9 
   
 
 
 
 
 
THC (%)12 65.6 61.7 
HO
2.8a
MeN
O
OB
O
O
HO
2.8b
MeN
O
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Figure 2.3. (A) The 1H-NMR spectrum of diethanolamine adduct 2.8b at 60 °C demonstrates full 
coalescence of the methylene proton resonances indicating that the boronate is fluxional at this temperature. 
(B) The 1H-NMR spectra of MIDA boronate 2.8a at 23 °C and 150 °C are the same, indicating that the 
MIDA boronate is conformationally rigid even at high temperature. 
 
 To probe the physical organic underpinnings which contribute to the observed 
difference in conformational rigidity of 2.8a and 2.8b (and as a corollary, 2.3a and 2.3f), 
we collaborated with Professor Kendall Houk and Dr. Paul Cheong to study these 
compounds using computer modeling.14 In some regards, the difficulty in modeling the 
N→B dative bond15 restricted the nature of these studies. However, preliminary studies 
shed light on an important interaction: the lone pair electrons of the oxygen atoms of the 
diethanolamine ligand have a strong interaction with the B–N σ* orbital of the boronate 
23 °C 60 °C
O
OBR NMe
MeN
O
OB
R
MeN
O
OB
HO 12
23 °C 150 ºC 
O
OBR NMe
O
O
MeN
O
OB
O
O
R
MeN
O
OB
O
O
HO 3
(A) 
(B) 
Reproduced with permission from Gillis, E.; Burke, M. D. J. Am. Chem. Soc. 2008, 130, 14084-14085. 
Copyright 2008 American Chemical Society. 
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(Figure 2.4). This interaction should lead to a weakening of the N→B bond. This 
interaction is substantially reduced in the case of the MIDA boronate due to the electron 
withdrawing capacity of the adjacent carbonyl functionality. Interestingly, computational 
studies also suggest that the magnitude of the resonance contribution of the MIDA 
boronate N→B dative bond to adjacent unsaturated systems is greater than 
hyperconjugation of a σ-bond but is weaker than the resonance contribution of a π-bond. 
Collectively, these studies and literature precedents1,8 indicate that the difference in 
reactivity of MIDA boronates and diethanolamine adducts is due to a difference in the 
conformational rigidity of these boronates. These results also have implications for the 
chemistry described in chapter 4.  
 
 
Figure 2.4. (A) Computer modeling suggests that lone pair electron density of the oxygen atoms of the 
diethanolamine ligand strongly interacts with the B–N σ* orbital. (B) This interaction is substantially 
reduced in the case of the MIDA boronate. 
 
2-4 DEPROTECTION OF MIDA BORONATES UNDER MILD CONDITIONS 
 The generality of an ICC strategy depends critically on the ability to transform the 
latent functional group of a bifunctional building block into a reactive form under mild 
conditions. Because boron-heteroatom bonds in sp3-hybridized complexes are predicted 
to be approximately 11 kcal/mol weaker than those in the corresponding sp2 species,16 we 
hypothesized that it might be possible to remove the ligand on boron under relatively 
mild conditions; this in fact was a principal consideration in our approach towards 
attenuating the reactivity of a boronic acid via a hybridization state change. To test this 
hypothesis, in a preliminary study a number of bases were screened in the conversion of 
MIDA boronate 2.9 to boronic acid 2.10 (Table 2.3). Weak bases were moderately 
effective (entries 1, 2, 3, and 5) but in the absence of bulk water or alcohol little 
(A) (B) 
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conversion was observed (entries 4 and 5). On the other hand, the use of strong bases led 
to full conversion within one hour (entries 7, 8, 9, 10). Interestingly, the observation of 
slow hydrolysis with weak bases would become important in developing the slow-release 
protocol (chapter 3). The stability of MIDA boronates to anhydrous conditions, as was 
indicated in earlier sections, was also determined through this initial screen. 
Table 2.3 
n-Bu
MeN
O
OB
O
O
Base ROH % 2.10, t = 1 h
THF:ROH (1:1), 23 oC
base
a a% 2.10, t = 24 hEntry
NaHCO3
K2CO3
NaOH
KOH
Na2CO3
NaOEt
KOt-Bu
H2O
H2O
H2O
K3PO4
K2CO3
K3PO4
None
H2O
None
H2O
H2O
EtOH
t-BuOH
1
2
3
4
5
6
7
8
9
10
< 5%
< 5%
< 5%
< 5%
< 5%
< 5%
100%
~ 25%
~ 25%
~ 25%
~ 25%
< 5%
< 5%
100%
100%
100%
100%
100%
100% 100%
a Estimated based on TLC
n-Bu
B(OH)2
2.9 2.10
 
 
 Based on these initial qualitative results, a series of follow-up experiments on the 
hydrolysis of MIDA boronates were performed. From these studies two mild and 
effective deprotection conditions were identified (Scheme 2.4). Specifically, it was 
discovered that treatment of a THF solution of 2.3a with aqueous NaOH (1 M) led to 
complete conversion to boronic acid 2.2 in just 10 minutes at room temperature. Further, 
it was determined that 2.3a could be efficiently converted to 2.2 at room temperature in 
six hours by employing the mild conditions of aq. NaHCO3/MeOH. In this second 
transformation the use of MeOH was critical, presumably because a significant amount of 
aqueous base is dissolved in the organic phase, but also possibly because the alcohol 
catalyses the process through a methyl boronic ester intermediate. On the other hand, 
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when MIDA boronates are dissolved in EtOAc, acetone:EtOAc, THF, dioxane, CH2Cl2 
or other similar solvents, the rate of aq. NaHCO3-promoted hydrolysis at room 
temperature is negligible over the course of one hour to the point that these systems can 
be generally used for aqueous workups of MIDA boronate products (chapter 4). 
 Bulk water or alcoholic solvents, even in the absence of base, appear to slowly 
hydrolyze MIDA boronates to the corresponding boronic acid over the course of 24 hours, 
although studies on these processes are limited. Under normal handling and storage 
practices atmospheric moisture does not lead to any observable hydrolysis of MIDA 
boronates. This phenomenon was studied quantitatively in the context of slow-release 
cross-coupling (chapter 3). Further, at least one equivalent of water appears to be 
tolerated by the MIDA boronate functional group even under SMC conditions in the 
presence of K3PO4 at 60 °C for 18 h.17 
 
 
Scheme 2.4. Complimentary mild conditions for the hydrolysis of MIDA boronates to the corresponding 
boronic acid. 
 
2-5 BORON-PROTECTED HALOBORONIC ACID BUILDING BLOCKS 
 Building on the promising results of the early studies, we next sought to prepare a 
collection of Boron-protected haloboronic acid bifunctional building blocks in order to 
test these reagents in the context of ICC. The MIDA ligand was selected for this purpose 
due to its commercial availability, the ease with which MIDA boronates can be accessed, 
and the favorable properties of the resulting MIDA boronate esters: highly attenuated 
reactivity under SMC reaction conditions, mild conversion of the boronate to the boronic 
acid, stability to SiO2 chromatography, and stability to storage under ambient atmosphere 
at room temperature. Towards this end, a variety of haloboronic acids were complexed 
with MIDA to yield a series of B-protected bifunctional building blocks (Scheme 2.5). 
All three positional isomers of bromophenyl boronic acid as well as the heteroaromatic 5-
 34
bromothiopheneboronic acid reacted cleanly to generate 2.12a–2.12d in excellent yields. 
The same complexation conditions yielded vinyl and alkyl boronate esters 2.12e and 
2.12f in high yields. Further, boronates 2.12a, 2.12b, 2.12c, 2.12d, and 2.12f were 
isolated as analytically pure, colorless, crystalline solids after a single SiO2 
chromatographic step. MIDA boronates 2.12a–2.12f and were also found to be 
completely stable to storage at room temperature under ambient atmosphere. The stability 
of MIDA boronates to SiO2 chromatography and storage has since proved to be a general 
phenomenon and should be assumed for all MIDA boronates discussed in this 
dissertation unless explicitly stated otherwise. 
 
Scheme 2.5. A collection of aryl, heteroaryl, vinyl and alkyl boronates was prepared by condensing the 
corresponding boronic acid with the MIDA ligand under Dean-Stark conditions. 
 
 The potential of the MIDA ligand to enable selective cross-couplings was probed 
by allowing each of 2.12a–2.12f to react with p-tolylboronic acid (Table 2.4). Although 
the reactivity of aryl, heteroaryl, vinyl, and alkyl boronic acids can vary dramatically,18 
the MIDA ligand was effective for all four classes of nucleophiles, yielding selective 
cross-coupling products 2.13a–2.13f. All four classes of nucleophiles were also 
efficiently deprotected under the standard aqueous basic conditions (1 M aqueous 
NaOH:THF, 23 °C, 10 min). The pure boronic acids 2.14a–2.14f were isolated simply by 
neutralizing the aqueous phase with pH 7.0 phosphate buffer, partitioning the phases, and 
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then concentrating the organic phase in vacuo. Aqueous NaHCO3:MeOH was also 
effective (entry 3). The generally effective cross-coupling of 2.12a–2.12f and subsequent 
deprotection of 2.13a–2.13f represents a realization of the two steps of an ICC sequence. 
At this point we sought to investigate whether ICC could be used in the synthesis of a 
small molecule natural product. 
Table 2.4 
Protected product
1M aq. NaOH
Entry
1
2
3
MeN
O
OB
O
Op-Tol THF, 23 oC
2.12e
2.12a
2.12b
2.12c
p-Tol
( ) 2.14f
p-Tol
2.12f6
5
87 86
92
97
82 83
94 91
2.14e
p-Tol
B(OH)2
B(OH)2
B(OH)2
% Yield Deprotected product % Yield
p-Tol
( ) 2.13f
p-Tol
2.13e
p-Tol
MeN
O
OB
O
O
MeN
O
OB
O
O
MeN
O
OB
O
O
Pd(OAc)2
2.12d4
2.13 2.14
Sp-Tol
MeN
O
OB
O
O Sp-Tol B(OH)2
2.13a (para)
2.13b (meta)
2.13c (ortho)
2.13d 2.14d
81 88
85
80
2.14a (para)
2.14b (meta)
2.14c (ortho)
2.12
10 min
B-Deprotection was achieved via treatment with saturated aq. NaHCO3/MeOH, 23 oC, 6 h, (85%).
p-Tol-B(OH)2
B(OH)2p-Tol
MeN
O
OB
O
OBr
2.12 K3PO4
THF, 65 oC
b
b
c S-Phos was used instead of Cy-JohnPhos.
c
a
a The same yield was observed whether this reaction was set up in the glovebox or under air.
Cy-JohnPhos
Reproduced with permission from Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2007, 129, 6716-6717. Copyright 2007
American Chemical Society.
 
 
2-6 ITERATIVE CROSS-COUPLING IN THE SYNTHESIS OF RATANHINE 
 To test the hypothesis that ICC could be used as the basis for the synthesis of a 
small molecule natural product, we targeted the first total synthesis of the natural product 
ratanhine (2.15) (Scheme 2.6), the most complex member of a large family of neolignans 
isolated from Ratanhiae radix.19 Retrosynthetic fragmentation of 2.15 into four simpler 
building blocks (2.16–2.19) was achieved via recursive application of three SMC 
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transforms (Scheme 2.6). There were several challenges associated with this plan that 
were anticipated to provide rigorous tests for the new methodology. First, the initial SMC 
reaction would require the selective coupling of vinyl boronic acid 2.16 in the presence of 
aryl boronate 2.17. The cross-coupling of aryl boronic acids tends to be more facile than 
the that of their vinyl counterparts,18 making this coupling unsecured. In addition, 
heteroaryl boronic acids such as the deprotected analogue of 2.17 are known to be very 
sensitive to proto-deboronation.20 Moreover, cross-coupling with the highly electron-rich 
and sterically encumbered aryl bromide 2.18 was expected to require elevated 
temperatures and/or prolonged reaction times that would test the limits of stability for the 
MIDA ligand. 
  
Scheme 2.6. The natural product ratanhine was retrosynthetically fragmented via recursive SMC trans-
forms to identify four building blocks, two of which are bifunctional building blocks (2.17 and 2.18). 
 
Before the ICC synthesis of 2.15 could be attempted, access to building blocks 
2.16–2.19 needed to be secured. Propenylboronic acid (2.16) was purchased from Sigma 
Aldrich, but can now be efficiently accessed from propenylmagnesium bromide via the 
corresponding MIDA boronate (chapter 4). The synthesis of 2.17 was accomplished 
according to the synthetic route outlined in Scheme 2.7. Through modifications of a 
related Rap-Stoermer condensation,21 benzofuran 2.22 was synthesized in 77% overall 
yield from 2.20 and 2.21 and was then converted to boronic acid 2.23 following the 
literature procedure.22 Condensation of 2.23 with MIDA under Dean-Stark conditions 
afforded 2.17 in 90% yield as a colorless, crystalline solid that was stable to storage 
under ambient air at room temperature for at least eight months.  
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Scheme 2.7. Synthesis of building block 2.17. 
 
The synthesis of 2.18 was realized according to the route outlined in Scheme 2.8. 
The synthesis commenced with bromination of 3-methoxyphenol according to the 
literature procedure23 that afforded a mixture of isomers24 from which 2.24 was isolated 
in early runs via silica gel chromatography and later more efficiently via C18 reverse-
phase chromatography. Protection of phenol 2.24 as the corresponding MOM ether 2.25, 
followed by lithium-halogen exchange and trapping with iodine afforded aryl iodide 2.26. 
A more direct route to 2.26 via iodination of 3-methoxyphenol was not successful. 
Bromination of 2.26 with N-bromosuccinimide (NBS) in the presence of catalytic SiO2 
afforded 2.27. Selective Miyaura borylation25  of 2.27 followed by hydrolysis of the 
resulting boronic ester under aqueous basic conditions provided boronic acid 2.28. The 
related bis(pinacolato)diboron reagent was also effective in this transformation but 
hydrolysis of the pinacol ester to afford 2.28 was significantly more challenging. Silica 
gel chromatography of 2.28 proved problematic due to the partial instability of the 
boronic acid to SiO2. However, this problem was obviated by carrying 2.28 forward in 
crude form into a subsequent Dean-Stark condensation with MIDA. The resulting product 
was readily purified by silica gel chromatography to afford bifunctional building 2.18 as 
a colorless, crystalline solid. Concurrently, the synthesis of bromide 2.19 was achieved 
by Professor Martin Burke via the route outlined in Scheme 2.9. Halide 2.19 is stable to 
storage at -4 °C for at least one year. 
 
 38
 
Scheme 2.8. Synthesis of building block 2.18. 
 
 
Scheme 2.9. Synthesis of halide 2.19. 
 
With building blocks 2.16–2.19 in hand, the synthesis of ratanhine commenced 
with the selective SMC reaction between propenyl boronic acid 2.16 and haloboronate 
2.17 under anhydrous conditions to afford boronate 2.29 (Scheme 2.10). Applying the 
standard aqueous NaOH deprotection conditions afforded boronic acid 2.30 in 93% yield 
and excellent purity which was then carried forward into an anhydrous SMC reaction 
with the electronically rich and sterically encumbered aryl bromide 2.18. Focused 
screening of reaction conditions for this coupling indicated that high temperature (80 °C) 
and a prolonged reaction time (28 h) were ideal. Even under these relatively more forcing 
conditions the MIDA boronate functional group was found to be stable, allowing 
boronate 2.31 to be isolated in 73% yield. Treatment of 2.31 with aqueous NaOH under 
the standard conditions afforded boronic 2.32. However, boronic acid 2.32 proved to be 
especially unstable to isolation and decomposed immediately if concentrated in vacuo 
 39
from an acetonitrile solution at temperatures greater than 30 °C. Alternatively, the 
boronic acid was isolated free of solvent in 99% yield by performing at ˂ 30 °C cycles of 
coevaporation with toluene, then acetonitrile, and finally dichloromethane. Storage of 
2.32, and to a lesser degree 2.30, was found to be problematic, but could be conveniently 
avoided by generating 2.32 and 2.30 from the corresponding MIDA boronates 
immediately prior to use. A SMC reaction between 2.32 and 2.19 proceeded to only 60% 
conversion of the halide when 2% Pd loading was used due to significant deboronation of 
2.32 as a side reaction. Alternatively, when the Pd loading was increased to 4% full 
conversion of the halide and an 81% isolated yield of 2.33 was obtained. 
Treatment of 2.33 with concentrated aqueous hydrochloric acid in methanol at 
65 °C for 1 hour followed by C18 HPLC purification afforded the natural product 2.15 as 
an iridescent oil in 41% yield. The modest yield realized in the deprotection of 2.33 is 
consistent with the observation by HPLC of a considerable quantity of an unknown 
byproduct. Performing the deprotection step at room temperature instead of 65 °C led to a 
slower reaction rate but did not change the ratio of product to byproduct. Additionally, no 
improvement in the yield was found when the deprotection was performed with 
anhydrous HCl, camphorsulfonic acid (CSA), pyridinium p-toluenesulfonic acid (PPTS), 
trifluoroacetic acid (TFA), or trimethylsilyl iodide. Additionally, 2.15 was discovered to 
be unstable to chromatography with SiO2 or Florisil. At this point a lack of material 
prevented any further attempts at improving the yield of 2.33 to 2.15. The spectral 
properties of 2.15 as analyzed by 1H NMR, 13C NMR, HRMS, and IR were in agreement 
with the literature characterization for ratanhine, confirming the original structure 
proposed by Arnone and coworkers,19 and thus completing the first total synthesis of this 
natural product. More importantly, this synthesis represents, to the best of our knowledge, 
the first synthesis of a small molecule natural product in which only a single type of 
reaction is used to unite a pre-assembled collection of bifunctional building blocks. The 
inherent efficiency and flexibility of this approach has important implications for 
potential automation of small molecule synthesis. 
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Scheme 2.10. The synthesis of the neolignan natural product ratanhine was accomplished by employing an 
iterative cycle of SMC reactions to unit a collection of four building blocks. 
 
2-7 MULTI-GRAM SCALE APPLICATION OF ICC WITH MIDA BORONATES 
 MIDA boronates appear well suited to large scale synthetic applications due to the 
numerous favorable properties of these compounds. Unlike boronic acids which readily 
dehydrate to form waxy oligomeric boroxines,26 MIDA boronates are monomeric and 
therefore allow precise control of the stoichiometry of a reaction. MIDA boronates in 
general are highly crystalline solids, regardless of the organic group appended to the 
MIDA boronate functional group. 27  Although not routinely practiced in our early 
development of the MIDA boronate platform, we predicted that this property should 
allow MIDA boronates to be purified on a multi-gram scale simply via recrystallization, 
and further, should simplify their handling. Additionally, the stability of MIDA boronates 
to storage under ambient atmosphere at room temperature should facilitate the storage 
and transport of MIDA boronates on a multi-gram to kilo-gram scale. 
 To test the efficiency of each step in the ICC process upon scale-up, a 
complexation step, a selective SMC step, and a deprotection step were performed on a 
multi-gram scale (Scheme 2.11). First, 4-bromophenylboronic acid (2.11a, 25.0 g) was 
exposed to MIDA under Dean-Stark dehydration conditions (step A). Toluene was used 
in place of benzene to mitigate concerns with the toxicity of the solvent. Additionally, the 
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amount of DMSO used in the reaction was greatly reduced from the precedent ratios and 
thus allowed the product to be directly crystallized from the crude reaction solution to 
afford 4-bromophenyl MIDA boronate (2.12a) as an analytically pure material in 94% 
yield.28 By avoiding SiO2 purification, this procedure represents a process by which very 
large amounts of a MIDA boronate can be synthesized from the corresponding boronic 
acid.29 The bifunctional building block (25.0 g) was then engaged in an anhydrous SMC 
reaction with p-tolylboronic acid where the experiment was set up and executed with the 
avoidance of glove box manipulations (step B). The crude product was purified by 
aqueous workup followed by recrystallization from acetone:Et2O to provide MIDA 
boronate 2.13a in 77% yield. This product was then treated with aqueous NaOH 
following the standard procedure which, after simple partitioning of the aqueous and 
organic phases, afforded 4-(p-tolyl)-phenylboronic acid (2.14a) in 94% yield and in good 
purity30 (step C). These experiments indicate that all of the steps of an ICC sequence are 
amenable to multi-gram scale synthesis. All purifications were achieved through 
recrystallization or simple aqueous extraction, only standard manipulations following 
Schlenk technique were used, and no physical or chemical properties were observed that 
would indicate that these reactions could not be scaled further. 
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Scheme 2.11. Each step of the ICC cycle was evaluated in a multi-gram scale experiment. In all cases it 
was determined that the scale of the reaction does not impact the outcome of the step. Further, purification 
procedures were developed which avoided the use of SiO2 chromatography to allow the efficient 
purification of large amounts of material. 
 
 To further enable the development and use of MIDA boronates, we developed an 
improved synthesis of MIDA to provide practical access to this material in mulit-gram to 
kilo-gram quantities at a low cost. The original procedure as practiced in our laboratories 
was later improved upon with contributions from Steve Ballmer, Brice Uno, and Jenna 
Klubnick. Specifically, the optimized route to MIDA was based on methylation of the 
commodity chemical iminodiacetic acid using Eschweiler-Clarke conditions 
(formaldehyde/formic acid) (Scheme 2.12). 31  Tens of thousands of metric tons of 
iminodiacetic acid are produced each year as a starting material for herbicides, 
surfactants, and environmental chelating reagents,32 thus this starting material is very 
inexpensive. Additionally, all of the components of this reaction, including the MIDA 
ligand, are environmentally benign.33 From a technical standpoint the reaction is very 
efficient. The reaction is complete within two hours and is run at a very high 
concentration (3 M). The product is isolated and purified simply by diluting the aqueous 
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reaction solution with approximately six volume equivalents of acetone and filtering the 
resulting mixture. It was discovered that a colorless product is reliably obtained if the 
formalin is added to the reaction solution rather than if the formic acid is added to the 
reaction solution. Further, the highest quality material is obtained if the isolated solids are 
dried in a vacuum oven at 110 ºC overnight. This route has been performed on a kilogram 
scale to provide MIDA at a cost, including all chemicals and solvents, of $0.05/g to 
$0.10/g. It has been estimated by commercial suppliers that the cost of MIDA could be as 
low as $0.017/g if synthesized on a kilo-ton scale. 
 
 
Scheme 2.12. MIDA can be accessed on a large scale and at a low cost from the commodity chemical 
iminodiacetic acid. All components of this reaction are environmentally benign and the process is fast and 
technically simple. 
 
2-8 AN ACID-CLEAVED LIGAND THAT ATTENUATES THE REACTIVITY OF 
BORONIC ACIDS UNDER SMC CONDITIONS 
 During the development of the ICC platform a triol-based ligand with distinctly 
different properties from MIDA was discovered to effectively attenuate the reactivity of a 
boronic acid. Targeting a boronate hybridized through a B→O interaction rather than a 
B→N interaction, boronate 2.3j was synthesized in two steps from commercially 
available cis-cis-1,3,5-cyclohexanetriol dihydrate as shown in Scheme 2.13. The triol was 
mixed with boronic acid 2.2 and sodium hydroxide to afford sodium borate 2.34,34 which 
was then alkylated with MeI to afford 2.3j. Interestingly, borate 2.34 participated in a 
SMC reaction with p-bromoacetophenone without added base to generate a significant 
amount of the biaryl product,35 a finding later mirrored by methodology reported by 
Miyaura and co-workers.36 Boronate 2.3j was found to be stable to Florisil but not to 
SiO2 chromatography. Also, 2.3j was fully converted to boronic acid 2.2 upon mixing 
with one equivalent acetic acid in MeOH:H2O (2:1) at room temperature for 35 minutes. 
In a competition experiment similar to that of Table 2.1, one equivalent of boronate 2.3j 
and one equivalent of boronic acid 2.4 were allowed to react with a limiting quantity of 
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p-bromobenzaldehyde (2.5) under anhydrous SMC conditions (Scheme 2.14). In this 
experiment a 101:1.0 ratio of biaryls 2.6 and 2.7 was observed, consistent with strong 
preferential reactivity with the sp2-hybridized boronic acid 2.4. Combined with the 
discovery that 2.3j can be converted to 2.2 under mild acidic conditions, the high 
selectivity found in experiment suggests that this ligand or its derivatives could serve as a 
complementary protecting group to MIDA. However, 2.3i was more difficult to 
synthesize and isolate than 2.3a and further studies on 2.3j were not pursued. 
 
 
Scheme 2.13. Synthesis of a boronate that is hybridized through a B→O interaction rather than a B→N 
interaction. 
 
 
 
Scheme 2.14. In a competition experiment between 2.4 and 2.3j, boronate 2.3j was found to be 
substantially less reactive than boronic acid 2.4. The product ratio of 2.6 : 2.7 was determined by HPLC 
(average of three runs). 
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2-9 SUMMARY 
 In summary, the realization of an iterative cross-coupling strategy based on the 
Suzuki-Miyaura cross-coupling reaction required the discovery of a ligand with the 
capacity to reversibly attenuate the reactivity of boronic acids. N-methyliminodiacetic 
acid (MIDA) was discovered to be such a ligand, transforming boronic acids into MIDA 
boronate esters which are inert to Suzuki-Miyaura cross-coupling under anhydrous 
conditions. It was found that the boronic acid can be regenerated under very mild 
conditions by exposing the MIDA boronate functional group to mild aqueous base at 
room temperature. The favorable properties of MIDA boronates were found to be general 
across aryl, heteroaryl, alkenyl and alkyl substrates. These properties include high 
crystallinity, and stability to both SiO2 chromatography and to storage under ambient 
atmosphere at room temperature. The applicability of ICC to the synthesis of natural 
products was confirmed through in the first total synthesis of ratanhine. Additional 
studies have indicated that the MIDA boronate methodology, while initially developed on 
a small laboratory scale, is applicable on a multi-gram scale. Access to large quantities of 
MIDA at low cost was achieved through the optimized methylation of the commodity 
chemical iminodiacetic acid. 
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CHAPTER 2: EXPERIMENTAL SECTION 
 
 
Materials. Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, 
Alfa Aesar, Lancaster Synthesis, or Frontier Scientific, and were used without further 
purification unless otherwise noted.  N-Bromosuccinimide and 4-butylphenylboronic acid 
were recrystallized from hot water prior to use.  Solvents were purified via passage 
through packed columns as described by Pangborn and coworkers1 (THF, Et2O, CH3CN, 
CH2Cl2: dry neutral alumina; hexane, benzene, and toluene, dry neutral alumina and Q5 
reactant; DMSO, DMF: activated molecular sieves).  All water was deionized prior to use. 
Triethylamine, diisopropylamine, diethylamine, pyridine, 2,6-lutidine, and ethanol were 
freshly distilled under an atmosphere of nitrogen from CaH2. The following compounds 
were prepared according to literature precedent: N-isopropyliminodiacetic acid,2 (E)-3-
bromostyrenylboronic acid, 3  5-bromo-2-benzofuranylboronic acid, 4  2-bromo-5-
methoxyphenol,5 4-(methoxymethoxy)benzoic acid.6  Building block 2.19 was prepared 
by Martin Burke. 7  The multi-gram scale synthesis of 2.12a, 2.13a, and 2.14a was 
performed by Steven Ballmer.8 Solutions of n-butyllithium were titrated according to the 
method of Hoye and coworkers.9 
 
General Experimental Procedures.  Suzuki-Miyaura cross-coupling reactions were 
typically performed under an atmosphere of argon in oven- or flame-dried I-Chem or 
Wheaton vials sealed with PTFE-lined plastic caps.  All other reactions were performed 
in oven- or flame-dried round-bottom or modified Schlenk flasks fitted with rubber septa 
under a positive pressure of argon or nitrogen unless otherwise indicated.  Organic 
solutions were concentrated via rotary evaporation under reduced pressure.  Reactions 
were monitored by analytical thin layer chromatography (TLC) performed using the 
indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  Compounds were 
visualized by exposure to a UV lamp (λ = 254 nm), a glass chamber containing iodine, 
and/or a solution of KMnO4, an acidic solution of p-anisaldehyde, or a solution of ceric 
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ammonium molybdate (CAM) followed by brief heating using a Varitemp heat gun.  
Flash column chromatography was performed as described by Still and coworkers10 using 
EM Merck silica gel 60 (230-400 mesh). 
 
Structural analysis.  1H NMR spectra were recorded at 23 °C on one of the following 
instruments: Varian Unity 400, Varian Unity 500 or Varian Unity Inova 500NB 
spectrometer.  Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (CHCl3, δ = 
7.26; CD2HCN, δ = 1.93, center line; acetone-d6 δ = 2.05, center line) or to added 
tetramethylsilane (δ = 0.00).  Data are reported as follows: chemical shift, multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = septet, m = multiplet, 
b = broad, app = apparent), coupling constant (J) in Hertz (Hz), and integration.  13C 
NMR spectra were recorded at 23 °C on a Varian Unity 400 or Varian Unity 500 
spectrometer. Chemical shifts (δ) are reported in ppm downfield from tetramethylsilane 
and referenced to carbon resonances in the NMR solvent (CDCl3, δ = 77.0, center line; 
CD3CN, δ = 1.30, center line, acetone-d6 δ = 29.80, center line) or to added 
tetramethylsilane (δ = 0.00).  Carbons bearing boron substituents were not observed 
(quadrupolar relaxation). 11B NMR were recorded using a General Electric GN300WB or 
Varian Unity 400 spectrometer and referenced to an external standard of (BF3•Et2O). 
High resolution mass spectra (HRMS) were performed by Furong Sun and Dr. Steve 
Mullen at the University of Illinois School of Chemical Sciences Mass Spectrometry 
Laboratory.  Infrared spectra were collected from a thin film on NaCl plates on a Perkin-
Elmer Spectrum BX FT-IR spectrometer.  Absorption maxima (νmax) are reported in 
wavenumbers (cm-1).  X-ray crystallographic analyses of 2.8a and 2.8b were carried out 
by Dr. Scott Wilson at the University of Illinois George L. Clark X-Ray facility. 
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Synthesis of boronates (Scheme 2.3) 
 
 
 
 
Boronate ester 2.3a 
A 500 mL flask was charged with p-tolylboronic acid (3.00 g, 22.1 mmol, 1 
equiv.), N-methyliminodiacetic acid (3.25 g, 22.1 mmol, 1 equiv.), benzene (360 mL) and 
DMSO (40 mL). The flask was fitted with a Dean-Stark trap and a reflux condenser, and 
the mixture was refluxed with stirring for 16 h followed by concentration in vacuo.  The 
resulting crude product was adsorbed onto Florisil gel from a MeCN solution.  The 
resulting powder was dry-loaded on top of a silica gel column slurry-packed with EtOAc.  
The product was eluted using a gradient (EtOAc Æ EtOAc:MeCN 2:1) to yield boronate 
ester 2.3a as a colorless, crystalline solid (5.05 g, 93%). 
 
TLC (EtOAc) 
Rf = 0.40, stained by KMnO4 
1H-NMR (500 MHz, CD3CN) 
δ 7.37 (d, J = 8 Hz, 2H), 7.20 (d, J = 8 Hz, 2H), 4.05 (d, J = 17 Hz, 2H), 3.87 (d, J 
= 17 Hz, 2H), 2.47 (s, 3H), 2.33 (s, 3H). 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 140.0, 133.4, 129.6, 62.7, 48.4, 21.4. 
11B-NMR (100 MHz, CD3CN) 
 δ 12.2 
HRMS (EI+) 
 Calculated for C12H14O4NB (M)+: 247.1016 
 Found:   247.1014 
 52
IR (thin film, cm-1) 
3046, 3023, 3003, 2958, 2917, 1746, 1612, 1454, 1424, 1397, 1335, 1257, 1243, 
1188, 1150, 1038, 1012, 993, 961, 867, 807, 786, 650, 638. 
 
 
The following data are consistent with the assignment of 2.3a as an sp3-hybridized 
boronate ester. 
 
1.  1H NMR: The diastereotopic methylene protons of 2.3a appear as a well-resolved pair 
of doublets at δ 4.05 and 3.87 with a large geminal coupling constant of 17 Hz.  This is 
consistent with literature precedent for related conformationally-rigid arylboronate ester 
complexes.11 One such complex has been characterized unambiguously by single crystal 
X-ray diffraction analysis.12 
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2.  11B NMR: Boron NMR spectroscopy is a well-established method for probing the 
structure of boronic acids and boronate ester complexes.13  The 11B NMR spectra for p-
tolyboronic acid and 2.3a demonstrate chemical shifts of δ 29.6 and δ 12.2, respectively.  
These data are consistent with the assignment of 2.3a as a pyramidalized boronate ester. 
 
3.  These same diagnostic 1H and 11B NMR signals are observed for the vinylic 
haloboronate ester 2.12e.  We have obtained an X-ray structure of this compound 
(Scheme 2.5) which confirmed unambiguously the sp3-hybridization of the boron center. 
 
 
 
 
 
Boronate ester 2.3c 
In an unoptimized procedure, a 250 mL roundbottom flask was charged with p-
tolylboronic acid (7.36 mmol, 1.00 g), N-isopropyliminodiacetic acid (7.36 mmol, 1.29 g), 
benzene (150 mL) and DMSO (15 mL).  The flask was fitted with a Dean-Stark trap and 
a reflux condenser, and the mixture was refluxed with stirring for 14 h and then 
concentrated in vacuo.  Purification by flash chromatography (Et2O Æ Et2O:MeCN 1:2) 
yielded boronate ester 2.3c as a colorless, crystalline solid (747 mg, 37%). 
 
TLC (EtOAc) 
Rf = 0.36, stained by KMnO4 
1H-NMR (500 MHz, CD3CN) 
δ 7.40 (d, J = 8 Hz, 2H), 7.19 (d, J = 8 Hz, 2H), 4.05 (d, J = 17 Hz, 2H), 3.81 (d, J 
= 17 Hz, 2H), 3.06 (sept, J = 6.5 Hz, 1H), 2.33 (s, 3H), 1.05 (d, J = 6.5 Hz, 6H). 
13C-NMR (125 MHz, CD3CN) 
 δ 169.8, 139.9, 133.6, 129.5, 59.8, 57.2, 21.4, 17.2. 
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11B-NMR (100 MHz, CD3CN) 
 δ 11.96 
HRMS (EI+) 
 Calculated for C14H18O4NB (M)+: 275.1329  
 Found:   275.1331 
IR (thin film, cm-1) 
 3011, 2951, 1761, 1744, 1727, 1312, 1240, 1048, 1021, 982, 862, 808. 
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Boronate ester 2.3f 
In an unoptimized procedure, a 100 mL roundbottom flask was charged with p-
tolylboronic acid (3.68 mmol, 500 mg), N-methyldiethanolamine (3.68 mmol, 422 µL) 
and toluene (70 mL).  The flask was fitted with a Dean-Stark trap and a reflux condenser, 
and the solution was refluxed with stirring for 8 h and then allowed to cool to 23 oC.  
CaCl2 (app. 200 mg, a fine powder) and NaHCO3 (app. 200 mg) were then added, and the 
resulting mixture was stirred for 15 min. and then was filtered.  The filtrate was 
concentrated in vacuo and residual solvent was removed via co-evaporation with CH2Cl2 
to yield boronate ester 2.3f as a colorless, crystalline solid (399 mg, 50%). 
 
TLC  
Compound is unstable to SiO2 
1H NMR (500 MHz, CD3CN) 
δ 7.42 (d, J = 8 Hz, 2H), 7.07 (d, J = 8 Hz, 2H), 3.99 (ddd, J = 10, 8, 5 Hz, 2H), 
3.93 (ddd, J = 10, 6, 4 Hz, 2H), 3.17 (ddd, J = 12, 5, 4 Hz, 2H), 2.93 (ddd, J = 12, 
8, 6 Hz, 2H), 2.28 (s, 3H), 2.20 (s, 3H). 
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13C NMR (125 MHz, CD3CN) 
 δ 137.3, 134.3, 128.7, 62.9, 61.1, 48.0, 21.4. 
 
11B NMR (100 MHz, CD3CN) 
 δ 12.7 
HRMS (EI+) 
 Calculated for C12H18O2NB (M)+: 219.1431  
 Found:   219.1427 
IR (thin film, cm-1) 
2999, 2948, 2911, 2873, 2830, 1606, 1455, 1370, 1338, 1280, 1250, 1222, 1193, 
1181, 1150, 1097, 1035, 994, 944, 808, 786, 735, 718. 
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Competition studies (Table 2.1) 
 
Preparation of catalyst stock solution. 
In a glove box, to a vial equipped with a small stir bar and containing the 2-(di-
tert-butylphosphino)biphenyl ligand was added a 0.02 M solution of Pd(OAc)2 in THF in 
a volume sufficient to yield a 0.04 M solution with respect to the phosphine ligand.  The 
vial was sealed with a PTFE-lined cap, removed from the glove box, and maintained at 
65°C with stirring for 30 min. 
 
Reaction setup 
In a glove box, a glass vial equipped with a small stir bar was charged with 
boronate ester 2.3 (0.06 mmol) and anhydrous K3PO4 as a finely ground powder (32 mg, 
0.15 mmol).  To this vial was then added a 250 µL of a THF solution of 4-
butylphenylboronic acid (2.4) (0.24 M, 0.06 mmol), 4-bromobenzaldehyde (2.5) (0.20 M, 
0.05 mmol) and biphenyl (0.08 M, internal std. for HPLC analysis).  Finally, to this same 
vial was added 50 uL of the catalyst stock solution described above.  The vial was then 
sealed with a PTFE-lined cap, removed from the glove box, and maintained in a 65 °C oil 
bath with stirring for 12 h.  The reaction solution was then allowed to cool to 23 ºC and 
filtered through a plug of silica gel, eluting with MeCN:THF 1:1.  The filtrate was then 
analyzed by HPLC as described below.  
 
Analysis 
The ratio of products 2.6 and 2.7 was determined using an HPLC system (Agilent 
Technologies) fitted with a Waters SunFire Prep C18 5µm column (10 x 250 mm, Lot No. 
156-160331) with a flow rate of 4 mL/min and a gradient of MeCN:H2O 5:95 Æ 95:5 
over 23 min., with UV detection at 268 nm (4-bromobenzaldehyde, tR = 14.66 min.; 
biphenyl, tR = 21.80 min.) and 293 nm (2.6, tR = 25.79 min.; 2.7, tR = 20.50 min.; it was 
determined that the absorption coefficients for 2.6 and 2.7 at 293 nm are identical within 
the limits of experimental error).  
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Table 2.1, Entry 1 
The general procedure was followed using 2.3a (0.06 mmol).  The ratio of 2.6:2.7 
was 24:1.0, average of 3 runs. 
 
Table 2.1, Entry 2 
The general procedure was followed using 2.2 (0.06 mmol).  The ratio of 2.6:2.7 
was 1.0:1.0, average of 3 runs. 
 
Table 2.1, Entry 3 
The general procedure was followed using 2.3c (0.06 mmol). The ratio of 2.6:2.7 
was 26:1.0, average of 3 runs. 
 
Table 2.1, Entry 4 
The general procedure was followed using 2.3d (0.06 mmol). The ratio of 2.6:2.7 
was 11:1.0, average of 3 runs. 
 
Table 2.1, Entry 5 
The general procedure was followed using 2.3f (0.06 mmol).  The ratio of 2.6:2.7 
was 1.0:1.0, average of 3 runs. 
 
Table 2.1, Entry 6 
The general procedure was followed using 2.3h (0.06 mmol).  The ratio of 2.6:2.7 
was 21:1.0, average of 3 runs. 
 
Table 2.1, Entry 7 
The general procedure was followed using 2.3i (0.06 mmol).  The ratio of 2.6:2.7 
was 8.2:1.0, average of 3 runs. 
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Synthesis of haloboronate esters 2.12 (Scheme 2.5) 
 
 
 
 
General procedure for the synthesis of haloboronate esters 
A roundbottom flask equipped with a stir bar was charged with haloboronic acid 
(1 equiv.), N-methyliminodiacetic acid (1-1.5 equiv.), and benzene:DMSO (10:1).  The 
flask was fitted with a Dean-Stark trap and a reflux condenser, and the mixture was 
refluxed with stirring for 12-18 hours.  The reaction solution was allowed to cool to 23 oC 
and the solvent was removed in vacuo.  The resulting crude solid was absorbed onto 
Florisil gel from a MeCN solution.  The resulting powder was dry-loaded on top of a 
silica gel column slurry-packed with Et2O.  The column was flushed with a copious 
volume of Et2O; the product was then eluted with a mixture of Et2O:MeCN.  All products 
thus obtained were analytically pure, colorless, crystalline solids that were indefinitely 
bench stable at 23 oC under air. 
 
 
 
Boronate ester 2.12a 
The general procedure was followed using 4-bromophenylboronic acid (1.00 g, 
4.98 mmol, 1 equiv.), N-methyliminodiacetic acid (733 mg, 4.98 mmol), benzene (150 
mL) and DMSO (15 mL).  The mixture was refluxed for 12 h.  The product was eluted 
using a gradient; Et2O Æ Et2O:CH3CN 1:1.  The title compound was isolated as an 
analytically pure, colorless, crystalline solid (1.53 g, 98%). 
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TLC (EtOAc) 
Rf = 0.36, stained by KMnO4 
1H-NMR (500 MHz, CD3CN) 
δ 7.53 (d, J = 8 Hz, 2H), 7.41 (d, J = 8 Hz, 2H), 4.07 (d, J = 17 Hz, 2H), 3.89 (d, J 
= 17 Hz, 2H), 2.50 (s, 3H). 
13C-NMR (125 MHz, CD3CN) 
  δ 169.4, 135.5, 131.9, 124.4, 62.8, 48.5. 
11B NMR (100 MHz, CD3CN) 
 δ 11.9 
HRMS (EI+) 
 Calculated for C11H11O4NBrB (M)+: 310.9964 
Found:      310.9967 
Elemental Analysis 
Calculated: C, 42.36 H, 3.55 N, 4.49 Br, 25.62  
Found:   C, 42.25 H, 3.50 N, 4.46 Br, 25.30  
IR (thin film, cm-1) 
3006, 2961, 1743, 1582, 1559, 1458, 1447, 1384, 1342, 1181, 1153, 1040, 1018, 
997, 981, 865, 811. 
 
 
 
MIDA boronate 2.12b 
The general procedure was followed using 3-bromophenylboronic acid (2.00 g, 
9.96 mmol), N-methyliminodiacetic acid (1.47 g, 9.96 mmol), benzene (300 mL) and 
DMSO (30 mL).  The mixture was refluxed for 18 h.  The product was eluted with 
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Et2O:CH3CN 1:1.  The title compound was isolated as an analytically pure, colorless, 
crystalline solid (2.89 g, 93%). 
 
TLC (EtOAc) 
Rf = 0.57, stained by KMnO4   
 
1H-NMR (500 MHz, CD3CN) 
δ 7.63 (m, 1H), 7.56 (m, 1H), 7.46 (m, 1H), 7.30 (m, 1H), 4.07 (d, J = 17 Hz, 2H), 
3.90 (d, J = 17 Hz, 2H), 2.52 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.3, 136.1, 133.1, 132.3, 131.0, 123.3, 62.9, 48.6. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 11.5 
 
HRMS (EI+) 
 Calculated for C11H11O4NBrB (M)+: 310.9964 
Found:      310.9966 
 
Elemental Analysis 
Calculated: C, 42.36 H, 3.55 N, 4.49 
Found:   C, 42.83,  H, 3.42 N, 4.51 
 
IR (thin film, cm-1) 
3012, 2959, 1766, 1468, 1454, 1395, 1335, 1286, 1235, 1211, 1096, 1075, 1038, 
1001, 892, 860, 787, 693. 
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MIDA boronate 2.12c 
The general procedure was followed using 2-bromophenylboronic acid (2.00 g, 
9.96 mmol), N-methyliminodiacetic acid (1.47 g, 9.96 mmol), benzene (300 mL) and 
DMSO (30 mL).  The mixture was refluxed for 13 h.  The product was eluted with 
Et2O:MeCN 1:1. The title compound was isolated as an analytically pure, colorless, 
crystalline solid (3.01 g, 97%). 
 
TLC (EtOAc) 
Rf = 0.44, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.66 (dd, J = 7.5, 2 Hz, 1H), 7.60 (dd, J = 8, 1 Hz, 1H), 7.38 (app dt, J = 7.5, 1 
Hz, 1H), 7.29 (app dt, J = 8, 2 Hz, 1H), 4.13 (d, J = 17 Hz, 2H), 4.02 (d, J = 17 
Hz, 2H), 2.70 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 137.4, 134.6, 132.4, 128.7, 128.0, 65.2, 49.5. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 12.1 
 
HRMS (EI+) 
 Calculated for C11H11O4NBrB (M)+: 310.9964  
 Found:   310.9967  
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Elemental Analysis 
Calculated: C, 42.36 H, 3.55 N, 4.49 Br, 25.62 
Found:   C, 42.41 H, 3.53 N, 4.50 Br, 25.21 
 
IR (thin film, cm-1) 
3011, 2963, 1767, 1709, 1485, 1556, 1453, 1418, 1338, 1299, 1276, 1198, 1119, 
1060, 1036, 1002, 879, 858, 759. 
 
 
 
MIDA boronate 2.12d 
The general procedure was followed using 4-bromothiophene-2-boronic acid (281 
mg, 1.36 mmol), N-methyliminodiacetic acid (240 mg, 1.63 mmol), benzene (50 mL) and 
DMSO (5 mL).  The mixture was refluxed for 13 h.  The product was eluted with 
Et2O:MeCN 3:1.  The title compound was isolated as an analytically pure, colorless, 
crystalline solid (429 mg, 99%). 
 
TLC (Et2O:MeCN 3:1) 
Rf = 0.56, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.17 (d, J = 3.5 Hz, 1H), 7.06 (d, J = 3.5 Hz, 1H), 4.06 (d, J = 17 Hz, 2H), 3.90 
(d, J = 17 Hz, 2H), 2.64 (s, 3H). 
 
13C-NMR (100 MHz, CD3CN) 
 δ 168.9, 135.1, 132.8, 116.2, 62.5, 48.4 
 
11B-NMR (100 MHz, CD3CN) 
 δ 10.6 
 63
HRMS (EI+) 
 Calculated for C9H9O4NBrBS (M)+: 316.9529 
 Found:   316.9526 
 
Elemental Analysis 
Calculated: C, 34.00 H, 2.85 N, 4.41 
Found:   C, 34.12 H, 2.45 N, 4.34 
 
IR (thin film, cm-1) 
3003, 1771, 1519, 1452, 1422, 1337, 1293, 1284, 1210, 1166, 1031, 981, 966, 870, 
824, 790. 
 
 
 
MIDA boronate 2.12e 
The general procedure was followed 2-(3-bromophenyl)ethenylboronic acid (227 
mg, 1.0 mmol), N-methyliminodiacetic acid (147 mg, 1.0 mmol), benzene (50 mL) and 
DMSO (5 mL).  The mixture was refluxed for 11 h.  The product was eluted with 
Et2O:MeCN 5:1.  The title compound was isolated as an analytically pure, colorless, 
crystalline solid (334 mg, 99%). 
 
TLC (EtOAc) 
Rf = 0.27, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.70 (m, 1H), 7.47 (m, 1H), 7.42 (m, 1H), 7.26 (m, 1H), 6.89 (d, J = 18 Hz, 1H), 
6.32 (d, J = 18 Hz, 1H), 3.99 (d, J = 17 Hz, 2H), 3.83 (d, J = 17 Hz, 2H), 2.80 (s, 
3H). 
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13C-NMR (125 MHz, CD3CN) 
 δ 169.3, 141.6, 141.5, 131.6, 131.4, 130.2, 126.6, 123.2, 62.4, 47.7. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 11.3 
 
HRMS (EI+) 
 Calculated for C13H13O4NBrB (M)+: 337.0121 
 Found:   337.0123 
 
Elemental Analysis 
Calculated: C, 46.20 H, 3.88 N,  4.14 
Found:   C, 46.22 H, 3.51 N,  4.12 
 
IR (thin film, cm-1) 
3010, 2958, 1759, 1627, 1588, 1560, 1469, 1424, 1337, 1291, 1233, 1198, 1154, 
1114, 1088, 1071, 1029, 994, 956, 875, 826, 778, 729, 679, 661, 593. 
 
 
MeN
O
OB
O
OBr
( ) 2.12f  
MIDA boronate 2.12f 
The general procedure was followed using 2-(3-bromophenyl)cyclopropylboronic 
acid (2.11f, see below for the preparation of this material) (316 mg, 1.31 mmol), N-
methyliminodiacetic acid (232 mg, 1.58 mmol), benzene (50 mL) and DMSO (5 mL).  
The mixture was refluxed for 6 h.  The product was eluted with MeCN:Et2O 5:1.  The 
title compound was isolated as an analytically pure, colorless solid (408 mg, 88%). 
 
TLC (EtOAc) 
Rf = 0.27, stained by KMnO4 
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1H-NMR (500 MHz, CD3CN) 
δ 7.28-7.26 (m, 2H), 7.15 (m, 1H), 7.09 (m, 1H), 3.96 (app dd, J = 17, 3 Hz, 2H), 
3.84 (app dd, J = 17, 9.5 Hz, 2H), 1.77 (ddd, J = 8, 5.5, 5 Hz, 1H), 0.96-0.87 (m, 
2H), 0.19 (ddd, J = 10, 7, 5.5 Hz, 1H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 169.3, 169.1, 148.3, 131.1, 129.1, 129.1, 125.4, 123.0, 63.1, 63.0, 47.4, 19.6, 
13.8. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 12.6 
 
HRMS (EI+) 
 Calculated for C14H15O4NBrB (M)+: 351.0277 
Found:      351.0274 
 
Elemental Analysis 
Calculated: C, 47.77 H, 4.30 N, 3.98 
Found:   C, 47.89 H, 4.35 N, 3.95 
 
IR (thin film, cm-1) 
 3004, 2968, 2922, 1749, 1716, 1422, 1363, 1222, 1092, 900, 736. 
 
 
 
 
2-(3-bromophenyl)cyclopropylboronic acid (2.11f) 
 To a stirred solution of 2.12e (1.21 g, 3.59 mmol) and Pd(OAc)2 (0.0239 g, 0.11 
mmol) in THF (24 mL) at 0 oC in a 250 mL Schlenk flask was added a freshly prepared 
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ethereal solution of diazomethane (35 mL of a 0.25 M solution, 8.8 mmol) dropwise over 
20 minutes.  Additional Pd(OAc)2 was then added (0.0239 g, 0.11 mmol) as a solution in 
THF (1 mL) followed by the dropwise addition over 20 min of an additional 35 mL of 
0.25 M ethereal diazomethane (8.8 mmol).  The reaction was then allowed to warm to 23 
oC and the excess diazomethane was removed under a stream of N2.  The crude reaction 
mixture was then poured into 120 mL of 0.5 M pH 7 sodium phosphate buffer and 
extracted with THF:Et2O 1:1 (3 x 120 mL).  The combined organic fractions were then 
washed with brine, dried over Na2SO4, and concentrated in vacuo.  Purification by flash 
chromatography (SiO2, Et2O Æ Et2O:CH3CN 1:1) yielded 2.12f (1.21 g, 96%) (See 
above for characterization of 2.12f.)  To a stirred solution of 2.12f (0.513 g, 1.46 mmol) 
in THF (20 mL) was added 1M aq. NaOH (4.37 mL, 4.37 mmol) and the resulting 
mixture was stirred at 23 0C for 20 minutes.  The reaction was then quenched with the 
addition of 0.5 M pH 7 phosphate buffer (20 mL) and diluted with Et2O (20 mL).  The 
layers were separated and the aq. layer was extracted with THF:Et2O 1:1 (40 mL).  The 
combined organic fractions were dried over MgSO4 and concentrated in vacuo to yield 
the desired cyclopropylboronic acid 2.11f as a colorless solid (0.339 g, 97%). 
 
TLC (Et2O:CH3CN 3:1) 
Rf = 0.64, visualized by UV 
 
1H-NMR (500 MHz, d6-DMSO:D2O 95:5) 
δ 7.30 (d, J = 8 Hz, 1H), 7.23 (s, 1H), 7.19 (app t, J = 8 Hz, 1H), 7.07 (d, J = 8 
Hz, 1H), 1.95 (m, 1H), 1.06 (m, 1H), 0.96 (m, 1H), 0.07 (m, 1H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 147.2, 130.3, 127.9, 127.7, 124.3, 121.7, 20.8, 14.8. 
 
HRMS (EI+) 
 Calculated for C9H10O2BrB (M)+: 239.9957 
Found:      239.9956 
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 Selective Suzuki-Miyaura coupling with haloboronate esters (Table 2.4) 
 
MeN
O
OB
O
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Pd(OAc)2
2.13PCy2
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O
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O
OBr
2.12 K3PO4
THF, 65 oC
Me B(OH)2
 
 
General procedures for selective Suzuki-Miyaura coupling reactions 
 
Note: The same yield was observed for the transformation of 2.12a Æ 2.13a 
whether this reaction was set up in the glovebox or in the air (see below). 
 
Preparation of catalyst stock 
In a glove box, to a vial equipped with a stir bar was added the phosphine ligand.  
To the vial was then added a 0.02 M solution of Pd(OAc)2 in THF in a volume sufficient 
to yield a 0.04 M solution with respect to the phosphine ligand.  The vial was sealed with 
a PTFE-lined cap, removed from the glove box, and maintained at 65°C with stirring for 
30 min. 
 
Suzuki-Miyaura Coupling 
To a 40 mL vial equipped with a stir bar was added the haloboronate ester (1.0 
mmol) and the boronic acid (typically 1.2-1.5 mmol).  The vial was brought into the 
glove box.  To the vial was added K3PO4 (3.0 mmol, 636.8 mg, a finely ground powder), 
THF (9.0 mL), and then the catalyst stock solution (1.0 mL).  The vial was capped with a 
PTFE-lined cap, removed from the glove box, and placed in a 65°C oil bath with stirring 
for 12 h.  The reaction mixture was allowed to cool to 23 ºC and then filtered through a 
very thin pad of silica gel topped with sand and then celite, eluting with a copious volume 
of MeCN.  To the resulting solution was added Florisil gel (app. 25 mg/mL of solution), 
and then solvent was removed in vacuo.  The resulting powder was dry-loaded on top of 
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a silica gel column slurry-packed with Et2O.  The column was flushed with a copious 
volume of Et2O; the product was then eluted with Et2O:MeCN. 
 
 
 
MIDA boronate 2.13a 
The general procedure was followed using 2.12a (312 mg, 1.00 mmol), 
tolylboronic acid (163 mg, 1.20 mmol), and 2-(dicyclohexylphosphino)biphenyl.  The 
product was eluted with Et2O:MeCN 1:1.  The title compound was isolated as a colorless 
solid (280 mg, 87%). 
 
This same reaction was also set up using standard Schlenk techniques without the 
use of a glove box.  A flame-dried 25 mL Schlenk flask equipped with a stir bar was 
evacuated and purged with argon 3 times.  This flask was charged with 2-
(dicyclohexylphosphino)biphenyl (14.1 mg, 0.04 mmol) Pd(OAc)2 (4.4 mg, 0.02 mmol), 
and THF (10 mL).  The flask was then fitted with a reflux condensor and the yellow 
solution was heated to reflux for 5 minutes resulting in discoloration.  A separate flame-
dried 25 mL Schlenk flask equipped with a stir bar was evacuated and purged with argon 
3 times.  This flask was charged with haloboronate ester 2.12a (312.1 mg, 1.00 mmol), 
tolylboronic acid (163.2 mg, 1.20 mmol), and freshly ground anhydrous K3PO4 (637.2 
mg, 3.00 mmol).  This flask was then fitted with a reflux condensor. The catalyst solution 
was then transferred via cannula into the flask containing the coupling partners and base.  
The resulting mixture was heated at reflux for 12 hours.  The reaction was worked-up as 
described in the general procedure above.  The product was eluted with Et2O:MeCN 3:1 
Æ 1:1.  The title compound was isolated as a nearly colorless solid (279.6 mg, 87%). 
 
TLC (EtOAc) 
Rf = 0.29, stained by KMnO4 
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1H-NMR (500 MHz, CD3CN) 
δ 7.64 (d, J = 8 Hz, 2H), 7.55 (app d, J = 7.5 Hz, 4H), 7.27 (d, J = 8 Hz, 2H), 4.07 
(d, J = 17 Hz, 2H), 3.90 (d, J = 17 Hz, 2H), 2.54 (s, 3H), 2.37 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 142.5, 138.6, 138.4, 134.0, 130.5, 127.7, 127.1, 62.8, 48.5, 21.1. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 12.0 
 
HRMS (EI+) 
 Calculated for C18H18O4NB (M)+: 323.1329 
 Found:   323.1332 
 
IR (thin film, cm-1) 
3012, 2952, 1765, 1711, 1607, 1455, 1340, 1297, 1237, 1202, 1040, 992, 891, 866, 
840, 806. 
 
 
 
MIDA boronate 2.13b 
The general procedure was followed using 2.12b (312 mg, 1.00 mmol), 
tolylboronic acid (163 mg, 1.20 mmol), and 2-(dicyclohexylphosphino)biphenyl.  The 
product was eluted with Et2O:MeCN 1:1.  The title compound was isolated as a colorless, 
crystalline solid (276 mg, 85%). 
 
TLC (EtOAc) 
Rf = 0.38, stained by KMnO4 
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1H-NMR (500 MHZ, CD3CN) 
δ 7.12 (m, 1H), 7.64 (m, 1H), 7.55 (m, 2H), 7.45 (m, 2H), 7.27 (app d, J = 8 Hz, 
2H), 4.07 (d, J = 17 Hz, 2H), 3.91 (d, J = 17 Hz, 2H), 2.53 (s, 3H), 2.36 (s, 3H). 
 
13C-NMR (100 MHz, CD3CN) 
δ 169.6, 141.2, 139.2, 138.2, 132.3, 131.7, 130.5, 129.4, 128.7, 127.8, 62.9, 48.6, 
21.1. 
 
11B-NMR (100 MHZ, CD3CN) 
 δ 12.2 
 
HRMS (EI+) 
 Calculated for C18H18O4NB (M)+: 323.1329 
 Found:     323.1326 
 
IR (thin film, cm-1) 
3050, 3017, 2959, 2920, 1765, 1515, 1456, 1420, 1389, 1336, 1295, 1238, 1220, 
1203, 1097, 1058, 1035, 965, 891, 861, 794, 730, 710, 652. 
 
 
 
MIDA boronate 2.13c 
The general procedure was followed using 2.12c (312 mg, 1.00 mmol), 
tolylboronic acid (172 mg, 2.00 mmol) and 2-(dicyclohexylphosphino)biphenyl.  The 
product was eluted with a gradient of Et2O:MeCN 5:1 Æ 1:1.  The title compound was 
isolated as a pale yellow solid (257 mg, 80%). 
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TLC (EtOAc) 
Rf = 0.40, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.72 (dd, J = 7.25, 1 Hz, 1H), 7.43-7.34 (m, 2H), 7.18-7.08 (m, 5H), 3.73 (d, J = 
17 Hz, 2H), 3.27 (d, J = 17 Hz, 2H), 2.42 (s, 3H), 2.34 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 168.9, 148.8, 141.8, 137.4, 135.2, 132.0, 130.5, 129.9, 129.4, 127.6, 63.5, 48.5, 
21.1. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 12.5 
 
HRMS (EI+): 
 Calculated for C18H18O4NB (M)+: 323.1329 
 Found:   323.1332 
 
IR (thin film, cm-1) 
3051, 3013, 2956, 2923, 2869, 1770, 1592, 1515, 1452, 1431, 1336, 1299, 1279, 
1197, 1112, 1030, 1005, 887, 857, 824, 770, 755, 706, 639. 
 
 
 
MIDA boronate 2.13d 
The general procedure was followed using 2.12d (318 mg, 1.00 mmol), 
tolylboronic acid (204 mg, 1.50 mmol), K2CO3 (415 mg, 3.00 mmol,) and 2-
(dicyclohexylphosphino)-2’,4’,6’-tri-isopropyl-1,1’-biphenyl.  The product was eluted 
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using a gradient of Et2O:MeCN 5:1 Æ 3:1.  The title compound was isolated as a pale 
yellow solid (266 mg, 81%). 
 
TLC (EtOAc) 
Rf = 0.52, stained by KMnO4 
 
1H-NMR (400 MHz, CD3CN) 
δ 7.56 (d, J = 8 Hz, 2H), 7.41 (d, J = 3.2 Hz, 1H), 7.23 (d, J = 3.2 Hz, 1H), 7.21 (d, 
J = 8 Hz, 2H), 4.08 (d, J = 17 Hz, 2H), 3.92 (d, J = 17 Hz, 2H), 2.66 (s, 3H), 2.33 
(s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.0, 149.4, 138.8, 135.4, 132.4, 130.6, 126.6, 125.2, 62.4, 48.4, 21.1. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 11.2 
 
HRMS (TOF ES+) 
 Calculated for C16H16O4BNNaS (M+Na)+: 352.0791 
 Found:     352.0800 
 
IR (thin film, cm-1) 
 2999, 2948, 1755, 1453, 1337, 1284, 1248, 1169, 1031, 978, 894, 869, 802. 
 
 
2.13e
MeN
O
OB
O
O
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MIDA boroante 2.13e 
The general procedure was followed using 2.12e (338 mg, 1.00 mmol), 
tolylboronic acid (163 mg, 1.20 mmol), and 2-(dicyclohexylphosphino)biphenyl.  The 
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product was eluted with Et2O:MeCN 5:1.  The title compound was isolated as an off-
white solid (282 mg, 82%). 
 
TLC (EtOAc) 
Rf = 0.29, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.76 (app t, J = 1.5 Hz, 1H), 7.55 (m, 2H), 7.50 (m, 2H), 7.40 (app t, J = 8 Hz, 
1H), 7.27 (app d, J = 8 Hz, 2H), 7.01 (d, J = 18.5 Hz, 1H), 6.37 (d, J = 18.5 Hz, 
1H), 4.00 (d, J = 17 Hz, 2H), 3.84 (d, J = 17 Hz, 2H), 2.81 (s, 3H), 2.36 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 169.5, 143.3, 142.2, 139.8, 138.8, 138.5, 130.6, 130.1, 127.9, 127.5, 126.4, 
126.2, 62.5, 47.8, 21.2. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 11.9 
 
HRMS (EI+) 
 Calculated for C20H20O4NB (M)+: 349.1485 
 Found:   349.1480 
 
IR (thin film, cm-1) 
3005, 2952, 2922, 2868, 1764, 1628, 1598, 1582, 1517, 1427, 1396, 1337, 1289, 
1233, 1192, 1153, 1114, 1086, 1028, 995, 956, 878, 823, 785, 697. 
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MIDA boronate 2.13f 
The general procedure was followed using 2.12f (237 mg, 0.674 mmol), 
tolylboronic acid (109 mg, 0.808 mmol), K3PO4 (429 mg, 2.02 mmol), catalyst stock 
solution containing 2-(dicyclohexylphosphino)biphenyl (674 µL), and THF 6.06 mL.  
The product was eluted with Et2O:MeCN (1:1).  The title compound was isolated as an 
off-white crystalline solid (229 mg, 94%). 
 
TLC (EtOAc) 
Rf = 0.33, stained by KMnO4 
1H-NMR (500 MHz, CD3CN) 
δ 7.51 (app d, J = 8 Hz, 2H), 7.35 (m, 2H), 7.29 (app t, J = 8 Hz, 1H), 7.07 (app d, 
J = 8 Hz, 1H), 3.96 (app dd, J = 17, 4 Hz, 2H), 3.84 (app dd, J = 17, 12 Hz, 2H), 
1.84 (ddd, J = 8, 5.5, 5 Hz, 1H), 0.99 (ddd, J = 10, 5, 4 Hz, 1H), 0.91 (ddd, J = 
8,7,4 Hz, 1H), 0.25 (ddd, J = 10, 7, 5.5 Hz, 1H). 
13C-NMR (125 MHz, CD3CN) 
δ 168.0, 167.9, 144.6, 140.5, 137.8, 136.9, 129.1, 128.5, 126.5, 123.7, 123.5, 
123.4, 61.8, 61.7, 46.1, 19.8, 18.7, 12.2. 
11B-NMR (100 MHz, CD3CN) 
δ 13.1 
HRMS (EI+) 
 Calculated for C21H22O4NB (M)+:  363.1642 
 Found:     363.1645 
IR (thin film, cm-1) 
3014, 2963, 2921, 1762, 1603, 1517, 1485, 1458, 1379, 1338, 1292, 1246, 1153, 
1115, 1084, 1030, 960, 891, 861, 825, 792, 707. 
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Deprotection of MIDA boronate esters (Table 2.4) 
 
 
 
General procedure for NaOH-mediated hydrolysis of boronate esters 
A round bottom flask equipped with a stir bar was charged with the boronate ester 
(1 equiv.), THF (10 mL), and 1M aq. NaOH (3 equiv.) and the resulting mixture was 
vigorously stirred at 23 oC for 10 minutes.  The reaction mixture was then diluted with aq. 
sodium phosphate buffer (0.5 M, pH 7.0, 10 mL) and Et2O (10 mL), the layers were 
separated, and the aq. phase was extracted once with THF:Et2O 1:1 (20 mL).  (On some 
occasions phosphate salts precipated and during the extraction process and were 
redissolved by the addition of water.  The combined organic fractions were then dried 
over MgSO4 and concentrated in vacuo.  Residual solvent was co-evaporated with MeCN. 
 
 
 
Boronic acid 2.14a 
The general procedure was followed using 2.13a (261 mg, 0.806 mmol) and 1 M 
aq. NaOH (2.42 mL, 2.42 mmol).  The title compound was isolated as a white solid 
(147.4 mg, 86%) 
 
TLC (EtOAc) 
Rf = 0.55, stained by KMnO4 
 
1H-NMR (500 MHz, d6-DMSO:D2O 95:5) 
δ 7.87 (d, J = 8 Hz, 2H), 7.62 (d, J = 8 Hz, 2H), 7.59 (d, J = 8 Hz, 2H), 7.28 (d, J 
= 8 Hz, 2H), 2.35 (s, 3H). 
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13C-NMR (125 MHz, d6-DMSO:D2O 95:5) 
 δ 141.5, 137.1, 136.9, 134.7, 129.5, 126.4, 125.3, 20.6. 
 
HRMS (EI+) 
 Calculated for C13H13O2B (M)+: 212.1009 
 Found:     212.1011 
 
 
 
Boronic acid 2.14b 
The general procedure was followed using 2.13b (268 mg, 0.830 mmol) and 1 M 
aq. NaOH (2.49 mL, 2.49 mmol).  The title compound was isolated as a white solid (161 
mg, 92%). 
 
TLC (EtOAc) 
Rf = 0.59, stained by KMnO4 
 
1H-NMR (500 MHz, d6-DMSO:D2O 95:5) 
δ 8.09 (s, 1H), 7.75 (d, J = 7 Hz, 1H), 7.68 (d, J = 8 Hz, 2H), 7.57 (d, J = 8 Hz, 
2H), 7.43 (app t, J = 7.5 Hz, 1H), 7.29 (d, J = 8 Hz, 2H), 2.35 (s, 3H). 
 
13C-NMR (125 MHz, d6-DMSO:D2O 95:5) 
 δ 139.0, 137.5, 136.5, 132.8, 132.1, 129.4, 128.1, 128.0, 126.4, 20.6. 
 
HRMS (EI+) 
 Calculated for C13H13O2B (M)+: 212.1009 
 Found:     212.1008 
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Boronic acid 2.14c 
Hydrolysis with NaOH.  The general procedure was followed using 2.13c (236 mg, 0.729 
mmol) and 1M aq. NaOH (2.19 mL, 2.19 mmol).  The title compound was isolated as a 
white solid (150 mg, 97%). 
 
Hydrolysis with NaHCO3.  To a 40 mL I-Chem vial equipped with a stir bar and 
containing 2.13c (0.672 mmol, 217 mg) was added MeOH (7 mL) and sat. aq. NaHCO3 
(3.5 mL).  The mixture was vigorously stirred for 6 h at 23 oC.   The mixture was then 
diluted with saturated aq. NH4Cl (7 mL) and Et2O (14 mL), and the phases were 
separated.  The aqueous phase was twice extracted with Et2O (14 mL), and the combined 
organics were dried over MgSO4 and concentrated in vacuo.  The residue was twice 
suspended in MeCN followed by concentration in vacuo and then dissolved in CH2Cl2 
and concentrated in vacuo to yield 2.14c as a colorless, crystalline solid (121 mg, 85%). 
 
TLC (EtOAc) 
Rf = 0.84, stained by KMnO4 
 
1H-NMR (500 MHz, d6-DMSO:D2O 95:5) 
 δ 7.45-7.27 (m, 6H), 7.21 (d, J = 8 Hz, 2H), 2.34 (s, 3H). 
 
13C-NMR (125 MHz, d6-DMSO:D2O 95:5) 
 δ 144.0, 140.2, 135.8, 132.1, 128.7, 128.2, 128.0, 127.9, 125.7, 20.5. 
 
HRMS (EI+) 
 Calculated for C13H13O2B (M)+: 212.1009 
 Found:     212.1005 
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Boronic acid 2.14d 
The general procedure was followed using 2.13d (226 mg, 0.686 mmol) and 1 M 
aq. NaOH (2.06 mL, 2.06 mmol).  The title compound was isolated as a pale green solid 
(131 mg, 88%). 
 
TLC (Et2O:CH3CN 3:1) 
Rf = 0.57, visualized by UV 
 
1H-NMR (500 MHz, d6-DMSO:D2O 95:5) 
δ 7.64 (d, J = 3.5 Hz, 1H), 7.57 (d, J = 8 Hz, 2H), 7.47 (d, J = 3.5 Hz, 1H), 7.24 (d, 
J = 8Hz, 2H), 2.32 (s, 3H). 
 
13C-NMR (125 MHz, d6-DMSO:D2O 95:5) 
 δ 148.9, 137.2, 137.2, 131.0, 129.6, 125.4, 124.1, 20.6. 
 
HRMS (TOF ES+) 
 Calculated for C11H12O2BS (M+H)+:  219.0651 
 Found:     219.0659 
 
 
 
Boronic acid 2.14e 
The general procedure was followed using 2.13e (243 mg, 0.696 mmol) and 1 M 
aq. NaOH (2.09 mL, 2.09 mmol).  The title compound was isolated as an off-white solid 
(138 mg, 83%). 
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TLC (EtOAc) 
Rf = 0.40, stained by KMnO4 
 
1H-NMR (500 MHz, d6-DMSO:D2O 95:5) 
 δ 7.79-7.26 (m, 9H), 6.24 (d, J = 18.5 Hz, 1H), 2.35 (s, 3H). 
 
13C-NMR (125 MHz, d6-DMSO:D2O 95:5) 
 δ 145.8, 140.4, 138.1, 136.9, 136.9, 129.5, 129.3, 126.5, 126.5, 125.2, 124.7, 20.6. 
 
HRMS (CI+) 
 Calculated for C15H16O2B (M+H)+: 239.1243 
 Found:     239.1244 
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Boronic acid 2.14f 
The general procedure was followed using 2.13f (202 mg, 0.56 mmol) and 1M aq. 
NaOH (1.67 mL, 1.67 mmol).  The title compound was isolated as an off-white solid 
(127 mg, 91%). 
 
TLC (EtOAc) 
Rf = 0.41, visualized by UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.49 (d, J = 8 Hz, 2H), 7.40-7.22 (m, 5H), 7.07 (m, 1H), 2.40 (s, 3H), 2.29 (m, 
1H), 1.33 (m, 1H), 1.22 (m, 1H), 0.44 (m, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 145.2, 143.2, 141.3, 138.4, 137.0, 129.4, 128.7, 127.0, 124.6, 124.3. 
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HRMS (FAB+) 
 Calculated for C16H18O2B (M+H)+: 253.1400 
 Found:     253.1401 
 
 
 
Total synthesis of ratanhine (Schemes 2.7, 2.8 and 2.10) 
 
 
 
 
MIDA boronate 2.17 
The general procedure for the synthesis of haloboronate esters 2.13 (see above) 
was followed using 5-bromo-2-benzofuranylboronic acid (2.23)4 (1.33 g, 5.50 mmol), N-
methyliminodiacetic acid (970 mg, 6.60 mmol), benzene (80 mL) and DMSO (8 mL).  
The mixture was refluxed for 13 h.  The product was eluted using a gradient of 
Et2O:MeCN 1:1 Æ 1:2.  The title compound was isolated as an analytically pure, off-
white, crystalline solid (1.73 g, 90%). 
 
TLC (EtOAc) 
Rf = 0.31, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.55 (d, J = 1.5 Hz, 1H), 7.42 (d, J = 8.5 Hz, 1H), 7.34 (dd, J = 8.5, 1.5 Hz, 1H), 
7.05 (d, J = 1.5 Hz, 1H), 6.50 (dd, J = 16, 1.5 Hz, 1H), 6.24 (dq, J = 16, 6.5 Hz, 
1H), 4.11 (d, J = 17 Hz, 2H), 3.96 (d, J = 17 Hz, 2H), 2.69 (s, 3H), 1.85 (dd, J = 
6.5, 1.5 Hz, 3H). 
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13C-NMR (125 MHz, CD3CN) 
δ 169.0, 157.1, 131.3, 128.3, 124.8, 116.0, 115.2, 114.0, 62.6, 48.2. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 9.3 
 
HRMS (EI+) 
 Calculated for C13H11O5NBrB (M)+: 350.9914 
Found:      350.9913 
 
Elemental Analysis 
Calculated: C, 44.36 H, 3.15 N, 3.98 Br, 22.70  
Found:   C, 44.43 H, 2.81 N, 3.98 Br, 22.96  
 
IR (thin film, cm-1) 
3012, 2964, 1754, 1467, 1446, 1282, 1233, 1199, 1140, 1078, 1047, 1002, 989, 
802. 
 
 
 
Synthesis of MIDA boronate 2.18 
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Methoxymethylether 2.34 
To a stirred mixture of 2-bromo-5-methoxyphenol (2.24)5 (2.19 g, 10.8 mmol) 
and K2CO3 (4.46 g, 32.3 mmol) in acetone (55 mL) was added chloromethyl methyl ether 
(1.63 mL, 21.5 mmol).  The mixture was refluxed for 3 h and then allowed to cool to 23 
oC.  The mixture was filtered and the filtrate was concentrated in vacuo.  The crude 
product was then purified by flash chromatography (SiO2, hexanes:EtOAc 95:5) to 
provide 2.25 as colorless liquid (2.43 g, 92%). 
 
TLC (hexanes:EtOAc 95:5) 
Rf = 0.17, stained by anisaldehyde (red) 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.40 (d, J = 9 Hz, 1H), 6.77 (d, J = 3 Hz, 1H), 6.46 (dd, J = 9, 3 Hz, 1H), 5.22 (s, 
2H), 3.77 (s, 3H), 3.51 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 160.0, 154.4, 133.1, 108.1, 103.4, 103.2, 95.1, 56.3, 55.5. 
 
HRMS (EI+) 
 Calculated for C9H11O3Br (M)+: 245.9892 
 Found:   245.9891 
 
IR (thin film, cm-1) 
3087, 2998, 2959, 2938, 2907, 2835, 1587, 1483, 1426, 1393, 1307, 1281, 1253, 
1219, 1155, 1086, 1056, 1023, 991, 841, 792. 
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Aryliodide 2.2614 
To a stirred solution of 2.25 (1.04 g, 4.23 mmol) in THF (13 mL) at -95 ºC 
(hexanes/N2) was added n-BuLi (1.6 M in hexanes, 2.91 mL, 4.65 mmol) and the 
resulting solution was stirred for 5 min.  To this solution was then added by syringe a 
solution of I2 (1.28 g, 5.07 mmol) in THF (8.5 mL) until a yellow color persisted.  The 
solution was then permitted to warm to 23 oC and concentrated in vacuo.  The residue 
was purified by flash chromatography (SiO2, petroleum ether:Et2O 8:1) to provide 2.26 as 
a pale-orange oil (1.04 g, 84%). 
 
TLC (petroleum ether:Et2O 8:1) 
Rf = 0.16, stained by anisaldehyde (red) 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.62 (d, J = 8.5 Hz, 1H), 6.70 (d, J = 3 Hz, 1H), 6.39 (dd, J = 8.5, 3 Hz, 1H), 
5.22 (s, 2H), 3.78 (s, 3H), 3.51 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 161.2, 156.8, 139.1, 109.0, 102.3, 95.0, 75.8, 56.4, 55.5. 
 
HRMS (EI+): 
 Calculated for C9H11O3I (M)+: 293.9753  
 Found:   293.9758  
 
IR (thin film, cm-1) 
2999, 2959, 2936, 2904, 2835, 1580, 1477, 1424, 1392, 1304, 1279, 1253, 1218, 
1162, 1085, 1052, 991, 924, 840, 791. 
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Aryl bromide 2.27 
To a stirred solution of 2.26 (5.24 g, 17.8 mmol) in MeCN (55 mL) was added 
silica gel (1.32 g), 2,6-di-tert-butyl-4-hydroxytoluene (60 mg), and then N-
bromosuccinimide (3.17 g, 17.8 mmol).  The mixture was stirred at 23 oC for 1 hour and 
then filtered.  The filtrate was concentrated in vacuo and the residue was dissolved in 
CH2Cl2 (100 mL).  To this solution was added water (100 mL) and the resulting mixture 
was vigorously stirred for 5 min.  The layers were then separated and the aq. phase was 
extracted with CH2Cl2 (2 x 100 mL).  The combined organics were dried over MgSO4 
and concentrated in vacuo.  The residue was purified by flash-column chromatography 
(SiO2, petroleum ether:Et2O 8:1) to provide 2.27 as a yellow oil (5.05 g, 76%). 
 
TLC (petroleum ether:Et2O 8:1) 
Rf = 0.17, stained by anisaldehyde (red) 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.85 (s, 1H), 6.73 (s, 1H), 5.23 (s, 2H), 3.87 (s, 3H), 3.52 (s, 3H). 
 
13C-NMR (CD3CN) 
 δ 157.0, 156.6, 141.3, 104.7, 100.1, 95.4, 75.5, 56.5, 56.4. 
 
HRMS (EI+): 
 Calculated for C9H10O3BrI (M)+: 371.8858  
 Found:   371.8859  
 
IR (thin film, cm-1) 
2999, 2963, 2937, 2906, 2853, 2826, 1575, 1470, 1439, 1408, 1358, 1283, 1268, 
1217, 1151, 1086, 1056, 994, 993, 878, 818. 
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MIDA boronate 2.18 
In a glove box, to a 40 mL I-Chem vial equipped with a stir bar and containing 
2.27 (500 mg, 1.34 mmol) was added potassium acetate (395 mg, 4.02 mmol), 
bis(neopentylglycolato)diboron (363 mg, 1.61 mmol) and PdCl2(dppf) (33 mg, 0.040 
mmol).  The vial was sealed with a septum cap and then removed from the glove box.  To 
the vial was then added DMSO (11 mL) and the resulting mixture was sealed under an 
atmosphere of argon and stirred at 80 ºC for 13 h.  The mixture was then allowed to cool 
to 23 oC and 1 M aq. NaOH was added (0.9 mL, 0.9 mmol).  The mixture was stirred at 
23oC for 10 minutes and then diluted with saturated aq. NH4Cl (50 mL), water (50 mL), 
and Et2O (100 mL).  The layers were separated and the organic phase was washed with 
water (3 x 100 mL), dried over MgSO4, and concentrated in vacuo.  The residue was 
thrice dissolved in MeCN and concentrated in vacuo to afford a crude sample of boronic 
acid 2.28 as a light brown solid (343 mg): TLC (EtOAc) Rf = 0.50, stained by KMnO4; 
1H-NMR (400 MHz, CDCl3) δ 7.97 (s, 1H), 6.75 (s, 1H), 5.97 (s, 2H), 5.29 (s, 2H), 3.91 
(s, 3H), 3.52 (s, 3H).  To this crude boronic acid dissolved in benzene:DMSO (10:1) was 
added N-methyliminodiacetic acid (210 mg, 1.43 mmol).  The flask was fitted with a 
Dean-Stark trap and a reflux condenser and the mixture was refluxed with stirring for 11 
h followed by concentration in vacuo.  The resulting crude product was adsorbed onto 
Florisil gel from a MeCN solution.  The resulting powder was dry-loaded on top of a 
silica gel column slurry-packed with Et2O.  The column was flushed with a copious 
volume of Et2O and then the product was eluted with Et2O:MeCN 1:1 to yield MIDA 
boronate 2.18 as an off-white solid (365 mg, 68% yield over two steps). 
 
TLC (Et2O:CH3CN 3:1) 
Rf = 0.44, stained by KMnO4 
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1H-NMR (500 MHz, CD3CN) 
δ 7.62 (s, 1H), 6.76 (s, 1H), 5.18 (s, 2H), 4.06 (d, J = 17 Hz, 2H), 3.94 (d, J = 17 
Hz, 2H), 3.85 (s, 3H), 3.39 (s, 3H), 2.64 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.5, 161.6, 158.6, 139.0, 103.6, 100.1, 95.1, 64.4, 64.2, 56.9, 48.4. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 11.9 
 
HRMS (EI+) 
 Calculated for C14H17O7NBrB (M)+: 401.0281  
 Found:    401.0281  
 
IR (thin film, cm-1) 
3008, 2963, 2944, 2904, 1768, 1596, 1558, 1488, 1446, 1367, 1337, 1276, 1198, 
1164, 1147, 1048, 1035, 1006, 951, 858. 
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Iterative Suzuki-Miyaura coupling of building blocks 2.16–2.19 
 
 
 
 
MIDA boronate 2.29 
The general procedure for Suzuki-Miyaura coupling reactions (see above) was 
followed using 2.17 (352 mg, 1.00 mmol) and (E)-1-propenylboronic acid (144 mg, 2.00 
mmol).  The product was eluted using a gradient of Et2O:MeCN 10:1 Æ 1:1.  The desired 
product 2.29 was isolated as a colorless crystalline solid (251 mg, 80%). 
TLC (EtOAc) 
Rf = 0.34, stained by KMnO4 
1H-NMR (500 MHz, CD3CN) 
δ 7.55 (m, 1H), 7.42 (d, J =  8.5 Hz, 1H), 7.34 (dd, J = 8.5 Hz, 1H), 7.05 (d, J = 1 
Hz, 1H), 6.51 (m, 1H), 6.25 (dq, J = 16, 7 Hz, 1H), 4.11 (d, J = 17 Hz, 2H), 3.96 
(d, J = 17 Hz, 2H), 2.69 (s, 3H), 1.85 (dd, J = 7, 2 Hz, 3H). 
13C-NMR (125 MHz, CD3CN) 
δ 169.1, 157.6, 134.0, 131.8, 129.5, 125.5, 123.7, 119.4, 115.8, 112.2, 62.6, 48.1, 
18.6. 
11B-NMR (100 MHz, CD3CN) 
δ 9.8 
HRMS (EI+): 
Calculated for C16H16O5NB (M)+:  313.1122 
Found:     313.1123 
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IR (thin film, cm-1) 
3008, 2958, 1767, 1711, 1563, 1453, 1336, 1283, 1253, 1175, 1053, 1006, 963, 
855. 
 
 
Boronate ester 2.31 
The general procedure for deprotection of boronate esters (see above) was 
followed using 2.29 (313 mg, 1.00 mmol), and 1 M aq. NaOH (3.0 mL, 3.0 mmol) to 
afford boronic acid 2.30 as an off-white solid (188 mg, 93%);  TLC: (EtOAc) Rf = 0.2, 
visualized by UV; HRMS (EI+): Calculated for C11H11O3B (M)+ 202.0801, Found 
202.0805.  Boronic acid 2.30 was found to be very sensitive to decomposition upon 
storage and was therefore used immediately in the next reaction.  In a glove box, to a 40 
mL I-Chem vial containing 2.18 (141 mg, 0.351 mmol) was added boronic acid 2.30 (106 
mg, 0.526 mmol) as a solution in THF (3.15 mL) followed by solid K2CO3 (145 mg, 1.05 
mmol).  To the vial was then added 350 µL of a THF catalyst stock solution containing 2-
(dicyclohexylphosphino)biphenyl (0.04 M) and Pd2dba3 (0.01 M) which was 
preincubated at 65 ºC for 30 min. with stirring.  The vial was sealed with a PTFE-lined 
cap, removed from the glove box, and maintained at 80 ºC with stirring for 28 h.  The 
reaction mixture was allowed to cool to 23 oC, and was then passed through a thin pad of 
silica gel topped with Celite, eluting with a copious volume of Et2O.  The filtrate was 
concentrated in vacuo and the resulting crude product was adsorbed onto Florisil gel from 
a MeCN solution.  The resulting powder was dry-loaded on top of a silica gel column 
slurry-packed with Et2O.  The column was flushed with a copious volume of Et2O; the 
product was then eluted with Et2O:MeCN 3:1 to yield boronate ester 2.31 as an off-white 
solid (123 mg, 73%). 
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TLC (Et2O:CH3CN 3:1) 
Rf = 0.36, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 8.15 (s, 1H), 7.53 (d, J = 2 Hz, 1H), 7.44 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 2 
Hz, 1H), 7.22 (s, 1H), 6.85 (s, 1H), 6.51 (dd, J = 16, 1.5 Hz, 1H), 6.26 (dq, J = 16, 
6.5 Hz, 1H), 5.25 (s, 2H), 4.11 (d, J = 17 Hz, 2H), 3.99 (d, J = 17 Hz, 2H), 3.99 (s, 
3H), 3.42 (s, 3H), 2.68 (s, 3H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 169.7, 162.5, 160.0, 154.0, 153.8, 134.2, 133.6, 131.9, 131.2, 125.3, 123.0, 118.
8,  
113.1, 111.4, 105.4, 98.6, 95.0, 64.5, 57.0, 56.4, 48.4, 18.6. 
 
11B-NMR (100 MHz, CD3CN) 
 δ 12.0 
 
HRMS (FAB+) 
 Calculated for C25H27O8NB (M+H)+:  480.1830 
 Found:      480.1828 
 
IR (thin film, cm-1) 
3009, 2959, 2911, 2850, 1768, 1710, 1605, 1575, 1501, 1446, 1368, 1337, 1299, 
1267, 1193, 1153, 1139, 1080, 1036, 1008, 964, 859, 816. 
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MOM-ratanhine 2.33 
A 6 mL vial equipped with a stir bar was charged with boronate ester 2.31 (51 mg, 
0.106 mmol), THF (1.0 mL), and 1 M aq. NaOH (0.32 mL, 0.32 mmol).  The resulting 
mixture was vigorously stirred for 10 min., then diluted with 0.5 M pH 7 phosphate 
buffer (2.0 mL) and Et2O (1.0 mL).  The phases were separated and the aq. phase was 
extracted once with THF:Et2O 1:1 (2.0 mL).  The combined organics were dried over 
MgSO4, filtered, and then concentrated in vacuo.  Residual solvent was removed via 
coevaporation with PhMe, followed by MeCN (2X), and then CH2Cl2 (2X) (bath 
temperature maintained at < 30 oC) to yield boronic acid 2.32 as an off-white solid (39.2 
mg, 99%):  TLC (EtOAc) Rf = 0.53, visualized by UV;  1H NMR (400 MHz, CDCl3) δ 
8.49 (s, 1H), 7.49 (s, 1H), 7.42 (d, J = 8 Hz, 1H), 7.26 (m, 1H), 7.17 (s, 1H), 6.84 (s, 1H), 
6.49 (d, J = 16 Hz, 1H), 6.20 (dq, J = 16, 6.4 Hz, 1H), 5.77 (s, 2H), 5.35 (s, 2H), 4.03 (s, 
3H), 3.55 (s, 3H), 1.90 (d, J = 6.4 Hz, 3H); HRMS (TOF ES+): Calculated for C20H22O6B 
(M+H)+ 369.1509, Found 369.1515.   
This boronic acid was then quantitatively transferred as a solution in THF to a 6 
mL vial containing 2.19 (28.5 mg, 0.071 mmol) and the solvent was removed in vacuo. In 
the glove box, to this vial was added solid K2CO3 (39.2 mg, 0.28 mmol), and a freshly-
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prepared THF solution (1.06 mL) of 2-(dicyclohexylphosphino)biphenyl (0.008 M) and 
Pd2dba3 (0.002 M). A stir bar was added and the vial was sealed with a PTFE-lined cap, 
removed from the glove box, and maintained at 65 ºC with stirring for 20 h.  The reaction 
mixture was then allowed to cool to 23 oC and passed through a thin pad of silica gel 
topped with Celite, eluting with a copious volume of EtOAc.  The filtrate was 
concentrated in vacuo, and the resulting crude product was adsorbed onto Florisil gel 
from a CH2Cl2 solution.  The resulting powder was dry-loaded on top of a silica gel 
column slurry-packed with hexanes:EtOAc 10:1.  The column was eluted with 
hexanes:EtOAc 10:1 Æ 3:1 to yield 2.33 as a viscous yellow oil (37.0 mg, 81%). 
 
TLC (Hexanes:ethyl acetate 1:1) 
 Rf = 0.47, visualized by UV 
 
1H-NMR (500 MHz, CDCl3) 
7.76 (s, 1H), 7.65 (d, J = 9 Hz, 2H), 7.49 (d, J = 2 Hz, 1H), 7.44 (d, J = 1 Hz, 1H), 
7.31 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 2 Hz, 1H), 7.24 (dd, J = 8.5, 1.5 Hz, 
1H), 6.99 (s, 1H), 6.98 (d, J = 8.5 Hz, 1H), 6.64 (d, J = 9 Hz, 2H), 6.61 (s, 1H), 
6.49 (dd, J = 16, 1 Hz, 1H), 6.45 (dd, J = 16, 1 Hz, 1H), 6.26 (dq, J = 16, 6.5 Hz, 
1H), 6.20 (dq, J = 16, 6.5 Hz, 1H), 5.53 (d, J = 1.5 Hz, 1H), 5.51 (d, J = 1.5 Hz, 
1H), 4.84 (s, 2H), 4.64 (s, 2H), 3.92 (s, 3H), 3.28 (s, 3H), 3.17 (s, 3H), 1.91 (app d, 
J = 6.5 Hz, 6H). 
 
13C-NMR (125 MHz, CDCl3) 
164.2, 160.9, 157.2, 155.2, 152.8, 152.5, 146.6, 144.4, 135.7, 135.6, 132.7, 131.8, 
131.3, 130.3, 130.1, 128.8, 127.8, 125.8, 125.3, 124.1, 124.0, 122.8, 122.1, 121.8, 
119.2, 117.6, 114.5, 112.9, 110.6, 104.3, 98.5, 94.4, 93.5, 55.9, 55.8, 55.6, 18.5, 
18.5. 
 
HRMS (TOF ES+) 
Calculated for C40H39O8 (M+H)+:  647.2645 
Found:     647.2642 
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IR (thin film, cm-1) 
2961, 2928, 2913, 1732, 1606, 1574, 1508, 1448, 1379, 1264, 1243, 1197, 1168, 
1151, 1080, 1065, 1002, 967,  
 
 
 
 
Ratanhine 2.15 
A 6 mL vial equipped with a stir bar was charged with 2.33 (27 mg, 0.042 mmol), 
THF (0.3 mL), MeOH (0.6 mL), and concentrated HCl (12 µL).  The vial was sealed with 
a PTFE-lined cap and maintained at 65 ºC with stirring for 1 h.  The solution was then 
allowed to cool to 23 ºC and diluted with H2O (1 mL), THF (1 mL) and Et2O (2 mL).  
The phases were separated and the aq. phase was extracted repeatedly with EtOAc.  The 
combined organics were concentrated in vacuo and the resulting crude product was 
purified by preparative HPLC (Waters SunFire Prep C18 OBD 30 x 150 mm column, Lot 
# 168I161701, 25 mL/min., H2O:MeCN 95:5 Æ 5:95 over 20 min., then H2O:MeCN 5:95 
for 15 min.; tR = 24.84 min with UV detection at 325 and 218 nm) to yield 2.15 (9.6 mg, 
41%) [1H NMR analysis demonstrated that this sample contained a small amount (~5-
10%) of an unidentified impurity.]  An optimized preparative HPLC method was 
subsequently developed (Waters SunFire Prep C18 OBD 30 x 150 mm column, Lot # 
168I161701, 33 mL/min., isochratic H2O:MeCN 20:80; tR = 21.72 min with UV 
detection at 325 and 218 nm) that yielded the pure natural product.  1H NMR, 13C NMR, 
HRMS, and IR analysis of synthetic 2.15 were fully consistent with the data reported for 
the isolated natural product ratanhine (see below), thus confirming the original structure 
proposed by Arnone and coworkers. 15 
 
 93
TLC (Hexanes:EtOAc, 1:1) 
Rf = 0.49, visualized by UV 
 
1H-NMR (500 MHz, d6-DMSO) 
δ  10.25 (br s, 1H), 9.82 (br s, 1H), 7.52 (s, 1H), 7.48 (d, J = 8.5 Hz, 2H), 7.48 (s, 
1H), 7.40 (s, 1H), 7.39 (m, 1H), 7.39 (m, 1H), 7.25 (d, J = 8.5 Hz, 1H), 7.07 (d, J 
= 8 Hz, 1H), 7.01 (s, 1H), 6.59 (d, J = 8.5 Hz, 2H), 6.47 (s, 1H), 6.47 (d, J = 16 
Hz, 1H), 6.47 (d, J = 16 Hz, 1H), 6.31 (dq, J = 16, 7 Hz, 1H), 6.23 (dq, J = 16, 7 
Hz, 1H), 5.51 (s, 1H), 5.44 (s, 1H), 3.86 (s, 3H), 1.86 (m, 3H), 1.86 (m, 3H). 
 
13C-NMR (125 MHz, d6-DMSO) 
δ 163.8, 162.3, 156.8, 156.4, 152.5, 152.1, 146.6, 142.8, 135.3, 135.0, 132.4, 
131.7 (2C), 131.1, 130.0, 129.7, 127.7, 127.4, 125.7, 125.2, 123.7, 123.2, 121.6, 
120.7, 119.0, 118.8, 117.5, 114.8 (2C), 110.4, 109.5, 103.3, 99.4, 55.5, 18.3, 18.3. 
 
HRMS (TOF ES+) 
 Calculated for C36H31O6 (M+H)+: 559.2121 
 Found:     559.2118 
 
IR (thin film, cm-1) 
 3344, 1700, 1608, 1591, 1502, 1447, 1267, 1197, 1163, 1101, 1076, 1031, 964, 
912. 
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1H NMR data for natural15 and synthetic ratanhine: δH/ppm (integration) 
 
Natural 2.15  
(300 MHz, d6-DMSO) 
Synthetic 2.15 
(500 MHz, d6-DMSO) 
10.22 (1H) 10.25 (1H) 
9.78 (1H) 9.82 (1H) 
7.52 (1H)  7.52 (1H) 
7.51 (2H) 7.48 (2H) 
7.51 (1H) 7.48 (1H) 
7.41 (1H) 7.40 (1H) 
7.39 (1H) 7.39 (1H) 
7.38 (1H) 7.39 (1H) 
7.24 (1H) 7.25 (1H) 
7.07 (1H) 7.07 (1H) 
7.02 (1H) 7.01 (1H) 
6.62 (2H) 6.59 (2H) 
6.50 (1H) 6.47 (1H) 
6.47 (1H) 6.47 (1H) 
6.47 (1H) 6.47 (1H) 
6.31 (1H) 6.31 (1H) 
6.23 (1H) 6.23 (1H) 
5.53 (1H) 5.51 (1H) 
5.46 (1H) 5.44 (1H) 
3.87 (3H) 3.86 (3H) 
1.86 (3H) 1.86 (3H) 
1.86 (3H) 1.86 (3H) 
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13C NMR data for natural15 and synthetic ratanhine: δC/ppm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Natural 2.15  
(69.2 MHz, d6-DMSO) 
Synthetic 2.15 
(125 MHz, d6-DMSO) 
163.8 163.8 
162.1 162.3 
156.7 156.8 
156.3 156.4 
152.5 152.5 
152.0 152.1 
146.5 146.6 
142.8 142.8 
135.3 135.3 
134.9 135.0 
132.3 132.4 
131.7 (2C) 131.7 (2C) 
131.0 131.1 
130.0 130.0 
129.7 129.7 
127.7 127.7 
127.4 127.4 
125.6 125.7 
125.1 125.2 
123.7 123.7 
123.1 123.2 
121.6 121.6 
120.7 120.7 
119.0 119.0 
118.7 118.8 
117.4 117.5 
114.8 (2C) 114.8 (2C) 
110.4 110.4 
109.5 109.5 
103.3 103.3 
99.4 99.4 
55.4 55.5 
18.2 18.3 
18.2 18.3 
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CHAPTER 3 
SLOW-RELEASE CROSS-COUPLING OF MIDA BORONATES 
 
Eric P. Gillis, David M. Knapp, Graham R. Dick and Martin D. Burke 
 
In order for the ICC approach to be as broadly applicable as possible, it is 
necessary that boronic acids representing any structural motif can be efficiently engaged 
in the SMC reaction. This chapter describes the development of a highly general SMC 
protocol based on the in situ slow-release of boronic acids from the corresponding MIDA 
boronates. The scope of this slow-release cross-coupling (SRCC) protocol is 
demonstrated in numerous high yielding couplings between otherwise unstable boronic 
acids and aryl chlorides, including couplings of the notoriously unstable 2-pyridyl motif. 
The condensation of MIDA with borate salts at high temperature was found to be an 
efficient route to otherwise difficult-to-access MIDA boronates. David M. Knapp 
contributed to the work presented in this chapter by contributing ideas used in the 
development of SRCC and by performing the experiments described in Table 3.2, Table 
3.3, Table 3.4, Scheme 3.3, and Figure 3.2. Graham R. Dick contributed all of the results 
described in section 3-6. 
 
 
 
Adapted from Knapp, D. M.; Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2009, 131, 6961-6963 and Dick, 
G. R.; Knapp, D. M.; Gillis, E. P.; Burke, M. D. Org. Lett. 2010, 12, 2314-2317. 
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3-1 BACKGROUND 
Traditionally efforts towards increasing the substrate scope of the SMC reaction1 
have focused on the design of more reactive catalysts for this transformation.2 However, 
despite these remarkable developments certain classes of boronic acids/esters remain 
ineffective coupling partners in the SMC reaction, especially in reactions employing 
difficult halide coupling partners such as electron-rich aryl chlorides.3,4,5 Specifically, 
boronic acids representing 2-heterocyclic,3,4,5 vinyl,6  and cyclopropyl derivatives7  are 
known to be particularly sensitive to decomposition. In some cases this instability renders 
storage of these reagents difficult and limits the ability to input a pure form of the boronic 
acid to the SMC reaction. In addition, decomposition processes for boronic acids are 
thought to be accelerated in the presence of heat, base, and/or a Pd catalyst, causing the in 
situ decomposition of unstable boronic acids to compete with their cross-coupling.3 This 
latter challenge is exacerbated in coupling reactions which utilize slower-reacting halides, 
such as unactivated aryl chlorides.3  
To address the challenge of using unstable boronic acids in the SMC reaction, 
efforts have been directed towards developing surrogates for the boron coupling partner 
that possess more favorable properties. 8  These surrogates include trialkoxy or 
trihydroxyborate salts,9,10 diethanolamine adducts,11 sterically bulky boronic esters,12 and 
boroxines.13  As perhaps the most notable advance, trifluoroborates have emerged as 
powerful boron coupling partners that address a number of the shortcomings associated 
with boronic acids. For example, trifluoroborate salts are generally monomeric, free-
flowing, crystalline solids, and many of these building blocks are stable to storage under 
ambient air at room temperature.14 Trifluoroborate salts can serve as useful surrogates for 
otherwise unstable boronic acids,15 and further, the use of trifluoroborate salts in the 
SMC reaction has also expanded the scope of organic groups which can be transferred 
from boron in this transformation.16 However, despite these many advantages, limitations 
remain. Significantly, the general incompatibility of trifluoroborate salts with SiO2 
chromatography17,18 limits the efficiency with which these reagents can be functionalized 
and purified. Further, the use of trifluoroborate salts is associated with the release of HF19 
which can damage glassware and poses a safety and environmental risk. There are a few 
examples of SMC reactions between 2-heterocyclic trifluoroborate salts and electron-rich 
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and/or sterically encumbered aryl chlorides (Table 3.1, entries 1-3);15b there is also a 
recent example of a coupling to an electron-rich aryl mesylate (entry 4).15a However, it 
has not been established that 2-heterocyclic trifluoroborates are generally effective 
coupling partners in reactions with electron-rich aryl chlorides. Further, the stability 
problems inherent to 2-pyridyl boronic acid cannot be addressed through the use of a 
trifluoroborate salt.15c The lack of a boron reagent class and a SMC protocol by which 
otherwise unstable boronic acids could be generally and efficiently utilized in SMC 
couplings with even highly challenging coupling partners such as electron rich- and/or 
sterically encumbered aryl chlorides prompted us to explore a possible solution to this 
important and unmet need. 
 
Table 3.1 
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3-2 STABILITY OF BORONIC ACIDS AND MIDA BORONATES TO STORAGE 
 Although the instability to storage of 2-heterocyclic, vinyl and cyclopropyl 
boronic acids has frequently been discussed in the literature anecdotally,3-7 there is very 
little quantitative data available on this phenomenon. To ground ourselves in a 
quantitative understanding of the stability of these types of boronic acids, a collection of 
freshly prepared boronic acids were stored under ambient air at room temperature and the 
purity of the samples was assayed after 15 days (Table 3.2). Specifically, boronic acids 
3.1a–3.1h were prepared in > 95% purity via base-promoted hydrolysis of the 
corresponding MIDA boronates 3.2a–3.2h. In many cases the yield for this 
transformation was high (entries 1-5). Surprisingly, even vinyl boronic acid (3.2g), which 
has been reported to be unstable to isolation,6a could be accessed as a pure material in 
45% yield through this approach (entry 7). Multiple samples of each pure boronic acid 
3.1a–3.1h were stored at 23 °C on the benchtop in vials that were sealed under ambient 
atmosphere. At specific time intervals a sample of each boronic acid was uncapped, 
assayed via 1H-NMR, and then was discarded. As Table 3.2 indicates, for every boronic 
acid 3.1a–3.1h at least some decomposition was observed after 15 days of storage. For 
boronic acids 3.1a, 3.1e, and 3.1f, the extent of decomposition was so significant that 
essentially no boronic acid was observed after 15 days, and for 3.1g nearly complete 
decomposition (>95%) was observed after just two days. Interestingly, the rate of 
decomposition for 3.1a was not linear, and may indicate an autocatalytic process.20 On 
the other hand, when MIDA boronates were examined under the same storage conditions 
there was no noticeable change in the composition of the samples even after sixty days. 
The stability of MIDA boronates to storage is consistent with the previously observed 
properties of these compounds (chapter 2), and indicates that MIDA boronates might 
serve as bench-stable surrogates for otherwise unstable boronic acids. 
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Table 3.2 
 
 
3-3 FAST-RELEASE CROSS-COUPLING OF MIDA BORONATES 
 Although MIDA boronates can serve as stable surrogates for otherwise unstable 
boronic acids, the MIDA boronate functionality is inert under anhydrous SMC conditions 
and requires a separate hydrolysis step to expose the corresponding reactive boronic acid. 
As indicated above, for many MIDA boronates this deprotection step is straightforward 
and affords a pure boronic acid product which can be isolated in high yield. However, it 
would be more expedient if MIDA boronates could be used directly in the SMC reaction. 
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Further, a number of boronic acids are stable in solution but their isolation can be 
problematic.21 Noting that aqueous base is used both to deprotect MIDA boronates and as 
a standard reagent in the SMC reaction, we wondered if a MIDA boronate under aqueous 
SMC conditions might be deprotected in situ to the corresponding boronic acid, and that 
this boronic acid might be quickly consumed in a SMC reaction. It is known that the 
MIDA ligand can form complexes with PdII species,22 and under the proposed aqueous 
SMC conditions there would likely be at least a 50-fold excess of MIDA relative to the 
Pd catalyst. An important question to be addressed was whether the MIDA ligand 
released by deprotecting a MIDA boronate would have a deleterious impact on the 
reactivity of the Pd catalyst. To address this question, bromoacetophenone 3.3 and 
biphenyl MIDA boronate 3.4 were exposed to SMC conditions utilizing K2CO3 as the 
base in the presence of bulk water (Scheme 3.1). Analysis of the reaction solution by 
TLC indicated that a significant amount of triaryl product 3.5 had been formed. This 
result suggested that the free MIDA ligand (or the diacetate salt of MIDA) did not 
significantly affect the reactivity of the Pd catalyst.23 
 
MeN
O
OB
O
O
Br
Me
O
+
Pd(PPh3)4, K2CO3
THF:H2O (5:1)
65 oC, 12 h
Me
O
3.3 3.4 3.5
 
Scheme 3.1. Exposing MIDA boronate 3.4 to aqueous SMC conditions resulted in formation of a 
significant amount of triaryl product 3.5. This result is attributed to the in situ deprotection of 3.4 under the 
action of aqueous base leading to the release of the corresponding reactive boronic acid. The presence of 
free MIDA ligand in the reaction mixture does not appear to have inhibited the reactivity of the Pd catalyst. 
 
 In a subsequent study, the yields obtained in aqueous “direct release” SMC 
reactions of MIDA boronates were compared to the yields obtained when the 
corresponding boronic acids were subjected to the otherwise identical reaction conditions 
(Table 3.3). Of note, these otherwise standard SMC reaction conditions employed an 
increased amount of base to account for the equivalents of this reagent which are 
consumed in the deprotection of the MIDA boronate. As described in Table 3.3, in all 
cases the yields obtained from 3.6 and 3.7 were effectively the same, with the exceptions 
of entries 5 and 6. In these latter cases the lower yields obtained with 3.6 are likely due to 
partial decomposition of the boronic acids which were used as received from the 
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commercial sources. These results provide further evidence that the MIDA ligand (or the 
diacetate salt of MIDA) does not attenuate the reactivity of the Pd catalyst under “direct 
release” SMC conditions. 
 
Table 3.3 
MeN
O
OB
O
O
ROH
OH
B
R
or
3.6 3.7
Br
R' 3.8a
3.8b
3.8c
R'
C(O)Me
OMe
Me
Pd(PPh3)4, NaOH
THF:H2O 5:1, 60 oC, 24 h
R
R'
R' = C(O)Me,
OMe, or Me
Entry 3.6 or 3.7: R aryl bromide Product Yield from 3.6 (%) Yield from 3.7 (%)
1
2
3
5
6
7
Me
MeO
Me
3
N
4
3.8a
3.8b
3.8a
3.8b
3.8a
3.8a
3.8a
Me
MeO
Me
3
N
R'
R'
R'
R'
R'
96 97
96 93
98
94
98
96
90 96
87 95
96 96
a
a Reaction conditions: 1 equiv. aryl bromide, 1.5 equiv. of 3.6 or 3.7, 7.5 equiv. NaOH, 2 mol % Pd(PPh3)4  
 
 MIDA boronates are fully converted to the corresponding boronic acid within 10 
minutes upon treatment with aqueous NaOH at room temperature (chapter 2). It was 
determined that this transformation at 65 °C is also complete after 10 minutes, although it 
is likely that this process was complete much earlier than this time point. Assuming that 
the MIDA ligand acts as a spectator species, there is little distinction after the first few 
minutes between a SMC process performed using pure boronic acid and a “fast-release” 
SMC process performed using a MIDA boronate with aqueous NaOH present. In essence, 
both of these reactions necessarily have a similar amount of boronic acid present at any 
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point in time. As a consequence, although “fast-release” Suzuki-Miyaura couplings 
employing aqueous NaOH allow MIDA boronates to be used directly in this reaction, and 
by using MIDA boronates the challenge of storing unstable boronic acids is mitigated, 
this approach does not address the problem that is faced when the boronic acid is unstable 
to the conditions of the SMC reaction. For example, it was observed that both freshly-
prepared furanyl boronic acid 3.1a and MIDA boronate 3.2a performed similarly poorly 
in a SMC reaction with deactivated aryl chloride 3.9a (Scheme 3.2). Subsequent 
experiments (see below) indicate that 3.1a is prone to rapid deboronation in the presence 
of aqueous base, which is consistent with the well recognized limitation of using unstable 
boronic acids in the SMC reaction.3,4,5 
 
Scheme 3.2. A SMC reaction between 3.1a and electron-rich aryl chloride 3.9a proceeded in modest yield. 
The corresponding MIDA boronate performed similarly poorly under the same SMC reaction conditions. 
The MIDA boronate is almost certainly completely deprotected within the first few minutes of the reaction, 
thus both of these reactions necessarily have a similar amount of boronic acid present at any point in time. 
 
3-4 SLOW-RELEASE CROSS-COUPLING OF MIDA BORONATES 
 A likely explanation for the low yields observed in the SMC reactions presented 
in Scheme 3.2 is that the rate of consumption of 3.1a through a productive coupling 
reaction is competitive with the rate of consumption of 3.1a through a destructive proto-
deboronation reaction. The sub-stoichiometric quantity of catalyst, in this case ≤ 5% 
relative to the halide, represents a significant bottleneck in the reaction. For example, at 
the start of the reaction (t = 0) only at most 5% of the boronic acid can undergo a reaction 
with the palladium catalyst, leaving the remaining 95% of the boronic acid in solution 
and vunerable to decomposition. Since the decomposition pathways for the boronic acid 
likely involve water and/or base,24 but not palladium,25 the 95% of boronic acid that 
remains outside of the catalytic cycle will begin to decompose at a rate independent of 
the turn-over frequency (TOF) of the catalyst. Meanwhile, the productive consumption of 
the boronic acid is dependent on the TOF of the catalyst, the most dilute species in the 
reaction. 
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 One approach towards increasing the efficiency of SMC reactions employing 
sensitive boronic acids, where the rate of decomposing of the boronic acid is competitive 
with the rate of productive coupling, is to increase the amount of catalyst used in the 
reaction. The effect of adding more catalyst to the reaction is that more catalytic sites will 
be available; with all reactant concentrations otherwise equal, the increased amount of 
catalyst will not affect the TOF of the catalyst.26 With more catalytic sites available to the 
boronic acid, the bottleneck in the productive consumption of this reagent is reduced. As 
described in chapter 2, this type of approach was applied successfully to improve the 
conversion of 2.32 to 2.33. However, this approach is not practical for highly sensitive 
boronic acids because the amount of Pd catalyst required to obtain a favorable yield 
would be prohibitive. 
 Alternatively, a sensitive boronic acid might be efficiently utilized in a SMC 
reaction if it were added to the reaction flask at a rate slower than the TOF of the 
catalyst.27 The reasoning underlying this hypothesis is that the productive consumption of 
the boronic acid would be fastest if there was a higher stoichiometry of the catalyst than 
the borane. That is, the reaction would be fastest if every molecule of boronic acid had 
access to a free catalytic site at the start of the reaction. For example, assuming that the 
catalytic species had already been formed from the pre-catalyst, repeating the reaction of 
Scheme 3.2 with 1/10,000th of the original amount of boronic acid would be expected to 
lead to very high consumption of 3.1a through the productive versus destructive pathway. 
Once the catalytic species returned to equilibrium, a second portion of the same very 
small amount of boronic acid could be added, with the expectation of an equally effective 
coupling. If in theory if this process was repeated an additional 10,000 times, almost all 
of the boronic acid might be consumed in a productive coupling. A more reasonable way 
to implement a similar concept would be to add the boronic acid to the SMC reaction at a 
rate that is slower than the catalyst TOF. Therefore, to test the hypothesis that slow 
addition of an unstable boronic acid might lead to an efficient SMC reaction, the coupling 
experiment of Scheme 3.2 was repeated with the difference that freshly prepared 3.1a 
was added to the flask over the course of 3 hours via a syringe pump. Consistent with our 
hypothesis, a nearly quantitative 98% yield of the biaryl product 3.10a was isolated 
(Scheme 3.3). 28  This finding is consistent with the report that slow addition of 3-
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thiophenylboronic acid to a SMC reaction led to an improvement in yield relative to if the 
entirety of the boronic acid was added at the start of the reaction.3 With this result, we 
proposed that a similar phenomenon might be observed if, instead of using a syringe-
pump, the slow introduction of boronic acid resulted from slow in situ deprotection of a 
MIDA boronate. 
 
 
Scheme 3.3. Slow addition of furanyl boronic acid 3.1a to the SMC to the reaction mixture resulted in 
nearly quantitative yield of the biaryl product 3.10a. This remarkable increase in yield is attributed to the 
addition rate of the boronic acid being slower than the TOF of the Pd catalyst. 
 
 
Discovery of slow-release conditions for MIDA boronates 
To test our hypothesis that slow release of boronic acids from MIDA boronates 
would lead to high yields in the SMC reaction regardless of the sensitivity of the 
corresponding boronic acid, we first needed to discover conditions that would effect the 
deprotection of a MIDA boronate at a rate slower than the TOF of the Pd catalyst. Our 
prior result using a syringe-pump indicated that release of the boronic acid over the 
course of three hours would likely lead to an efficient SMC reaction. However, to more 
accurately determine the rates of the processes involved, we first attempted to establish 
the rate of the SMC reaction between 3.1a and aryl chloride 3.9a. To do this, freshly-
prepared boronic acid 3.1a and aryl chloride 3.9a were combined under the SMC 
conditions of Scheme 3.3 (but without syringe-pump addition) and the conversion of 3.9a 
was monitored over the course of the reaction (Figure 3.1). Consistent with our previous 
findings described in Scheme 3.2, the reaction stalled at 62% conversion. Still, these 
results indicated that the SMC reaction required only 30 minutes to reach maximum 
conversion. To provide evidence that the poor conversion of this reaction was due to the 
decomposition of the boronic acid, in a subsequent experiment freshly prepared 3.1a was 
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combined with aqueous K3PO4 and dioxane at 60 oC and the percentage of boronic acid 
that remained was monitored over the course of six hours (Figure 3.2). Under these 
conditions approximately 40% of 3.1a had decomposed within 1 hour, and essentially all 
of 3.1a had decomposed within 6 hours. To an approximation, the results presented in 
Figure 3.2 account for the fact that the coupling between 3.1a and 3.9a stalls at 62% 
conversion within one hour. This coupling likely cannot proceed past 62% conversion 
because at this point all of 3.1a has been consumed either through a cross-coupling 
reaction or a decomposition process. Overall, these experiments indicated that MIDA 
boronates should be deprotected at 60 °C over the course of at least 30 minutes in order 
to achieve a rate of release that is slower than the TOF of the catalyst. 
 
 
 
Figure 3.1. The conversion of 3.9a in a SMC reaction with boronic acid 3.1a was monitored by GC. These 
results indicate that this reaction is fast but stalls at 60% conversion. These results are consistent with the 
previously observation that under similar conditions this coupling affords the product in 64% yield.  
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Reproduced with permission from Knapp, D. M.; Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2009, 131, 6961-6963. 
Copyright 2009 American Chemical Society. 
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Figure 3.2. The rate of decomposition of boronic acid 3.1a under mock SMC conditions (absent the Pd 
complex) was monitored by 1H-NMR. Specifically, the amount of boronic acid remaining was determined 
over the course of six hours. 
 
 Early work in the context of testing the stability of MIDA boronates to base 
(chapter 2, table 2.5) indicated that MIDA boronates upon treatment with aqueous 
NaHCO3, Na2CO3, K2CO3 or K3PO4 at room temperature hydrolyzed to the 
corresponding boronic acid. Importantly, it was observed that this process was much 
slower than when MIDA boronates were treated with NaOH, and in fact was only 
partially complete after 24 hours. Building on these results, we surveyed the rate of 
hydrolysis of a MIDA boronate when treated with aqueous K3PO4 at 23 °C, 40 °C and 
60 °C and observed by TLC that the rate of hydrolysis increased as the temperature of the 
reaction increased. Specifically, the hydrolysis reaction at 60 °C was complete between 4 
and 12 hours, while the reactions at 23 °C and 40 °C were incomplete after 12 hours. 
To quantitatively determine the rate of deprotection of 3.2a upon treatment with 
aqueous K3PO4, a series of experiments was performed in which 3.2a was dissolved in 
dioxane-d8 and was treated with K3PO4 in D2O. These reactions were stirred at 60 °C or 
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Reproduced with permission from Knapp, D. M.; Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2009, 131, 6961-6963. 
Copyright 2009 American Chemical Society. 
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100 °C. Every hour a sample at each temperature was diluted with CD3CN, by 1H-NMR 
the amount of 3.2a remaining was judged against an internal standard, and then the 
sample was discarded. The results of these experiments are summarized in Figure 3.3 and 
indicate that at 60 °C the deprotection of 3.2a required between three and four hours to 
complete. This rate of deprotection is slower than the rate of cross-coupling observed in 
Figure 3.1, meeting the criteria that the rate of boronic acid release must be slower than 
the TOF of the catalyst. Even at 100 °C the deprotection of 3.2a required between 30 and 
60 minutes to complete. This result suggests that the slow-release cross-coupling 
approach may be applicable even at 100 °C. On the other hand, at 23 °C the deprotection 
of 3.2a required 24 hours to complete. Interestingly, in these experiments it was 
necessary to measure the N-CH3 resonances of the MIDA boronates because the 
diastereotopic methylene protons were completely exchanged for deuterium atoms within 
the first 10 minutes of treatment with K3PO4 in D2O, even when this reaction was 
performed at room temperature. 
 
 
Figure 3.3. The rate of hydrolysis of 3.2a is dependent on the temperature of the reaction. In all cases the 
rate of hydrolysis is much slower than the similar reaction employing NaOH. This phenomenon is referred 
to as “slow-release”. 
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Reproduced with permission from Knapp, D. M.; Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2009, 131, 6961-6963. 
Copyright 2009 American Chemical Society. 
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The organic group appended to boron may potentially influence the rate of 
deprotection of a MIDA boronate. To explore this possibility, a series of experiments was 
performed in which MIDA boronates representing aryl, heteroaryl, vinyl and alkyl 
(cyclopropyl) appendages were treated with K3PO4 in dioxane-d8:D2O at 60 °C and the 
disappearance of the MIDA boronate was monitored by 1H-NMR as described above 
(Figure 3.4). Consistent with the growing body of evidence suggesting that the reactivity 
of MIDA boronates is general, all four classes of MIDA boronates underwent hydrolysis 
at similar rates, requiring between three and four hours to reach full conversion. 
 
 
 
Figure 3.4. The rate of MIDA boronate hydrolysis was found to be general across aryl, heteroaryl, vinyl 
and alkyl substrates. In all cases the hydrolysis required between three and four hours at 60 °C. 
 
To test our hypothesis that in situ slow-release of a boronic acid from a MIDA 
boronate would enable the efficient coupling of an otherwise unstable boronic acid, a 
SMC experiment was performed employing the conditions which were identified to 
provide a release rate of boronic acid that is slower than the TOF of the catalyst.27 
Specifically, 1.0 equivalent of furanyl MIDA boronate 3.2a and 1.0 equivalent of aryl 
R B(OH)2dioxane-d8:D2O (5:1)
60 oC
MeN
O
OB
O
OR
K3PO4
time (h) 
%
 M
ID
A
 b
or
on
at
e 
re
m
ai
ni
ng
 
Reproduced with permission from Knapp, D. M.; Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2009, 131, 6961-6963. 
Copyright 2009 American Chemical Society. 
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chloride 3.9a were exposed to aqueous K3PO4 under SMC reaction conditions at 60 °C 
(Table 3.4). In agreement with our hypothesis, the product 3.10a was isolated in a very 
high 94% yield (entry 1). The efficiency of this reaction is in agreement with the results 
obtained through the syringe-pump mediated experiment described in Scheme 3.3. From 
a methodology standpoint, this result was very exciting because it demonstrated that only 
a single equivalent of the MIDA boronate, serving as stable a surrogate for an otherwise 
highly sensitive boronic acid, was required to obtain a high yield in a coupling reaction 
with a very demanding halide partner. Following this result, the efficiency of this slow-
release cross-coupling (SRCC) method was compared with the standard coupling of a 
boronic acid. Specifically, MIDA boronates 3.2b–3.2h were exposed to the SRCC 
condition and the yields obtained through this process were compared to the yields 
obtained through an otherwise identical process employing freshly prepared boronic 
acids 3.1b–3.1h (Table 3.4). In all cases the SRCC reactions employing MIDA boronates 
(3.2) afforded yields of ≥ 90% using a single equivalent of the boron reagent. In contrast, 
boronic acids 3.1b–3.1g produced substantially inferior results compared to the yields 
obtained from 3.2b–3.2g. Strikingly, the cross-coupling reaction with 3.1f afforded 3.10f 
in only 14% yield while the same coupling with the corresponding MIDA boronate 3.2f 
proceeded in 93% yield. Interestingly, freshly prepared boronic acid 3.1h and MIDA 
boronate 3.2h were equally effective in coupling to 3.9a (entry 8), indicating that many 
of the challenges associated with the use of 3.1h7a may be primarily attributable to its 
instability to storage (Table 3.2, entry 8). 
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Table 3.4 
RR
B(OH)2 or
Pd(OAc)2, SPhos
60 C, 6 h
Ot-Bu
Cl
entry
% isolated yield
from cross-coupling
3.1 3.2
1
aReaction conditions: 1.0 equiv of 3.9a (1 mmol), 1.0 equiv of 3.1 (freshly
prepared, >95% pure) or 1.0 equiv of 3.2, 5 mol % Pd(OAc)2, 10 mol % SPhos,
7.5 equi. K3PO4, 0.07 M in dioxane:H2O 5:1, 60 C, 6 h. dCross-couplings were
run at 100 C.
9645
MeN
O
OB
O
O
3.10
d
S
S
2
S
S
3.10d
Ot-Bu
R 3.1 3.2
3.10
Ot-Bu
R
5
O
a
Ot-Bu
O 3.10a 68 94
3.9a
1.0 equiv 1.0 equiv
Me Me
g
3.10g
Ot-Bu
O
S
Boc
N
N
PhO2S
3
4
6
7d
8d
O
Ot-Bu
Ot-Bu
S 3.10c
Ot-Bu
Boc
N 3.10e
3.10b
N
PhO2S
3.10f
Ot-Bu
3.10h
Ot-Bu
50 92
37 94
b
c
e
f
h
9061
9314
9879
9695
K3PO4, dioxane:H2O 5:1
a
Reproduced with permission from Knapp, D. M.; Gillis, E. P.; Burke, M. D. J. Am.
Chem. Soc. 2009, 131, 6961-6963. Copyright 2009 American Chemical Society.
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The scope of SRCC reactions with aryl chlorides 
In theory, the substrate scope of SRCC reactions should be limited only by the 
substrate scope of the Pd catalyst employed in the reaction and by the ability to identify 
SMC conditions under which the rate of boronic acid release is slower than the TOF of 
the catalyst. A further restriction is that the catalyst must be stable for the duration of the 
boronic acid release. To probe the generality of the SRCC methodology in the coupling 
of aryl chlorides with otherwise unstable boronic acids, we evaluated the efficiency of a 
large number of SRCC reactions in which MIDA boronates 3.2a-3.2g were engaged in 
couplings with aryl chlorides that are electron-rich (3.9b, 3.9d, 3.9f, 3.9g, 3.9h), electron-
neutral (3.9c), electron-poor (3.9e, 3.9i), heteroaryl (3.9d, 3.9f, 3.9g, 3.9h, 3.9i), and 
sterically encumbered (3.9b, 3.9c, 3.9e) (Table 3.5). The average yield of these reactions 
was found to be 92%, indicating that the SRCC protocol is general and highly effective. 
Each coupling reaction was set up without the use of a glove box or glove bag, was 
generally complete within 6 hours, and in general was executed following the standard 
SRCC conditions employing only 1.2 equivalents of the MIDA boronate. Exceptions to 
this generalization are that couplings with vinyl MIDA boronate 3.2g and cyclopropyl 
MIDA boronate 3.2h required heating at 100 °C, and couplings with 3.2g were best 
suited to short reaction times (2 h). Entries 7, 8 and 20 employed 1.5 equivalents of the 
MIDA boronate. Due to the efficiency of these reactions the formation of byproducts was 
negligible, and any byproducts that were formed were easily removed via aqueous 
workup followed by chromatography on SiO2. In contrast to reports on the SMC of 
potassium vinyl trifluoroborate,15d SRCC reactions with 3.2g did not lead to the 
formation of byproducts resulting from Heck coupling of the vinyl borane species.  
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Table 3.5 
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Table 3.5 (Continued) 
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The stoichiometry of K3PO4 
 During the course of our studies on SRCC we discovered that the stoichiometry of 
the base that is used in the reaction is critical to the reproducibility of the reaction. 
Specifically, we discovered that if relative to the halide only 5.0 equivalents of K3PO4 are 
employed in the reaction, the results of the coupling can become very irreproducible. On 
the other hand, if relative to the halide 7.5 equivalents of K3PO4 are employed, the results 
of the SRCC reaction are very reproducible. A possible explanation for this difference is 
that when reduced base is employed the pH of the aqueous phase changes significantly 
over the course of the reaction, and as a result the rates of the many process which are 
balanced under the SRCC condition become varied. In any case, SRCC reactions should 
always be set up using at least 7.5 equivalents of base relative to the halide. 
 
3-5 SYNTHESIS AND CROSS-COUPLING OF 2-PYRYDYL MIDA BORONATE 
 Encouraged by the success observed using MIDA boronates as surrogates for 
otherwise unstable boronic acids in SRCC reactions with aryl chlorides, we questioned if 
the SRCC approach could be extended to include couplings of the notoriously 
challenging 2-pyridyl motif. A highly effective and air-stable 2-pyridyl borane building 
block represented a very important objective, as this subunit is found in many 
pharmaceuticals,29  natural products and/or their derivatives,30  unnatural nucleotides,31 
fluorescent probes,32 metal-complexing ligands,33 and materials.34 However, the corre-
sponding boronic acid is notoriously unstable5,35 and difficult to cross-couple,5,9a,15c,36 
particularly with aryl chlorides.9a Current available surrogates are either not air-
stable9a,9b,10 or cannot be isolated in chemically pure form.11 Based on the general 
properties of MIDA boronates, we predicted that if 2-pyridyl MIDA boronate could be 
synthesized, the resulting compound would be stable and isolable in pure form. At this 
point the stability and structure of MIDA boronate 4.18 (chapter 4) had been confirmed, 
providing further evidence that otherwise extremely unstable boranes are rendered stable 
via transformation into the corresponding MIDA boronate. However, it was unclear how 
the MIDA boronate group might be introduced to the 2-pyridyl motif, and additionally, it 
was uncertain if 2-pyridyl MIDA boronate would function as an efficient cross-coupling 
partner in a SMC reaction. 
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Synthesis of 2-pyridyl MIDA boronate 
 Consistent with reports on the instability of 2-pyridylboronic acid,5,35 accessing 
this boronic acid proved to be very challenging and precluded a route to 2-pyridyl MIDA 
boronate (3.11) based on standard Dean-Stark condensation of MIDA with the boronic 
acid.37 Instead, based on the success of its application in the synthesis of vinyl MIDA 
boronate 3.2g (chapter 4), we attempted to form 2-pyridyl MIDA boronate 3.11 through 
C-Si/C-B exchange38,39 (Scheme 3.4). In this case no formation of 3.11 was observed, 
likely due to the incompatibility of the very strong Lewis acid BBr3 with the strongly 
Lewis basic pyridine. In subsequent studies Brice Uno investigated this route by varying 
the temperature, varying the equivalents of each reagent, and by shielding the nitrogen 
lone-pair via complexation with BF3·Et2O; however, this route to 3.11 remained 
unsuccessful. 
MeN
O
OB
O
O
N
3.11
N
SiMe3 BBr3;
NaO
N
ONa
O OMe
 
Scheme 3.4. A route to 2-pyridyl MIDA boronate via C-Si/C-B exchange did not prove viable. 
 
 Alternatively, 2-pyridyl triisopropyl borate 3.12 can be synthesized from 2-
pyridylbromide and can be isolated as a hygroscopic, water-sensitive solid.9a Using 
borate 3.12 as a starting material, we explored conditions for the conversion of 3.12 to 
3.11 via complexation with MIDA (Table 3.6). We reasoned that exposure of 3.12 to 
excess MIDA would neutralize the borate, affording the corresponding 
diisopropylboronic ester from which two equivalents of i-PrOH might be displaced by 
MIDA to form 3.11. When 3.12 was contacted with MIDA and the resulting i-PrOH 
formed in the reaction was removed by azeotropic distillation with toluene at up to 
110 °C, a small amount (< 2% yield) of 3.11 was isolated (entry 1). 40  When the 
experiment was repeated and the resulting i-PrOH was removed under vacuum from a 
distilling mixture of DMSO at 45 °C, MIDA boronate 3.11 was isolated in 13% yield 
(entry 2). Finally, the experiment was repeated employing portion-wise addition of 3.11 
as a solid mixture on Celite41 to a DMSO solution containing 3.12 and MIDA that was 
distilling at 45 °C under vacuum. Under these conditions a 27% yield of 3.12 was 
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obtained (entry 3). In agreement with the evidence that the properties of MIDA boronates 
are general, 3.11 was isolated after SiO2 chromatography as a pure, free-flowing, 
crystalline solid that demonstrated no change in composition after storage under ambient 
air at room temperature for 60 days (Figure 3.5). Additionally, 3.11 was found to have 
good solubility in acetone, MeCN and DMF. To the best of our knowledge, 3.11 
represents the first example of an air-stable 2-pyridyl borane that can be isolated in 
chemically pure form. 
 
Table 3.6 
3.11N
B(Oi-Pr)3
HO
N
OH
O OMe
Li
N
Br B(Oi-Pr)3n-BuLi
THF 3.12 DMSO
3 eq.
MeN
O
OB
O
O
N
Distillation temp. (°C) Pressure (Torr)
750
1
1
110
45
45
Entry
1
2
3
Yield of 3.11
< 2%
18%
27%
a
a 3.12 was added portion-wise to the reaction as a mixture adsorbed on Celite  
 
 
Figure 3.5. The crystal structure of 2-pyridyl MIDA boronate (3.11) obtained through X-ray 
crystallography. 
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SMC reactions with 2-pyridyl MIDA boronate 
With 2-pyridyl MIDA boronate (3.11) in hand, our efforts were directed towards 
identifying conditions under which this reagent could be efficiently utilized in a SMC 
reaction. When 3.11 was exposed to 4-bromoacetophenone (3.3) under conditions similar 
to the SRCC conditions employed in Table 3.5, no conversion of 3.3 was observed by GC 
(Table 3.1, entry 1). Copper additives have been reported to be beneficial in SMC 
reactions employing 2-pyridyl boranes.9b,11,12c When the SMC reaction between 3.11 and 
3.3 was repeated with the inclusion of 0.2 equivalents of CuI, the formation of 3.13a was 
observed by 1H-NMR, in accordance with 11% conversion of 3.3 as observed by GC 
(entry 2).42 When DMF:i-PrOH (5:1) was employed in the reaction instead of THF:H2O 
(5:1) and K2CO3 was used in place of K3PO4 the conversion of 3.3 was further improved 
to 30% (entry 3). By employing pre-catalyst 3.14 in the reaction and adjusting the ratio of 
DMF:i-PrOH to 1:1 full conversion of 3.3 was realized (entry 4).  
 
Table 3.7 
 
 
When the optimized condition for the SMC reaction between 3.11 and 3.3 was 
applied to a SMC reaction between 3.11 and corresponding aryl chloride 3.15a, only 21% 
conversion of 3.15a was observed (Scheme 3.5). In order to improve the conversion of 
this reaction, we surveyed a number of copper sources [CuI, Cu(SO4)2, CuO, Cu2O, 
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Cu(NO3)2, CuTC], a number of bases [Ba(OH)2, KOAc, K2CO3, Cs2CO3, CaCO3, TBAF, 
CsF, K3PO4], and a number of temperatures, solvents and pre-catalysts. From these 
experiments we determined that Cu(OAc)2 was significantly more effective than CuI; 
C2CO3 and K2CO3 where equally the most effective bases; and that XPhos:Pd2dba3 was 
the most useful palladium:ligand combination. Further, the reaction was most successful 
at 100 °C, with a solvent composition of DMF:i-PrOH (4:1). Under these optimized 
conditions the SMC reaction between 3.11 and 3.15a afforded the product 3.13a in 72% 
yield (Table 3.8, entry 1). Further, we discovered that these conditions were generally 
effective for a range of aryl chlorides and bromides (Table 3.8). For example, 3.11 
underwent efficient coupling with chlorobenzonitrile 3.15b (entry 2), and 
chloroheteroarenes 3.15c–3.15e (entries 3–5). SMC reactions between 3.11 and an 
electron-rich aryl bromide (entry 6) and a heteroaryl bromide (entry 7) were also 
successful. The coupling between 3.11 and 3.3 furnished 3.14a in approximately the 
same yield as the reaction employing the corresponding chloride (entry 8). Finally, 
bipyridine 3.13h was accessed through the coupling of 3.11 with 2-bromopyridine 
(3.15h) (entry 9). Collectively, these results and the demonstrated stability of 3.11 to 
purification and storage indicate that 2-pyridyl MIDA boronate is an effective and useful 
surrogate for highly unstable 2-pyridylboronic acid in SMC reactions.  
 
 
Scheme 3.5. Under conditions optimized for the coupling of 4-bromoacetophenone with 3.11, coupling of 
4-chloroacetophenone with 3.11 remained inefficient.  
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Table 3.8 
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3-6 AN IMPROVED SYNTHESIS OF 2-PYRIDYL MIDA BORONATE 
 To improve the efficiency with which 2-pyridyl MIDA boronate (3.11) can be 
accessed, we reinvestigated the synthesis of this reagent. The synthesis of 3.11 as 
described in Table 3.6 provided small quantities of this boronate that enabled the SMC 
studies reported above. However, the scalability of this route was limited by the relatively 
low yield (27%) and technical challenges (solid addition under vacuum) associated with 
this synthesis. Further, the use of SiO2 chromatography in the purification step made 
preparation of multi-gram quantities of 3.11 tedious and inefficient. In pursuing the goal 
of an improved synthesis of 3.11 I had the pleasure of advising a very capable 
undergraduate student named Graham Dick. The results summarized below are from 
experiments performed by Graham Dick and are included to place the discoveries of this 
chapter in the broader context of how SRCC might evolve. 
 Our first efforts in optimizing the synthesis of 3.11 were directed towards 
lowering the temperature of the reaction condition used in the conversion of 3.12 to 3.11, 
with the goal of suppressing deboronation of 3.12 and/or the corresponding diisopropoxy 
boronic ester. Further, we intended to eliminate the technically-challenging solid addition 
of 3.12 associated with our existing procedure by instead adding a THF suspension of 
3.12 dropwise to solution of MIDA in DMSO. When this synthesis was performed at 
temperatures between 25 °C and 55 °C only irreproducible and relatively poor yields of 
3.11 were obtained (Figure 3.6). Enabling an alternative approach, it was discovered that 
2-pyridyl MIDA boronate does not undergo any detectable change in composition upon 
heating in DMSO at 130 °C for one hour. This discovery prompted us to investigate 
higher temperatures in the conversion of 3.12 to 3.11. To our surprise, the yield of the 
reaction improved substantially as the reaction temperature was increased, where the best 
yield was obtained when the reaction was run at 130 °C (Figure 3.6). In practice, a 
reaction temperature of 115 °C was found to offer the best compromise between a high 
yield and a technically simple procedure.43 
Application of the optimized high-temperature MIDA complexation conditions in 
the synthesis of 3.11 afforded a 59% yield of 2-pyridyl MIDA boronate (Table 3.9, entry 
1). These reaction conditions also proved useful in the synthesis of several derivatives of 
2-pyridyl MIDA boronate (Table 3.9). Further, a procedure for the isolation of 3.11 was 
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developed that comprises only trituration and crystallization steps, allowing 2-pyridyl 
MIDA boronate to be efficiently accessed on a multi-gram scale. Finally, these 
complexation conditions were found to be effective in the synthesis of 5-thiazole MIDA 
boronate (3.19) (Scheme 3.6) and 2-pyrazinyl MIDA boronate (3.20) (Scheme 3.7). To 
the best of our knowledge, 3.20 represents the first air-stable unsubstituted 2-pyrazinyl 
borane.  
 
 
Figure 3.6. Yield of 3.11 (determined via 1H-NMR, average of two runs) as a function of the internal 
reaction temperature. 
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Reproduced with permission from Dick, G. R.; Knapp, D. M.; Gillis, E. P.; Burke, M. D.  
Org. Lett. 2010, 12, 2314-2317. Copyright 2010 American Chemical Society. 
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Table 3.9 
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Scheme 3.6. Synthesis of 5-thiazole MIDA boronate (3.19). 
 
 
 
Scheme 3.7. Synthesis of 2-pyrazinyl MIDA boronate (3.20). 
 
 
3-7 SUMMARY 
 In summary, it was discovered that MIDA boronates, upon treatment with 
aqueous K3PO4, undergo slow hydrolysis to afford the corresponding boronic acid. When 
MIDA boronates are employed in Suzuki-Miyaura cross-coupling (SMC) reactions with 
aqueous K3PO4 this slow-release phenomenon enables otherwise highly unstable boronic 
acids to undergo efficient coupling with deactivated aryl chlorides. In combination with 
the general stability of MIDA boronates to storage under air at room temperature, the 
slow-release cross-coupling protocol with MIDA boronates represents a general solution 
to the challenge of utilizing unstable boronic acids in the SMC reaction. As a 
demonstration of the generality of this approach, a collection of MIDA boronates 
comprising 2-heterocyclic, vinyl and cyclopropyl motifs was engaged in high yielding 
SMC reactions with electronically and/or sterically deactivated aryl chlorides. Further, 
the synthesis of 2-pyridyl MIDA boronate provided the first example of an air-stable 2-
pyridyl borane that can be isolated in chemically pure form. Employing modified slow-
release cross-coupling conditions, 2-pyridyl MIDA boronate was successfully engaged in 
SMC reactions with aryl chlorides and aryl bromides. In a subsequent study the synthesis 
of 2-pyridyl MIDA boronate was substantially improved and a collection of 2-pyridyl 
Reproduced with permission from Dick, G. R.; Knapp, D. M.; Gillis, E. P.; Burke, M. D.  
Org. Lett. 2010, 12, 2314-2317. Copyright 2010 American Chemical Society. 
Reproduced with permission from Dick, G. R.; Knapp, D. M.; Gillis, E. P.; Burke, M. D.  
Org. Lett. 2010, 12, 2314-2317. Copyright 2010 American Chemical Society. 
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MIDA boronate derivatives was accessed. Following the disclosure of the slow-release 
cross-coupling protocol, others have found this approach useful in different reaction 
manifolds.44,45 
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CHAPTER 3: EXPERIMENTAL SECTION 
 
 
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, 
Alfa Aesar, TCI America, or Frontier Scientific, and were used without further 
purification unless otherwise noted. Solvents and amines were dried as noted in chapter 2. 
MIDA boronate 3.2g was synthesized according to the literature procedure.1  MIDA 
boronates 3.2a–3.2f and 3.2h and boronic acids 3.1a–3.1h were prepared by David 
Knapp.2 MIDA boronates 3.18b–3.18j, 3.19 and 3.20 were prepared by Graham Dick.3 
 
General Experimental Procedures. The general experimental procedures followed in 
these studies are the same as those detailed in chapter 2, except where noted. Column 
chromatography was performed using standard methods 4  or on an Teledyne-Isco 
CombiFlash Rf purification system using Merck silica gel grade 9385 60Å (230-400 
mesh). For loading, compounds were adsorbed onto Celite in vacuo from an acetone 
solution. Specifically, for a 1 g mixture of crude material the sample is dissolved in 
reagent grade acetone (25 to 50 mL) and to the flask is added Celite 454 Filter Aid (5 to 
15 g). The mixture is then concentrated in vacuo to afford a powder, which is then loaded 
on top of a silica gel column. The procedure is typically repeated with a small amount of 
acetone (5 mL) and Celite (2 g) to ensure quantitative transfer. 
 
Structural analysis. Structural analysis was performed and described as detailed in 
chapter 2. 
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Kinetics Studies 
 
Kinetics of boronic acid cross-coupling (Figure 3.1) 
Under ambient atmosphere, to a 25 mL Schlenk flask equipped with a stir bar was 
added 2-dicyclohexylphosphino-2’,6’-dimethoxybiphenyl (SPhos) (41 mg, 0.10 mmol), 
Pd(OAc)2 (11 mg, 0.050 mmol) and freshly-prepared 2-furylboronic acid (3.1a) (106 mg, 
0.949 mmol). The flask was placed under Ar atmosphere and to the flask was added 
dioxane (12.5 mL). To the solution was added dodecane (100 μL, internal standard) and 
1-tert-butoxy-4-chlorobenzene (3.9a) (175 μL, 0.980 mmol), and the solution was stirred 
at 23 °C for 10 minutes. The solution was sampled and analyzed by GC to determine the 
ratio of halide:dodecane. To the dark amber solution was added aq. K3PO4 (3.0 M, 2.5 
mL, degassed by sparging with Ar for 30 min) and the dark mixture was stirred for 5 
minutes. The organic phase was sampled as the initial time-point (t=0), and the mixture 
was then immediately placed in a 60 °C oil bath with stirring. The organic phase was 
sampled periodically and the consumption of the halide was determined by GC analysis 
versus the internal standard. 
 
 
Kinetics of in-situ boronic acid decomposition (Figure 3.2) 
A stock solution of 2-furylboronic acid (3.1a) and 4-bromoanisole (internal std) in 
dioxane-d8 was prepared as follows: 2-furylboronic acid (9 mg, 0.08 mmol) and 4-
bromoanisole (15 mg, 0.080 mmol) were dissolved in dioxane-d8 (1.0 mL). To each of 
eight argon-filled 1.5 mL vials equipped with stir bars and sealed with PTFE-lined 
septum-screwcaps was added the boronic acid stock solution (100 μL), followed by a 
solution of K3PO4 in D2O (3.0 M, 20 μL) by syringe. The mixtures were heated to 60 °C 
with stirring for the specified time (10 min, 20 min, 30 min, 1 h, etc.) The mixtures were 
then immediately quenched by the addition of a solution of pH 7 potassium phosphate 
buffer in D2O (2M, 120 μL) and were diluted with DMSO-d6 (0.5 mL, containing TMS 
internal std). The resulting solutions, once cooled to 23 °C, were immediately analyzed 
by 1H NMR. The percent boronic acid remaining was calculated by comparing the ratio 
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of the integrated 4-bromoanisole C-H signal (doublet, 7.41 ppm) to that of the boronic 
acid C-H signal (doublet, 7.74 ppm). 
 
 
Kinetics of slow-release of boronic acids from MIDA boronates (Figure 3.3) 
Stock solutions of the MIDA boronate and 4-bromoanisole (internal std.) in 
dioxane-d8 were prepared as follows: 4-tolyl MIDA boronate (16 mg, 0.064 mmol) and 
4-bromoanisole (12 mg, 0.065 mmol) were dissolved in dioxane-d8 (800 μL); 2-furyl 
MIDA boronate (3.1a) (54 mg, 0.24 mmol) and 4-bromoanisole (45 mg, 24 mmol) were 
dissolved in dioxane-d8 (3.0 mL); vinyl MIDA boronate (3.1g) (11.7 mg, 0.064 mmol) 
and 4-bromoanisole (12 mg, 0.065 mmol) were dissolved in dioxane-d8 (800 μL); 
cyclopropyl MIDA boronate (3.1h) (12.8 mg, 0.065 mmol) and 4-bromoanisole (12.0 mg, 
0.064 mmol) were dissolved in dioxane-d8 (800 μL). To each 1.5 mL vial equipped with 
a small stir bar was added the boronate stock solution (100 μL) followed by a solution of 
K3PO4 in D2O (3.0 M, 20 μL). The mixtures were stirred at the specified temperature 
(23 °C, 60 °C, or 100 °C) for the specified time (0.5 h, 1.0 h, 2.0 h, etc.). The mixtures 
were then immediately cooled to room temperature and were diluted with CD3CN (0.5 
mL containing TMS internal std). The solutions were immediately analyzed by 1H-NMR. 
The percent MIDA boronate remaining was calculated by comparing the ratio of the 
integrated 4-bromoanisole OCH3 singlet (3.76 ppm, internal std) to that of the MIDA 
boronate NCH3 singlet (tolyl = 2.47 ppm; furyl = 2.60 ppm; vinyl = 2.77 ppm; 
cyclopropyl = 2.98 ppm). 
 
 
“Fast-Release” kinetics 
To a 1.5 mL vial equipped with a small stir bar was added the 2-furyl MIDA 
boronate stock solution (100 μL) followed by a solution of NaOH in D2O (3.0 M, 20 μL). 
The mixture was stirred at 60 °C for 10 min. The mixture was diluted with CD3CN (0.5 
mL containing TMS internal std) and was immediately analyzed by 1H-NMR. This 
analysis revealed complete hydrolysis of the MIDA boronate. 
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Slow-release cross-coupling with MIDA boronates (Table 3.5) 
 
 
 
General Procedure 
Under ambient atmosphere, to a 40 mL I-Chem vial equipped with a stir bar was 
added the aryl chloride (1.00 mmol), the MIDA boronate (1.20 mmol), 
dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl  (SPhos) (41 mg, 0.10 mmol) and 
Pd(OAc)2 (11 mg, 0.050 mmol). The vial was sealed with a PTFE-lined septum screw-
cap, and then placed under an Ar atmosphere. To the vial was added dioxane (12.5 mL) 
and the resulting mixture was stirred at 23 °C for 10 min. To the vial was added aq 
K3PO4 (3.0 M, 2.5 mL, degassed by sparging with Ar for 30 min). The vial was placed in 
a 60 °C oil bath with stirring for 6 h. The mixture was cooled to room temperature, and 
was then transferred to a 60 mL separatory funnel and diluted with aq NaOH (1.0 M, 10 
mL). The mixture was extracted with Et2O (3 × 10 mL). The combined organic fractions 
were dried over MgSO4, filtered, and then concentrated in vacuo. The resulting residue 
was subjected to flash-chromatography on silica gel (hexanes:EtOAc). 
 
O
MeO OMe
3.10i  
2-(2,4-dimethoxyphenyl)furan5 (3.10i) [Table 3.5, Entry 1] 
 The general procedure was followed using 1-chloro-2,4-dimethoxybenzene 
(3.9b) (173 mg, 1.00 mmol), 2-furan MIDA boronate (3.2a) (267 mg, 1.20 mmol), SPhos 
(41 mg, 0.10 mmol) and Pd(OAc)2 (12 mg, 0.052 mmol) to afford 3.10i as a pale orange 
liquid (202 mg, 99%). 
 
TLC (hexanes:EtOAc 9:1) 
Rf = 0.36, visualized by UV (λ = 254 nm) 
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1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.74 (d, J = 8.5 Hz, 1H), 7.41 (d, J = 1.0 Hz, 1H), 6.79 (d, J = 3.5 Hz, 1H), 6.55 
(dd, J = 8.5, 2.5 Hz, 1H), 6.52 (d, J = 2.0 Hz, 1H), 6.46 (q, J = 2.0 Hz, 1H), 3.89 
(s, 3H), 3.82 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 159.9, 156.5, 150.4, 140.4, 126.8, 113.4, 111.4, 107.8, 104.6, 98.7, 55.4 (2 
carbons) 
 
HRMS (EI+) 
 Calculated for C12H12O3 (M)+: 204.0787 
 Found:   204.0790 
 
IR (thin film, cm-1) 
 3002, 2960, 2937, 2836, 1614, 1585, 1514, 1468, 1418, 1307, 1288, 1270, 1208, 
1160, 1054, 1029, 1003, 827, 798, 735 
 
 
2-(2,4,6-trimethylphenyl)furan6 (3.10j) [Table 3.5, Entry 2] 
The general procedure was followed using mesityl chloride (3.9c) (154 mg, 1.00 
mmol), 2-furyl MIDA boronate (3.2a) (267 mg, 1.20 mmol), SPhos (42 mg, 0.10 mmol) 
and Pd(OAc)2 (11 mg, 0.049 mmol) to afford 3.10j as a colorless crystalline solid (181 
mg, 97%). 
 
TLC (hexanes) 
Rf = 0.40, visualized by UV (λ = 254 nm) 
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1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.46 (s, 1H), 6.90 (s, 2H), 6.44 (t, J = 3.0 Hz, 1H), 6.23 (d, J = 3.0 Hz, 1H), 2.28 
(s, 3H), 2.15 (s, 6H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 152.4, 141.4, 138.3, 138.3, 128.2, 128.2, 110.3, 109.0, 21.0, 20.4 
 
HRMS (EI+) 
 Calculated for C13H14O (M)+: 186.1045 
 Found:   186.1043 
 
IR (thin film, cm-1) 
 2975, 2954, 2919, 1612, 1505, 1473, 1440, 1373, 1257, 1212, 1169, 1148, 1028, 
1005, 898, 863, 743 
 
 
5-(2-furanyl)-2-methylbenzoxazole (3.10k) [Table 3.5, Entry 3] 
The general procedure was followed using 5-chloro-2-methylbenzoxazole (3.9d) 
(168 mg, 1.00 mmol), 2-furyl MIDA boronate (3.2a) (266 mg, 1.19 mmol), SPhos (41 
mg, 0.10 mmol) and Pd(OAc)2 (11 mg, 0.049 mmol) to afford 3.10k as a pale orange 
crystalline solid (198 mg, 99%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.30, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.93 (d, J = 1.0 Hz, 1H), 7.61 (dd, J = 8.5, 1.5 Hz, 1H), 7.47 (d, J = 1.0 Hz, 1H), 
7.44 (d, J = 8.5 Hz, 1H), 6.63 (d, J = 3.5 Hz, 1H), 6.47 (dd, J = 3.5, 2.0 Hz, 1H), 
2.62 (s, 3H) 
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13C-NMR (125 MHz, CDCl3) 
 δ 164.5, 153.7, 150.3, 141.9, 141.9, 127.6, 120.8, 114.6, 111.6, 110.3, 104.6, 14.5 
 
HRMS (EI+) 
 Calculated for C12H9NO2 (M)+: 199.0633 
 Found:   199.0634 
 
IR (KBr, cm-1) 
 2934, 2857, 1576, 1504, 1458, 1383, 1300, 1269, 1228, 1170, 1011, 885, 811 
 
 
3-(2-furanyl)-2,5-dimethylpyrazine7 (3.10l) [Table 3.5, Entry 4] 
The general procedure was followed using 3-chloro-2,5-dimethylpyrazine (3.9e) 
(143 mg, 1.00 mmol), 2-furyl MIDA boronate (3.2a) (267 mg, 1.20 mmol), SPhos (41 
mg, 0.10 mmol) and Pd(OAc)2 (11 mg, 0.049 mmol) to afford 3.10l as a golden liquid 
(159 mg, 91%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.28, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 8.20 (s, 1H), 7.61 (d, J = 1.0 Hz, 1H), 7.00 (d, J = 3.5 Hz, 1H), 6.54 (dd, J = 3.0, 
1.5 Hz, 1H), 2.74 (s, 3H), 2.54 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 151.7, 150.2, 146.5, 143.9, 142.5, 141.2, 112.3, 111.7, 23.3, 21.2 
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HRMS (EI+) 
 Calculated for C10H10N2O (M)+: 174.0793 
 Found:   174.0799 
 
IR (thin film, cm-1) 
 3116, 3038, 2966, 2926, 2858, 2359, 2228, 1553, 1537, 1449, 1446, 1389, 1357, 
1289, 1255, 1220, 1203, 1174, 1149, 1095, 1061, 1012, 973, 928, 886, 867, 821, 
735, 596 
 
 
2-(2,4-dimethoxyphenyl)benzofuran (3.10m) [Table 3.5, Entry 5] 
The general procedure was followed using 1-chloro-2,4-dimethoxybenzene (3.9b) 
(172 mg, 1.00 mmol), 2-benzofuranyl MIDA boronate (3.2b) (328 mg, 1.20 mmol), 
SPhos (41 mg, 0.10 mmol) and Pd(OAc)2 (12 mg, 0.051 mmol) to afford 3.10m as a 
colorless liquid (239 mg, 94%) 
 
TLC (hexanes:EtOAc 9:1) 
Rf = 0.25, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS) 
δ 7.97 (d, J = 8.5 Hz, 1H), 7.56 (d, J = 7.5 Hz, 1H), 7.48 (d, J = 7.5 Hz, 1H), 7.24-
7.17 (m, 3H), 6.60 (dd, J = 8.5, 2.5 Hz, 1H), 6.55 (d, J = 2.0 Hz, 1H), 3.95 (s, 3H), 
3.84 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
δ 160.8, 157.7, 153.6, 152.4, 130.0, 127.9, 123.5, 122.5, 120.7, 112.7, 110.6, 
104.8, 104.2, 98.7, 55.4, 55.4 
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HRMS (EI+) 
 Calculated for C16H14O3 (M)+: 254.0943 
 Found:   254.0941 
 
IR (thin film, cm-1) 
  3002, 2960, 2937, 2834, 1611, 1586, 1503, 1452, 1291, 1255, 1211, 1160, 1050, 
1032, 1013 
 
 
5-(2-benzofuranyl)indole8 (3.10n) [Table 3.5, Entry 6] 
The general procedure was followed using 5-chloroindole (3.9f) (153 mg, 1.01 
mmol), 2-benzofuranyl MIDA boronate (3.2b) (329 mg, 1.20 mmol), SPhos (41 mg, 0.10 
mmol) and Pd(OAc)2 (12 mg, 0.053 mmol). The extraction step was modified to use Et2O 
(10 mL), then EtOAc (2 x 10 mL). Benzofuran 3.10n was isolated as a pale yellow solid 
(220 mg, 94%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.31, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, acetone-d6)  
δ 10.44 (br s, 1H), 8.23 (s, 1H), 7.74 (dd, J = 8.5, 1.5 Hz, 1H), 7.59 (d, J = 7.0 Hz, 
1H), 7.56 (app. d, J = 8.5 Hz, 2H), 7.41 (t, J = 3.0 Hz, 1H), 7.26 (td, J = 7.5, 1.0 
Hz, 1H), 7.22 (td, J = 7.5, 1.0 Hz, 1H), 7.13 (s, 1H), 6.62 (t, J = 2.0 Hz, 1H) 
 
13C-NMR (125 MHz, acetone-d6) 
δ 158.7, 155.4, 137.4, 130.7, 129.2, 126.9, 124.3, 123.6, 122.6, 121.3, 119.7, 
118.0, 112.7, 111.5, 103.1, 100.0 
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HRMS (EI+) 
 Calculated for C16H11NO (M)+: 233.0841 
 Found:   233.0843 
 
IR (KBr, cm-1) 
3439, 1582, 1475, 1458, 1444, 1417, 1332, 1295, 1254, 1020, 1006, 890, 877, 807, 
753, 728, 594, 487, 442, 410 
 
 
5-(2-benzofuranyl)-2-pyridinamine (3.10o) [Table 3.5, Entry 7] 
The general procedure was followed using 2-amino-5-chloropyridine (3.9g) (128 
mg, 1.00 mmol), 2-benzofuranyl MIDA boronate (3.2b) (359 mg, 1.50 mmol), SPhos (41 
mg, 0.10 mmol) and Pd(OAc)2 (12 mg, 0.052 mmol). The extraction step was modified to 
use Et2O (10 mL), then EtOAc (2 x 10 mL). Benzofuran 3.10o was isolated as a pale 
orange solid (180 mg, 85%). 
 
TLC (EtOAc) 
Rf = 0.45, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, acetone-d6)  
δ 8.57 (d, J = 2.0 Hz, 1H), 7.89 (dd, J = 9.0, 2.5 Hz, 1H), 7.57 (d, J = 8.5 Hz, 1H), 
7.50 (d, J = 8.5 Hz, 1H), 7.24 (td, J = 7.5, 1.5 Hz, 1H), 7.20 (td, J = 7.5, 1.5 Hz, 
1H), 7.03 (d, J = 1.0 Hz, 1H), 6.66 (d, J = 8.5 Hz, 1H), 5.85 (br s, 2H) 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 160.8, 155.9, 155.3, 146.1, 134.6, 130.4, 124.4, 123.8, 121.3, 116.6, 111.5, 
108.8, 99.4 
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HRMS (EI+) 
 Calculated for C13H10N2O (M)+: 210.0793 
 Found:   210.0793 
 
IR (KBr, cm-1) 
 3436, 3308, 3114, 3106, 2964, 1650, 1614, 1574, 1500, 1451, 1399, 1352, 1321, 
1294, 1271, 1254, 1207, 1151, 1142, 1040, 1007, 934, 918, 835, 806, 747, 532, 
515, 450, 412 
 
 
2-(3-thienyl)benzofuran9 (3.10p) [Table 3.5, Entry 8] 
The general procedure was followed using 3-chlorothiophene (3.9h) (119 mg, 
1.01 mmol), 2-benzofuranyl MIDA boronate (3.2b) (360 mg, 1.50 mmol), SPhos (41 mg, 
0.10 mmol) and Pd(OAc)2 (11 mg, 0.050 mmol) to afford 3.10p as a colorless solid (171 
mg, 85%). 
 
TLC (hexanes:EtOAc 9:1) 
Rf = 0.53, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.67 (d, J = 1.5 Hz, 1H), 7.52 (d, J = 8.0 Hz, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.40 
(d, J = 4.5 Hz, 1H), 7.32 (dd, J = 4.5, 3.0 Hz, 1H), 7.24 (t, J = 7.5 Hz, 1H), 7.19 (t, 
J = 7.5 Hz, 1H), 6.77 (s, 1H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 154.5, 152.6, 132.2, 129.0, 126.5, 125.0, 124.0, 122.9, 121.4, 120.8, 111.0, 
101.0 
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HRMS (EI+) 
 Calculated for C12H8OS (M)+: 200.0296 
 Found:   200.0295 
 
IR (KBr, cm-1) 
  3100, 1607, 1452, 1280, 1255, 1041, 944, 854, 807, 785, 749, 601, 436 
 
 
2-(2,4-dimethoxyphenyl)thiophene10 (3.10q) [Table 3.5, Entry 9] 
The general procedure was followed using 1-chloro-2,4-dimethoxybenzene (3.9b) 
(173 mg, 1.00 mmol), 2-thiophenyl MIDA boronate (3.2c) (285 mg, 1.19 mmol), SPhos 
(41 mg, 0.10 mmol) and Pd(OAc)2 (11 mg, 0.051 mmol) to afford 3.10q as a pale golden 
liquid (215 mg, 98%). 
 
TLC (hexanes:EtOAc 9:1) 
Rf = 0.27, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.53 (d, J = 9.5 Hz, 1H), 7.37 (d, J = 3.5 Hz, 1H), 7.25 (d, J = 5.5 Hz, 1H), 7.05 
(t, J = 4.5 Hz, 1H), 6.53-6.51 (m, 2H), 3.88 (s, 3H), 3.82 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 160.1, 156.7, 139.6, 129.3, 126.7, 124.3, 124.2, 116.5, 105.0, 98.9, 55.5, 55.4 
 
HRMS (EI+) 
 Calculated for C12H12O2S (M)+: 220.0558 
 Found:   220.0563 
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IR (thin film, cm-1) 
 3102, 3069, 3000, 3959, 3937, 2835, 1610, 1577, 1528, 1464, 1432, 1417, 1354, 
1303, 1273, 1242, 1210, 1160, 1114, 1031, 959, 927, 848, 824, 798, 697, 577 
 
 
2-methyl-5-(2-thienyl)benzoxazole (3.10r) [Table 3.5, Entry 10] 
The general procedure was followed using 5-chloro-2-methylbenzoxazole (3.9d) 
(168 mg, 1.00 mmol), 2-thiophenyl MIDA boronate (3.2c) (287 mg, 1.20 mmol), SPhos 
(41 mg, 0.10 mmol) and Pd(OAc)2 (11 mg, 0.051 mmol) to afford 3.10r as a crystalline 
pale yellow solid (213 mg, 99%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.35, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.85 (d, J = 1.0 Hz, 1H), 7.50 (dd, J = 8.0, 1.5 Hz, 1H), 7.39 (d, J = 8.5 Hz, 1H), 
7.26 (d, J = 3.0 Hz, 1H), 7.24 (d, J = 5.0 Hz, 1H), 7.04 (dd, J = 5.0, 3.5 Hz, 1H), 
2.59 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 164.4, 150.3, 144.0, 142.1, 130.9, 127.9, 124.6, 123.0, 122.8, 116.6, 110.2, 14.4 
 
HRMS (EI+) 
 Calculated for C12H9NOS (M)+: 215.0405 
 Found:   215.0403 
 
IR (KBr, cm-1) 
 3098, 3064, 1622, 1577, 1473, 1428, 1380, 1271, 1160, 1050, 923, 867, 798 
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2-(2-thienyl)quinoxaline11 (3.10s) [Table 3.5, Entry 11] 
The general procedure was followed using 1-chloroisoquinoline (3.9i) (165 mg, 
1.00 mmol), 2-thiophenyl MIDA boronate (3.2c) (287 mg, 1.20 mmol), SPhos (41 mg, 
0.10 mmol) and Pd(OAc)2 (11 mg, 0.050 mmol) to afford 3.10s as a yellow solid (206 mg, 
97%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.42, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 9.20 (s, 1H), 8.04 (app d, J = 8.0 Hz, 2H), 7.82 (s, 1H), 7.71 (t, J = 7.0 Hz, 1H), 
7.66 (t, J = 7.0 Hz, 1H), 7.52 (d, J = 4.0 Hz, 1H), 7.17 (s, 1H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 147.2, 142.1, 142.0, 141.9, 141.2, 130.3, 129.7, 129.1, 129.0, 129.0, 128.3, 
126.8 
 
HRMS (EI+) 
 Calculated for C12H8N2S (M)+: 212.0408 
 Found:   212.0407 
 
IR (thin film, cm-1) 
  3118, 3093, 1573, 1547, 1491, 1428, 1321, 1238, 1208, 1134, 1054, 998, 941, 
926, 852 
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N-(tert-butoxycarbonyl)-2-(2,3-dimethoxyphenyl)pyrrole (3.10t) [Table 3.5, Entry 12] 
The general procedure was followed using 1-chloro-2,4-dimethoxybenzene (3.9b) 
(87 mg, 0.51 mmol), 2-(N-tert-butoxycarbonyl)pyrrole MIDA boronate (3.2e) (196 mg, 
0.61 mmol), SPhos (20 mg, 0.048 mmol), Pd(OAc)2 (6 mg, 0.03 mmol), K3PO4 (3.0 M, 
1.25 mL) and dioxane (6.0 mL) to afford 3.10t as a very pale yellow oil (124 mg, 81%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.59, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.32 (s, 1H), 7.17 (d, J = 8.0 Hz, 1H), 6.48 (d, J = 8.5 Hz, 1H), 6.45 (s, 1H), 
6.22 (t, J = 3.0 Hz, 1H), 6.10 (s, 1H), 3.82 (s, 3H), 3.72 (s, 3H), 1.36 (s, 9H) 
 
13C-NMR (125 MHz, CDCl3) 
δ 160.7, 158.3, 149.4, 131.1, 130.6, 121.6, 117.0, 113.5, 110.2, 103.4, 98.2, 82.6, 
55.3, 55.2, 27.6 
 
HRMS (EI+) 
 Calculated for C17H21NO4 (M)+: 303.1471 
 Found:   303.1469 
 
IR (thin film, cm-1) 
2976, 2938, 2834, 1736, 1617, 1584, 1512, 1464, 1437, 1419, 1394, 1370, 1341, 
1316, 1209, 1159, 1127, 1034, 974, 840, 726 
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5-(N-tert-butoxycarbonyl-pyrrole)-2-methylbenzoxazole (3.10u) [Table 3.5, Entry 13] 
The general procedure was followed using 5-chloro-2-methylbenzoxazole (3.9d) 
(84 mg, 0.50 mmol), 2-(N-tert-butoxycarbonyl)pyrrole MIDA boronate (3.2e) (195 mg, 
0.61 mmol), SPhos (21 mg, 0.050 mmol), Pd(OAc)2 (6 mg, 0.03 mmol), K3PO4 (3.0 M, 
1.25 mL) and dioxane (6.0 mL) to afford 3.10u as a very pale yellow oil (146 mg, 98%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.42, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.63 (s, 1H), 7.43 (d, J = 8.5 Hz, 1H), 7.36 (s, 1H), 7.28 (d, J = 8.5 Hz, 1H), 
6.23 (t, J = 3.0 Hz, 1H), 6.20 (s, 1H), 2.64 (s, 3H), 1.34 (s, 9H) 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.2, 150.2, 149.1, 140.9, 134.4, 130.6, 126.1, 122.4, 120.0, 114.7, 110.4, 
109.0, 83.5, 27.5, 14.5 
 
HRMS (EI+) 
 Calculated for C17H18N2O3 (M)+: 298.1318 
 Found:   298.1317 
 
IR (thin film, cm-1) 
2982, 1739, 1584, 1584, 1456, 1395, 1365, 1370, 1336, 1313, 1264, 1166, 1140, 
985, 906, 836, 809 
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N-phenylsulfonyl-2-(2,3-dimethoxyphenyl)indole (3.10v) [Table 3.5, Entry 14] 
The general procedure was followed using 1-chloro-2,4-dimethoxybenzene (3.9b) 
(173 mg, 1.00 mmol), 1-(phenylsulfonyl)indole-2-MIDA boronate (3.2f) (495 mg, 1.20 
mmol), SPhos (42 mg, 0.10 mmol) and Pd(OAc)2 (11 mg, 0.049 mmol) to afford 3.10v as 
an off-white solid (382 mg, 97%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.37, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, acetone-d6)  
δ 8.19 (d, J = 8.0 Hz, 1H), 7.57-7.53 (m, 3H), 7.50 (d, J = 7.5 Hz, 1H), 7.43 (t, J = 
7.5 Hz, 2H), 7.32 (dt, J = 7.0, 1.0 Hz, 1H), 7.23 (t, J = 7.5 Hz, 1H), 7.17 (d, J = 
8.0 Hz, 1H), 6.62 (d, J = 2.0 Hz, 1H), 6.58 (dd, J = 8.0, 2.0 Hz, 1H), 6.56 (s, 1H), 
3.87 (s, 3H), 3.72 (s, 3H) 
 
13C-NMR (125 MHz, acetone-d6) 
δ 163.0, 160.6, 139.4, 139.3, 138.1, 134.5, 133.2, 131.3, 129.8, 127.4, 125.0, 
124.5, 121.5, 116.1, 115.0, 113.0, 104.7, 98.8, 55.7, 55.7 
 
HRMS (EI+) 
 Calculated for C12H19NO4S (M)+: 393.1035 
 Found:   393.1036 
 
IR (KBr, cm-1) 
 3000, 2978, 2938, 2842, 1617, 1501, 1449, 1445, 1360, 1284, 1239, 1187, 1163, 
1121, 1093, 1069, 1048, 832, 752, 728, 681, 582, 559 
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5-(N-phenylsulfonyl-indole)-2-methylbenzoxazole (3.10w) [Table 3.5, Entry 15] 
The general procedure was followed using 5-chloro-2-methylbenzoxazole (3.9d) 
(168 mg, 1.00 mmol), 1-(phenylsulfonyl)indole-2-MIDA boronate (3.2f) (495 mg, 1.20 
mmol), SPhos (41 mg, 0.10 mmol) and Pd(OAc)2 (12 mg, 0.052 mmol) to afford 3.10w 
as an off-white solid (366 mg, 93%). 
 
TLC (hexanes:EtOAc 1:1) 
Rf = 0.36, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, acetone-d6)  
δ 8.27 (d, J = 8.5 Hz, 1H), 7.78 (d, J = 1.0 Hz, 1H), 7.61 (d, J = 8.5 Hz, 1H), 7.55 
(t, J = 7.5 Hz, 1H), 7.51 (d, J = 8.0 Hz, 2H), 7.45 (app. d, J = 8.0 Hz, 2H), 7.39 
(app. t, J = 8.0 Hz, 3H), 7.28 (dt, J = 7.0, 1.0 Hz, 1H), 6.75 (s, 1H), 2.65 (s, 3H) 
 
13C-NMR (125 MHz, acetone-d6) 
δ 165.6, 152.3, 142.9, 142.4, 139.3, 138.6, 134.8, 131.7, 129.9, 129.6, 128.2, 
127.5, 125.8, 125.4, 122.0, 121.9, 117.3, 114.9, 110.1, 14.4 
 
HRMS (EI+) 
 Calculated for C22H16N2O3S (M)+: 388.0882 
 Found:   388.0880 
 
IR (thin film, cm-1) 
 3063, 3012, 1712, 1623, 1581, 1477, 1449, 1432, 1365, 1262, 1220, 1177, 1157, 
1122, 1092, 1065, 1021, 999, 921, 823 
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2,4,6-trimethylstyrene12 (3.10x) [Table 3.5, Entry 16] 
The general procedure was followed using mesityl chloride (3.9c) (155 mg, 1.01 
mmol), vinyl MIDA boronate (3.2g) (220 mg, 1.20 mmol), SPhos (41 mg, 0.10 mmol) 
and Pd(OAc)2 (12 mg, 0.051 mmol). The reaction time and temperature were modified so 
that the reaction mixture was heated to 100 °C for 2 h. Styrene 3.10x was isolated as a 
colorless liquid (150 mg, 91%; yield corrected for residual 3.9c). 
 
TLC (hexanes) 
Rf = 0.64, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 6.86 (s, 2H), 6.66 (dd, J = 18.0, 11.5 Hz, 1H), 5.50 (dt, J = 11.5, 2.0 Hz, 1H), 
5.23 (dt, J = 18.0, 2.0 Hz, 1H), 2.27 (s, 6H), 2.26 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 136.1, 135.7, 135.0, 134.8, 128.5, 119.0, 20.9, 20.8 
 
HRMS (EI+) 
 Calculated for C11H14 (M)+: 146.1096 
 Found:   146.1098 
 
IR (thin film, cm-1) 
  3080, 2999, 2952, 2918, 2856, 1631, 1612, 1481, 1442, 1376, 994, 919, 850 
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2-vinylquinoxaline (3.10y) [Table 3.5, Entry 17] 
The general procedure was followed using 2-chloroquinoxaline (3.9i) (165 mg, 
1.00 mmol), vinyl MIDA boronate (3.2g) (219 mg, 1.20 mmol), SPhos (41 mg, 0.10 
mmol) and Pd(OAc)2 (11 mg, 0.051 mmol). The reaction time and temperature were 
modified so that the reaction mixture was heated to 100 °C for 2 h. Following the 
aqueous workup, the crude residue was subjected to purification on C18 silica gel (43g 
RediSep column) eluting with H2O:THF (95:5 → 55:45, 24 mL/min over 25 min) to 
afford 3.10y as an orange oil (133 mg, 87%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.31, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 9.00 (s, 1H), 8.08 (app. t, J = 9.0 Hz, 2H), 7.77-7.70 (m, 2H), 7.04 (dd, J = 17.5, 
11.0 Hz, 1H), 6.48 (d, J = 17.5 Hz, 1H), 5.79 (d, J = 11.0 Hz, 1H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 150.4, 143.5, 142.1, 141.7, 134.8, 130.2, 129.5, 129.3, 129.1, 122.1 
 
HRMS (ESI+) 
 Calculated for C10H9N2 (M+H)+: 157.0766 
 Found:   157.0768 
 
IR (thin film, cm-1) 
 3064.0, 3018, 2928, 2847, 1631, 1596, 1546, 1492, 1466, 1414, 1365, 1342, 1331, 
1303, 1282, 1258, 1212, 1185, 1121, 1065, 1014, 989, 972, 927, 762 
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2-amino-5-vinylpyridine (3.10z) [Table 3.5, Entry 18] 
The general procedure was followed using 2-amino-5-chloropyridine (3.9g) (129 
mg, 1.00 mmol), vinyl MIDA boronate (3.2g) (220 mg, 1.20 mmol), SPhos (42 mg, 0.10 
mmol) and Pd(OAc)2 (11 mg, 0.050 mmol). The reaction time and temperature were 
modified so that the reaction mixture was heated to 100 °C for 2 h. The extraction step 
was modified to use Et2O (10 mL), then EtOAc (2 x 10 mL). Pyridine 3.10z was isolated 
as a pale orange crystalline solid (91 mg, 76%). 
 
TLC (EtOAc) 
Rf = 0.48, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 8.05 (s, 1H), 7.56 (dd, J = 8.5, 2.0 Hz, 1H), 6.58 (dd, J = 17.5, 11.0 Hz, 1H), 
6.48 (d, J = 9.0 Hz, 1H), 5.56 (d, J = 17.5 Hz, 1H), 5.11 (d, J = 11.0 Hz, 1H), 4.60 
(br s, 2H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 157.9, 147.0, 134.4, 133.3, 124.0, 111.2, 108.5 
 
HRMS (EI+) 
 Calculated for C7H8N2 (M)+: 120.0688 
 Found:   120.0688 
 
IR (KBr, cm-1) 
 3448, 3296, 3128, 1631, 1599, 1509, 1388, 1324, 1274, 1144, 1002, 888, 828 
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5-vinyl-2-methylbenzoxazole (3.10aa) [Table 3.5, Entry 19] 
The general procedure was followed using 5-chloro-2-methylbenzoxazole (3.9d) 
(167 mg, 1.01 mmol), vinyl MIDA boronate (3.2g) (218 mg, 1.19 mmol), SPhos (42 mg, 
0.10 mmol) and Pd(OAc)2 (11 mg, 0.050 mmol). The reaction time and temperature were 
modified so that the reaction mixture was heated to 100 °C for 2 h. Benzoxazole 3.10aa 
was isolated as a pale golden liquid (152 mg, 96%). 
 
TLC (hexanes:EtOAc 3:1) 
Rf = 0.46, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 7.67 (s, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 6.79 (dd, J = 
17.5, 11.0 Hz, 1H), 5.74 (d, J = 17.5 Hz, 1H), 5.24 (d, J = 11.0 Hz, 1H), 2.61 (s, 
3H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 164.3, 150.6, 141.9, 136.5, 134.2, 122.9, 116.8, 113.4, 109.9, 14.5 
 
HRMS (EI+) 
 Calculated for C10H9NO (M)+: 159.0684 
 Found:   159.0685 
 
IR (thin film, cm-1) 
 3087, 3006, 2984, 2928, 1623, 1622, 1578, 1477, 1433, 1381, 1335, 1262, 1179, 
1114, 1040, 989, 918, 881, 840, 815 
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2,4,6-trimethyl-cyclopropylbenzene13 (3.10bb) [Table 3.5, Entry 20] 
The general procedure was followed using mesityl chloride (3.9c) (155 mg, 1.00 
mmol), cyclopropyl MIDA boronate (3.2h) (296 mg, 1.50 mmol), SPhos (42 mg, 0.10 
mmol) and Pd(OAc)2 (11 mg, 0.047 mmol). The reaction time and temperature were 
modified so that the reaction mixture was heated to 100 °C for 24 h. The title compound 
was isolated as a colorless liquid (127 mg, 79%). 
 
TLC (hexanes) 
Rf = 0.66, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 6.81 (s, 2H), 2.38 (s, 6H), 2.24 (s, 3H), 1.64 (m, 1H), 0.96 (m, 2H), 0.49 (m, 
2H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 138.8, 136.0, 135.5, 128.6, 20.8, 20.5, 11.7, 8.0 
 
HRMS (EI+) 
 Calculated for C12H16 (M)+: 160.1252 
 Found:   160.1252 
 
IR (thin film, cm-1) 
3080, 3003, 2969, 2954, 2918, 2859, 1612, 1485, 1457, 1375, 1223, 1057, 1025, 
901, 850, 814 
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2,4-dimethoxy-cyclopropylbenzene (3.10cc) [Table 3.5, Entry 21] 
The general procedure was followed using 1-chloro-2,4-dimethoxybenzene (3.9b) 
(173 mg, 1.00 mmol), cyclopropyl MIDA boronate (3.2h) (236 mg, 1.20 mmol), SPhos 
(41 mg, 0.10 mmol) and Pd(OAc)2 (11 mg, 0.048 mmol). The reaction temperature was 
modified so that the reaction mixture was heated to 100 °C for 6 h. The title compound 
was isolated as a colorless liquid (175 mg, 97%). 
 
TLC (hexanes:EtOAc 9:1) 
Rf = 0.65, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 6.77 (d, J = 8.5 Hz, 1H), 6.44 (d, J = 2.5 Hz, 1H), 6.39 (dd, J = 8.5, 2.5 Hz, 1H), 
3.83 (s, 3H), 3.77 (s, 3H), 2.03 (m, 1H), 0.85 (m, 2H), 0.57 (m, 2H) 
 
13C-NMR (125 MHz, CDCl3) 
 δ 159.2, 158.6, 125.7, 124.2, 103.8, 98.4, 55.5, 55.3, 9.0, 6.9 
 
HRMS (EI+) 
 Calculated for C11H14O2 (M)+: 178.0994 
 Found:   178.0995 
 
IR (thin film, cm-1) 
 3080, 3000, 2955, 2940, 2835, 1615, 1585, 1510, 1464, 1439, 1416, 1370, 1319, 
1290, 1261, 1209, 1172, 1158, 1117, 1062, 1037, 938, 884, 834, 823, 799 
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Synthesis of 2-pyridyl MIDA boronate 3.11 
 
 
 
2-pyridyl MIDA boronate (3.11) 
To a 250 mL Schlenk flask equipped with a stir bar was added 2-bromopyridine 
(6.00 mL, 62.9 mmol), triisopropylborate (15.0 mL, 65.2 mmol) and THF (100 mL). The 
solution was cooled to -78 °C. To the stirred solution was added dropwise n-BuLi (25.0 
mL, 2.5 M in hexanes) at a rate sufficiently slow as to avoid the accumulation of a red 
color in the mixture (app. 20 minutes). The resulting beige mixture was stirred for 30 min 
and then was allowed to warm to room temperature with stirring overnight (12 h). The 
mixture was concentrated in vacuo onto Celite (10 g) to afford a free-flowing powder. 
Separately, a 500 mL 3-neck round-bottom flask equipped with a stir bar was charged 
with N-methyliminodiacetic acid (15.77 g, 107.2 mmol) and DMSO (100 mL). To one 
neck of the flask was fitted a solid addition funnel charged with the Celite-adsorbed 
lithium triisopropyl 2-pyridylborate. To a second neck was fitted a short-path distillation 
apparatus connected to vacuum. The third neck of the flask was sealed with a septum. 
The system was placed under vacuum (1 Torr) and the mixture was heated to 75 °C upon 
which the DMSO began to distill. The lithium triisopropyl 2-pyridylborate was added to 
the distilling mixture portion-wise over 1 h. The mixture was further distilled to near 
dryness (1 h). The resulting residue was suspended in acetone, and then concentrated in 
vacuo onto additional Celite (10 g). The resulting powder was lyophilized for 3 days to 
remove additional DMSO, and then was subjected to flash chromatography on silica gel 
(40 g silica gel, Et2O:MeCN, 100:0 → 0:100). The product thus obtained was suspended 
in acetone (5 mL) and then diluted with Et2O (100 mL) to promote crystallization. The 
mixture was filtered to isolate 3.11 as an off-white crystalline solid (4.024 g, 27%). 
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TLC (MeCN) 
 Rf = 0.26, visualized by UV (λ = 254 nm) and KMnO4 stain 
 
1H-NMR (500 MHz, CD3CN)  
 δ 8.67 (ddd, J = 2.5, 1.5, 1.0 Hz, 1H), 7.70 (td, J = 7.5, 1.5 Hz, 1H), 7.62 (dt, J = 
7.5, 1.0 Hz, 1H), 7.28 (ddd, J = 8.5, 1.5 Hz, 1H), 8.67 (ddd, J = 4.5, 1.5, 1.0 Hz, 
1H), 4,09 (d, J = 17 Hz, 2H), 3.98 (d, J = 17 Hz, 2H), 2.55 (s, 3H) 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 150.8, 135.8, 128.1, 124.3, 62.9, 47.6 
 
11B-NMR (96 MHz, CD3CN) 
 δ 10.3 
 
HRMS (CI+) 
 Calculated for C10H12O4N2B (M+H)+: 235.0890 
 Found:      235.0895 
 
IR (KBr, cm-1) 
3004, 2956, 1774, 1749, 1633, 1590, 1466, 1340, 1289, 1279, 1214, 1152, 1095, 
1054, 1045, 998, 964, 894, 866, 775, 754, 708, 683 
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Suzuki-Miyaura cross-coupling of 2-pyridyl MIDA boronate 3.11 (Table 
3.8) 
 
 
 
General Procedure 
Under ambient atmosphere, to a 15 mL vial equipped with a stir bar was added 
the halide (1.0 mmol), 2-pyridyl MIDA boronate (3.11) (1.5 mmol), K2CO3 (5.0 mmol) 
and Cu(OAc)2 (0.50 mmol). In a glove box, to the vial was added a DMF mixture of 2-
dicyclohexylphosphino-2’,4’,6’-triisopropylbiphenyl (X-Phos) (0.06 mmol) and Pd2dba3 
(0.015 mmol) (8.0 mL DMF, pre-mixed and incubated for 5 min at 100 °C, then 
transferred at ~40 °C to avoid incomplete solubility at room temperature.) To the vial was 
added dry and degassed i-PrOH (2 mL). The reaction mixture was stirred at 100 °C for 4 
h. The mixture was cooled to room temperature and then was transferred to a 60 mL 
separatory funnel and was diluted with aq NaOH (1.0 M, 10 mL). The mixture was 
extracted with Et2O (3 × 10 mL). The combined organics were dried over MgSO4, 
filtered and concentrated in vacuo. The crude residue was subjected to flash-
chromatography on silica gel (hexanes:EtOAc). 
 
 
4-(2-pyridinyl)acetophenone14 (3.13a) [Table 3.8, Entry 1] 
The general procedure was followed using 4-chloroacetophenone (3.15a) (155 mg, 
1.00 mmol), 2-pyridyl MIDA boronate (3.11) (349 mg, 1.49 mmol), K2CO3 (694 mg, 
5.02 mmol) and Cu(OAc)2 (90 mg, 0.50 mmol). Flash chromatography on silica gel 
(hexanes:EtOAc, 100:0 → 80:20) afforded 3.13a as a colorless solid (142 mg, 72%). 
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TLC (hexanes:EtOAc 1:1) 
Rf = 0.47, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3)  
δ 8.73 (d, J = 5.0 Hz, 1H), 8.10 (d, J = 8.5 Hz, 2H), 8.06 (d, J = 8.5 Hz, 2H), 7.79 
(m, 2H), 7.29 (q, J = 4.5 Hz, 1H), 2.65 (s, 3H) 
 
13C-NMR (125 MHz, CDCl3) 
δ 197.8, 156.0, 149.9, 143.5, 137.1, 136.9, 128.8, 127.0, 122.9, 121.0, 26.7 
 
HRMS (CI+) 
 Calculated for C13H12ON (M+H)+: 198.0919  
 Found:   198.0919 
 
IR (KBr, cm-1) 
3048, 2999, 1679, 1604, 1584, 1574, 1558, 1466, 1434, 1400, 1356, 1315, 1266, 
1156, 1113, 1013, 989, 960, 849, 785, 723, 696, 618, 600, 592 
 
 
4-(2-pyridinyl)benzonitrile15 (3.13b) [Table 3, Entry 2] 
The general procedure was followed using 4-chlorobenzonitrile (3.15b) (137 mg, 
1.00 mmol), 2-pyridyl MIDA boronate (3.11) (352 mg, 1.50 mmol), K2CO3 (693 mg, 
5.01 mmol) and Cu(OAc)2 (91 mg, 0.50 mmol). Flash chromatography on silica gel 
(hexanes:EtOAc, 9:1) afforded 3.13b as a pale yellow solid (109 mg, 60%). 
 
TLC (hexanes:EtOAc 1:1) 
Rf = 0.59, visualized by UV (λ = 254 nm) 
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1H-NMR (500 MHz, CDCl3)  
δ 8.73 (d, J = 5.0 Hz, 1H), 8.11 (d, J = 9.0 Hz, 2H), 7.81 (td, J = 7.5, 1.5 Hz, 1H), 
7.75 (m, 3H), 7.31 (ddd, J = 7, 4.5, 1 Hz, 1H) 
 
13C-NMR (125 MHz, CDCl3) 
δ 155.2, 150.0, 143.4, 137.1, 132.5, 127.4, 123.3, 121.0, 118.8, 112.5 
 
HRMS (CI+) 
 Calculated for C12H9N2 (M+H)+: 181.0766  
 Found:   181.0765 
 
IR (KBr, cm-1) 
2228, 1588, 1466, 1433, 1393, 1303, 1152, 1152, 990, 852, 776, 738, 718, 620, 
563, 518 
 
 
2-(2-pyridinyl)quinoxaline16 (3.13c) [Table 3, Entry 3] 
The general procedure was followed using 2-chloroquinoxaline (3.15c) (165 mg, 
1.00 mmol), 2-pyridyl MIDA boronate (3.11) (353 mg, 1.51 mmol), K2CO3 (693 mg, 
5.01 mmol) and Cu(OAc)2 (91 mg, 0.50 mmol). Flash chromatography on silica gel 
(hexanes:EtOAc, 100:0 → 80:20) afforded 3.13c as a pale orange solid (164 mg, 79%). 
 
TLC (hexanes:EtOAc (1:1) 
Rf = 0.56, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3)  
δ 9.95 (s, 1H), 8.77 (ddd, J = 5.0, 1.5, 1.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.15 
(m, 2H), 7.88 (td, J = 7.5, 1.5 Hz, 1H), 7.77 (m, 2H), 7.39 (ddd, J = 7.5, 4.5, 1.0 
Hz, 1H) 
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13C-NMR (125 MHz, CDCl3) 
δ 154.5, 150.1, 149.4, 144.1, 142.5, 141.7, 137.1, 130.1, 130.0, 129.7, 129.3, 
124.6, 122.0 
 
HRMS (CI+) 
 Calculated for C13H10N3 (M+H)+: 208.0875 
 Found:   208.0871 
 
IR (KBr, cm-1) 
3050, 3004, 1591, 1548, 1492, 1479, 1457, 1437, 1403, 1367, 1143, 1131, 1059, 
1043, 996, 961, 806, 785, 772, 742, 716, 670, 556 
 
 
2,5-dimethyl-3-(2-pyridinyl)pyrazine (3.13d) [Table 3, Entry 4] 
The general procedure was followed using 3-chloro-2,5-dimethylpyrazine (3.15d) 
(142 mg, 1.00 mmol), 2-pyridyl MIDA boronate (3.11) (352 mg, 1.50 mmol), K2CO3 
(694 mg, 5.02 mmol) and Cu(OAc)2 (90 mg, 0.50 mmol). The aqueous phase was 
extracted an additional time with EtOAc (10 mL). Flash chromatography on silica gel 
(hexanes:EtOAc, 100:0 → 55:45) afforded 3.13d as a pale amber liquid (96 mg, 52%). 
 
TLC (hexanes:EtOAc 1:1) 
Rf = 0.39, visualized by UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CDCl3 w/ TMS)  
δ 8.72 (d, J = 3.5 Hz, 1H), 8.38 (s, 1H), 7.83 (m, 2H), 7.33 (m, 1H), 2.73 (s, 3H), 
2.59 (s, 3H) 
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13C-NMR (125 MHz, CDCl3) 
δ 157.2, 150.2, 149.9, 149.4, 148.7, 142.6, 136.6, 124.1, 123.0, 120.1, 22.6, 21.0 
 
HRMS (CI+) 
 Calculated for C11H12N3 (M+H)+: 186.1031 
 Found:   186.1034 
IR (thin film, cm-1) 
3055, 2927, 1693, 1589, 1561, 1474, 1452, 1422, 1371, 1292, 1171, 1071, 1048, 
995, 804, 752, 744 
 
N
N
3.13e  
1-(2-pyridinyl)isoquinoline (3.13e) [Table 3, Entry 5] 
The general procedure was followed using 1-chloroisoquinoline (3.15e) (164 mg, 
1.00 mmol), 2-pyridyl MIDA boronate (3.11) (350 mg, 1.49 mmol), K2CO3 (697 mg, 
5.05 mmol) and Cu(OAc)2 (89 mg, 0.49 mmol). The aqueous phase was extracted an 
additional time with EtOAc (10 mL). Flash chromatography on silica gel 
(hexanes:EtOAc, 70:30 → 30:70) afforded 3.13e as an off-white solid (152 mg, 74%). 
 
TLC (EtOAc) 
Rf = 0.47, visualized by UV (λ = 254 and 366 nm) 
 
1H-NMR (500 MHz, CDCl3)  
δ 8.79 (ddd, J = 5.0, 1.5, 1.0 Hz, 1H), 8.63 (d, J = 5.5 Hz, 1H), 8.60 (d, J = 8.5 Hz, 
1H), 7.99 (dt, J = 8.0 Hz, 1.0 Hz, 1H), 7.91 (td, J = 7.5, 2.0 Hz, 1H), 7.87 (d, J = 
8.0 Hz, 1H), 7.70 (d, J = 5.5 Hz, 1H), 7.69 (ddd, J = 8.0, 7.0, 1.5, 1H), 7.59 (ddd, 
J = 8.5, 7.0, 1 Hz, 1H), 7.40 (ddd, J = 7.5, 5.0, 1.0 Hz, 1H) 
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13C-NMR (125 MHz, CDCl3) 
δ 158.2, 157.6, 148.6, 141.8, 137.0, 136.9, 130.0, 127.7, 127.6, 126.8, 126.6, 
125.2, 123.2, 121.2 
 
HRMS (CI+) 
 Calculated for C14H11N2 (M+H)+: 207.0922 
 Found:   207.0926 
 
IR (KBr, cm-1) 
3051, 3012, 1581, 1562, 1551, 1470, 1455, 1434, 1379, 1350, 1322, 1245, 1129, 
1095, 992, 979, 966, 826, 811, 780, 753, 742, 713, 674, 644, 618, 573, 465, 441 
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CHAPTER 4 
MULTISTEP SYNTHESIS OF COMPLEX BORONIC ACIDS FROM 
SIMPLE MIDA BORONATES 
 
Eric P. Gillis, Brice E. Uno, and Martin D. Burke 
 
 In order to maximize the generality of the ICC approach, efficient access to a 
large collection of building blocks, including structurally complex boronic acids, is 
necessary. The significant demand for boronic acids and boronic esters has led to the 
commercial availability of hundreds of these reagents. However, most of these 
commercially available compounds are structurally simple, lacking complex functionality 
and/or stereochemical elements. In theory, multi-step organic synthesis could be used to 
elaborate simple boronic acids into complex boron-containing building blocks. Due to the 
incompatibility of boronic acids and esters with many organic reagents and SiO2 
chromatography, only a few reports describe this practice. This chapter details the 
discovery that MIDA boronates are compatible with a wide range of synthetic reagents 
and reaction conditions. Enabled by this discovery and the favorable properties of MIDA 
boronates, including the general compatibility of these reagents with SiO2 
chromatography, it is now possible to readily transform simple boron-containing building 
blocks into complex boronic acids via multi-step synthesis with MIDA boronates. The 
potential of this approach was tested in the synthesis of the natural product (+)-crocacin C. 
Brice E. Uno contributed to the work presented in this chapter by optimizing the 
synthesis of vinyl MIDA boronate, exploring the utility of this building block in several 
reactions, and by confirming the structure of Br-B(MIDA) via X-ray crystallography. 
 
Adapted from Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2008, 130, 14084-14085 and  Uno, B. E.; Gillis, 
E. P.; Burke, M. D. Tetrahedron 2009, 65, 3130-3138. 
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4-1 BACKGROUND 
 Efficient access to structurally complex and/or functionally rich boronic acids 
remains a significant challenge in synthetic chemistry. In theory, multi-step organic 
synthesis could be used to elaborate simple boronic acids into complex boron-containing 
building blocks. However, due to the reactive p-orbital of boronic acids and esters, boron 
functional groups are typically incompatible with many reagents used in organic 
synthesis. Treatment of boronic acids with oxidants typically leads to oxidation of the C-
B bond;1 exposure to halogens results in exchange of the C-B bond for a C-X bond;2 
mixing with hydride sources leads to formation of the corresponding borohydride 
species;3 and treatment with carbon nucleophiles leads to addition at the boron center.4 
Further, boronic acids and esters constitute the key reactive functional group in a number 
of transformations such as the Suzuki reaction, Chan-Lam coupling, Heck coupling, the 
Petasis boronic acid Mannich reaction, rhodium-catalyzed 1,4-addition to enones, and 
allylations of carbonyl compounds. As an alternative approach, complex boronic acids 
might be accessed by late-stage installation of boron to an already functionally rich 
substrate. In practice, the scope of substrates which can be accessed by this approach is 
limited because most methods for installing boron have poor functional group 
tolerance.5,6   
 
Carrying sp2-hybridized boranes through synthetic steps 
 The reactivity of a boronic acid can be modulated by its conversion to a boronic 
ester. Since the goal of this transformation is often to impart added stability to the boron 
functionality the ligands used in this process are typically sterically bulky diols, the most 
popular of which is pinacol. Relative to boronic acids, pinacol boronic esters are more 
easily stored, handled, and characterized; are more readily purified via SiO2 
chromatography; and are more stable to common reagents used in organic synthesis. As 
such, there several reports which detail the carriage of pinacol esters through multiple 
synthetic steps.7 In an example reported by Sulikowski and co-workers, a pinacol boronic 
ester functional group proved stable to the conditions of DMP oxidation, a TiCl4 
mediated aldol reaction, silylation, and LiBH4 reduction (Scheme 4.1).7a In another 
example, the pinacol boronic ester functional group was found to be stable to the 
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conditions of TBAF deprotection, the Horner-Wadsworth-Emmons reaction, DIBAL-H 
reduction, and Sharpless epoxidation (Scheme 4.2).7b Also, Matteson and co-workers 
reported that a pinacol boronic ester was stable to PDC oxidation (Scheme 4.3).7c  
Pinanediol derived boronic esters, which have been reported to be more stable 
than pinacol boronic esters,8 also demonstrate some compatibility with common reagents. 
For example, Matteson and co-workers demonstrated that a pinanediol boronic ester was 
stable to DDQ-mediated debenzylation and Swern oxidation (Scheme 4.4).9 Likewise, 
boronic esters derived from a sterically-bulky, tartrate-based ligand have been shown by 
Pietruszka to be stable to cyclopropanation, oxidation, HF, DIBAL-H, Horner-
Wadsworth-Emmons conditions and radical decarboxylation. 10  In fact, these boronic 
esters are even unreactive under Suzuki-Miyaura cross-coupling (SMC) conditions.11 
Boranes derived from complexation with 1,8-diaminonapthalene (dan) are also inert 
under the conditions of the SMC reaction and are stable to concentrated aqueous NaOH.12  
 
Scheme 4.1. Sulikowski and co-workers executed a synthetic route in which a pinacol boronic ester 
functional group was carried through multiple synthetic steps. 
 
 
Scheme 4.2. Gopalarathnam and Nelson demonstrated that a pinacol boronic ester group was stable to 
TBAF, oxidation, Horner-Wadsworth-Emmons, DIBAL-H, Sharpless expoxidation and silylation 
conditions. 
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Scheme 4.3. Matteson and co-workers reported that a pinacol boronic ester was stable to PDC oxidation. 
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Scheme 4.4. Pinanediol-derived boronic esters are generally highly stable, and in an example by Matteson 
were shown to be compatible with DDQ-mediate debenzylation and Swern oxidation conditions. 
   
 One drawback to utilizing strongly binding ligands to modulate the reactivity of 
boron is that cleaving these ligands to regenerate the boronic acid generally requires 
relatively harsh conditions. In some cases removing the ligand is unnecessary since the 
boronic ester can be utilized directly in the desired reaction. However, some applications 
demand the use of a boronic acid. Because the equilibrium between a pinacol boronic 
ester and the corresponding boronic acid lies in favor of the pinacol boronic ester,8 the 
hydrolysis of the ester must be biased on Le Chatelier’s principle. Specifically, in order to 
completely hydrolyze a pinacol boronic ester it is often necessary to employ, along with 
an acid catalyst, an oxidant such as NaIO4 to destroy the free pinacol ligand. 13 
Alternatively, pinacol and related diol boronic esters can be hydrolyzed via the 
intermediacy of an insoluble diethanolamine boronate complex.8, 14  Cleavage of 1,8-
diaminonapthalene from boron typically requires treatment with aqueous 5M HCl for 4-8 
hours or treatment with aqueous 2M H2SO4 for 10-27 hours.12 Cleavage of Pietruszka’s 
tartrate-based diol from boron typically requires the use of LiAlH4 and proceeds through 
a borohydride intermediate.10,11 
 For a limited set of reactions it is possible to use the boronic acid directly and 
thereby avoid the overhead and complications of employing a boronic ester. Specifically, 
Hall and co-workers demonstrated that boronic acids can be stable to conditions that 
effect an IBX oxidation of a benzylic or primary alcohol, DIBAL-H reduction of an ester, 
acetylation, peptide coupling, a Grubbs cross-metathesis reaction, and a cycloaddition.15 
Further, with 4-formylphenylboronic acid it was demonstrated that the boronic acid 
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moiety was stable to a NaBH4 reduction, BF3·OEt2 promoted allylation, the Horner-
Wadsworth-Emmons reaction, and an alkynylation/dipolar cycloaddition sequence.15 In 
another example, NBS was employed in the oxidation of o-tolylboronic acid (Scheme 
4.5).16 Bromine was also tolerated in this transformation but was not tolerated by p-
tolylboronic acid. Although boronic acids and esters have been demonstrated to be 
generally stable to a limited set of reaction conditions, and are tolerant of other reagents 
in some specific examples, the limited number of published examples on carrying 
boronic acids and esters through synthetic steps indicates that this approach is not general. 
 
 
Scheme 4.5. In specific cases the use of NBS in the presence of boronic acids is tolerated. In this example 
NBS was used to brominate o-tolylboronic acid. Bromine was also tolerated. However, bromine was not 
tolerated in the bromination of p-tolylboronic acid. 
 
Carrying sp3-hybridized boranes through synthetic sequences 
 Boronic acids and boronic esters are susceptible to reactions with common 
reagents due to the Lewis acidic p-orbital on boron. On the other hand, sp3-hybridized 
boronates lack this p-orbital and are therefore not Lewis acidic. As a result, boronates are 
stable to a broader range of reagents than their corresponding sp2-hybridized counterparts. 
In a straightforward approach to the synthesis of bifunctional boronic acids, Luliński and 
co-workers employed the lithium borate species that results from trapping of 
organolithium reagents with B(i-OPr)3 or MeOB(Pin) as a protected form of a boronic 
acid.17 In a representative example shown in Scheme 4.6, 1,3,5-tribromobenzene was 
treated with n-BuLi followed by trapping with B(i-OPr)3. The boron atom of the resulting 
product is sp3-hybridized and anionic and is therefore stable to n-BuLi. Subsequent 
treatment with additional n-BuLi followed by trapping with CO2 afforded the 
trifunctional building boronic acid product in 82% overall yield (Scheme 4.6). A 
limitation of this approach is that trialkoxyborate salts are not generally stable to long 
term storage and are reactive with many other reagents. In a related approach, the sp3-
hybridized, neutral boronate derived from condensation of 3,4-difluoroboronic acid with 
N-butyldiethanolamine functioned as a protected boronic acid equivalent in a LDA-
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mediated lithiation/B(Oi-Pr)3 trapping sequence (Scheme 4.7).18 N-butyldiethanolamine 
boronates are stable to storage and are therefore in some applications more advantageous 
that trialkoxyborate salts. However, these boronates are prone to hydrolysis and are 
unstable to SiO2 purification, which limits their utilization in organic synthesis. 
 
Scheme 4.6. The trialkoxyborate that results from trapping of an aryllithium species with B(Oi-Pr)3 is not 
electrophilic and therefore functions as a protected boronic acid in a subsequent lithiation/electrophile 
trapping sequence. 
 
 
Scheme 4.7. Boronates derived from condensation of boronic acids with N-butyldiethanolamine function 
as protected boronic acid equivalents in LDA mediated lithiation/electrophile trapping sequences. 
 
 The most popular and broadly applicable form of a protected boronic acid 
equivalent is the trifluoroborate functional group. The facile synthesis of trifluoroborate 
salts from boronic acids/esters was first described by Vedejs and co-workers,19 and these 
reagents have been extensively developed by Molander and Genet.20,21 Trifluoroborates, 
unlike trialkoxyborates, are not sensitive to atmospheric moisture and can be easily 
handled and stored under ambient atmosphere. The improved stability of trifluoroborates 
is likely due to the very strong boron-fluorine bonds that are inherent to this functional 
group. Further, although the trifluoroborate functionality is anionic, this borate group is 
reported to be stable under a broad range of reaction conditions.22,21,23,24 As such, the 
development of trifluoroborate salts has contributed to a large number of examples 
wherein the trifluoroborate group is unaffected by single synthetic operations, a selection 
of which are summarized in Table 4.1. For example, trifluoroborates were functionalized 
under oxidative conditions including TPAP/NMR, Swern oxidation, and DMP oxidation 
(entry 1);22d were functionalized via ozonolysis (entry 2); 22g underwent reductive 
amination (entry 3); 22i were utilized as reagents in a Witting olefination (entry 4); 22f were 
stable to n-BuLi mediated lithiation followed by trapping with electrophiles (entry 5), 22e 
and were functionalized via SN2 displacement of a primarily halide followed by simple 
alkylation (entry 6). 22j  
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Table 4.1 
 
 
 
 
Despite the observation that trifluoroborate salts are compatible with a broad 
range of reagents, the use of trifluoroborate salts in multi-step synthesis is limited.22,21 In 
fact, excluding application in SMC reactions, we are aware of few examples in which a 
trifluoroborate salt is sequentially subjected to more than one reaction condition while 
maintaining intact the trifluoroborate functionality.22b,22f,22j,25 One likely explanation for 
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the limited use of trifluoroborates in multi-step synthesis is that trifluoroborate salts are 
generally not stable to SiO2 purification,21, 26  the most widely utilized technique for 
isolating intermediate compounds in synthetic organic chemistry. Rather, reaction-
specific optimization of aqueous workup and/or crystallization conditions is required for 
the purification of these reagents.22 Therefore, at the time of our work there was a 
significant unmet need for a general strategy for carrying boron reagents through multi-
step synthesis to generate complex boronic acids and their derivatives.  
 
4-2 COMPATABILITY OF MIDA BORONATES WITH ORGANIC REAGENTS 
 Due to the lack of the p-orbital that is typically involved in the reactivity of 
boronic acids, we hypothesized that sp3-hybridized MIDA boronates might be stable to 
mild reagents. At the time of these studies it had already been demonstrated that MIDA 
boronates were stable to the conditions of the SMC reaction under anhydrous conditions 
(chapter 2) and were stable to the related Pd-catalyzed reactions: Sonogashira, Stille, 
Negishi, and Heck coupling, and Miyaura borylation.27 Our aim was to discover if MIDA 
boronates might be stable to other reagents commonly used in organic synthesis. Towards 
this end, we first explored the compatibility of the model substrate p-
hydroxymethylphenyl MIDA boronate 4.1a with a range of oxidants and found that 
Swern conditions were well tolerated and afforded the desired benzaldehyde 4.2 in 88% 
yield (Scheme 4.8). PDC, TPAP/NMO, and Dess-Martin periodinane were also tolerated 
and effective in this transformation. Treatment of benzaldehyde 4.2 with NaBH4 at 0 °C 
rapidly regenerated 4.1a in 76% yield, while treatment of 4.2 with DIBAL-H or LiAlH4 
at -78 °C led to rapid loss of the MIDA boronate functional group as judged by TLC.  
Expecting to identify the limits of stability of the MIDA boronate group, 4.1a was 
exposed to the aqueous, strongly acidic, and highly oxidizing conditions of the Jones 
reaction (Scheme 4.9). Surprisingly, these conditions led to a 90% yield of benzoic acid 
4.3. 28  This stability proved to be unique among related boron reagents as the 
corresponding boronic acid 4.1b, pinacol boronic ester 4.1c, 1,8-diaminonaphthalene 
adduct 4.1d,12 trifluoroborate salt 4.1e,20 and N-methyldiethanolamine boronate 4.1f all 
decomposed rapidly and completely under the same reaction conditions. It is known that 
4.1c, 4.1d, 4.1e and 4.1f are unstable to aqueous acid to varying degrees. However, under 
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the Jones conditions all of these reagents decomposed at a rate (full decomposition within 
5 minutes) that far exceeds the rates of acid-promotoed hydrolysis typically associated 
with these boron functional groups.12,13 The surprising difference in stability between 
MIDA boronate 4.1a and diethanolamine boronate 4.1f was probed via X-ray 
crystallographic studies and variable temperature 1H-NMR studies, the results of which 
are reported in chapter 2. The high degree of stability observed for the MIDA boronate is 
attributed the strong conformational rigidity inherent to the MIDA boronate group, while 
the reactivity of 4.1f is attributed to the fluxional nature of this complex. 
 
 
Scheme 4.8. MIDA boronate 4.1a was discovered to be stable to oxidation under Swern conditions. PDC, 
DMP and TPAP/NMO were also tolerated in this transformation. The MIDA boronate functionality was 
stable to treatment with NaBH4 but not to treatment with DIBAL-H or LiAlH4. 
 
 
 
Scheme 4.9. MIDA boronate 4.1a proved to be stable to the aqueous, highly acidic and highly oxidizing 
conditions of the Jones reaction. This stability was found to be unique as boron reagents 4.1b–4.1f rapidly 
and completely decomposed under the same reaction conditions. 
 
 Encouraged by these preliminary studies on the stability of the MIDA boronate 
functional group to oxidation and reduction, we next tested the compatibility of 4.1a and 
its derivatives with a variety of common reagents and conditions (Scheme 4.10). 
Remarkably, even TfOH (pKa of -14) was tolerated, enabling the acid-catalyzed p-
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methoxybenzylation of 4.1a to yield 4.4. Treatment of 4.4 with DDQ regenerated 4.1a in 
79% yield. Alcohol 4.1a was efficiently converted to silyl ether 4.5 under standard 
conditions. Treatment of 4.5 with 3.9 equivalents of a commercial preparation of 1.0 M 
TBAF in THF led to a complete loss of the MIDA functional group within 5 minutes as 
observed by TLC.29 Because commercial TBAF is never anhydrous and is inevitably 
contaminated with varying unknown amounts of n-BuN4H2F,30 it is not clear from this 
experiment which species is reactive with the MIDA boronate functional group. On the 
other hand, treatment of 4.5 with an excess of HF·pyr at room temperature followed by 
quenching with aqueous NaHCO331 provided 4.1a in 83% yield. 
 
Scheme 4.10. Alcohol 4.1a and its derivatives were found to be stable to a variety of reagents and 
conditions. 
 The compatibility of the MIDA boronate functional group observed with soft 
nucleophiles encouraged us to explore a series of C-C bond-forming reactions with 
benzaldehyde 4.2 (Scheme 4.11). The conditions of the Evans aldol reaction32 proved to 
be compatible with the MIDA boronate functional group and afforded 4.7 as a single 
diastereomer as observed by 1H-NMR in 79% yield. The product, which initially contains 
a dibutylborate complex resulting from the use of dibutylboron triflate in the reaction, 
could be freed of dibutylborinic acid using aqueous H2O2:MeOH as long as the system 
was buffered to pH 6.0. Decomposition of 4.7 was observed if the system was unbuffered 
or was buffered to pH 7.0. The Horner-Wadsworth-Emmons olefination reaction33 also 
proved compatible with the MIDA boronate functionality and afforded 4.8 as the pure E-
isomer as judged by 1H-NMR in 71% yield. Surprisingly, 4.8 was found have a low 
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solubility in most organic solvents, 34  and was most conveniently purified by 
recrystallization. Boronate 4.2 was also engaged in a Takai olefination to provide vinyl 
iodide 4.9 as a 17:1 E:Z mixture as judged by 1H-NMR in 88% yield. 
 
Scheme 4.11. The MIDA boronate functionality was found to be compatible with several C-C bond 
forming reactions. 
 MIDA boronates also proved useful in several C-N bond forming reactions 
(Scheme 4.12). Aldehyde 4.2 underwent one-pot reductive amination with morpholine to 
afford the tertiary amine 4.10 in 76% yield.35 Additionally, 4.2 could be transformed into 
benzimidazole 4.11 via reductive cyclization with 1,2-phenylenediamine. This product 
was then engaged in a Chan-Lam coupling36 with p-tolylboronic acid to afford a mixture 
of 4.12:4.11 in a 59:41 ratio. 
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Scheme 4.12. The MIDA boronate functional group was found to be compatible with several C-N bond 
forming reactions. 
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4-3 MIDA BORONATES IN CROSS-METATHESIS REACTIONS 
 As a means to more readily access alkenyl MIDA boronates, we became 
interested in using the olefin cross-metathesis reaction as a means to install the MIDA 
boronate group directly to terminal olefins. 37 , 38  Previous experience with preparing 
alkenyl boronic acids via hydroboration of alkynes with catecholborane demonstrated to 
us that a hydroboration approach was less than ideal. Specifically, separating the boronic 
acid product from the catechol byproduct often proved difficult. On the other hand, if a 
MIDA boronate functional group could be introduced by the metathesis reaction the 
product would be amenable to facile SiO2 chromatography. Further, we hypothesized that 
the sterically bulky nature of the MIDA boronate group would cause alkenyl MIDA 
boronates to behave like a type III olefin39 (analogous to tert-butylethylene) in the cross-
metathesis reaction, thereby avoiding any homodimerization and providing high yields 
and stereoselectivities with many classes of olefins.  
 In a preliminary study to test the reactivity of a MIDA boronate in a cross-
metathesis reaction, a solution of cis-propenyl MIDA boronate 4.12 and styrene was 
treated with Grubbs’ second generation ruthenium catalyst (Scheme 4.13). In agreement 
with the prediction for high E-selectivity in this process, the sole product of the reaction 
as detected by 1H-NMR was the E-styrene product 4.13 in 94% yield. A subsequent 
cross-metathesis reaction was attempted between boronate 4.12 and acrolein but 
surprisingly this experiment furnished only trans-propenyl MIDA boronate (4.15) in 93% 
yield (Scheme 4.14). In fact, boronate 4.12 was used in these studies because cis-
propenyl boronic acid ($60/g from Aldrich) was approximately 1/3 the price of trans-
propenyl boronic acid ($200/g from Aldrich). Following optimization, it was found that 
only 0.5% of Grubbs II catalyst was needed to affect complete isomerization of 4.12.40 
This finding was paired with the “hot-protocol” procedure developed by Graham Dick41 
to realize a very efficient and scalable synthesis of 4.15 (Scheme 4.15). 
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Scheme 4.13. The olefin cross-metathesis reaction between styrene and 4.12 afforded exclusively the E-
isomer of 4.13 as observed by 1H-NMR. 
 
Scheme 4.14. The olefin cross-metathesis reaction between acrolein and 4.12 did not form the expected 
product but instead completely isomerized 4.12 to the E-isomer 4.15. 
 
Scheme 4.15. Isomerization of 4.15 via the metathesis reaction enables a practical large-scale synthesis of 
trans-propenyl MIDA boronate. All purifications steps involve a simple recrystallization. 
 The cross-metathesis of an alkenyl MIDA boronate with acrolein to generate 4.14 
was an important goal because the product 4.14 was targeted for use in the synthesis of 
(+)-crocacin C (see below). Because terminal olefins are generally more reactive than 
internal olefins in the cross-metathesis reaction,39 we hypothesized that vinyl MIDA 
boronate (4.17) might be more reactive than 4.12 or 4.15. However, consistent with 
reports that vinyl boronic is thermally unstable and is prone to polymerization at elevated 
temperatures,42 isolation of vinyl boronic acid followed by exposure to MIDA under 
Dean-Stark conditions did not afford 4.17. As a potential alternative route to 4.17, it is 
known that arylsilanes under go C-Si/C-B bond exchange when treated with BBr3.43 
Based on this precedent, vinyltrimethylsilane was exposed to BBr3 and the resulting 
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dibromoborane was treated with the disodium salt of MIDA (4.16) to realize a 48% yield 
of 4.17 (Scheme 4.16). Interestingly, a byproduct was formed in this reaction that 
produced a 1H-NMR spectrum containing only resonances for the diasteotopic methylene 
protons and N-CH3 protons of MIDA. The same compound was prepared by mixing 
MIDA with BBr3 in CD3CN (Scheme 4.17), and in a subsequent study the structure of 
4.18 was definitively assigned based on X-ray crystallographic data. Remarkably, 4.18 
was found to be completely stable to SiO2 chromatography and storage under ambient 
atmosphere at room temperature! 
 
Scheme 4.16. Vinyl MIDA boronate 4.17 was accessed via C-Si/C-B bond exchange with BBr3 followed 
by trapping with the disodium salt of MIDA (4.16). 
 
 
Scheme 4.17. Treatment of MIDA with BBr3 afforded bromo MIDA boronate 4.18. Remarkably, this 
compound was found to be stable to SiO2 chromatography and demonstrated no change in composition 
upon storage under ambient air at room temperature. 
 
 Cross-metathesis reactions employing trans-propenyl pinacol boronic ester are 
known to proceed in some cases with moderate E:Z selectivity, and can be complicated 
by the instability of the pinacol boronic ester product to SiO2 chromatography. 37 In 
contrast, when MIDA boronate 4.17 was employed in cross-metathesis reactions with a 
range of alkenes, the products were always obtained as the pure E-isomers (no Z-isomers 
were detected by 1H-NMR) (Table 4.2). Owing to the general stability of the MIDA 
boronate functional group to the conditions of the cross-metathesis reaction conditions 
and to SiO2 chromatography, the yields of these processes were uniformly high. 
Substrates that previously proved problematic in the cross-metathesis reaction with trans-
propenyl pinacol boronic ester,37 such as 4.19a, 4.19c and 4.19e, were found to undergo 
 180
an efficient reaction with MIDA boronate 4.17 (entries 1, 3 and 5). Boronates 4.20b and 
4.20c, both potentially two synthetic steps from 4.14, were accessed efficiently through 
the metathesis reaction (entries 2 and 3).44 As is common with many cross-metathesis 
reactions,39 increased substitution at the allylic position was well tolerated (entries 4 and 
5). Additionally, the cross-metathesis reaction of styrenes 4.19f-4.19h was found to 
provide an efficient route to bromo-MIDA boronates 4.20f-4.20g (entries 6, 7 and 8). 
 Expanding the collection of conditions for which MIDA boronates have been 
demonstrated to be stable, we discovered that boronate 4.17 could be further 
functionalized under several reaction manifolds (Scheme 4.18). Exposure of 4.17 to 
Pd(OAc)2/CH2N2 resulted in the formation of cyclopropane 4.21. Further, treatment of 
4.17 with m-CPBA followed by SiO2 chromatography led to the isolation of oxirane 4.22. 
Molander and co-workers have demonstrated the epoxidation of substituted 
alkenyltrifluoroborate salts with DMDO or m-CPBA. 45  However, to the best of our 
knowledge 4.22 represents the first example of an unsubstituted oxiranylborane. Boronate 
4.17 also underwent Heck coupling with p-bromoacetophenone using optimized reaction 
conditions to afford 4.23. Consistent with the low reactivity of 4.17 in this reaction, 
byproducts from Heck coupling are not typically observed in slow-release cross-coupling 
reactions employing 4.17 (chapter 3). In a different manifold of the Heck reaction, 
boronate 4.17 participated in an oxidative Heck coupling with phenylboronic acid under 
the action of the White catalyst to afford 4.24.46 
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Table 4.2. 
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O
4.19
R R
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O
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O
O
BrBr
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4.20g (meta)
4.20h (para)
MeN
O
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O
O
Grubbs II
CH2Cl2
40 oC, 12 h
MeN
O
OB
O
O
MeN
O
OB
O
Oi-Pr3Sii-Pr3Si
4.20
4.17 (1 equiv.)
Entry cross partner cross product
isolated
yield (%)
1
2
3
4
5
4.19a 4.20a
4.19d 4.20d
4.19f (ortho)
4.19g (meta)
4.19h (para)
E:Z >20:1
6
7
8
85
84
98
96
94
81
91
89
MeN
O
OB
O
OAcO
MeN
O
OB
O
OBzO
AcO
BzO
OAc
OBz
4.19b
4.20b
4.19c (E:Z 1:1) 4.20c
MeN
O
OB
O
OHO
MeMe
HO
MeMe
4.19e
4.20e
1.5-2.5 eq.
Reproduced with permission from Uno, B. E.; Gillis, E. P.; Burke, M. D.
Tetrahedron 2009, 65, 3130-3138. Copyright 2009 Elsevier.
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Scheme 4.18. The MIDA boronate functional group was found to be stable to the conditions of 
cyclopropanation, epoxidation and Heck coupling. 
 
4-4 THE TOTAL SYNTHESIS OF (+)-CROCACIN C 
 Based on the observation that MIDA boronates are compatible with a broad range 
of reagents, we hypothesized that simple MIDA boronates could be efficiently elaborated 
to functionally dense and synthetically useful building blocks through a series of 
synthetic steps. Up to this point our studies had focused on single-step manipulations of 
MIDA boronates, but the products were always obtained as pure compounds in high yield 
after SiO2 chromatography, suggesting that the reaction sequence could be extended. To 
test this hypothesis, and the corollary that complex boronic acid building blocks should 
enable the efficient synthesis of a natural product, we targeted the total synthesis via ICC 
of (+)-crocacin C (4.25)47. The natural product was retrosynthetically fragmented via 
recursive cross-coupling transforms to afford known building blocks 4.2647b and 4.27, 
and the structurally complex halo MIDA boronate 4.28 (Scheme 4.19). Access to 4.28 
would depend on the on the ability to elaborate a simply MIDA boronate starting material 
through multi-step synthesis en route to the complex building block. 
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Scheme 4.19. The natural product (+)-crocacin C was retrosynthetically fragmented via recursive cross-
coupling transformations to identify known building blocks 4.26 and 4.27, and the structurally complex 
halo MIDA boronate 4.28. 
 
 The synthesis of 4.28 commenced with acrolein MIDA boronate 4.14 (Scheme 
4.20), which was prepared via condensation of the known boronic acid48 with MIDA. 
This building block was engaged in a Sn(OTf)2-mediated Paterson aldol reaction49 to 
furnish β-hydroxyketone 4.31 as well as a small amount of the undesired diastereomer 
which is typical of the Paterson reaction.49 Enabled by the stability of MIDA boronates to 
SiO2, simple chromatography was used to separate the diastereomers, and 4.31 was 
isolated in 70% yield. Although acrolein MIDA boronate 4.29 is not readily soluble in 
CH2Cl2 at -78 °C, the aldol reaction was nonetheless effective because the product (4.31) 
is readily soluble under these conditions which in accordance with Le Chatelier’s 
principal promotes the continued dissolution of 4.29 throughout the course of the reaction. 
β-hydroxyketone 4.3147d next underwent diastereoselective reduction with 
Me4N(AcO)3BH47d to afford diol 4.32 in 71% yield. Interestingly, a number of 
experiments indicated that this reaction needed to be quenched carefully in order to avoid 
recovering large amounts of 4.31. Exposure of 4.31 to Meerwein’s salt proceeded in 82% 
yield to furnish 4.33, which was then treated with aqueous ceric ammonium nitrate 
(CAN) to effect the cleavage of the PMB ether to afford 4.34. Although DDQ could be 
used to convert 4.33 to 4.34, the removal of excess DDQ and the hydroquinone 
byproduct following the reaction was much more demanding than the simple aqueous 
extraction associated with CAN. Subsequent DMP oxidation50 of 4.34 afforded aldehyde 
4.35 which was next engaged in a Takai olefination47b to afford E-vinyl iodide 4.28 as a 
single isomer as observed by 1H-NMR in 74% yield. As an important note, although 
MIDA boronates undergo hydrolysis to the boronic acid when mixed with aqueous 
NaHCO3 in methanol (chapter two), saturated aqueous solutions of NaHCO3 were used in 
the workup steps employed in the syntheses of 4.31, 4.34, 4.35 and 4.28, where the 
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following conditions of the workup were met: the absence of MeOH, favorable 
partitioning of the MIDA boronate into the organic phase, and an organic phase that is 
poorly miscible with water. Aqueous washes with NH4Cl (4.31), dilute HCl (4.33), 
NaHSO3 (4.34) and Na2S2O3 (4.28) were also found to be compatible with the MIDA 
boronate group. 
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Scheme 4.20. The synthetic route to bifunctional building block 4.28. 
 
 
Scheme 4.21. The synthesis of (+)-crocacin C was completed via an ICC sequence involving an initial 
Stille coupling between 4.28 and 4.26, and then a SMC reaction between 4.36 and 4.27. 
   
 With bifunctional building block 4.28 in hand, the ICC sequence began with a 
Stille cross-coupling reaction between 4.26 and 4.28 (Scheme 4.21)51. After a brief 
survey of conditions for the Stille reaction the CsF/CuI conditions reported by Baldwin52 
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were selected, and under these conditions boronate 4.28 was smoothly transformed into 
boronate 4.36 in 74% yield. The subsequent SMC between 4.36 and 4.27 presented an 
early test for the slow-release SMC conditions that were being developed concurrently 
with David Knapp (chapter 3). In this case, aqueous K3PO4 was added to a vial 
containing 4.36, 4.27, and the palladium catalyst in order to effect the slow in-situ 
deprotection of 4.36 to the corresponding boronic acid. This coupling was efficient and 
afforded (+)-crocacin C (4.25) in 77% yield.47 
 
4-5 BORONIC ACIDS FROM MIDA BORONATES 
 The hydrolysis of MIDA boronates upon treatment with aqueous NaOH has been 
found to be fast and efficient (chapter 2). Therefore, the discovery that MIDA boronate 
building blocks can be functionalized using many common reagents represents a pathway 
not only to complex MIDA boronate esters, but also to complex boronic acids. To 
confirm that the MIDA boronates synthesized in the above studies can indeed be 
converted to the boronic acids, we exposed boronates 4.1a and 4.2-4.10 to the standard 
aqueous deprotection conditions (aq. 1 M NaOH:THF, 23 °C, 10 minutes) and isolated 
the corresponding boronic acids (Table 4.3). MIDA boronate 4.6 was not included in this 
study because the benzylic iodide functionality is very sensitive to water. In all cases the 
yields of pure boronic acid were high. The yield of boronic acid 4.37 was increased if the 
milder aqueous NaHCO3:MeOH conditions (chapter 2) were employed. Similarly, 
deprotection of 4.7 with aq. NaOH led to apparent epimerization of the product, while 
aqueous NaHCO3:MeOH-mediated deprotection of 4.7 avoided this problem and 
afforded the pure boronic acid. 
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Table 4.3. 
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O OH
Me
O N
O 4.37f
OH
OH
B
TBSO
4.37e
OH
OH
B
O
4.37d
MeO
OH
OH
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OH
OH
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H 4.37b
OH
OH
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N
4.37i
Entry
4.1a 4.1b
4.2
4.3
4.4
4.5
4.7
4.8
4.9
1
2
3
4
5
6
7
8
85%
76%
89%
84%
81%
85%
75%
89%
O
76%9 4.10
*
*
* Denotes that the MIDA boronate was deprotected using alternative
conditions: sat. aq. NaHCO3 : MeOH, 23 oC, 3.5 h  
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4-6 SUMMARY 
 In summary, it was discovered that the MIDA boronate functional group is 
compatible with a broad range of common reagents and reaction conditions. These 
reagents include oxidants, reductants, soft nucleophiles, carbon nucleophiles, strong acids, 
Lewis-acids, as well as reagents employed in epoxidation, cyclopropanation, Heck 
coupling, cross-metathesis and C-N bond forming reactions. Consistent with the 
observation of a unique susceptibility to hard anionic nucleophiles, it was found that the 
MIDA boronate functional group was not compatible with NaOH, TBAF, LiAlH4 or 
DIBAL-H. Because MIDA boronates are generally stable to SiO2 purification, isolation 
of the products from these reactions was straightforward. Enabled by these collective 
discoveries, a complex halo MIDA boronate building block was synthesized via multi-
step synthesis starting from a simple MIDA boronate. This halo MIDA boronate 
bifunctional building block was utilized in the ICC synthesis of the natural product (+)-
crocacin C. The results described in this chapter demonstrate that it is now possible to 
reliably access complex MIDA boronate and boronic acid products via multi-step organic 
synthesis where a boron atom protected as a MIDA boronate is carried through each 
synthetic step. 
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CHAPTER 4: EXPERIMENTAL SECTION 
 
 
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, 
Alfa Aesar, TCI America, or Frontier Scientific, and were used without further 
purification unless otherwise noted. Solvents and amines were dried as noted in chapter 2. 
1,2-Dichloroethane was dried over 4Å molecular sieves for 24 h before use. The 
following compounds were prepared according to known literature procedures: 
trifluoroborate 4.1e1, stannane 4.262, ketone 4.303. MIDA boronates 4.17, 4.20a–4.20h, 
4.21, 4.22, 4.23 and 4.24 (via oxidative Heck coupling) were synthesized by Brice Uno.4 
 
General Experimental Procedures. The general experimental procedures followed in 
these studies are the same as those detailed in chapter 2. Column chromatography was 
performed as described in chapter 3. 
 
Structural analysis. Structural analysis was performed and described as detailed in 
chapter 2. 
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MIDA boronate 4.1a 
From boronic acid 4.1b: 
 
 
 
To a 25 mL roundbottom flask was added 4-(hydroxymethyl)phenylboronic acid 
4.1b (759 mg, 5.00 mmol), N-methyliminodiacetic acid (808 mg, 5.49 mmol), DMSO (2 
mL) and toluene (5 mL). The flask was fitted with a Dean-Stark trap filled with toluene. 
The Dean-Stark trap was fitted with a water-cooled reflux condenser vented to ambient 
atmosphere. The stirred mixture was refluxed with azeotropic removal of water for 3 h. 
The mixture was concentrated in vacuo (1 Torr, 100 °C) to afford a yellow oil residue. To 
the flask was added water (10 mL) which caused the crystallization of a colorless solid. 
The mixture was filtered. The isolated solid was washed with water (5 mL), and then the 
residual water was removed via co-evaporation with acetone (2 x 25 mL) to afford MIDA 
boronate 4.1a as a colorless crystalline solid (1.241 g, 94%). 
 
From aldehyde 4.2: 
 
 
 
To a 50 mL Schlenk flask charged with aldehyde 4.2 (261 mg, 1.00 mmol) was 
added MeOH (15 mL) and THF (15 mL). The suspension was cooled to 0 °C. To the 
stirred mixture was added in one portion NaBH4 (58 mg, 1.5 mmol). The mixture became 
a homogeneous, colorless solution within 2 min. The solution was stirred for 20 min. and 
then was carefully quenched via the addition of sat. aq. NH4Cl (10 mL). When the 
effervescence had ceased the mixture was warmed to room temperature, diluted with H2O 
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(10 mL) and EtOAc (50 mL) and was transferred to a 100 mL separatory funnel. The 
mixture was shaken; the phases were separated. The aq. phase was extracted with EtOAc 
(2 x 50 mL). The combined organics were dried over MgSO4, filtered, then concentrated 
in vacuo. The resulting white solid residue was adsorbed onto Florisil gel from an 
acetone suspension and the resulting powder was subjected to flash chromatography on 
silica gel (Et2O:MeCN 100:0 → 50:50) to afford 4.1a as a colorless, crystalline solid (201 
mg, 76%). 
 
To a 25 mL Schlenk flask charged with aldehyde 4.2 (132 mg, 0.505 mmol) was 
added dry EtOH (10 mL) and THF (10 mL). The mixture was cooled to 0 °C. NaBH4 (32 
mg, 0.85 mmol) was added, and the mixture was stirred for 30 min. Acetaldehyde (1 mL) 
was then added, and the resulting mixture was stirred for 15 min. Acetic acid (0.1 mL) 
was then added, and the resulting solution was stirred for 5 min. The solution was then 
warmed 23 °C, transferred to a 65 mL roundbottom flask, and diluted with EtOAc (25 
mL). The solution was then concentrated in vacuo and the resulting residue was adsorbed 
onto Celite in vacuo from an acetone solution. The resulting powder was subjected to 
flash chromatography on silica gel (Et2O:MeCN 100:0 → 50:50) to afford 4.1a as a 
colorless, crystalline solid (87 mg, 65%). 
 
From benzyl ether 4.4: 
 
 
 
Under ambient atmosphere, to a 15 mL vial charged with boronate 4.4 (96 mg, 
0.25 mmol) as a solution in CH2Cl2 (6 mL) was added water (360 µL) and 2,3-dichloro-
5,6-dicyano-p-benzoquinone (71 mg, 0.31 mmol). The mixture was stirred for 1 h. 
Na2SO4 (7.5 g) was then added, and the resulting mixture stirred for 15 min. The mixture 
was then filtered and the isolated purple solids were washed with several portions of 
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acetone until colorless (75 mL total acetone). The filtrate was concentrated in vacuo and 
the resulting residue was adsorbed onto Celite in vacuo from an acetone solution. The 
resulting powder was subjected to flash chromatography on silica gel (Et2O:MeCN 100:0 
∏ 70:30) to afford 4.1a as an off-white, crystalline solid (50 mg, 79%). 
 
From silyl ether 4.5: 
 
 
 
To a 15 mL polypropylene vial charged with silyl ether 4.5 (188 mg, 0.499 mmol) 
in THF (5 mL) was added HF•pyridine complex (0.5 mL). The resulting solution was 
stirred for 20 min at 23 °C and then water (0.5 mL) was added. To the resulting mixture 
was added carefully NaHCO3 (2.00 g – effervescence commenced upon addition) as a 
solid in several small portions. The mixture was stirred for 30 min, during which time the 
effervescence ceased. The quench was confirmed via the addition of one drop of aqueous 
saturated NaHCO3 and the observation of no effervescence. Na2SO4 (3 g) and acetone (20 
mL) were then added and the resulting mixture was stirred for 15 min. The mixture was 
then filtered and the isolated solid was washed with acetone (3 x 10 mL). The combined 
filtrates were concentrated in vacuo and the resulting residue was azeotropically dried 
using MeCN (20 mL). The residue was then adsorbed onto Celite in vacuo from an 
acetone solution. The resulting powder was subjected to flash chromatography on silica 
gel (Et2O:MeCN 100:0 → 50:50). The isolated pale-yellow solid was triturated with Et2O 
(5 mL) to afford 4.1a as a colorless, crystalline solid (109 mg, 83%). 
 
TLC (Et2O:MeCN 3:1) 
Rf = 0.33, stained by KMnO4 
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1H-NMR (500 MHz, CD3CN)  
δ 7.45 (d, J = 8 Hz, 2H), 7.34 (d, J = 8 Hz, 2H), 4.58 (s, 2H), 4.06 (d, J = 17 Hz, 
2H), 3.88 (d, J = 17 Hz, 2H), 3.27 (b, 1H), 2.48 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.7, 144.1, 133.4, 127.2, 64.6, 62.7, 48.4 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.1 
 
HRMS (ESI+) 
 Calculated for C12H15BNO5: 264.1043 
 Found:   264.1046 
 
IR (thin film, cm-1) 
 3412, 3010, 2946, 1766, 1611, 1457, 1405, 1340, 1299, 1229, 1038, 994, 891, 867, 
790, 710. 
 
 
 
 
Boronamide 4.1d 
In an unoptimized procedure, to a 100 mL roundbottom flask was added 4-
(hydroxymethyl)-phenylboronic acid (456 mg, 3.00 mmol), 1,8-diaminonaphthalene (489 
mg, 3.09 mmol), toluene (25 mL) and DMSO (2 mL). The flask was fitted with a Dean-
Stark trap filled with toluene. The Dean-Stark trap was fitted with a water-cooled reflux 
condenser vented to ambient atmosphere. The stirred solution was refluxed with 
azeotropic removal of water for 12 h. The solution was then transferred to a 125 mL 
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separatory funnel, diluted with EtOAc (25 mL), and washed with brine (25 mL). The 
organic phase was dried over MgSO4 and concentrated in vacuo. The dark residue was 
adsorbed onto Celite in vacuo from an acetone solution. The resulting powder was 
subjected to flash chromatography on silica gel (hexanes:EtOAc 85:15 → 50:50) to 
afford 4.1d as a pale purple solid (676 mg, 82%).  
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.27, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.74 (d, J = 8 Hz, 2H), 7.40 (d, J = 8 Hz, 2H), 7.11 (app. t, J = 7.5 Hz, 2H), 6.98 
(dd, J = 8.5, 0.5 Hz, 2H), 6.95 (s, 2H), 6.53 (dd, J = 7, 1 Hz, 2H), 4.61 (d, J = 6 
Hz, 2H), 3.22 (t, J = 6 Hz, 1H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 145.2, 142.9, 137.3, 133.1, 128.7, 127.1, 120.7, 117.9, 106.7, 64.6 
 
11B-NMR (96 MHz, CD3CN) 
 δ 29.9 
 
IR (thin film, cm-1) 
3540, 3514, 3411, 3382, 3349, 3044, 2910, 2868, 1623, 1599, 1526, 1494, 1409, 
1372, 1330, 1236, 1166, 1086, 1036, 818, 764. 
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MIDA boronate 4.1f 
In an unoptimized procedure, to a 50 mL roundbottom flask was added 4-
(hydroxymethyl)phenylboronic acid (1.000 g, 6.581 mmol), N-methyldiethanolamine 
(754 µL, 6.581 mmol) and acetone (30 mL). The flask was fitted with a short-path 
distillation apparatus. The mixture was distilled with periodic addition of acetone to 
maintain a volume of 10 to 40 mL. When 60 mL of distillate was collected, the 
distillation was stopped. The suspension from the distillation pot was transferred to a 500 
mL roundbottom flask and then diluted with acetone to a volume of 300 mL. The mixture 
was filtered through a pad of Celite, and the solution was concentrated in vacuo to a 
minimum volume. The solution was then diluted with Et2O (400 mL), gently agitated, 
and left to stand at 0 ºC for 2 h. The resulting crystalline solid was collected via vacuum 
filtration to afford 1f as a colorless, crystalline solid (1.104 g, 71%). 
 
TLC (EtOAc) 
Compound is unstable to SiO2 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.50 (d, J = 8 Hz, 2H), 7.20 (d, J = 8 Hz, 2H), 4.52 (s, 2H), 4.00 (m, 2H), 3.94 
(m, 2H), 3.18 (m, 2H), 2.95 (m, 2H), 2.21 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 142.3, 134.9, 127.2, 65.6, 63.5, 61.8, 48.7 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.7 
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HRMS (ESI+) 
 Calculated for C12H19BNO3: 236.1458 
 Found:   236.1455 
 
IR (thin film, cm-1) 
 3336, 2863, 1607, 1455, 1396, 1217, 1081, 993. 
 
 
MIDA boronate 4.2 
From 4-formylphenylboronic acid: 
 
 
 
To a 25 mL roundbottom flask was added 4-formylphenylboronic acid (749 mg, 
5.00 mmol), N-methyliminodiacetic acid (806 mg, 5.48 mmol), DMSO (2 mL) and 
toluene (4 mL). The flask was fitted with a Dean-Stark trap filled with toluene. The 
Dean-Stark trap was fitted with a water-cooled reflux condenser vented to ambient 
atmosphere. The stirred mixture was refluxed with azeotropic removal of water for 3 h. 
The mixture was concentrated in vacuo and then most of the residual DMSO was 
removed via lypholization (2 days). The resulting colorless solid was adsorbed onto 
Celite from an acetone solution. The resulting powder was subjected to flash 
chromatography on silica gel (Et2O:MeCN 100:0 → 65:35) to afford 4.2 as a colorless 
crystalline solid (1.122 g, 86%). 
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From alcohol 4.1a: 
 
 
 
To a 10 mL Schlenk flask was added CH2Cl2 (2.0 mL) and oxalyl chloride (0.18 
mL, 2.0 mmol). The solution was cooled to –78 ºC and then DMSO (0.35 mL) was added. 
The solution was stirred for 15 min. To the solution was then added dropwise via cannula 
MIDA boronate 4.1a (264 mg, 1.00 mmol) as a solution in CH2Cl2:DMSO (1.0 mL : 1.0 
mL). The resulting white suspension was stirred for 20 min and then Et3N (1.0 mL, 7.2 
mmol) was added. The mixture was stirred at -78 ºC for 5 min and then allowed to warm 
to 23 ºC with stirring for 2 h. The mixture was then transferred to a 125 mL separatory 
funnel and diluted with EtOAc (75 mL), saturated aqueous NH4Cl (5 mL) and water (10 
mL). The mixture was shaken and the phases were separated. The aqueous phase was 
extracted once with EtOAc (75 mL). The combined organics were dried over MgSO4 and 
then were filtered through a pad of Celite. The filtrate was concentrated in vacuo and the 
residue was adsorbed onto Florisil in vacuo from an acetone solution. The resulting 
powder was subjected to flash chromatography on silica gel (Et2O:MeCN 3:1 → 1:1) to 
afford MIDA boronate 4.2 as a colorless crystalline solid (231 mg, 88%). 
 
TLC (EtOAc) 
Rf = 0.23, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 10.02 (s, 1H), 7.88 (d, J = 8 Hz, 2H), 7.70 (d, J = 8 Hz, 2H), 4.10 (d, J = 17 Hz, 
2H), 3.92 (d, J = 17 Hz, 2H), 2.50 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 193.9, 169.4, 138.2, 134.2, 129.6, 63.0, 48.6 
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11B-NMR (96 MHz, CD3CN) 
 δ 11.8 
 
HRMS (ESI+) 
 Calculated for C12H13BNO5: 262.0887 
 Found:   262.0886 
 
IR (thin film, cm-1) 
2951, 2837, 2739, 1746, 1693, 1462, 1439, 1391, 1337, 1288, 1238, 1049, 1025, 
1001, 985, 873, 819. 
 
 
B
HO acetone
23 oC, 30 min4.1
MeN
O
OB
O
O
HO
O 4.3
Jones Reagent
 
 
MIDA boronate 4.3  
Preparation of Jones reagent stock solution. A stock solution of chromic acid was 
prepared by the addition of concentrated H2SO4 (app. 18.4 M, 1.82 mL) to a stirred 
solution of CrO3 (2.1 g, 21 mmol) in water (5.32 mL). The solution was stirred for 5 min. 
The red solution thus obtained is app. 3 M in chromic acid. 
 
Representative procedure; oxidation of 4.1a. To a 20 mL vial charged with boronate 4.1a 
(132 mg, 0.501 mmol) was added acetone (5 mL). The stirred solution was cooled to 0 °C. 
To the solution was added the Jones reagent stock solution (0.5 mL, 1.5 mmol). The 
mixture was stirred for 1 min. and then allowed to warm to 23 °C with stirring for 30 min. 
To the mixture was added i-PrOH (1.0 mL) followed by continued stirring for 5 min. The 
mixture was then transferred to a 60 mL separatory funnel and diluted with water (10 
mL) and EtOAc (25 mL). The mixture was shaken and the phases were separated. The 
aqueous phase was extracted once with EtOAc (25 mL). The combined organics were 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was adsorbed onto 
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Celite in vacuo from an acetone solution. The resulting powder was subjected to flash 
chromatography on silica gel (Et2O:MeCN 4:1 with 0.5% AcOH) to afford MIDA 
boronate 4.3 as a colorless crystalline solid (125 mg, 90%). 
 
TLC (Et2O:MeCN 4:1 with 0.5% AcOH) 
Rf = 0.36, stained by KMnO4 
 
1H-NMR (500 MHz, acetone-d6) 
δ 8.02 (d, J = 8 Hz, 2H), 7.67 (d, J = 8 Hz, 2H), 4.39 (d, J = 17 Hz, 2H), 4.19 (d, J 
= 17 Hz, 2H), 2.77 (s, 3H). 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.98 (d, J = 8 Hz, 2H), 7.61 (d, J = 8 Hz, 2H), 4.09 (d, J = 17.5 Hz, 2H), 3.91 (d, 
J = 17.5 Hz, 2H), 2.49 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.4, 168.0, 133.7, 131.7, 129.8, 62.9, 48.5 
 
11B-NMR (96 MHz, CD3CN) 
 δ 11.8 
 
HRMS (ESI+) 
 Calculated for C12H13BNO6: 278.0836 
 Found:   278.0826 
 
IR (thin film, cm-1) 
3010, 2956, 1762, 1560, 1507, 1452, 1399, 1340, 1292, 1222, 1186, 1121, 1042, 
994, 891, 846, 769, 709. 
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Oxidation of 4.1b-4.1f. Following the above procedure exactly, 4.1b, 4.1c, 4.1d, 4.1e and 
4.1f were each separately exposed to the Jones reagent. Upon workup the crude residues 
were analyzed by 1H-NMR (acetone-d6). In each case, a complex mixture of oxidized 
products (four or more compounds) was observed. 
 
 
 
 
MIDA boronate 4.4   
Preparation of 4-methoxybenzyl 2,2,2-trichloroacetimidate. To a 10 mL Schlenk flask 
charged with NaH (18 mg, 0.76 mmol) was added Et2O (2 mL), and the resulting stirred 
suspension was cooled to 0 °C. To the suspension was added 4-methoxybenzyl alcohol 
(375 µL, 3.03 mmol). The resulting solution was warmed to 23 °C with stirring for 30 
min and then recooled to 0 °C. Trichloroacetonitrile (135 µL, 2.95 mmol) was then added, 
and the solution was warmed to 23 °C with stirring for 1.5 h. The reaction mixture was 
then transferred to a 30 mL separatory funnel containing saturated aqueous NaHCO3 (2 
mL). The mixture was diluted with Et2O (2 mL), shaken, and then the phases were 
separated. The aqueous phase was extracted with Et2O (2 x 2 mL). The combined organic 
layers were dried over MgSO4, and then filtered through a pad of Celite. The filtrate was 
concentrated in vacuo to afford 4-methoxybenzyl 2,2,2-trichloroacetimidate as a yellow 
liquid which was used immediately in the next reaction without further purification. 
 
Synthesis of MIDA boronate 4.4. To a 25 mL Schlenk flask charged with 4-
methoxybenzyl 2,2,2-trichloroacetimidate (prepared above, assumed quantitative yield, 
2.95 mmol) was added boronate 4.1a (264 mg, 1.00 mmol) and THF (10 mL). The stirred 
mixture was cooled to 0 °C and then trifluoromethanesulfonic acid (10 µL, 0.11 mmol) 
was added. The resulting mixture was allowed to warm to 23 °C and stirred for 5 h. The 
solution was then transferred to a 60 mL separatory funnel containing water (5 mL) and 
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brine (5 mL). The mixture was diluted with EtOAc (25 mL) and shaken and the phases 
were then separated. The aqueous phase was extracted once with EtOAc (25 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. 
The resulting residue was adsorbed onto Celite in vacuo from an acetone solution. The 
resulting powder was subjected to flash chromatography on silica gel (Et2O:MeCN 100:0 
→ 70:30) to afford MIDA boronate 4.4 as a colorless solid (248 mg, 64%). 
 
TLC (Et2O:MeCN 2:1) 
Rf = 0.43, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.47 (d, J= 7.5 Hz, 2H), 7.35 (d, J = 7.5 Hz, 2H), 7.28 (d, J = 8.5 Hz, 2H), 6.89 
(d, J = 8.5 Hz, 2H), 4.51 (s, 2H), 4.46 (s, 2H), 4.05 (d, J = 17 Hz, 2H), 3.87 (d, J 
= 17 Hz, 2H), 3.76 (s, 3H), 2.47 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 160.2, 140.9, 133.4, 131.6, 130.4, 128.2, 114.6, 72.6, 72.5, 62.7, 55.8, 
48.4. 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.2 
 
HRMS (ESI+) 
 Calculated for C20H23BNO6: 384.1618 
 Found:   384.1617 
 
IR (thin film, cm-1) 
2997, 2951, 2848, 1768, 1612, 1512, 1457, 1336, 1297, 1247, 1171, 1038, 993, 
818. 
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MIDA boronate 4.5 
To a 250 mL roundbottom flask was added boronate 4.1a (2.105 g, 8.002 mmol), 
tert-butyldimethylsilyl chloride (1.448 g, 9.609 mmol), imidazole (763 mg, 11.2 mmol) 
and THF (100 mL). The mixture was stirred for 9 h and then concentrated in vacuo. The 
resulting colorless solid residue was adsorbed onto Florisil gel in vacuo from an acetone 
solution. The resulting powder was subjected to flash chromatography on silica gel 
(Et2O:MeCN 100:0 → 1:2) to afford MIDA boronate 4.5 as a colorless solid (2.956 g, 
98%). 
 
TLC (EtOAc) 
Rf = 0.47, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.45 (d, J = 8 Hz, 2H), 7.33 (d, J = 8 Hz, 2H), 4.74 (s, 2H), 4.05 (d, J = 17 Hz, 
2H), 3.87 (d, J = 17 Hz, 2H), 2.48 (s, 3H), 0.92 (s, 9H), 0.09 (s, 6H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 143.6, 133.4, 126.7, 65.6, 62.7, 48.4, 26.3, 19.0, -5.1 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.1 
 
HRMS (ESI+) 
 Calculated for C18H29BNO5Si: 378.1908 
 Found:   378.1901 
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IR (thin film, cm-1) 
 3008, 2953, 2925, 2853, 1767, 1464, 1336, 1285, 1253, 1114, 1088, 1035, 837. 
 
 
 
 
MIDA boronate 4.6 
To a 50 mL Schlenk flask was added boronate 4.1a (264 mg, 1.00 mmol), 
triphenylphosphine (281 mg, 1.21 mmol), imidazole (104 mg, 1.53 mmol) and CH2Cl2 
(20 mL). To the resulting stirred mixture was added solid I2 (303 mg, 1.19 mmol). The 
suspension was stirred for 1 h and then transferred to a 60 mL separatory funnel and 
diluted with water (20 mL). The mixture was shaken, the phases were separated, and the 
aqueous phase was extracted with CH2Cl2 (20 mL). The combined organic layers were 
dried over MgSO4, filtered, and concentrated in vacuo. The resulting residue was 
adsorbed onto Florisil gel in vacuo from an acetone solution. The resulting powder was 
subjected to flash chromatography on silica gel (Et2O:MeCN 2:1) to afford MIDA 
boronate 4.6 as a colorless, crystalline solid (329 mg, 88%). 
 
TLC (Et2O:MeCN 2:1) 
Rf = 0.64, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.42 (m, 4H), 4.55 (s, 2H), 4.05 (d, J = 17 Hz, 2H), 3.88 (d, J = 17 Hz, 2H), 
2.48 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.5, 141.8, 133.9, 129.1, 62.7, 48.4, 6.7 
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11B-NMR (96 MHz, CD3CN) 
 δ 12.0 
 
HRMS (ESI+) 
 Calculated for C12H14BINO4: 374.0061 
 Found:   374.0052 
 
IR (thin film, cm-1) 
3015, 2957, 1770, 1696, 1608, 1457, 1400, 1337, 1294, 1252, 1160, 1039, 993, 
890, 868, 833, 796. 
 
 
 
 
MIDA boronate 4.7 
To a 10 mL Schlenk flask charged with (R)-(−)-4-Benzyl-3-propionyl-2-
oxazolidinone (118 mg, 0.505 mmol) was added CH2Cl2 (10 mL) and the resulting 
solution was cooled to 0 °C. To this stirred solution was added di-n-butylboron 
trifluoromethanesulfonate (1.0 M in CH2Cl2, 600 µL, 0.60 mmol) followed by freshly 
distilled triethylamine (0.65 mmol, 90 µL, dropwise). The solution was cooled to -78 °C. 
To this solution was then added MIDA boronate 4.2 (144 mg, 1.10 mmol) in one portion 
as a solid. The mixture was stirred at -78 °C for 20 min. and then allowed to warm to 
0 °C with stirring for 2 h. The reaction was then quenched at 0 °C with the addition of 
aqueous pH 6.0 sodium phosphate buffer (1.0 M, 1.0 mL) followed by MeOH (1.5 mL) 
and aqueous 30% H2O2. The resulting mixture was stirred at 0 °C for 45 min and then 
was transferred to a 60 mL separatory funnel. The mixture was diluted with EtOAc (25 
mL) and brine (5 mL) and shaken and the layers were separated. The aqueous layer was 
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extracted with EtOAc (3 x 25 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was adsorbed onto Celite in vacuo from 
an acetone solution. The resulting powder was subjected to flash chromatography on 
silica gel (hexanes:EtOAc:MeOH 50:50:0 → 45:45:10) to afford MIDA boronate 4.7 as a 
colorless, crystalline solid (196 mg, 79%). 
 
TLC (hexanes:EtOAc:MeOH 2:2:1) 
Rf = 0.52, UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.44 (d, J = 8 Hz, 2H), 7.35 (d, J = 8 Hz, 2H), 7.32-7.17 (m, 5H), 4.95 (d, J = 5 
Hz, 1H), 4.52 (m, 1H), 4.12 (app dd, J = 9, 2.5 Hz, 1H), 4.06-3.98 (m, 4H), 3.87 
(app dd, J = 17, 4 Hz, 2H), 3.01 (dd, J = 14, 4 Hz, 1H), 2.95 (dd, J = 14, 7.5 Hz, 
1H), 2.46 (s, 3H), 1.14 (d, J = 6.5 Hz, 3H).  
 
13C-NMR (125 MHz, CD3CN) 
δ 176.3, 169.6, 169.6, 154.2, 144.8, 136.6, 133.2, 130.7, 129.6, 128.0, 126.6, 74.5, 
67.2, 62.7, 62.7, 55.8, 48.4, 45.9, 37.8, 11.8 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.1 
 
HRMS (ESI+) 
 Calculated for C25H27BN2O8Na: 517.1758 
 Found:   517.1746 
 
IR (thin film, cm-1) 
3502, 3004, 2951, 1770, 1695, 1456, 1390, 1340, 1287, 1226, 1114, 1038, 993, 
887, 815, 763, 707. 
 
[ ]24Dα +86.5 (c 1.0, MeOH) 
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MIDA boronate 4.8 
 To a 10 mL Schlenk flask charged with NaH (27 mg, 1.1 mmol) and DMF (5 mL) 
was added triethyl phosphonoacetate (250 µL, 1.25 mmol). The resulting mixture was 
stirred at 23 °C for 30 min and then boronate 4.2 (262 mg, 1.00 mmol) was added as a 
solid in one portion. The resulting solution was stirred for 30 min and then poured into a 
60 mL separatory funnel containing saturated aqueous NH4Cl (10 mL).  The mixture was 
diluted with EtOAc (25 mL) and shaken and the layers were separated allowing the 
colorless precipitate to be collected along with the organic phase. The aqueous phase was 
extracted with EtOAc (2 x 25 mL). The combined organic phases were diluted with 
acetone (app. 20 mL) to afford a homogeneous solution. The solution was dried over 
MgSO4, filtered, and concentrated in vacuo to a volume of app. 75 mL. To the solution 
was added Et2O (75 mL) which caused a colorless solid to crystallize. The mixture was 
left to stand at room temperature with periodic agitation for 1 h. The mixture was then 
filtered and the isolated solid was washed with Et2O (20 mL). Residual solvent was 
removed in vacuo to afford MIDA boronate 4.8 as a colorless solid (235 mg, 71%). 
Alternatively, the product can be purified via column chromatography on silica gel 
(Hexanes:EtOAc:MeOH).  
 
TLC (Hexanes:EtOAc:MeOH 2:2:1) 
Rf = 0.60, stained by KMnO4 
 
1H-NMR (500 MHz, DMSO-d6) 
δ 7.69 (d, J = 8 Hz, 2H), 7.64 (d, J = 16 Hz, 1H), 7.47 (d, J = 8 Hz, 2H), 6.65 (d, J 
= 16 Hz, 1H), 4.34 (d, J = 17 Hz, 2H), 4.18 (q, J = 7 Hz, 2H), 4.12 (d, J = 17 Hz, 
2H), 2.51 (s, 3H), 1.25 (t, J = 7 Hz, 3H). 
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13C-NMR (125 MHz, DMSO-d6) 
 δ 169.3, 166.2, 144.4, 134.4, 133.0, 127.5, 118.2, 61.8, 60.0, 47.6, 14.2 
 
11B-NMR (96 MHz, DMSO-d6) 
 δ 11.4 
 
HRMS (ESI+) 
 Calculated for C16H19BNO6: 332.1305 
 Found:   332.1297 
 
IR (thin film, cm-1) 
2996, 2971, 1746, 1697, 1636, 1465, 1450, 1365, 1340, 1325, 1308, 1225, 1188, 
1046, 1021, 980, 960, 827. 
 
 
 
 
MIDA boronate 4.9 
With the exclusion of light, to a 50 mL Schlenk flask charged with a suspension 
of anhydrous CrCl2 (1.007 g, 8.332 mmol) in THF (20 mL) was added dropwise via 
cannula a solution of CHI3 (1.085 g, 2.755 mmol) in dioxane (5 mL + 5 mL washing). To 
the resulting deep red mixture was added MIDA boronate 4.2 (132 mg, 0.504 mmol) as a 
solid in one portion. The mixture was stirred at 23 °C for 1 h and then was transferred to 
a 250 mL roundbottom flask equipped with a large stir bar. The mixture was then diluted 
with EtOAc (100 mL), and to the resulting solution was added saturated aqueous 
NaHCO3 (50 mL). This mixture was stirred at 23 °C for 5 min and then filtered through a 
pad of Celite. The filtrate was transferred to a 250 mL separatory funnel and the layers 
were separated. The organic layer was washed with 0.5 M aqueous Na2S2O3 (50 mL) and 
then brine (25 mL). The organic layer was dried over MgSO4, filtered, and concentrated 
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in vacuo. The residue was adsorbed onto Celite in vacuo from an acetone solution, and 
the resulting powder was subjected to flash chromatography on silica gel (Et2O:MeCN 
100:0 → 70:30) to afford MIDA boronate 4.9 as a pale orange solid (170 mg, 88%, E:Z 
17:1). 
 
TLC (Et2O:MeCN 3:1) 
Rf = 0.55, UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CD3CN, E-isomer) 
δ 7.51 (d, J = 15 Hz, 1H), 7.46 (d, J = 8 Hz, 2H), 7.37 (d, J = 8 Hz, 2H), 7.07 (d, J 
= 15 Hz, 1H), 4.05 (d, J = 17 Hz, 2H), 3.87 (d, J = 17 Hz, 2H), 2.48 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN, E-isomer) 
 δ 169.5, 145.7, 139.3, 133.9, 126.4, 78.8, 62.7, 48.4 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.1 
 
HRMS (ESI+) 
 Calculated for C13H14BINO4: 386.0061 
 Found:   386.0067 
 
IR (thin film, cm-1) 
 3049, 3008, 2951, 1768, 1457, 1337, 1290, 1231, 1038, 993, 834, 772. 
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MIDA boronate 4.10 
To a 10 mL Schlenk flask charged with boronate 4.2 (262 mg, 1.00 mmol) in 1,2-
dichloroethane (5 mL) was added morpholine (96 µL, 1.1 mmol) followed by sodium 
triacetoxyborohydride (299 mg, 1.41 mmol) and the resulting mixture was stirred at 
23 °C for 8 h. Aqueous dibasic sodium tartrate solution (0.5 M, 5 mL) was then added, 
and the mixture was stirred for 5 min and then transferred to a 60 mL separatory funnel. 
The mixture was diluted with EtOAc (25 mL), shaken, and the layers were separated. The 
aqueous layer was extracted with EtOAc (2 x 25 mL). The combined organics were dried 
over MgSO4, filtered, and then concentrated in vacuo. The residue was adsorbed onto 
Celite in vacuo from an acetone solution, and the resulting powder was subjected to flash 
chromatography on silica gel (Et2O:MeCN 100:0 → 50:50) to afford MIDA boronate 
4.10 as a colorless solid (255 mg, 76%). 
 
TLC (Et2O:MeCN) 
Rf = 0.16, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.44 (d, J = 8 Hz, 2H), 7.32 (d, J = 8 Hz, 2H), 4.05 (d, J = 17 Hz, 2H), 3.87 (d, J 
= 17 Hz, 2H), 3.59 (app t, J = 4.5 Hz, 4H), 3.47 (s, 2H), 2.47 (s, 3H), 2.37 (m, 
4H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 140.3, 133.3, 129.6, 67.5, 63.7, 62.7, 54.4, 48.4 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.2 
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HRMS (ESI+) 
 Calculated for C16H22BN2O5: 333.1622 
 Found:   333.1607 
 
IR (thin film, cm-1) 
 3003, 2954, 2806, 1768, 1457, 1336, 1292, 1233, 1114, 1039, 994, 890, 864, 792. 
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MIDA boronate 4.11 
 To a 10 mL round-bottom flask was added aldehyde 4.2 (261 mg, 1.00 
mmol), 1,2-phenylenediamine (108 mg, 1 mmol), Na2S205 (192 mg, 1.01 mmol) and 
DMF (2 mL). The flask was sealed with a rubber septum, then was placed in a 65 °C oil 
bath with stirring for 6 h. The solution was allowed to cool to room temperature, and then 
was concentrated in vacuo. The residue was adsorbed onto Florisil gel from an acetone 
suspension and the resulting powder was subjected to flash chromatography on silica gel 
(Et2O:MeCN 100:0 → 25:75) to afford MIDA boronate 4.11 as an off-white, free-
flowing solid (161 mg, 46%). 
 
TLC (Et2O:MeCN, 2:1) 
Rf = 0.32, yellow, visualized by UV 
 
TLC C18 (H2O:MeCN, 1:1) 
Rf = 0.63, yellow, visualized by UV 
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1H-NMR (500 MHz, acetone-d6) 
δ 8.22 (d, J = 8.0 Hz, 2H), 7.69 (d, J = 8.0 Hz, 2H), 7.68 (dd, J = 0.5, 0.4 Hz, 1H), 
7.51 (dd, J = 0.5, 0.4 Hz, 1H), 7.21 (m, 2H), 5.62 (s, 1H), 4.39 (d, J = 17.0 Hz, 
2H), 4.20 (d, J = 17.0 Hz, 2H) 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.2, 133.9, 126.6, 123.5, 122.6, 120.1, 111.9, 62.8, 48.3 
 
11B-NMR (96 MHz, CD3CN) 
 δ 12.0 
 
 
 
 
MIDA boronate 4.13 
 In a glove box, to a 10 mL Schlenk flask was added Grubbs II catalyst (21 
mg, 0.025 mmol). On the Schlenk line, to the flask was added MIDA boronate 4.12 and 
CH2Cl2 (2.5 mL), and then styrene (63 μL, 0.55 mmol). The flask was fitted with a water-
cooled reflux condenser vented to inert atmosphere. The flask was placed in a 45 °C oil 
bath with stirring for 20 h. The solution was allowed to cool to room temperature. To the 
solution was added Florisil gel. The solution was concentrated in vacuo and the resulting 
powder was subjected to flash chromatography on silica gel (Et2O:MeCN 100:0 → 
75:25) to a afford colorless solid (124 mg, 94%) determined by 1H-NMR to be a mixture 
of 4.13:4.12 (92:8). An optimized synthesis of 4.13 was later developed by Brice Uno.4 
 
TLC (Et2O:MeCN, 2:1) 
Rf = 0.28, stained with KMnO4 
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1H-NMR (500 MHz, CD3CN) 
δ 7.51 (d, J = 9.0 Hz, 2H), 7.33 (m, 3H), 6.94 (d, J = 18.0 Hz, 1H), 6.35 (d, J = 
18.5, 1H), 4.25 (d, J = 17.0 Hz, 2H), 4.07 (d, J = 17.0 Hz, 2H), 3.05 (s, 3H) 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.6, 143.3, 139.0, 129.5, 129.0, 127.6, 62.3, 47.6 
 
HRMS (ESI+) 
 Calculated for C13H14BNO4 (M)+:  259.1016 
 Found:   259.1017 
 
 
MIDA boronate 4.15 
 
 
 
Synthesis of 4.12:4.15 via the “Hot Protocol”5 
 To a 2 L 3-neck round-bottom equipped with a large stir bar and charged with a 
stirred solution of B(OMe)3 (47 mL, 0.42 mol) in THF (400 mL) cooled to -60 °C 
internal temperature was added was added via cannula over 60 min. 
propenylmagnesiumbromide (800 mL, 0.5 M in THF). During the transfer the internal 
temperature of the reaction solution was maintained below -50 °C. Upon completion of 
the addition the reaction solution was stirred for 2.5 h maintaining the internal 
temperature of the mixture below -60 °C. The mixture was then allowed to warm to room 
temperature with stirring for 2 h. 
 Separately, a 2 L 3-neck round-bottom flask was charged with N-
methyliminodiacetic acid (144.3g, 0.9810 mol), DMSO (400 mL) and hexanes (600 mL). 
The round-bottom necks were fitted as follows: 1) a thermometer, 2) a rubber septum, 
and 3) a distillation apparatus collecting into a 2 L round-bottom flask. [Note: for safety, 
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the distillation should be conducted under inert atmosphere at around 1 atm.] The mixture 
was heated to distill the hexanes which removed residual water via azeotrope. Through 
the septum was placed a large-gauge cannula connecting the distillation pot to the borate 
solution from the first step, such that once the internal temperature had reached 120 °C 
transfer of the borate solution was immediately started. The rate of addition was 
controlled to maintain the temperature of the reaction mixture between 95-120 °C. 
During this time the THF is rapidly distilled and was collected in the receiving flask. 
When the addition was complete and the temperature of the mixture rose to 125 °C, the 
heat source was removed and the mixture was allowed to cool to room temperature. The 
mixture was transferred to a 6 L separatory funnel using water (1.0 L), brine (1.0 L), 
acetone (1.0 L) and EtOAc (2.0 L). The mixture was shaken; the phases were separated. 
The aqueous phase was twice extracted with EtOAc:acetone (400 mL:200 mL). The 
combined organics were washed twice with water (125 mL); the water washes were 
combined and extracted with EtOAc:acetone (200 mL:100 mL). The combined organics 
were dried over MgSO4, filtered, and then concentrated in vacuo to afford the crude 
product as off-white solid which was purified via recrystallization from a minimum of 
hot acetone slowly diluted with Et2O to a total volume of 2 L. Isolation of the crystals via 
filtrated afforded a colorless crystalline solid, an otherwise pure mixture of 4.12:4.15 
(2:1) (41.4 g, 53%). 
 
Isomerization of 4:12:4.15 
 To a 2 L round-bottom flask was added the mixture of 4.12:4.15 obtained from 
above (41.4 g, 210 mmol) and Grubbs II metathesis catalyst (892 mg, 1.05 mmol). To the 
flask was added CH2Cl2. The flask was fitted with a water-cooled condenser connected to 
a slightly >1 atm. supply of N2. The flask was warmed with a 45 °C oil bath with stirring 
for 20 h. The mixture was filtered through a thin pad of SiO2, eluting with acetone. The 
filtrate was stirred with 3-aminopropyl-functionalized silica gel (5.0 g) for 60 min. to 
remove ruthenium. The mixture was then filtered concentrated in vacuo. The resulting 
solid residue was purified via recrystallization from a minimum of hot acetone slowly 
diluted with Et2O to a total volume of 2 L. Isolation of the crystals via filtrated afforded 
4.15 as an off-white crystalline solid (37.4 g, 90%). 
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Total Synthesis of (+)-Crocacin C 
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MIDA boronate 4.14 
Following the literature procedure for the synthesis of 3-acroleinboronic acid,6 to 
a 20 mL Schlenk flask was added BH3•SMe2 (695 µL, 7.33 mmol) and THF (2.5 mL) 
and the resulting stirred solution was cooled to 0 °C. (R)-(+)-α-pinene (2.38 mL, 15.0 
mmol) was added, and the solution was stirred for 10 min at 0 °C and then was allowed 
to warm to 23 °C with stirring for 2 h, during which time a colorless precipitate was 
formed. The mixture was recooled to 0 °C and propionaldehyde diethyl acetal (1.00 mL, 
6.98 mmol) was added. Effervescence was observed and the mixture became a 
homogeneous, pale yellow solution. The solution was stirred at 0 °C for 30 min and then 
allowed to warm to 23 °C and stirred for 2.5 h. The solution was then cooled to 0 °C, 
acetaldehyde (5.0 mL, 89 mmol) was added, and the flask was fitted with a water-cooled 
reflux condenser sealed with a rubber septum. The solution was then warmed to 45 °C in 
a closed-system with stirring for 12 h. The solution was then cooled to 0 °C, water (2.5 
mL) was added, and the resulting mixture was stirred at 0 °C for 1 h and then warmed to 
23 °C with stirring for 2 h. The mixture was then transferred to a 125 mL separatory 
funnel and was diluted with Et2O (20 mL) and EtOAc (20 mL). Solid NaCl (app. 0.5 g) 
was added and the mixture was shaken. The layers were separated, and the aqueous layer 
was extracted with Et2O:EtOAc (20 mL:20 mL). The combined organic layers were 
concentrated in vacuo upon which a colorless solid precipitated. The resulting mixture 
was diluted with hexanes (20 mL), agitated, and then allowed to stand at 23 °C for 1 h. 
The solution was decanted to leave the crude boronic acid as a white solid. To a 100 mL 
roundbottom flask containing this boronic acid was added N-methyliminodiacetic acid 
(984 mg, 6.70 mmol) and DMSO (25 mL). The flask was fitted with a short-path 
distillation apparatus. The DMSO mixture was distilled to dryness under vacuum (40 °C, 
1 Torr, bath temp = 75 °C). The resulting residue was lyophilized overnight to further 
remove residual DMSO and then adsorbed onto Florisil gel in vacuo from an acetone 
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solution. The resulting powder was subjected to flash chromatography on silica gel 
(Et2O:MeCN 100:0 → 50:50) to afford MIDA boronate 4.14 as a colorless, crystalline 
solid (806 mg, 55%). 
 
TLC (Et2O:MeCN 1:1) 
Rf = 0.69, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 9.57 (d, J = 8 Hz, 1H), 6.94 (d, J = 17.5 Hz, 1H), 6.46 (dd, J = 17.5, 7.5 Hz, 1H), 
4.03 (d, J = 17, 2H), 3.87 (d, J = 17, 2H), 2.82 (s, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 196.1, 169.0, 143.7, 62.9, 48.0 
 
11B-NMR (96 MHz, CD3CN) 
 δ 10.7 
 
HRMS (ESI+) 
 Calculated for C8H11BNO5: 212.0730 
 Found:   212.0733 
 
IR (thin film, cm-1) 
2997, 2970, 2819, 2724, 1761, 1685, 1617, 1465, 1445, 1344, 1294, 1227, 1120, 
1026, 1003, 954, 882, 803, 715. 
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MIDA boronate 4.31 
To a 100 mL Schlenk flask charged with Sn(OTf)2 (5.141 g, 12.33 mmol) was 
added CH2Cl2 (90 mL) and triethylamine (1.85 mL, 13.3 mmol). The resulting orange-
brown suspension was cooled to -78 °C and then (S)-1-(p-methoxybenzyloxy)-2-
methylpentan-3-one7 (1.98 g, 2.00 mL, 8.38 mmol) was added. The mixture was stirred 
for 2 h at -78 °C and then boronate 4.14 (1.732 g, 8.208 mmol) was added as a powder in 
one portion. The mixture was stirred for 12 h at -78 °C, and then poured into a 1000 mL 
separatory funnel containing saturated aqueous NH4Cl (150 mL). The mixture was 
diluted with CH2Cl2 (500 mL) and shaken, and the layers were separated. The aqueous 
phase was extracted with CH2Cl2 (2 x 500 mL). (The majority of a beige precipitate 
remained in the aqueous phase). The combined organic layers were dried over MgSO4, 
filtered through Celite, and then concentrated in vacuo to afford a yellow oil. This residue 
was adsorbed onto Celite in vacuo from an acetone solution and the resulting powder was 
subjected to flash chromatography on silica gel (hexanes:EtOAc:MeOH 9:9:2) to afford 
MIDA boronate 4.31 as a colorless, solid foam (2.558 g, 70%). 
 
TLC (CH2Cl2:hexanes:MeOH 2:2:1) 
Rf = 0.51, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.22 (dt, J = 8.5, 2 Hz, 2H), 6.88 (dt, J = 8.5, 2 Hz, 2H), 6.00 (dd, J = 18, 4.5 Hz, 
1H), 5.61 (dd, J = 18, 1.5 Hz, 1H), 4.43 (m, 1H), 4.37 (s, 2H), 3.93 (app dd, J = 
17, 2 Hz, 2H), 3.76 (s, 3H), 3.74 (app dd, J = 17, 2 Hz, 2H), 3.57 (dd, J = 9, 8 Hz, 
1H), 3.40 (dd, J = 9, 5.5 Hz, 1H), 3.10 (m, 1H), 2.88 (m, 1H), 2.73 (s, 3H), 0.98 
(d, J = 7 Hz, 3H), 0.96 (d, J = 7 Hz, 3H). 
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13C-NMR (125 MHz, CD3CN) 
δ 216.7, 169.3 (2 carbons), 160.2, 146.3, 131.3, 130.4, 114.6, 73.6, 73.3, 72.9, 
62.3, 62.3, 55.8, 51.2, 47.6, 45.9, 14.0, 11.0 
 
11B-NMR (96 MHz, CD3CN) 
 δ 11.2 
 
HRMS (ESI+) 
 Calculated for C22H31BNO8: 448.2143 
 Found:   448.2151 
 
IR (thin film, cm-1) 
3503, 2937, 1762, 1707, 1612, 1512, 1457, 1337, 1289, 1248, 1156, 1117, 1090, 
1030, 1006, 962, 852, 820.  
 
[ ]23Dα  -9.7 (c 1.2, CH2Cl2) 
 
 
 
 
MIDA boronate 4.32 
To a 25 mL Schlenk flask charged with tetramethylammonium triacetoxy-
borohydride (1.320 g, 5.017 mmol) was added dry acetic acid (8.5 mL) and MeCN (12 
mL). The resulting solution was stirred for 30 min at 23 °C and then cooled to -30 °C. To 
this cooled solution was added dropwise over 5 min MIDA boronate 4.31 (448 mg, 1.00 
mmol) as a solution in MeCN (2.5 mL + 2.5 mL washings). The resulting solution was 
stirred at -30 °C for 6 h. The solution was then transferred to a 300 mL roundbottom flask 
at 23 °C and diluted with EtOAc (140 mL). The solution was stirred for 20 min upon 
which the solution became cloudy. Aqueous dibasic sodium tartrate solution (0.5 M, 140 
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mL) was added, and the resulting mixture was stirred for 15 min. The mixture was then 
transferred to a 500 mL separatory funnel and the layers were separated. The organic 
layer was washed with saturated aqueous NaHCO3 (50 mL) and then brine (50 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was adsorbed onto Celite in 
vacuo from an acetone solution. The resulting powder was subjected to flash 
chromatography on silica gel (Et2O:MeCN 100:0 → 60:40) to afford MIDA boronate 
4.32 as a colorless, crystalline solid (317 mg, 71%). 
 
TLC (Et2O:MeCN 2:1) 
Rf = 0.24, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 7.25 (d, J = 8.5 Hz, 2H), 6.98 (d, J = 8.5 Hz, 2H), 6.07 (dd, J = 17.5, 4 Hz, 1H), 
5.63 (dd, J = 17.5, 2 Hz, 1H), 4.47 (m, 1H), 4.41 (s, 2H), 3.93 (app dd, J = 17, 0.5 
Hz, 2H), 3.77 (app dd, J = 17, 6 Hz, 2H), 3.77 (s, 3H), 3.53-3.57 (m, 2H), 3.48 
(dd, J = 9, 5.5 Hz, 1H), 2.76 (s, 3H), 1.96 (m, 1H), 1.82 (m, 1H), 0.93 (d, J = 7 Hz, 
3H), 0.83 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 169.4, 169.4, 160.2, 148.0, 131.6, 130.3, 114.6, 79.3, 73.8, 73.8, 73.4, 62.3, 62.3, 
55.8, 47.7, 40.1, 36.8, 15.2, 11.8. 
 
11B-NMR (96 MHz, CD3CN) 
 δ 11.5 
 
HRMS (ESI+) 
 Calculated for C22H32BNO8Na: 472.2119 
 Found:   472.2127 
 
 223
IR (thin film, cm-1) 
3434, 2962, 1764, 1646, 1612, 1513, 1459, 1338, 1300, 1248, 1116, 1089, 1028, 
1002, 819. 
 
[ ]23Dα  -5.1 (c 1.1, CH2Cl2) 
 
 
 
 
MIDA boronate 4.33 
 To a 10 mL Schlenk flask charged with MIDA boronate 4.32 (751 mg, 1.67 
mmol) was added CH2Cl2 (60 mL). To the stirred solution was added proton sponge 
(2.511 g, 11.72 mmol) as a solid in one portion followed by trimethyloxonium 
tetrafluoroborate (1.357 g, 9.172 mmol) as a solid in one portion. The resulting mixture 
was stirred at 23 °C for 2.5 h. The orange mixture was then transferred to a 500 mL 
separatory funnel. EtOAc (150 mL), aqueous 0.5 M HCl (75 mL), and brine (30 mL) 
were added and the mixture was shaken resulting in the formation of a precipitate.  The 
mixture was filtered and then returned to the separatory funnel, and the phases were 
separated. The organic layer was washed twice with a solution of aqueous 0.5 M 
HCl:brine (75 mL:30 mL). The organic layer was then dried over MgSO4, filtered, and 
concentrated in vacuo to afford a pale yellow residue. This residue was adsorbed onto 
Celite in vacuo from an acetone solution. The resulting powder was subjected to flash 
chromatography on silica gel (Et2O:MeCN 100:0 → 50:50) to afford MIDA boronate 
4.33 as a colorless solid (611 mg, 82%). 
 
TLC (Et2O:MeCN 2:1) 
Rf = 0.71, stained by KMnO4 
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1H-NMR (500 MHz, CD3CN)  
δ 7.21 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 5.97 (dd, J = 18, 6 Hz, 1H), 
5.59 (dd, J = 18, 1 Hz, 1H), 4.34 (m, 2H), 3.94 (app dd, J = 17, 2.5 Hz, 2H), 3.88 
(m, 1H), 3.77 (app dd, J = 17, 4.5 Hz, 2H), 3.76 (s, 3H), 3.51 (dd, J = 9, 5 Hz, 
1H), 3.38 (s, 3H), 3.22 (s, 3H), 3.21 (m, 1H), 3.06 (dd, J = 9, 3 Hz, 1H), 2.74 (s, 
3H), 2.01 (m, 1H), 1.72 (m, 1H), 1.02 (d, J = 7 Hz, 3H), 0.77 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 169.3, 160.1, 146.1, 132.1, 130.1, 114.5, 86.5, 83.3, 73.1, 72.2, 62.4, 62.4, 61.5, 
57.0, 56.9, 55.9, 55.8, 47.8, 47.8, 16.8, 10.8. 
11B-NMR (96 MHz, CD3CN) 
 δ 11.1 
 
HRMS (ESI+) 
 Calculated for C24H37BNO8: 478.2612 
 Found:   478.2617 
 
IR (thin film, cm-1) 
 2934, 1762, 1612, 1512, 1457, 1289, 1247, 1089, 1028. 
 
[ ]23Dα  +4.3 (c 1.0, CH2Cl2) 
 
 
 
 
MIDA boronate 4.32 
To a 50 mL roundbottom flask charged with boronate 4.33 (331 mg, 0.740 mmol) 
was added MeCN (6 mL) and H2O (600 µL). Ceric ammonium nitrate (1.011 g, 1.844 
mmol) was added, and the resulting solution was stirred for 15 min at 23 °C. Saturated 
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aqueous NaHCO3 (7.5 mL) and NaHSO3 (0.5 g) were then added, and the resulting 
mixture was vigorously stirred for 5 min and then transferred to a 60 mL separatory 
funnel. The layers were separated and the aqueous layer was extracted with EtOAc (3 x 
15 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated 
in vacuo. The resulting residue was adsorbed onto Celite in vacuo from an acetone 
solution. The resulting powder was subjected to flash chromatography on silica gel 
(Et2O:MeCN 85:15 ∏ 65:35) to afford MIDA boronate 4.32 as a colorless solid (202 mg, 
77%). 
 
TLC (Et2O:MeCN 2:1) 
Rf = 0.21, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 5.98 (dd, J = 18, 6 Hz, 1H), 5.61 (dd, J = 18, 1 Hz, 1H), 3.94 (d, J = 17 Hz, 2H), 
3.90 (ddd, J = 6, 2.5, 1.5 Hz, 1H), 3.79 (d, J = 17 Hz, 2H), 3.51 (m, 1H), 3.43 (m, 
1H), 3.42 (s, 3H), 3.23 (s, 3H), 3.11 (dd, J = 9.5, 3 Hz, 1H), 2.78 (s, 3H), 1.83 (m, 
1H), 1.73 (m, 1H), 1.05 (d, J = 7 Hz, 3H), 0.78 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
 δ 169.4, 169.4, 145.9, 87.5, 83.2, 64.0, 62.4, 62.4, 61.6, 56.9, 47.8, 42.0, 38.0, 
16.3, 10.7. 
 
11B-NMR (96 MHz, CD3CN) 
 δ 11.3 
 
HRMS (ESI+) 
 Calculated for C16H29BNO7: 358.2037 
 Found:   358.2047 
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IR (thin film, cm-1) 
3467, 2966, 2937, 2827, 1762, 1642, 1457, 1340, 1291, 1243, 1089, 1026, 957, 
862. 
 
[ ]22Dα  +8.2 (c 1.1, CH2Cl2) 
 
 
 
 
MIDA boronate 4.35 
To a 100 mL roundbottom flask charged with MIDA boronate 4.34 (155 mg, 
0.433 mmol) was added CH2Cl2 (10 mL). To this stirred solution was added Dess-Martin 
periodane (278 mg, 0.655 mmol) and the resulting mixture was stirred for 15 min under 
ambient atmosphere at 23 °C. Saturated aqueous NaHCO3 (5 mL) and 1.5 M aqueous 
Na2S2O3 (5 mL) were then added and the mixture was stirred for 15 min and then 
transferred to a 60 mL separatory funnel. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were dried 
over MgSO4, filtered, and concentrated in vacuo to afford MIDA boronate 4.35 as a 
colorless, crystalline solid (149 mg, 97%). The product thus obtained was of a high purity 
and was used directly in further steps. Further purification through a short plug of SiO2 is 
possible with <5% observed epimerization. 
 
TLC (Et2O:MeCN 2:1) 
Rf = 0.61, stained by KMnO4 
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1H-NMR (500 MHz, CD3CN) 
δ 9.69 (d, J = 1 Hz, 1H), 5.97 (dd, J = 18, 6 Hz, 1H), 5.63 (dd, J = 18, 1 Hz, 1H), 
3.95 (d, J = 17 Hz, 2H), 3.95 (m, 1H), 3.79 (app dd, J = 17, 1.5 Hz, 2H), 3.48 (dd, 
J = 9.5, 3 Hz, 1H), 3.39 (s, 3H), 3.25 (s, 3H), 2.77 (s, 3H), 2.71 (m, 1H), 1.81 (m, 
1H), 1.09 (d, J = 7 Hz, 3H), 0.71 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 205.3, 169.3 (2 carbons), 145.4, 84.7, 82.9, 62.4, 62.4, 59.9, 57.3, 48.9, 47.8, 
41.7, 10.8, 10.4. 
 
11B-NMR (96 MHz, CD3CN) 
 δ 11.1 
 
HRMS (ESI+) 
 Calculated for C16H27BNO7: 356.1881 
 Found:   356.1870 
 
IR (thin film, cm-1) 
2975, 2935, 2828, 1761, 1717, 1645, 1456, 1338, 1286, 1238, 1154, 1115, 1088, 
1027, 1003, 955, 866. 
 
[ ]23Dα  -8.3 (c 1.0, CH2Cl2) 
 
 
 228
 
 
MIDA boronate 4.28 
To a 50 mL Schlenk flask charged with anhydrous CrCl2 (740 mg, 6.12 mmol) 
was added THF (10 mL) and dioxane (5 mL). With the exclusion of light, to the stirred 
suspension was added dropwise via cannula a solution of MIDA boronate 4.35 (132 mg, 
0.370 mmol) and CHI3 (801 mg, 2.03 mmol) in THF:dioxane 10 mL:5 mL. The resulting 
red mixture was stirred at 23 °C for 1 h and then transferred to a 500 mL roundbottom 
flask equipped with a large stir bar and diluted with EtOAc (200 mL). To this stirred 
mixture was added saturated aqueous NaHCO3 (75 mL) followed by continued stirring 
for 10 min. The mixture was then filtered through a pad of Celite. The filtrate was 
transferred to a 500 mL separatory funnel and the layers were separated. The organic 
layer was washed with 0.5 M aqueous Na2S2O3 (75 mL) and then brine (50 mL). The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The resulting 
residue was adsorbed onto Celite in vacuo from an acetone solution. The resulting 
powder was subjected to flash chromatography on silica gel (Et2O:MeCN 100:0 → 
50:50) to afford MIDA boronate 4.28 as a colorless solid (132 mg, 74%). 
 
TLC (Et2O:MeCN 5:1) 
Rf = 0.28, stained by KMnO4 
 
1H-NMR (500 MHz, CD3CN) 
δ 6.51 (dd, J = 15, 9 Hz, 1H), 6.09 (d, J = 15 Hz, 1H), 5.97 (dd, J = 18, 6 Hz, 1H), 
5.61 (dd, J = 18, 1 Hz, 1H), 3.95 (d, J = 17 Hz, 2H), 3.91 (m, 1H), 3.79 (app dd, 
17, 1 Hz, 2H), 3.43 (s, 3H), 3.23 (s, 3H), 3.01 (dd, J = 9.5, 2 Hz, 1H), 2.78 (s, 3H), 
2.50 (m, 1H), 1.45 (m, 1H), 1.10 (d, J = 7 Hz, 3H), 0.71 (d, J = 7 Hz, 3H). 
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13C-NMR (125 MHz, CD3CN) 
δ 169.3 (2 carbons), 149.1, 145.7, 86.7, 82.8, 75.8, 62.4, 62.4, 61.7, 56.9, 47.8, 
43.8, 42.6, 18.3, 10.0 
11B-NMR (96 MHz, CD3CN) 
 δ 11.2 
 
HRMS (ESI+) 
 Calculated for C17H28BNO6I: 480.1054 
 Found:   480.1057 
 
IR (thin film, cm-1) 
 2970, 2925, 2827, 1761, 1456, 1339, 1287, 1238, 1090, 1025, 956. 
 
[ ]23Dα  +4.6 (c 1.0, CH2Cl2) 
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MIDA boronate 4.36 
In a glove box, to a dry 15 mL vial charged with stannane 4.26 (481 mg, 1.29 
mmol) was added MIDA boronate 4.28 (307 mg, 0.640 mmol) as a solution in DMF (8.8 
mL). To the vial was added Pd(PPh3)4 (36 mg, 0.031 mmol), then CsF (199 mg, 1.31 
mmol), then CuI (15 mg, 0.078 mmol). The mixture quickly darkened. The mixture was 
stirred at 23 °C for 5 h. The vial was removed from the glove box and the black reaction 
mixture was transferred to a 125 mL separatory funnel. The mixture was diluted with 
EtOAc (80 mL) and brine (40 mL). The mixture was shaken and the phases were 
separated. The aqueous phase was extracted with EtOAc (80 mL). The combined organic 
phases were dried over MgSO4, then were filtered. The filtrate was concentrated in vacuo 
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and the resulting residue oil was adsorbed onto Celite in vacuo from an acetone solution. 
The resulting powder was subjected to flash chromatography on silica gel (Et2O:MeCN 
80:20 ∏ 25:75 → 0:100) to afford MIDA boronate 4.36 as an off-white solid (173 mg, 
62%). A portion of 4.36 thus obtained was re-subjected to flash chromatography on a 
Teledyne Isco RediSep amine-functionalized SiO2 column (Et2O:MeCN 100:0 → 60:40) 
to provide an analytical sample. 
 
TLC (Et2O:MeCN 1:2) 
Rf = 0.51, UV (λ = 254 nm) 
 
1H-NMR (500 MHz, CD3CN) 
δ 6.18 (s, 1H), 6.09 (d, J = 16 Hz, 1H), 6.03 (dd, J = 16, 8 Hz, 1H), 5.95 (dd, J = 
18, 6 Hz, 1H), 5.78 (s, 1H), 5.71 (s, 1H), 5.59 (dd, J = 18, 1.5 Hz, 1H), 3.94 (d, J 
= 17 Hz, 2H), 3.93 (m, 1H), 3.78 (d, J = 17 Hz, 2H), 3.44 (s, 3H), 3.23 (s, 3H), 
3.09 (dd, J = 10, 2 Hz, 1H), 2.76 (s, 3H), 2.54 (m, 1H), 2.16 (d, J = 1 Hz, 3H), 
1.46 (m, 1H), 1.13 (d, J = 7 Hz, 3H), 0.72 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CD3CN) 
δ 169.7, 169.4 (2 carbons), 149.0, 145.7, 137.8, 134.7, 121.4, 87.2, 82.9, 62.4, 
62.4, 61.6, 57.0, 47.8, 42.6, 40.6, 19.0, 13.6, 10.1. 
 
11B-NMR (96 MHz, CD3CN) 
 δ 11.5 
 
HRMS (ESI+) 
 Calculated for C21H34BN2O7: 437.2459 
 Found:   437.2450 
 
IR (thin film, cm-1) 
3441, 3348, 3194, 2962, 2930, 2825, 1765, 1709, 1662, 1602, 1452, 1363, 1337, 
1293, 1247, 1191, 1153, 1117, 1089, 1026, 1001, 961, 864. 
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[ ]23Dα  +11.3 (c 1.0, CH2Cl2) 
 
 
 
 
(+)-Crocacin C (4.25) 
Preparation of catalyst stock solution. In a glove box, to a dry 7 mL vial charged with 2-
dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl (S-PHOS, 4.5 mg, 0.11 mmol) 
was added a freshly prepared 0.01 M solution of Pd(OAc)2 in THF (0.55 mL, 5.5 µmol). 
The solution was stirred at 60 °C for 30 min to afford a golden solution, 0.01 M in 
catalyst. 
 
Synthesis of (+)-crocacin c. In a glove box, to a 7.0 mL vial charged with MIDA 
boronate 4.36 (31 mg, 0.071 mmol) and K3PO4·H2O (82 mg, 0.36 mmol) was added the 
catalyst stock solution (95 µL, 9.5 µmol). The vial was sealed with a septum cap and 
removed from the glove box. To the vial was added by needle a freshly prepared 0.10 M 
solution of bromobenzene in THF (475 µL, 0.0475 mmol). To the vial was then added by 
needle degassed H2O (100 µL). The vial was placed in a 60 °C heating block with stirring 
for 24 h. The reaction mixture (yellow organic phase, colorless aqueous phase) was 
transferred to a 30 mL separatory funnel and was diluted with EtOAc (10 mL) and H2O 
(2 mL). The mixture was shaken, the layers were separated, and the aqueous layer was 
extracted once with EtOAc (10 mL). The combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo. The pale yellow solid residue was adsorbed 
onto Celite in vacuo from an acetone solution. The resulting powder was subjected to 
flash chromatography on C18 silica gel (H2O:MeCN 100:0 → 50:50) to afford 4.25 as a 
colorless solid (13.1 mg, 77%). 
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TLC (hexanes:EtOAc 1:2) 
Rf = 0.43, stained by KMnO4 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.46 (d, J = 7.5 Hz, 2H), 7.31 (t, J = 7.5 Hz, 2H), 7.22 (t, J = 7.5 Hz, 1H), 6.71 
(s, 1H), 6.58 (d, J = 16 Hz, 1H), 6.24 (dd, J = 16, 7.5 Hz, 1H), 6.15 (m, 1H), 6.10 
(d, J = 15.5 Hz, 1H), 6.05 (dd, J = 15.5, 7.5 Hz, 1H), 5.79 (s, 1H), 4.07 (ddd, J = 
7.5, 2.5, 1 Hz, 1H), 3.51 (s, 3H), 3.28 (s, 3H), 3.16 (dd, J = 10, 2.5 Hz, 1H), 2.57 
(m, 1H), 2.21 (d, J = 1.5 Hz, 3H), 1.54 (m, 1H), 1.16 (d, J = 7 Hz, 3H), 0.84 (d, J 
= 7 Hz, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 169.0, 148.1, 137.8, 137.0, 135.0, 132.5, 130.4, 129.4, 128.2, 127.2, 122.0, 87.1, 
81.7, 61.5, 56.4, 43.4, 40.7, 19.3, 13.4, 10.1 
 
HRMS (ESI+) 
 Calculated for C22H31NO3Na: 380.2202 
 Found:   380.2191 
 
IR (thin film, cm-1) 
3336, 3185, 3024, 2972, 2929, 2820, 1661, 1602, 1491, 1448, 1404, 1367, 1367, 
1321, 1186, 1155, 1120, 1088, 1030, 972, 909. 
 
[ ]23Dα  +46.3 (c 0.3, MeOH) 
 
 
 233
1H NMR data for natural8 and synthetic (+)-crocacin C (4.25): δH/ppm 
(integration) 
 
Natural 4.25  
(400 MHz, acetone-d6) 
Synthetic 4.25 
(500 MHz, acetone-d6) 
7.46 (2H) 7.46 (2H) 
7.31 (2H) 7.31 (2H) 
7.22 (1H)  7.22 (1H) 
6.65 (1H) 6.71 (1H, NH) 
6.65 (1H) 6.15 (1H, NH) 
6.59 (1H) 6.58 (1H) 
6.25 (1H) 6.24 (1H) 
6.09 (1H) 6.10 (1H) 
6.07 (1H) 6.05 (1H) 
5.80 (1H) 5.79 (1H) 
4.08 (1H) 4.07 (1H) 
3.52 (3H) 3.51 (3H) 
3.30 (3H) 3.28 (3H) 
3.19 (1H) 3.16 (1H) 
2.62 (1H) 2.57 (1H) 
2.21 (3H) 2.21 (3H) 
1.58 (1H) 1.54 (1H) 
1.20 (3H) 1.16 (3H) 
0.88 (3H) 0.84 (3H) 
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13C NMR data for natural8 and synthetic (+)-crocacin C (4.25): δC/ppm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Natural 4.25  
(100 MHz,  acetone-d6) 
Synthetic 4.25 
(125 MHz,  acetone-d6) 
169.0 169.0 
148.1 148.1 
137.8 137.8 
137.1 137.0 
135.0 135.0 
132.5 132.5 
130.4 130.4 
129.4 129.4 
128.2 128.2 
127.2 127.2 
122.0 122.0 
87.1 87.1 
81.8 81.7 
61.4 61.5 
56.5 56.4 
43.4 43.4 
40.8 40.7 
19.2 19.3 
13.5 13.4 
10.2 10.1 
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Boronic acids from MIDA boronates 
 
 
 
General procedure for the NaOH-mediated hydrolysis of boronate esters 
To a 7 mL vial equipped with a stir bar and charged with the boronate ester (0.1 
mmol) was added THF (1 mL) and 1M aq. NaOH (0.3 mL). The mixture was vigorously 
stirred at 23 °C for 10 minutes. The reaction mixture was then diluted with aq. sodium 
phosphate buffer (0.5 M, pH 7.0, 1 mL) and Et2O (1 mL). The mixture was shaken and 
the layers were separated. The aq. phase was extracted with THF:Et2O 1:1 (2 x 2 mL). 
(On some occasions phosphate salts precipitated during the extraction process and were 
redissolved by the addition of water.) The combined organics were dried over MgSO4, 
filtered, and then concentrated in vacuo at 30-40 °C. Residual solvent was co-evaporated 
with MeCN. 
 
 
 
 
Boronic acid 4.1b 
The general procedure was followed using 4.1a (28 mg, 0.11 mmol). The product 
was extracted with THF:Et2O 1:1 (3 x 2 ml). The title compound was isolated as a 
colorless solid (14 mg, 85%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.75 (d, J = 7.5 Hz, 2H), 7.29 (d, J = 7.5 Hz, 2H), 4.50 (s, 2H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 144.2, 133.9, 125.4, 62.7 
 236
 
 
Boronic acid 4.37b 
The general procedure was followed using 4.2 (27 mg, 0.10 mmol). The title 
compound was isolated as a colorless solid (12 mg, 76%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 10.04 (s, 1H), 7.99 (d, J = 7 Hz, 2H), 7.89 (d, J = 7 Hz, 2H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 193.6, 137.1, 134.5, 128.3 
 
 
 
 
Boronic acid 4.37c 
To a 7 mL vial equipped with a stir bar and charged with 4.3 (28 mg, 0.10 mmol) 
was added THF (1 mL) and 1M aq. NaOH (0.4 mL). The mixture was vigorously stirred 
at 23 °C for 10 minutes. The reaction mixture was diluted with aq. 2M HCl (1 mL) and 
Et2O (1 mL). The mixture was shaken and the layers were separated. The aq. phase was 
extracted with THF:Et2O 1:1 (3 x 2 mL). The combined organics were dried over MgSO4, 
filtered, and then concentrated in vacuo at 30-40 °C. Residual solvent was co-evaporated 
with MeCN. The title compound was isolated as a colorless solid (15 mg, 89%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.92 (d, J = 8 Hz, 2H), 7.90 (d, J = 8 Hz, 2H). 
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13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 167.4, 134.0, 131.7, 128.1 
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Boronic acid 4.37d 
To a 7 mL vial equipped with a stir bar and charged with 4.37d (38 mg, 0.10 
mmol) was added MeOH (1 mL) and sat. aq. NaHCO3 (0.5 mL). The mixture was 
vigorously stirred at 23 °C for 3.5 h. The reaction mixture was then diluted with sat. aq. 
NH4Cl (1 mL) and Et2O (2 mL). The mixture was shaken and the layers were separated. 
The aq. phase was extracted with Et2O (3 x 2 mL). The combined organics were dried 
over MgSO4, filtered, and then concentrated in vacuo at 30-40 °C. Residual solvent was 
co-evaporated with MeCN. The title compound was isolated as a colorless residue (22.6 
mg, 84%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.79 (d, J = 8 Hz, 2H), 7.31 (d, J = 8 Hz, 2H), 7.29 (d, J = 9 Hz, 2H), 6.93 (d, J 
= 9 Hz, 2H), 4.50 (s, 2H), 4.45 (s, 2H), 3.75 (s, 3H) 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 158.6, 140.3, 134.0, 130.1, 129.2, 126.4, 113.6, 71.1, 71.0, 55.0 
 
 
 238
 
 
Boronic acid 4.37e 
The general procedure was followed using 4.5 (38 mg, 0.10 mmol). The title 
compound was isolated as a colorless solid (22 mg, 81%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.76 (d, J = 8 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 4.71 (s, 2H), 0.90 (s, 9H), 0.08 (s, 
6 H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 143.0, 133.9, 124.9, 64.2, 25.7, 17.9, -5.4 
 
 
 
 
Boronic acid 4.37f 
To a 7 mL vial equipped with a stir bar and charged with 4.7 (47 mg, 0.10 mmol) 
was added MeOH (1 mL) and sat. aq. NaHCO3 (0.5 mL). The mixture was vigorously 
stirred at 23 °C for 3.5 h. The reaction mixture was then diluted with sat. aq. NH4Cl (1 
mL) and Et2O (2 mL). The mixture was shaken and the layers were separated. The aq. 
phase was extracted with Et2O (3 x 2 mL). The combined organics were dried over 
MgSO4, filtered, and then concentrated in vacuo at 30-40 °C. Residual solvent was co-
evaporated with MeCN. The title compound was isolated as a colorless solid (31 mg, 
85%). 
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1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.73 (d, J = 8 Hz, 2H), 7.33-7.24 (m, 5H), 7.17 (d, J = 8 Hz, 2H), 4.78 (d, J = 6 
Hz, 1H), 4.42 (m, 1H), 4.14 (d, J = 9 Hz, 1H), 3.98 (m, 2H), 2.95 (d, J = 5 Hz, 
2H), 1.12 (d, J = 6.5 Hz, 3H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
δ 173.0, 151.8, 144.2, 134.3, 132.6, 128.4, 127.4, 125.9, 124.0, 72.1, 64.9, 53.6, 
43.8, 35.4, 10.8 
 
 
 
 
Boronic acid 4.37g 
The general procedure was followed using 4.8 (32 mg, 0.10 mmol). The title 
compound was isolated as a colorless solid (16 mg, 75%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.84 (d, J = 8 Hz, 2H), 7.68 (d, J = 8 Hz, 2H), 7.66 (d, J = 16 Hz, 1H), 6.66 (d, J 
= 16 Hz, 1H), 4.20 (q, J = 7.5 Hz, 2H), 1.27 (t, J = 7.5 Hz, 3H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 166.2, 144.3, 135.3, 134.5, 127.2, 118.4, 60.1, 14.1 
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Boronic acid 4.37h 
The general procedure was followed using 4.9 (37 mg, 0.10 mmol). The title 
compound was isolated as a colorless solid (24 mg, 89%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.76 (d, J = 8 Hz, 2H), 7.50 (d, J = 15 Hz, 1H), 7.42 (d, J = 8 Hz, 2H), 7.30 (d, J 
= 15 Hz, 1H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 144.3, 138.8, 134.3, 125.0, 80.6 
 
 
 
 
Boronic acid 10b 
The general procedure was followed using 4.10 (32 mg, 0.10 mmol). The title 
compound was isolated as a colorless solid (16 mg, 76%). 
 
1H-NMR (500 MHz, DMSO-d6:D2O 95:5) 
δ 7.74 (d, J = 8 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 3.57 (t, J = 4.5 Hz, 4H), 3.46 (s, 
2H), 2.34 (s, 4H). 
 
13C-NMR (125 MHz, DMSO-d6:D2O 95:5) 
 δ 139.5, 133.9, 128.0, 66.0, 62.4, 53.0 
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CHAPTER 5 
AN AUTOMATED SMALL MOLECULE SYNTHESIZER 
 
Eric P. Gillis, Steven G. Ballmer, Seiko Fujii and Martin D. Burke 
 
 This chapter describes the development of a machine with the capacity to execute 
fully automated iterative cross-coupling (ICC) sequences utilizing bifunctional MIDA 
boronate building blocks. Critical to the development of this machine was the discovery 
that the unique chromatographic properties of MIDA boronates can be harnessed to 
enable a simple and highly general “catch-and-release” purification strategy. Additionally, 
it was that discovered MIDA boronates undergo hydrolysis in the absence of bulk water 
upon treatment with solid-supported hydroxide base (Amberlyst A26). Applying these 
discoveries in the context of an automated ICC protocol required the development and 
programming of a number of hardware components which are herein described. 
Additionally, a custom software program was authored in order to provide a simple 
interface to the machine and to allow eight syntheses to be executed in parallel. The 
viability of the automated ICC machine was tested in the syntheses of several natural 
products. Steven G. Ballmer performed many of the experiments on solid-phase iterative 
cross-coupling (ICC) with MIDA boronates that helped influence the alternative 
development of a solution-phase automated ICC approach. Additionally, Steven Ballmer 
helped assemble some components of the machine, ran a number of automated ICC 
experiments that contributed to the development of the machine, and performed the 
syntheses described in Scheme 5.13 and Scheme 5.14. Seiko Fujii contributed building 
block 5.31. 
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5-1 TOWARDS AN AUTOMATED ITERATIVE CROSS-COUPLING APPROACH 
TO SMALL MOLECULE SYNTHESIS 
 Small molecule synthesis can broadly and powerfully enable the advancement of 
science. The development of a fully automated iterative-cross coupling (ICC) platform 
for making small molecules could help shift the focus in small molecule science from 
synthesis to function. At the same time, developments in synthetic chemistry could be 
expected to expand the collection of building blocks that are available and applicable to 
the ICC strategy, thereby broadening the collection of products that might be accessed by 
this approach. It is our ultimate hope that the realization of an automated platform for 
ICC will help enable scientists from a diverse array of disciplines, regardless of expertise 
in chemical synthesis, to be able to access and apply novel small molecules in their 
research.  
 The discovery that MIDA boronates enable an ICC strategy was detailed in 
chapter 2. The scope of coupling partners which can be coupled in a final SMC step was 
expanded through the development of the slow-release cross-coupling (SRCC) protocol 
for the SMC reaction (chapter 3). As detailed in chapter 3, it was also discovered that 
slow addition of boronic acids to the SMC reaction via a syringe pump can overcome 
issues of instability associated with even highly sensitive boronic acids. Chapter 4 
described approaches that can be used to access a broad range of complex MIDA 
boronate building blocks. Together, this work has led to the commercialization of many 
MIDA boronates. 1  Collectively, these advances well positioned us to address the 
challenge of developing a machine to automate the ICC process. 
 This chapter describes the design and operation of a proof-of-concept, first 
generation machine that is capable of performing automated ICC. 2  This chapter is 
structured as follows: First, the general design concepts of the machine are discussed. 
Next, the individual components of the machine are presented accompanied by a brief 
account of the evolution of the various methods described. Following this, the 
components of the machine are discussed in the context of the entire machine, with 
attention focused on the connectivity and software design that allows the machine to 
function as a cohesive unit. Finally, a collection of proof-of-concept experiments is 
presented which demonstrate the viability of the automated ICC approach. 
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5-2 OVERVIEW OF THE DESIGN OF A MACHINE FOR AUTOMATED ICC 
 In considering the design of a machine to automate the ICC process, we aimed to 
maximize its simplicity and thereby simplify its development to in turn minimize its cost, 
the level of expertise required to operate it, and minimize susceptibility to mechanical 
failure. We felt that controlling these factors would be important if the machine were to 
become broadly applicable outside of our own laboratories. We also aimed to maximize 
the generality of our automated process. This restriction posed a significant challenge 
because in general, realizing full conversions and high yields in SMC reactions requires 
substrate-specific optimization of the catalyst identity, base identity, solvent composition, 
reaction time and reaction temperature. Also, properties of boronic acids, a key reagent in 
the SMC reaction, are not general. As described in chapter 3, the reactivity and stability 
of boronic acids varies significantly depending on the identity of the organic group 
appended to boron. Further, many of the purification strategies used in organic synthesis 
require exploiting differences in the properties between the desired product and the 
undesired impurities: for example, differences in solubility, boiling point, and 
chromatographic properties of the components. Finally, isolating the correct chemical 
species from a mixture requires properly identifying the compound, typically based on its 
mass or spectroscopic properties. In spite of these challenges, we sought to design a 
machine that always executed successful ICC sequences simply by sending the same set 
of scripted commands to the machine equipment, never requiring feedback on the 
outcome of these operations. This level of sophistication is similar to that encountered in 
the first peptide synthesizer.3 
 In our pursuit of maximizing generality, we found it instructive to consider all of 
the steps of the ICC cycle. The generality of the ICC approach could be limited by 
substrate-specific complications in two broadly defined areas: the reactivity of each 
chemical component in the ICC approach, and the isolation of intermediates and final 
products. Regarding the reactivity of the chemical components, we felt that based on the 
results described in chapters 2, 3, and 4 we could consider the reactivity of the MIDA 
boronates to be general. Specifically, irrespective of the identity of the corresponding 
boronic acid, a MIDA boronate will be inert under anhydrous SMC conditions (chapter 2), 
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will be hydrolyzed under the same conditions and at the same rate as any other MIDA 
boronate (chapters 2 and 3), and can be expected to be stable/unstable to the same 
reagents described for other MIDA boronates (chapter 4). Therefore, the ICC steps that 
involve direct manipulation of a MIDA boronate group would likely be general. 
 There are no reports of a single generally effective anhydrous SMC reaction 
condition, although there are catalysts that have been found to be widely applicable in 
this context. 4  On the other hand, our work on SRCC (chapter 3) indicated that for 
aqueous couplings we had discovered a highly general SMC condition. Therefore, we 
sought to translate the principals of SRCC to an anhydrous SMC condition which would 
be applicable in ICC. Specifically, we predicted that a high catalyst loading accompanied 
by slow syringe-pump addition of the boronic acid would provide a generally effective 
protocol for anhydrous SMC reactions. To ensure full conversion in the SMC reaction, 
we proposed employing a three to four-fold excess of the boronic acid coupling partner to 
ensure that the boronic acid would not become the limiting reagent in the SMC step. 
Additionally, this excess would provide some tolerance for variability in the yields of the 
prior reactions that generate the boronic acid. However, the addition of excess reagents 
would only be possible if these reagents and the resulting byproducts could be effectively 
removed in a subsequent purification step. Specifically, we anticipated that the crude 
SMC product would be contaminated with several equivalents of boronic acid and/or 
deboronated material, as well as lesser amounts of Pd catalyst, phosphine oxide, and 
possibly reagents from previous steps. Thus, of the number of potential challenges faced 
in developing an automated ICC platform, we felt that identifying a general, effective and 
robust purification strategy was the most important component. 
 An early and important decision in the development of the machine was whether 
to develop the automated iterative cross-coupling (ICC) platform as a solution-phase or 
solid-phase method. A solution-phase method would offer the advantage that the reaction 
conditions developed in chapter 2 for ICC would be applicable to automated ICC. 
However, it was not clear how the general purification and isolation of the MIDA 
boronate products and/or boronic acid intermediates would be accomplished. 
Alternatively, a solid-phase approach in which the SMC reaction product would be bound 
to a resin might allow a general purification method based on simple washing and 
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filtration. However, it was not clear if the reaction conditions developed for solution-
phase ICC would be applicable to solid-phase ICC. 
 Although we initially examined a solid-phase approach to automated ICC, this 
approach proved to be quite challenging. In particular, it was not possible to achieve 
proper mixing of the solid-phase resin with the insoluble bases that are typically 
employed in anhydrous SMC reactions. On the other hand, several discoveries with 
MIDA boronates made a solution-phase approach much more attractive. Specifically, the 
discovery that MIDA boronates are amenable to “catch-and-release” 
chromatography5,6,7,8,9,10,11,12,13 (see below) provided the general purification method that 
was required to automate a solution-phase ICC process. Additionally, our studies in slow-
release cross-coupling (chapter 3) informed us that the generality of the SMC reaction is 
greatly increased if the boronic acid is added slowly to the reaction via a syringe-pump. 
Further, it was discovered that solid-supported hydroxide (Amberlyst A26) is capable of 
effecting the general hydrolysis of MIDA boronates under minimally wet conditions. 
 Harnessing these discoveries, we proposed the design of an automated ICC 
machine to be comprised of three modules representing the three discrete steps of the 
automated ICC cycle: a reaction module, a purification module, and a deprotection 
module (Figure 5.1). As a central component in this design, a syringe pump would 
perform all solution handling operations and would allow for slow addition of a boronic 
acid solution to a SMC reaction (Figure 5.1B).  
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Figure 5.1. (A) The automated iterative cross-coupling cycle. (B) The automated ICC machine is organized 
around a syringe pump unit which operates three modules: the deprotection module, the reaction module, 
and the purification module. 
 
 
5-3 THE PURIFICATION MODULE 
 The purification module comprises all of the equipment necessary to input a THF 
solution containing the crude MIDA boronate product from a SMC reaction and to output 
a THF solution containing the purified product. The purification approach employed by 
this module exploits the specific elution properties of MIDA boronates (see below) and is 
therefore best applicable to the purification of compounds that contain this functional 
group or possibly its derivatives. Products obtained in the final coupling of the automated 
ICC cycle that do not contain a MIDA boronate functional group must be purified by an 
alternative technique such as standard SiO2 chromatography or HPLC chromatography, 
as is typically done with automated peptide synthesis. Provided below is a detailed 
description of the principals on which the purification module is based. A description of 
the design and design rationale for the purification module is then presented, followed by 
experimental data which validates the effectiveness of this module. 
 
“Catch-and-release” chromatography with MIDA boronates   
 Studies during the course of the development of the ICC platform indicated that 
MIDA boronates possess a very special and remarkably general affinity for silica gel in 
the presence of certain eluents. Specifically, it was discovered that MIDA boronates 
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always have an Rf of value of zero when diethyl ether is used as the eluent. This 
observation has proven to be general, and applies to every MIDA boronate that has been 
synthesized in the Burke group to this date. This rule holds true regardless of the formula 
weight of the molecule, the polarity of the compound, or the solubility of the MIDA 
boronate in diethyl ether. Most other organic molecules have an Rf greater than zero 
when eluted through SiO2 with Et2O, allowing MIDA boronates to be easily separated 
from these compounds on SiO2 by eluting an adsorbed mixture with copious volumes of 
Et2O. On the other hand, MIDA boronates generally have a very high Rf when eluted 
with acetonitrile. Thus, following flushing of the SiO2-adsorbed product with Et2O, the 
MIDA boronate can be efficiently eluted with MeCN. These features enable a powerful 
and remarkably general “catch-and-release”5-13-type purification of compounds that 
contain the MIDA boronate functional group. The immobilization of the MIDA boronate 
on SiO2 while flushing with Et2O is the “catch”, and the elution of the MIDA boronate 
with MeCN is the “release”. The highly unique and enabling feature of “catch-and-
release” chromatography is that all MIDA boronates can be efficiently purified through 
this general approach regardless of the identity of the organic group appended to boron. 
Thus, implementing this approach under automation might simply involve depositing the 
product mixture onto SiO2, performing an initial flush with a fixed volume of Et2O, and 
subsequently eluting the purified product with a fixed volume of MeCN. 
 In practice, it would be desirable if solvents other than Et2O and MeCN could be 
employed in the “catch-and-release” chromatography protocol. For one, it has been 
observed that some boronic acids tend to elute inefficiently in Et2O, possibly due to 
hydrogen-bonding interactions of the boron group with the SiO2. To address this, it 
would be ideal to include in the eluent a protic solvent to disrupt the hydrogen-bonding 
interaction of boron with SiO2. Secondly, if the product could be eluted directly in the 
solvent required for a subsequent SMC reaction at a reasonable molarity this would avoid 
an additional solvent exchange and/or concentration step. Fortuitously, it was discovered 
that a number of solvents fit the criteria of functioning as a “catch” solvent. Specifically, 
both Et2O:MeOH (98.5:1.5) and hexanes:THF (3:1) function as “catch” solvents, 
meaning that all MIDA boronates surveyed have an Rf of zero when eluted on SiO2 with 
these eluents. For the hexane:THF system it was found that solutions containing greater 
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than 25% THF (v/v) began to demonstrate non-zero Rf values for highly non-polar MIDA 
boronates such as 5.1 (Table 5.1). Regarding alternative “release” solvents, it was 
discovered that acetone and THF also efficiently elute most MIDA boronates through 
SiO2. The latter is preferred since it is a standard solvent in SMC reactions. Thus a 
“catch-and-release” protocol well suited to an automated ICC approach would involve 
flushing a SiO2-adsorbed product mixture with Et2O:MeOH (98.5:1.5) followed by 
“release” with THF. Interestingly, the requirements for a “catch” solvent or a “release” 
solvent do not appear to necessarily follow a trend in polarity as would be expected for 
standard SiO2 chromatography. For example, although chloroform has a higher polarity 
than THF,14 chloroform functions as a “catch” solvent while THF functions as a “release” 
solvent (Figure 5.2). 
 
Table 5.1. Elution properties of a non-polar MIDA boronate on SiO2. 
 
 
 
Figure 5.2. The requirements for a “catch” or a “release” solvent do not appear to necessarily follow a 
trend in polarity. For example, although chloroform has a higher polarity than THF, chloroform functions 
as a “catch” solvent while THF functions as a “release” solvent as demonstrated for the highly non-polar 
MIDA boronate 5.2. 
MeN
O
OB
O
OMe 10
5.2
Et2O 
Rf = 0.00  
Chloroform 
Rf = 0.00 
 250
Precipitation-based purification with MIDA boronates 
 Implementing “catch-and-release” chromatography in an automated fashion 
required a straightforward approach to adsorbing the crude reaction solution onto SiO2. 
Because hexanes:THF (3:1) functions as a “catch” solvent, immobilizing the MIDA 
boronate onto SiO2 was found to simply involve diluting the THF reaction solution with 
three parts hexane and then passing the resulting solution through the SiO2 column. 
Regardless of the volume of solvent used in this step, the final result is that the MIDA 
boronate is always immobilized at the first point of contact with the SiO2. Pads of SiO2 
that were only 0.5 cm in height were found to be effective when this approach was used 
to purify 0.50 mmol of MIDA boronate. 
 In practice, most MIDA boronates precipitate from hexanes:THF (3:1). This 
phenomenon offers a second mode of purification that is complementary to the “catch-
and-release” chromatography approach.15,16,17 TLC experiments indicated that most often 
the impurities from of a SMC reaction remained in the hexanes:THF (3:1) solution while 
the MIDA boronate components were quantitatively precipitated. This phenomenon 
might be harnessed to enable purification of MIDA boronates simply through selective 
precipitation of the boronate followed by filtration; however, because not all MIDA 
boronates are insoluble in hexanes:THF (3:1), this purification method is less general 
than “catch-and-release” chromatography. On the other hand, these two purification 
approaches can be implemented as complimentary methods. For cases in which the 
MIDA boronate substrate is at least partially soluble in hexanes:THF (3:1), filtration of 
the mother liquor through a SiO2 pad serves as an entry point for “catch-and-release” 
chromatography. In cases where the MIDA boronate is completely insoluble in 
hexanes:THF (3:1) and all subsequent wash solvents, the purification step is 
accomplished without the product contacting the SiO2. 
 
Design of the purification module 
 The design of the purification module is presented in Figure 5.3, and is composed 
of two sub-units: the precipitation chamber and the SiO2 column for catch-and-release 
chromatography. Unless stated otherwise, the tubing that connects all of the components 
and the vessels themselves is air- and liquid-tight. The precipitation chamber is a 
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polypropylene tube (25 mL volume capacity) with an opening at the top and the bottom 
of the tube. The bottom opening is guarded by a polypropylene frit that spans the 
diameter of the tube. The bottom of the tube is connected via tubing to a 3-way union. 
The top of the tube is fitted with a needle that allows solvents to be inputted from the 
“main pump”. The “main pump” refers to the syringe pump that is responsible for most 
of the solution handling in the automated ICC machine. The top connection is loosely 
fitted such that air can vent out of the tube. The solvent that is inputted through the top of 
the tube is delivered to the bottom of the tube without contacting the sidewalls of the 
vessel. Positioned above the frit, the tube is also equipped with a weakly magnetic stir bar 
and is charged with a mixture of 3-propylamine-functionalized SiO2 and Celite 
(approximately 0.4 g total). The precipitation chamber is positioned over a magnetic stir 
plate that is stirred at approximately 600 revolutions-per-minute (rpm). 
 The SiO2 column is a small Teflon tube (12 mm ID x 22 mm height) with 
openings as the top and the bottom of the tube. Both of the openings to the tube are 
guarded by polypropylene frits that span the diameter of the tube; in between the frits is 
placed tightly-packed SiO2. The bottom of the column is connected via tubing to the 
“auxiliary pump”. The “auxiliary pump” refers to a syringe pump that is dedicated solely 
to the purification module and can be operated independently and simultaneously with 
the “main pump”. The top of the SiO2 column is connected via tubing to the 3-way union. 
The 3-way union is also connected via tubing to the main syringe pump. Although 
solutions inputted through the 3-way union could potentially output through two ports 
simultaneously, in practice one of the two output ports is always terminated during a 
solvent transfer operation, such that the 3-way union functions similar to 2-way valve. 
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Figure 5.3. The schematic design of the purification module from a side view. 
 
 The operation of the purification module occurs as follows: First, the auxiliary 
pump injects hexanes through the SiO2 column, through the 3-way union, and into the 
bottom of the precipitation chamber. When the precipitation chamber is free of solvent, 
the stir bar is embedded in the Celite/SiO2 mixture and does not stir. However, when 
solvent is injected into the precipitation chamber the stir bar is dislodged and the mixture 
becomes vigorously stirred. This phenomenon ensures that the stir bar operates only 
when stirring is required–i.e., when solution is present in the precipitation chamber.18 
Once the precipitation chamber becomes partially filled with stirred hexanes, the main 
pump delivers the crude reaction solution (THF) through the top of the precipitation 
chamber to establish a hexanes:THF ratio of 3:1. As described above, most MIDA 
boronates precipitate immediately upon dilution with hexanes. Therefore, the hexanes 
must initially contact the THF solution only at a location where the accumulation of solid 
MIDA boronate is acceptable. In the development of the machine it was noted that 
clogging resulted if this contact point occurred within the tubing, within the syringe of 
the syringe pump, or within a more constricted vessel. Additionally, if the contact point 
could not be washed later with THF–for example, if the boronate precipitated on the 
sidewalls near to top of the precipitation chamber–the boronate that precipitated could not 
be recovered. We also discovered that during the precipitation event unidentified 
impurities from the SMC reaction often precipitate, and that these impurities can form a 
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sticky layer that clogs the frit. The inclusion of Celite in the precipitation chamber 
prevents this clogging since the precipitated impurities contact and bind to the Celite 
before they contact the frit. The inclusion of 3-propylamine-functionalized SiO2 (solid-
supported scavenger for Pd) in the precipitation chamber serves to decolorize the crude 
reaction solution, presumably by binding palladium compounds. It was discovered in the 
context of automated ICC of polyene compounds that solutions decolorized with 3-
propylamine-functionalized SiO2 led to higher conversion in subsequent SMC reaction 
steps. By placing the functionalized silica gel in the precipitation chamber rather than 
using this reagent in a chromatography step, the crude THF reaction solution is exposed 
to a larger surface area of this functionalized silica gel for a longer residence time. 
 The chromatography step in the purification procedure is performed by 
withdrawing solutions through the SiO2 chamber under vacuum rather than applying 
positive pressure as is typical in flash chromatography. Specifically, once the reaction 
solution has been diluted to a hexanes:THF ratio of 3:1, the auxiliary pump withdraws the 
solution through the frit of the precipitation chamber, through the 3-way union, and 
through the SiO2 column. The solution is then discarded to the waste can. To the 
precipitation chamber is added Et2O:MeOH (98.5:1.5) via the main pump; the solid 
mixture in the precipitation chamber is allowed to stir, and then the solution is withdrawn 
through the SiO2 column and discarded to waste. A final cycle of chromatography is 
executed using Et2O which is added to the precipitation chamber by the main pump in 
order to remove residual MeOH which, if carried through to the next ICC cycle, would 
lead to solvolysis of the MIDA boronate group in a subsequent SMC reaction. At this 
point the purified MIDA boronate product is distributed in the SiO2 column and/or the 
precipitation chamber, and is available to be dissolved in THF and outputted from the 
purification module. 
 An important criterion for the purification module is that the MIDA boronate 
must be outputted from this module as a THF solution at the highest molarity possible. In 
theory, the molarity of the product solution is limited by the solubility of the MIDA 
boronate product in THF. In practice, this molarity is not possible to achieve without a 
step that concentrates the THF solution. Although we explored possible approaches 
towards concentrating an organic solution in an automated fashion, a simple and efficient 
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protocol for such a manipulation was not discovered. Therefore, the molarity of the 
outputted solution is directly related to the amount of solvent required to saturate the 
surfaces on which the product is distributed, the amount of solvent required to dissolve 
the product, and the amount of solvent required to elute the product from the SiO2 
column.  
 The volume of THF required to elute the product from the SiO2 column is 
dependent on the Rf of the product multiplied by the volume of SiO2 the product must 
pass through in order to exit the column (the effective column volume). Based on the 
elution properties observed experimentally with MIDA boronates, Figure 5.4A represents 
schematically the most likely situation to result following deposition of the MIDA 
boronate onto the SiO2 column through the “catch” chromatography steps described 
above. Because an Rf of zero is predicted for all MIDA boronates eluted on SiO2 with 
hexane:THF (3:1), Et2O:MeOH (98.5:1.5) and Et2O, the MIDA boronate is predicted to 
be immobilized at the top of the SiO2 column. If the top portion of SiO2 were deactivated 
by impurities in the reaction solution, the MIDA boronate might be deposited slightly 
below the surface of the SiO2 pad. If the column were to be eluted from top to bottom, the 
effective column volume would be maximized (Figure 5.4B). Alternatively, if the column 
were eluted from the bottom to the top, the effective column volume would be 
theoretically as small as possible (Figure 5.4C). Further, the amount of solvent required 
to elute the product in Figure 5.4B cannot be predicted for every MIDA boronate. On the 
other hand, in the case of Figure 5.4C it reasons that the MIDA boronate product should 
always be completely eluted from the SiO2 column if the volume of solvent used in the 
elution step is equal or greater than the volume of solvent used in the deposition step 
because 1) the effective column volume is smaller in the elution step than it is the 
deposition step and 2) the product has a higher Rf value for the solvent used in the elution 
step than in the deposition step. In practice, we have found that adopting the method of 
Figure 5.4C has enabled a very efficient elution process. Further, the purity of the product 
obtained through the approach of Figure 5.4C is the same as that obtained through the 
approach of Figure 5.4B. 
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Figure 5.4. (A) A theoretical, schematic representation of the SiO2 column following deposition of a 
MIDA boronate through “catch” chromatography (side view of column). (B) Elution from top to bottom 
would result in the largest effective column volume. (C) Elution from the bottom to the top would result in 
the smallest effective column volume. 
 
 The transfer of the product as a THF solution from the purification module occurs 
as follows: First, the auxiliary pump injects THF (11 mL) through the bottom of the SiO2 
column, out through the top of the SiO2 column, through the 3-way union, and through 
the bottom of the precipitation chamber (Figure 5.3). In this process the all of the surfaces 
used in the purification process are contacted with THF and any MIDA boronate that 
remained in the precipitation chamber is exposed to THF for a long residence time to 
promote dissolution. After the mixture in the precipitation chamber is stirred for 30 
minutes, the solution is filtered through the bottom of the precipitation chamber and is 
withdrawn through the 3-way union and out to the main pump. The process is repeated 
with an additional small portion of THF to transfer any residual product. At this point the 
purification step is complete and the purified product is available for the next step in 
automated ICC, typically the deprotection step. 
 
Experimental results in the development of the purification module 
 To test the efficiency of the purification module, a THF solution of MIDA 
boronate 5.3 and 4-formylphenylboronic acid was introduced into the purification module 
(Scheme 5.1). The amounts of these reagents represent the quantity of these materials that 
is typically encountered in the first coupling step of an automated ICC synthesis. Further, 
4-formylphenylboronic acid was selected as a test substrate because this boronic is 
relatively difficult to elute from SiO2 and should provide a rigorous test of the 
purification method. The purification module was operated according to the procedures 
described above to afford a THF solution of purified 5.3. Concentration of the THF 
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solution followed by 1H-NMR analysis indicated that the material was quantitatively 
recovered in > 95% purity. An additional purification was performed with MIDA 
boronate 5.4 (Scheme 5.2). In this experiment 5.4 was combined with Pd(OAc)2 and S-
Phos in THF to produce an orange solution. This solution was inputted to the purification 
module which was operated as described above to afford a very pale yellow THF solution. 
Concentration of the THF solution followed by 1H-NMR analysis indicated that the 
MIDA boronate was quantitatively recovered in > 95% purity. Collectively, these 
experiments demonstrate that the purification module can effectively separate MIDA 
boronates from palladium, phosphine/phosphine oxide and boronic acid impurities. 
Results obtained from subsequent automated ICC experiments are consistent with the 
efficiency indicated in these early trials. 
 
 
Scheme 5.1. The effectiveness of the purification module was evaluated in the purification of MIDA 
boronate 5.3. 
 
 
 
Scheme 5.2. The effectiveness of the purification module was evaluated in the purification of MIDA 
boronate 5.4. 
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5-4 THE DEPROTECTION MODULE 
 The deprotection module comprises all of the equipment necessary to input a THF 
solution containing a pure MIDA boronate and to output a dry and deoxygenated THF 
solution containing the corresponding boronic acid. Provided below is a detailed 
description of early studies on the automated deprotection of MIDA boronates, followed 
by a description of the use of solid-supported hydroxide (Amberlyst) in the automated 
deprotection of MIDA boronates. The design and operation of the deprotection module is 
also detailed. 
 
Early approaches to automated MIDA boronate hydrolysis 
 Previous studies indicated that MIDA boronates are generally and efficiently 
hydrolyzed to the corresponding boronic acid upon treatment with aqueous NaOH at 
room temperature (chapters 2,3,4). However, translating this procedure to an automated 
platform represented a considerable challenge. For one, the partition coefficient of 
boronic acids between organic solvents and water is not general. This presented a 
problem in designing a generally effective workup condition by which the aqueous 
NaOH used in the deprotection step could be neutralized and the boronic acid product 
could be carried forward in high yields as a dry organic solution. Further complicating 
this approach was the lack of a simple and efficient automated method for concentrating 
an organic solution. One deprotection approach that was evaluated involved adding 
aqueous NaOH to a THF solution of the MIDA boronate, allowing the hydrolysis 
reaction to proceed, and then quenching the reaction with HCl dissolved in water 
saturated with NaCl. The organic phase was separated from the aqueous phase and was 
then dried over a solid desiccant. The efficiency of the drying step was evaluated by 
executing a mock deprotection sequence19 in which the water content of the resulting 
THF solution as it stirred over the desiccant was monitored by Karl Fisher analysis. The 
desiccants that were tested were MgSO4, Na2SO4, CaSO4, SiO2, K2CO3, and activated 
molecular sieves,20 where the only effective desiccant was found to be activated mol. 
sieves. However, 8.5 g of mol. sieves were required in order to reduce the water content 
of the THF to below 60 µg/mL. When this amount of mol. sieves was employed in a 
deprotection sequence with p-tolyl MIDA boronate, most of the resulting p-tolyl boronic 
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acid became adsorbed onto the mol. sieves as indicated by TLC. Further, the water 
introduced in the deprotection step was difficult to completely remove from the syringe 
pump and other machine equipment. 
 An alternative approach for the deprotection step that was evaluated involved 
using a minimal amount of water in the hydrolysis step followed by quenching with 
anhydrous acid. Specifically, when a THF:H2O (99:1) solution containing p-tolyl MIDA 
boronate (5.5) was treated with solid NaOH or KOH pellets, complete hydrolysis of the 
MIDA boronate was observed by TLC within 60 minutes (Scheme 5.3). Reactions 
performed with THF solutions containing less than 1% of water (v/v) resulted in only 
partial conversion. The formation of a large amount of solid ppt. and the disappearance of 
any organic compounds from the organic phase as analyzed by TLC is consistent with the 
formation of borate 5.6 as the insoluble product (Scheme 5.3).21 The dibasic potassium 
salt of MIDA is predicted to be a byproduct of this reaction and although not specifically 
analyzed for, was likely also part of the solid ppt. Upon treatment of the mixture with 
HCl in dioxane the majority of the solid ppt. disappeared and TLC analysis of the organic 
phase indicated the presence of a large amount of boronic acid. A sticky solid residue was 
also present in the tube which was likely MIDA, KCl and water. The boronic acid 
solution obtained through this step was further processed in a step that involved 
neutralization over solid K2CO3, drying with mol. sieves and sparging with Ar. The 
resulting boronic acid solution was then utilized in a successful automated SMC reaction 
(Scheme 5.11, see below). Thus, this deprotection protocol was found to be a viable 
approach for at least a certain set of MIDA boronates/boronic acids. However, when 
MIDA boronate 5.8 was engaged in the same procedure the hydrolysis stalled at 
approximately 50% conversion of the MIDA boronate as judged by TLC. In this reaction 
formation of a precipitate (attributed to borate 5.2b and the dibasic MIDA salt) led to 
separation of a large organic phase and a very small aqueous phase. Consequently, the 
unreacted KOH became sequestered within a sticky solid substance at the interface of the 
phases, a fact that likely accounts for the limited conversion observed in the reaction. The 
hydrolysis of E-propenyl MIDA boronate (5.4) under this protocol was similarly 
problematic. 
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Scheme 5.3. Boronate 5.5 was underwent hydrolysis when minimally wet conditions were employed. 
 
 
Scheme 5.4. The conversion of boronate 5.8 stalled at approximately 50% conversion when minimally wet 
conditions were employed. 
 
 To avoid the problem of phase separation observed in the approach described 
above, a new approach was tested employing anhydrous THF and NaOMe. Specifically, 
a THF solution of 5.10 was treated with NaOMe with stirring at room temperature for 60 
minutes to afford a gel that was difficult to stir, presumably a mixture of THF and borate 
5.11 (Scheme 5.5).22 Treatment of the gel with concentrated aqueous HCl afforded a low-
viscosity THF solution that upon analysis by TLC indicated the presence of boronic acid 
5.12. The acidification step was accompanied by the formation of a fine, colorless ppt. 
that was likely a form of the MIDA ligand or its methyl ester. The resulting THF solution 
was neutralized over K2CO3, treated with 5 Å mol. sieves to remove MeOH and H2O, 
sparged with Ar, and then introduced to an automated SMC reaction with 4-bromophenyl 
MIDA boronate. However, the SMC reaction proceeded to only partial conversion (68%) 
and the mass recovery of MIDA boronate starting material and product was low (56%). 
Further, treatment of boronate 5.5 with NaOMe under the same protocol led to a very 
thick gel that could not be stirred and which resulted in stalling of the deprotection 
reaction. However, the greatest problem in this approach was that at unpredictable points 
in downstream manipulations a fine solid would precipitate, resulting in clogs to the 
plumbing of the machine. Several approaches were investigated in which the boronic acid 
solution was scrubbed with solid reagents in order to remove the fine precipitate, but 
ultimately the problem could not be solved.  
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Scheme 5.5. Treatment of boronate 5.10 with NaOMe led to a thick gel, presumably borate 5.11 and a 
MIDA species. Treatment of the gel with concentrated aqueous HCl afforded a low-viscosity solution 
which by TLC indicated the presence of a boronic acid 5.12. 
 
 
Scheme 5.6. Treatment of boronate 5.5 with NaOMe resulted in the formation of a very thick gel which 
stalled the reaction. 
 
Deprotection of MIDA boronates with Amberlyst A26(OH) 
 A key advance in the development of the deprotection module was the discovery 
that MIDA boronates undergo hydrolysis upon treatment with Amberlyst A26(OH). 23 
Amberlyst A26(OH) is a macroporous resin that is functionalized with ammonium 
residues with a hydroxide counter ion.24 One advantage of employing Amberlyst in the 
deprotection of MIDA boronates is that the hydrolysis reaction proceeds with simple 
mixing via air bubbling through the resin/THF mixture—all other deprotection 
approaches required vigorous stirring. A second advantage to this approach is that the 
MIDA ligand that is produced as a byproduct in the hydrolysis reaction becomes 
completely sequestered within the Amberlyst resin. This allows the resin/THF mixture to 
be filtered without concern that residual MIDA will clog the equipment. However, the 
most important aspect of this approach is that it is highly general. This approach has been 
evaluated with a broad range of MIDA boronates and it has been found that hydrolysis of 
the boronate always proceeds to full conversion within 60 minutes upon treatment with 
Amberlyst A26(OH). 
 During the development of the deprotection module it was discovered that the 
preparation of the Amberlyst resin has a significant impact on the yield of boronic acid 
obtained from the hydrolysis step. Amberlyst resin as received from commercial sources 
is greater than 60% water by mass and if this resin is used directly in the machine the 
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large amount of water introduced cannot be effectively removed with mol. sieves. 
Therefore, prior to use in the deprotection module the resin must be washed with an 
organic solvent to remove a large amount of this water. However, when rigorously dried 
Amberlyst resin was employed in a deprotection reaction with MIDA boronate 5.14, a 
41% yield of the proto-deboronated product 5.15 was observed by GC (Scheme 5.7). This 
result prompted us to evaluate the impact of washing the Amberlyst resin with various 
solvents [EtOAc, CH2Cl2, acetone, MeCN, sat. aq. NaCl, THF]. Specifically, the different 
wash cycles were evaluated in regard to the amount of water removed from the resin, the 
efficacy of the washed resin to effect the hydrolysis of a MIDA boronate, and the amount 
of deboronated material obtained when the washed resin was used in a MIDA boronate 
deprotection reaction. From these studies THF was determined to be at least as effective 
as the other solvents, and therefore was selected as the solvent of choice for the wash 
step.25 It reasons that since THF is also the solvent used in the deprotection step, residual 
THF from the resin wash cycle should be minimally impacting in the subsequent MIDA 
boronate hydrolysis reaction. In a subsequent study, Amberlyst resin was equilibrated in 
various ratios of THF:H2O by performing five washes of the resin with this solvent 
combination. The resin was then employed in a standard deprotection step with MIDA 
boronate 5.14 and the yield of deboronated benzofuran 5.15 was determined by GC 
analysis of the THF reaction solution (Table 5.2). Under the conditions of the experiment 
the desired boronic acid was retained inside the resin and was not observed in the 
analysis (see below). In this study it was discovered that equilibration of the resin with a 
solution of THF:H2O (50:1) led to the best balance of low water content in the resin and a 
low associated rate of deboronate in the deprotection step. Therefore, all Amberlyst 
employed in the deprotection module is now equilibrated with THF:H2O (50:1) 
immediately prior to use in a MIDA boronate hydrolysis reaction. 
 
Amberlyst
A26(OH)
(dried)Me
O
B
MeN
O
O
O
O
THF, 23 ºC
60 min.
Me
O
Me
O
B(OH)2 +
5.15
5.14 41%  
Scheme 5.7. Treatment of boronate 5.14 with rigorously dried Amberlyst A26(OH) resin resulted in 
significant formation of the deboronated side-product 5.15. 
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Table 5.2 
Amberlyst
A26(OH)
THF:H2O
equilibration
Me
O
B
MeN
O
O
O
O
THF, 23 ºC, 60 min. Me
O
Me
O
B(OH)3
+
5.15
R3N Amberlyst
Not observed
Observed by GC
Entry THF:H2O (equilibration) % yield 5.15
1
2
3
4
5
1:0 18%
200:1
100:1
15%
8%
50:1
20:1
4%
3%
*
* Determined by GC against internal standards biphenyl and
dodedane, response corrected, avg. of two runs
5.14
 
 
 In order to release the boronic acid from the Amberlyst resin following 
deprotection of a MIDA boronate, the resin must be treated with acid. As is described in 
Scheme 5.8, upon exposure to Amberlyst A26(OH) in THF most boronic acids become 
trapped within the resin, presumably as the corresponding borate salt. As a specific 
example, exposure of p-tolyl MIDA boronate to Amberlyst A26(OH) resin for 60 
minutes followed by TLC analysis of the solution indicated the complete absence of both 
p-tolyl MIDA boronate and p-tolyl boronic acid in the THF solution. Subsequent 
treatment of the mixture with HCl led to release of the boronic acid into the THF solution, 
as indicated by TLC analysis. It is possible to envision a purification strategy based on 
this phenomenon in which the THF reaction solution could be exchanged for pure solvent 
while the borate remained trapped within the resin. Such a strategy would be similar to 
the method recently described by Hall,26 but would occur on the solid phase. However, 
such a purification approach was not implemented in the development of the machine 
because highly non-polar boronic acids appear to be an exception to the general trend of 
boronic acid sequestration. For example, when dodecyl MIDA boronate is exposed to 
Amberlyst A26(OH) resin, the resulting boronic acid does not become entrapped in the 
resin but instead is present in the THF solution. 
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 In regards to the acid that is used in the acidification step, both HCl in dioxane 
and AcOH in THF were found to be effective. Further, neither acid adversely affected 
downstream processes despite the potential of this complication. Specifically, the use of 
HCl in the treatment of a E,E-dienyl boronic acid did not lead to observation of Z-
isomers of the trienyl MIDA boronate product obtained in a subsequent step (Scheme 
5.9). Additionally, a MOM protecting group was found to be stable to treatment with HCl 
in THF:dioxane despite the presence of a small amount of water in the solution (Scheme 
5.10). Alternatively, the use of AcOH could potentially result in AcOH and/or 
AcONa/AcOK being carried through subsequent steps and into a SMC reaction. However, 
downstream SMC reactions were equally successful when ether AcOH or HCl was used 
to treat the Amberlyst resin in the deprotection step. Further, neither acid produced salts 
that accumulated or clogged the equipment. 
R B(OH)3
R'3N
Amberlyst A26(OH) bead
MeN
O
OB
O
OR THF, 23 ºC, 60 min.
Amberlyst A26(OH) Acid
R B(OH)2
R =
Me
O
OMe
Me
Me
S
Me
 
Scheme 5.8. Most boronic acids upon exposure to Amberlyst A26(OH) become sequestered within the 
resin beads leaving the reaction solution free of boronic acid and MIDA boronate. Presumably the boronic 
acid is trapped as the corresponding boronate species. Treatment of the resin with an acid results in the 
release of the boronic acid. 
 
 
Scheme 5.9. Treatment of a dienyl boronic acid with HCl did not lead to the observation of Z-alkene 
products in a subsequent SMC reaction. 
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Scheme 5.10. The MOM protecting group is stable to the acidic conditions employed in the deprotection 
module. 
 
Design of the deprotection module 
 The design of the deprotection module is presented in Figure 5.5, and is 
composed of four sub-units: the deprotection tube, the pre-drying tube, the drying tube, 
and the degassing tube. All of the vessels are polypropylene tubes (25 mL volume 
capacity) with an opening at the top and the bottom of the tube. The bottom opening is 
guarded by a polypropylene frit that spans diameter of the tube. The deprotection module 
does not require stirring in any step and therefore does not incorporate a stir plate. All of 
the solution handling operations in the deprotection module are performed by the “main” 
syringe pump which, as defined above, refers to the syringe pump that is responsible for 
most of the solution handling in the automated ICC machine. The tubes in the 
deprotection module are charged with reagents as follows: The deprotection tube is 
charged with water-washed Amberlyst A26(OH); the pre-drying tube is charged with a 
2:1 mixture by mass of MgSO4:Celite; the drying tube is charged with activated 4 Å 
molecular sieves, BaCO3 and a small amount of Celite; and the degassing tube remains 
empty. The tops of the deprotection tube and pre-drying tubes are vented to ambient 
atmosphere while the tops of the drying tube and degassing tube are vented to a N2 gas 
manifold. The bottoms of each vessel are connected via tubing to the main syringe pump, 
and it is through this connection that all reagents and gasses are inputted and withdrawn 
from the vessels. 
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Figure 5.5. The schematic layout of the deprotection module from a side view. 
 
 The operation of the deprotection module occurs as follows: First, the resin in the 
deprotection tube is washed five times with THF:H2O (50:1), where each wash solution is 
discarded to waste. A THF solution containing the MIDA boronate is then introduced to 
the deprotection tube and the mixture is agitated for 60 minutes via periodic injections of 
N2 gas through the bottom of the tube. The solution is then transferred to the pre-drying 
tube and the mixture is mixed via repeated injection/withdrawal sequences executed by 
the main syringe pump. As described above, during this step most boronic acids will 
remain completely sequestered within the Amberlyst resin. Further, it reasons that if the 
boronic acid is sufficiently non-polar such that it does not become trapped in the resin, it 
will likewise not become strongly adsorbed onto the MgSO4 in the pre-drying tube. 
Therefore, this step allows bulk water to be removed without the loss of boronic acid to 
adsorption on a solid desiccant. The THF solution is then returned to the deprotection 
tube and to the deprotection tube is added HCl in dioxane. The mixture is agitated for ten 
minutes via periodic injections of N2 gas through the bottom of the frit, and the resulting 
boronic solution is then transferred to the drying tube.  
 At this point the THF solution is acidic and must be neutralized with a weak, 
insoluble base. The base must be weak in order to avoid formation and subsequent 
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precipitation of a boron “ate” species, and the base must be insoluble so that it is not 
outputted from the deprotection module. The base that was chosen for this purpose is 
BaCO3 because this base is insoluble in water and therefore cannot be dissolved in the 
initially wet THF solution. On the other hand, when K2CO3 was employed in this 
application it was observed that this base became partially dissolved and then was re-
precipitated as a fine powder which subsequently clogged the machine equipment. Also 
included in the drying tube are activated 4 Å mol. sieves which over 30 minutes 
effectively dry the THF solution. Upon drying of the THF solution it has been observed 
that fine salts may precipitated and clog the frit, but this problem can be avoided if Celite 
is included in the drying tube to act as a filtering aid. Thus the operation of the machine 
in the drying step is as follows: After the THF solution is introduced into the drying tube, 
the mixture is mixed over the course of 30 minutes by period withdrawal/re-injection of 
the solution as executed by the main syringe pump. Following this step, the THF solution 
is transferred to the degassing tube where it is sparged for 15 minutes under a constant 
stream of argon that originates from the main syringe pump. At this point the boronic 
acid is outputted from the deprotection module as a dry, deoxygenated THF solution. 
 
 
5-5 THE REACTION MODULE 
 The reaction module comprises all of the equipment necessary to input a dry and 
deoxygenated THF solution containing a boronic acid and to output a homogeneous THF 
solution containing the crude product of a SMC reaction. The reaction module, although 
critical to the automated ICC process, is the least complex of the three main modules. 
Provided below is a detailed description of the design of this module and its operation. 
 
Design of the reaction module 
 The vessel used in the reaction module is a polypropylene tube (25 mL volume 
capacity) with an opening at the top and the bottom of the tube (Figure 5.6). The reaction 
vessel is charged with base (K3PO4 for aryl couplings, Cs2CO3 for polyene couplings), 
Pd(OAc)2, S-Phos and the halide. For all steps except the final coupling step, the halide is 
a halo MIDA boronate. The bottom opening of the vessel is connected to the main 
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syringe pump with tubing and is guarded by a polypropylene frit that spans the diameter 
of the vessel. On top of this frit sits a smaller diameter frit which is held in position by a 
piece of wire (wire not shown). A large and powerful stir bar rests on top of the second 
frit. The reason for this design is that many experiments in the development the reaction 
module indicated that high reproducibility in the automated SMC reaction requires that 
the reaction is stirred at > 500 rpm. At slower stir speeds the solid base that is used in the 
reaction may not be properly mixed. However, at stir speeds > 150 rpm the surface of the 
frit becomes damaged by the stir bar continuously grinding solid base into the surface 
pores of the frit. In earlier designs in which only one frit was employed in the reaction 
tube but a stir rate of > 500 rpm was applied, the frit in the reaction tube often became 
impenetrable to liquid and thus the solution could not be withdrawn following the SMC 
reaction. On the other hand, in a two frit design the top frit provides a surface that can be 
damaged while at the same time preventing the stir bar from contacting and damaging the 
lower frit. In this setup the lower frit is the only surface which must provide filtration for 
the reaction tube.  
 
 
Figure 5.6. A schematic depiction of the reaction module from a side view. 
 
Input: Argon stream 
Output: crude reaction 
product (Main pump) 
Input: crude reaction solution, 
Et2O wash solution 
(Main pump)
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Reaction 
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Large stir bar 
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Air-cooled portion 
of the reaction tube
Reagents: base, 
Pd(OAc)2, S-Phos, 
halide 
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 The top of the reaction vessel is air-tight except for an input needle and an output 
vent. The output vent is connected to a N2 gas manifold in order to allow the tube to be 
purged with argon while maintaining an inert atmosphere. Specifically, argon is inputted 
through the bottom of the reaction tube and exits through the vent in the top of the tube 
and out through the N2 gas manifold. The input needle is positioned directly over the 
center of the tube and is used to deliver the boronic acid solution slowly to the reaction 
mixture. A principal design feature of the automated ICC machine is that, based on the 
discoveries described in chapter 3, the boronic acid is introduced slowly to the SMC 
reaction in order to allow efficient coupling of even unstable boronic acids. The reason 
that the boronic acid is added dropwise from the top of the reaction tube is to ensure that 
the boronic acid solution remains at room temperature until it contacts the reaction 
mixture. In this case the boronic acid is not exposed to heating that might degrade the 
boron reagent prior to the SMC reaction. Alternatively, if the boronic acid solution was 
added through the bottom of the reaction tube the boronic acid would be heated in the 
dead-volume of frit before the boronic acid could be utilized in the SMC reaction. 
 The reaction tube is placed inside an aluminum heating block that jackets the 
lower half of the tube. The heating block is placed over a temperature-controlled hot-
plate, where the role of the heating block is to conduct the heat from the hot-plate to the 
reaction tube. Measurements have confirmed that the temperature of the THF solution 
inside of the reaction vessel is the same as the temperature specified on the hot-plate. The 
heating block also has an opening in the side of the block to accommodate the tubing 
connection between the bottom of the reaction vessel and the main syringe pump. 
Importantly, the polypropylene reaction vessel is a poor conductor of heat and as such 
only the surface of the vessel in contact with the heating block is heated. The portion of 
the reaction tube that is not in contact with the heating block functions as an air-cooled 
condenser and prevents heated solvent vapors from exiting the reaction tube. In practice, 
THF reaction solutions are typically heated to 60 ºC for at least six hours without an 
observable change in solvent volume. 
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Operation of the reaction module: 
  The operation of the reaction module occurs as follows: First, the reaction tube is 
purged with a constant stream of argon for fifteen minutes. Then to the reaction tube is 
added THF to allow the palladium, phosphine ligand and halide to pre-equilibrate prior to 
the introduction of the boronic acid. Once the reaction mixture has been stirred for ten 
minutes, the boronic acid is then added dropwise to the mixture over two hours. 
Following the complete addition of the boronic acid, the reaction mixture is stirred for 
four hours for arene couplings run at 60 ºC and for twenty-two hours for polyene 
couplings run at 23 ºC. Finally, the reaction solution is drawn through the frit in the 
bottom of the reaction tube and is outputted to the machine. 
 
 
5-6 CONNECTIVITY IN THE MACHINE AND SOFTWARE CONTROL 
 The automated ICC machine is designed to with the capacity to execute the 
fully automated synthesis of eight small molecules simultaneously. Each synthesis 
consists of between one and three iterative coupling sequences, where each sequence can 
include a deprotection step, cross-coupling step and a purification step. The organization 
of the machine is centered on eight “main” syringe pumps, where each main syringe 
pump is dedicated to only one synthesis. The previous sections described the modules 
that are used in a single step by a single synthesis. However, in the actual automated ICC 
machine there are many instances of the deprotection module, reaction module and 
purification module. Further, the eight main syringe pumps operate independently to 
execute iterative coupling sequences in parallel. This section describes how the various 
pieces of equipment in the machine are compartmentalized and connected in order to 
enable multiple processes to be executed simultaneously. This section also describes what 
resources are shared between the main syringe pumps, and how the resources are 
distributed and managed. Finally, this section describes how a piece of custom software 
is used to operate the machine and to coordinate the multiple processes that run 
simultaneously. 
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Connectivity of machine equipment 
 The automated ICC machine is composed of ten syringe pumps, twenty-six eight-
port valves, and approximately 400 feet of Teflon tubing that links these parts together 
and connects this equipment to the three modules previously described: the deprotection 
module, the reaction module and the purification module. Shown in Figure 5.7 is a 
schematic front view of the machine, which serves and an aid in identifying the 
equipment presented in the photograph of the machine (Figure 5.8). 
Each valve and each syringe pump is assigned within the software a virtual name 
that allows the equipment to be specifically addressed and controlled programmatically. 
The virtual names that are assigned to each piece of equipment are detailed in Figure 5.9. 
Although there is physically only one machine, in the software environment that controls 
the machine equipment there are eight virtual machines, where one virtual machine 
corresponds to each main pump. Each virtual machine is assigned one actual main 
syringe pump, one auxiliary pump, and valves numbered one through twelve. The same 
actual auxiliary pump and “valve #3” through “valve #12” are assigned to all eight virtual 
machines (they will share these resources), while each main pump and each “valve #1” 
and “valve #2” are assigned to solely their corresponding virtual machine (Figure 5.9). For 
example, “virtual machine #1” comprises “main syringe pump #1”, “pump 1’s valve #1”, 
“pump 1’s valve #2”, “shared valve #3” through “shared valve #12”, and the “auxiliary 
pump”. The aqueous solutions pump depicted in Figure 5.7 and Figure 5.8 is not used in 
the current generation of the machine but cannot be removed from the machine because 
communications to the hardware are directed through this equipment. 
 The use of virtual machines within the software environment serves to 
compartmentalize the equipment from a programming standpoint. As discussed below, 
this approach greatly simplifies the programming of the machine and makes the scripts 
that operate the equipment universal across the eight pumps. However, the 
compartmentalization of the equipment also influences how physical connections 
between the valves are mapped. The connectivity of the equipment is detailed in Figure 
5.10. The connectivity described in Figure 5.10 is specific to virtual machine #1, but this 
diagram also illustrates how the connectivity would be established for virtual machines 
#2 through #8. Features of this arrangement are that all of the connections to the 
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deprotection modules, reaction modules and purification module are made on valve #1 
and valve #2, the valves that are unique to each virtual machine. This means that any 
operations involving this equipment can occur without regard to the state of the other 
virtual machines. In contrast, the connections to solvents, such as THF, are made through 
valve #3 and valve #4 which are shared equipment, meaning that “valve #3” of each 
virtual machine maps to the same actual valve. A virtual machine may only manipulate a 
piece of shared equipment if the equipment is not in use by any other virtual machines, a 
condition that is enforced by the software (see below). In terms of mapping the 
equipment, care was taken to ensure that most pieces of equipment that are used regularly 
in the automated ICC process are not shared. If the equipment must be shared, operations 
on the equipment should be kept relatively brief, such that a synthesis does not become 
greatly slowed by many virtual machines queuing to use the same shared hardware. 
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 In the current design of the automated ICC machine, the equipment set assigned 
to each virtual machine is connected to two deprotection modules, three reaction modules, 
and one purification module. The single purification module is reused for each automated 
ICC cycle. Currently the two deprotection modules share the same pre-drying tube and 
the same degassing tube. Further, because there are only two deprotection modules per 
virtual machine, a three-step automated ICC sequences requires that the same 
deprotection module is used for the first cross-coupling and the third cross-coupling, 
where the reagents and tubes are cleaned and recharged manually between these coupling 
steps. 27  The connections between the valves on the machine and each deprotection 
module, reaction module and purification module are detailed in Table 5.3, and are 
general for each virtual machine. The port on valve #7 to which the bottom of the SiO2 
column in the purification module connects is specific to the virtual machine: machine #1 
= port A, machine #2 = port B, machine #3 = port C, etc. For example, in order for the 
main syringe pump of a virtual machine to connect to the drying tube in deprotection 
module #1, the following valves must change: valve #1 to port A, and valve #2 to port A. 
In order for virtual machine #1 to access THF, the following valves must change: valve 
#1 to port A, valve #2 to port H, valve #3 to port A, and valve #4 to port A (Figure 5.10). 
 
Table 5.3 
 Module 1 Module 2 Module 3 
Deprotection Module: 
Deprotection Tube 
Pre-drying Tube 
Drying Tube 
Degassing Tube
 
Valve 1, Port B 
Valve 1, Port D 
Valve 2, Port A 
Valve 2, Port C 
 
Valve 1, Port C 
Valve 1, Port D 
Valve 2, Port B 
Valve 2, Port C 
 
N/A 
N/A 
N/A 
N/A 
Reaction Module: 
Reaction Tube Bottom 
Reaction Tube Top Input
 
Valve 2, Port D 
Valve 1, Port E 
 
Valve 2, Port E 
Valve 1, Port F 
 
Valve 2, Port F 
Valve 1, Port G 
Purification Module: 
Precipitation Tube Input 
Output 
SiO2 Column (bottom)
 
Valve 1, Port H 
Valve 2, Port G 
Pump-Specific 
 
N/A 
N/A 
N/A 
 
N/A 
N/A 
N/A 
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Software control of the machine equipment 
 All machine equipment is controlled by a custom software program which was 
written in VB.NET and is run on a Windows-based computer. As described above, the 
machine is designed to run eight syntheses simultaneously. Each synthesis is executed 
from the software environment using an independent virtual machine, and each virtual 
machine can be scripted and started/stopped without regard to the state of the other 
virtual machines. The custom software program ensures that resources are queued 
appropriately. Additionally, the software program is designed to interpret instructions to 
the machine written in a simple, custom scripting language. This enables the end-user to 
write very general instructions to the machine that are then read by the software and then 
mapped and communicated to the appropriate hardware. The commands used in this 
scripting language are detailed in Appendix A. 
 The interface of the software program at rest is shown in Figure 5.11. The buttons 
across the top of the window labeled “Pump 1”, “Pump 2”, etc., select the virtual 
machine that is to be modified by the user. The large text box provides an area in which 
the scripting commands are typed, copied and edited. When the “Run” button is pressed 
the software proof-reads all of the scripting commands entered into the virtual machine. 
If the syntax of the commands is correct the virtual machine begins operation of the 
actual machine equipment; if there is a syntax error, the user is alerted to the line of code 
that raised the error and the machine does not begin operation until the error is corrected. 
Figure 5.12 illustrates the interface of the software program while it is running a script on 
the machine. The active line of code is highlighted in blue while the lines of code that 
have been run are indicated in grey and the remaining lines are indicated in black. The 
“Break” button stops execution of the code, and the “Pump Status” label alerts the user to 
the current operation of the virtual machine. If the virtual machine is queued for use of 
shared equipment, the status of the queue is updated in the “Pump Status” label. 
 An important aspect of the software is that scripts which are written for one 
virtual machine are applicable to all of the virtual machines. That is, the script files are 
portable even though the actual valves that are operated by the script will differ 
depending on which virtual machine the code is executed from. One mechanism by 
which the software ensures portability of the scripts is through the use of a “header” 
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section (Figure 5.13). The header is a set of scripting commands that is specific to each 
virtual machine and contains instruction on how to operate pieces of equipment that are 
unique to a particular virtual machine. For example, each virtual machine is mapped to a 
different port on valve #3 (Figure 5.10). Therefore, scripts that are written to be portable 
across all virtual machines typically use a placeholder variable to refer to valve #3. The 
header of each virtual machine includes code which specifies the value that will be used 
to replace the placeholder variable if the code is executed on that specific virtual machine. 
The header section is typically hidden from the user but is run as the first portion of code 
whenever the virtual machine executes a script. 
 
 
Figure 5.11. The software interface while the virtual machine is not operating. This is the screen from 
which the virtual machine is scripted. 
 
Buttons select the 
current virtual 
machine 
Begins execution of 
the script on the 
machine 
Area in which the 
scripting commands 
are edited 
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Figure 5.12. The software interface during execution of the script. This screen allows the user to monitor 
the progress of the script execution. 
 
 
 
Figure 5.13. The software interface used to change the “header” section of the script. 
 
The “header” 
section.  
Current line 
Completed lines 
Uncompleted lines 
Status of the virtual machine 
Button interrupts 
the execution of 
the script 
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From a technical stand point, the software is built from a collection of 
programming objects (classes). The most broadly defined object is the virtual machine 
object, which serves as a container for equipment objects. An equipment object comprises 
all of the software functions necessary to operate a single valve or syringe pump. 
Specifically, the equipment object translates relatively simple software instructions into 
the complex arrangement of ones and zeros that are understood by the hardware. The 
equipment object also stores information on the exact hardware address of the equipment, 
as well as the route by which commands must be sent to the equipment. The most 
elementary object is the command object, which interprets a single line of code to 
determine if the syntax of the code is correct. If the syntax is correct, the command object 
stores the parameters necessary to perform the requested action. Specifically, the 
command object stores the name of the virtual machine object and the name of the 
equipment object that will be required for the requested action, as well as the names of 
the functions that will be performed by the equipment object. When a user presses the 
“Run” button in the software program, each line of the script is sent to its own unique 
command object which interprets the code. The command objects are then organized in a 
list and the software program sequentially instructs each command object in the list to 
execute its action. To provide an example on how the software executes a script, the case 
in which a five line script is executed on virtual machine #2 is presented in Figure 5.14. 
This figure illustrates the path that the software instructions will take when the third line 
of the script is executed (“valve 1b”). This line of script is instructing the machine to turn 
virtual machine #2’s valve #1 to port B. The command object first identifies the virtual 
machine object that is required for the operation (virtual machine #2), and then instructs 
the virtual machine object to pass the command to valve #1. The virtual machine then 
passes the command to valve #1 which reads the function “turn to port B” and translates 
this command into binary code which is sent to the hardware. The equipment object 
checks the hardware to make sure that the operation was successful, and then instructs the 
virtual machine object that the command is done, which in turn instructs the command 
object that the action is complete, which then instructs the software that the command 
object is done, and finally the software in turn instructs command object #4 to execute its 
action. 
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Figure 5.14. An schematic illustration of the path that the software instructions will take when line #3 of a 
script (“valve 1b”) is executed by the software. 
 
 
5-7 AUTOMATED ITERATIVE CROSS-COUPLING 
 The machine has been employed successfully in the synthesis of a several small 
molecules in two general areas: the synthesis of polyarene compounds and the synthesis 
of polyene compounds. In both cases the automated ICC approach has enabled the 
syntheses of natural products or their protected analogs. Although the development of the 
automated ICC machine is ongoing, these early examples demonstrate the viability of the 
automated approach.  
 
Automated ICC syntheses of polyarene compounds 
 The first successful two-step, fully automated ICC sequence was realized in the 
synthesis of triaryl 5.17 as described in Scheme 5.11. Although the yield for this reaction 
was not determined, the 1H-NMR spectrum of the crude product was relatively pure, 
indicating that the purification step to afford intermediate boronate 5.16 was successful 
(Figure 5.15). As the first example of a successful automated ICC sequence, this result 
served as an important foundation for further development of the machine. 
 282
 
Scheme 5.11. The first example of a fully automated iterative cross-coupling sequence with MIDA 
boronates. 
 
 
Figure 5.15. 1H-NMR spectrum of 5.17 as the crude product from the first fully automated iterative cross-
coupling reaction with MIDA boronates. 
 
 Following the synthesis of 5.17, efforts were taken to improve the reproducibility 
of the automated ICC machine. Towards this goal, the propenylation of 5.18 was studied 
in detail. As discussed above, the key discovery that resulted from this effort was that the 
stir rate in the reaction module must be greater than 500 rpm. This discovery prompted 
the design of a new frit for the reaction tube, as described above, in order to allow high 
stir rates. The coupling between 5.4 and 5.18 under automated ICC has been repeated 
over ten times following this method and has been found to always proceed with full 
conversion of the halide to afford MIDA boronate 5.14 as the pure product in a 65% to 
75% yield. 
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Scheme 5.12. The automated SMC coupling between 5.4 and 5.18 has been found to be highly 
reproducible. 
 
 Following the successful synthesis of 5.14, the automated ICC machine was 
applied in the synthesis of the MOM-protected analogs of the two neolignan natural 
products ratanhiaphenol I 28  (MOM-analog 5.20) and 2-(2,4-dihydroxyphenyl)-5-(E)-
propenylbenzofuran28 (MOM-analog 5.22) (Figure 5.12). Both products 5.20 and 5.22 
were isolated in multi-milligram quantities after manual SiO2 purification of the crude 
final reaction solutions, where the yields given in Figure 5.12 are based on the halide 
employed in the final SMC reaction step. Between three and four equivalents of the 
boronic acid are employed in all SMC reactions in automated ICC sequences in order to 
ensure that the boronic acid does not become the limiting reagent. For example, the 
automated ICC sequence that afforded 5.20 began with 197 mg of MIDA boronate 5.4 
and used three equivalents of boronic acid in the first coupling step and four equivalents 
of boronic acid in the second coupling step. The diminution in mass that occurs in the 
automated ICC sequence as currently implemented makes this approach non-ideal in 
certain contexts. However, the syntheses of 5.20 and 5.22 demonstrate that automated 
ICC may be well suited towards enabling rapid access to small molecule products in 
quantities suitable for biological testing. The syntheses of 5.20 and 5.22 were run in 
parallel on the automated ICC machine and required approximately 36 hours to complete.  
 
 284
 
Scheme 5.13. The MOM analogs of two natural products, ratanhiaphenol I and 2-(2,4-dihydroxyphenyl)-5-
(E)-propenylbenzofuran, were synthesis by automated ICC. 
 
 The most complex small molecule accessed to date by automated ICC is the 
MOM-analog of the neolignan natural product ratanhine29 (5.25) (also 2.15, chapter 2) 
(Scheme 5.14). The synthesis of 5.25 was executed in a fully automated fashion without 
user intervention, requiring 36 hours to complete. This synthesis represented the first 
successful three-step automated ICC sequence; however, the product represented less 
than 10% of the material obtained from the final coupling as indicated by 1H-NMR. At 
the time of this synthesis the importance of a high stir rate in the reaction module and the 
properties of the Amberlyst resin were poorly understood. Current efforts are being 
directed towards harnessing these discoveries in an improved and highly reproducible 
synthesis of 5.25. 
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Scheme 5.14. The MOM-analog of the neolignan natural product ratanhine was synthesized in a fully 
automated fashion by automated ICC. 
 
 
Automated ICC syntheses of polyene compounds 
 Previous studies have demonstrated that ICC is well suited to the synthesis of 
polyene compounds, particularly because the SMC reaction is stereospecific and allows 
precise control of E:Z alkene geometry.30 In this regard, it would be advantageous to be 
able to access this important class of molecular architecture via an automated synthesis 
approach. It is known that polyene compounds, relative to polyarene structures, are 
typically more sensitive to decomposition and isomerization processes.30 However, by 
lowering the temperature of the reaction module to 23 °C, replacing K3PO4 with Cs2CO3, 
and extending the SMC reaction time to 24 hours, the successful syntheses of several 
polyene compounds via automated ICC have been achieved. Under this modified 
automated ICC protocol alkenyl MIDA boronate 5.24 was converted to dienyl MIDA 
boronate 5.27 in 52% yield (Scheme 5.15A). This yield is based on the halide and reflects 
the pure material obtained from an automated purification step. Extending the automated 
ICC sequence by an additional iteration afforded trienyl MIDA boronate 5.28 in 76% 
yield (Scheme 5.15B), where the yield reflects the pure material that was isolated 
following an automated purification step. Further, the automated ICC sequence was 
extended by an additional iteration to provided access to β-parinaric acid (5.30)30a 
(Scheme 5.16). In this case the final coupling step was performed employing aqueous 
KOH as base in order to effect an in situ deprotection of MIDA boronate 5.28. In this 
final coupling full conversion of 5.29 was observed by 1H-NMR, although the yield of 
the reaction was not determined. 
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Scheme 5.15. (A) The automated ICC approach was successfully applied to the synthesis of dienyl MIDA 
boronate 5.26. (B) The automated ICC approach was extended by an additional iteration to afford trienyl 
MIDA boronate 5.27. 
  
 
Scheme 5.16. The synthesis of β-parinaric acid was achieved in a three-step, fully automated synthesis. 
 
 The machine has also been applied successfully to the synthesis of the polyene 
natural product all-trans-retinal (5.33)30a (Scheme 5.17.). Specifically, the same 
conditions that were found to be effective for the synthesis of 5.27, 5.28 and 5.30 were 
also found to be effective for the two-step synthesis of 5.33. In fact, the automated ICC 
sequence used to access 5.33 differs from that of the other polyene couplings only in the 
identity of the building blocks that were inputted to the machine. The product, all-trans-
retinal, was isolated in 20% yield following manual SiO2 chromatography of the crude 
reaction solution that is outputted from the final coupling. Current efforts are focused on 
harnessing the modularity of the automated ICC approach to provide access to a number 
of derivatives of 5.33. 
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Scheme 5.17. The synthesis of all-trans-retinal was achieved in a fully automated fashion starting from 
building block 5.31. 
 
 
5-8 THESIS SUMMARY 
 This dissertation describes the development of a potentially general approach to 
small molecule synthesis based on the iterative-cross coupling (ICC) of bifunctional 
MIDA boronates. Critical to realizing this ICC approach in the context of small molecule 
synthesis was the discovery that the MIDA ligand possesses the capacity to attenuate the 
reactivity of boronic acids under Suzuki-Miyaura cross-coupling (SMC) conditions, yet 
can be cleaved from boron using mild aqueous base. Further, it was discovered that 
MIDA boronates are generally stable to storage under ambient air at room temperature, 
thus enabling MIDA boronates to serve as stable surrogates for otherwise unstable 
boronic acids. The rate-controlled in situ release of boronic acids from the corresponding 
MIDA boronates was found to offer a general approach by which otherwise unstable 
boronic acid can be engaged in high-yielding SMC reactions with un-activated aryl 
chlorides. The MIDA boronate functional group was also found to be stable to a large 
number of the reagents and conditions typically employed in organic synthesis. As a 
consequence of this unique stability, and enabled by the general compatibility of MIDA 
boronates with SiO2 chromatography, it was found that simple MIDA boronates can be  
efficiently elaborated to structurally complex and/or functionally rich MIDA boronate 
building blocks using multi-step organic synthesis. Further, the ICC methodology was 
utilized in the syntheses of the natural products ratanhine and (+)-crocacin C. 
 Building on the collective discoveries made in the development of the ICC 
platform, the development of an automated small-molecule synthesizer with the capacity 
to perform iterative solution-phase ICC reactions with MIDA boronates was realized. The 
development of this machine was made possible by the additional discovery that MIDA 
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boronates are amenable to a “catch-and-release” purification protocol that is generally 
effective for all compounds that contain a MIDA boronate functional group. 
Development of the automated ICC machine involved the design and programming of a 
number of custom hardware components, as well as the development of a custom 
software program. To date, the automated ICC protocol has been applied successfully to 
the syntheses of five natural products or their MOM-protected analogs: MOM-
ratanhiaphenol I, MOM-2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran, MOM- 
ratanhine, β-parinaric acid, and all-trans-retinal. It is likely that with further development 
this automated ICC approach will become amenable to any ICC synthesis that can be 
performed manually. It is hoped that the discoveries presented in this dissertation will 
enable a more general and accessible approach to small molecule synthesis.  
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CHAPTER 5: EXPERIMENTAL SECTION 
 
 
Materials.  Commercial reagents were purchased from Sigma-Aldrich and were used 
without further purification. Solvents were dried as noted in chapter 2. The following 
compounds were prepared as described previously: 5.3 (chapter 2), 5.4 (chapter 4), 5.5 
(chapter 2), 5.8,1 5.10,1 5.18 (chapter 2), 5.23 (chapter 2), 5.24 (chapter 2), 5.26.2 The 
syntheses of 5.14, 5.19, 5.20, 5.21, 5.22, and 5.25 were performed by Steven Ballmer. 
MIDA boronate 5.31 was synthesized by Seiko Fujii. 
 
Structural analysis. Structural analysis was performed and described as detailed in 
chapter 2. 
 
 
Equipment 
Syringe pumps: Syringe pumps were purchased from J-KEM Scientific (part 
#SYR1400-8 for P1-P8, part #SYR-1400PC for P9 and P10) and are connected to the 
controlling computer via a RS485 to USB connection. Each syringe pump is fitted with 
an eight-port stream selecting valve (J-KEM, part #SPDV8) and a 10 mL glass syringe 
equipped with a Teflon plunger (J-KEM, part #SPGS-10000). The syringe pump 
withdraws and injects at rates from 0.0 mL/min to 70.0 mL/min with a step of 0.0029 mL. 
 
Reaction tubes: To minimize cross-contamination and allow the rapid setup of a 
synthesis, all chemical manipulations are performed in disposable polypropylene tubes 
purchased from Luknova, item #FC003012. The dimensions of the tube are 21 mm x 120 
mm (ID x length). The bottom of the tube is fitted with a 21 mm diameter x 5 mm tall frit. 
The bottom of the tube is accessed through a male luer tip, while the top of the tube is 
sealed with an air-tight, threaded cap containing a female luer port. The tube holds a 
solvent volume of up to 25 mL. 
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Tubing and fittings: All tubing and fittings were purchased from IDEX Health and 
Science. The tubing used in the machine is 0.030 inch (ID) x 1/16 inch (OD) Teflon FEP 
tubing (part #1520xL). All tubing connections were made with 1/16 inch ETFE 
flangeless ferrules (part #P-200x) and ¼-28 acetal fittings (part #P-202x). Male luer 
fittings (part #P-625) and female luer fittings (part #P-658) are ETFE and PEEK, 
respectively. 
 
 
 
 
 
P-658P-625
P-200xP-202x
1520xL 
Female luer-port top 
Frit 
Threaded cap 
Top 
Bottom 
Reaction 
tube 
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Chemical Synthesis 
 
General procedure: 
All chemical manipulations were performed in polypropylene tubes purchased from 
Luknova, item #FC003012 (see above). 
 
Deprotection tubes. Amberlyst A26(OH) was purchased from Sigma-Aldrich and was 
stored under N2 atm. at 4 ºC. Amberlyst A26(OH) (suspension volume of 20 mL) was 
twice washed with MeCN (50 mL) with vigorous agitation for 60 seconds in each wash. 
The residual solvent was evaporated under a fast stream of air for 5 minutes until the 
resin was light beige in color and was free-flowing. To a polypropylene tube was added 
the Amberlyst resin (2.0 g resin for every 1.0 mmol of MIDA boronate to be deprotected) 
and, optionally, the MIDA boronate starting material. The tube was capped and then 
placed on the machine where the bottom luer tip connected to the deprotection table and 
the top luer port is covered with aluminum foil.  
 
Drying and degassing tubes. A polypropylene tube was charged 
with Celite, activated molecular sieves (4Å, 8-12 mesh) and 
K2CO3. The amounts of these reagents are proportional to the 
amount of Amberlyst A26 resin used in the deprotection step 
prior to drying/degassing, as indicated below. Onto the bed of 
solids was placed a plastic plunger, cut from the plunger of a 5 
mL polypropylene syringe (Fisher #14-817-28, Norm-Ject). The 
plunger prevents the solids from lifting during the degassing step. 
The tube was capped and then placed on the machine where the 
bottom luer tip connects to the degassing table and the top luer 
port is connected to the gas manifold. 
plunger 
solids 
frit 
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Amberlyst A26 
(previous step) 
Celite Mol. sieves K2CO3 
2.0 g 200 mg 2.0 g 2.0 g 
1.0 g 100 mg 1.0 g 1.0 g 
0.5 g 50 mg 0.5 g 0.5 g 
 
Reaction tubes. To assist in the transfer of small amounts or Pd(OAc)2 and S-Phos, these 
reagents were adsorbed onto Cs2CO3 as follows:To a 40 mL glass vial was added 
Pd(OAc)2 (22 mg) and Cs2CO3 (2.723 g). To the vial was added THF (10 mL), and the 
suspension was concentrated in vacuo to afford a pale amber powder, the Pd-mixture. To 
a 40 mL glass vial was added S-Phos (76 mg) and Cs2CO3 (2.667 g). To the vial was 
added THF (10 mL), and the suspension was concentrated in vacuo to afford a white 
powder, the SPhos-mixture. 
To a polypropylene tube was added a stir bar (Big Science Inc., SBM-1508-REH), the 
halide (0.333 mmol), the Pd-mixture (488 mg, 5% Pd) and the SPhos-mixture (488 mg, 
10% S-Phos). For aqueous couplings, to the tube was added a KOH pellet (75 mg, 1.7 
mmol). The tube was capped with a modified cap (see detail) and was placed in a heating 
block. The bottom of the tube is connected the reaction table, the top of the tube is vented 
to the gas manifold, and the second top input is connected to the reaction table for slow 
addition of the boronic acid. 
 
Automation. Each cross-coupling in the automated sequence was performed according 
to the following script: 
 
Deprotection 1) Add THF (11 mL) to deprotection tube 
 2) Agitate the mixture via gas bubbling for 60 minutes 
 3) Add HCl in dioxane (4.0 M, 5.0 mmol per 1.0 g of Amberlyst 
resin) 
 4) Agitate the mixture via gas bubbling for 15 minutes 
 5) Transfer the solution to the drying tube, washing the resin with  
  THF (5 x 1.0 mL) 
 295
Degassing 6) Sparge the mixture with Ar gas for 15 minutes 
 7) While sparging the reaction tube with Ar gas for 15 min., agitate  
  the THF mixture via gas bubbling every 2 minutes 
Cross-Coupling 8) Add THF (3 mL) to the reaction tube and allow the mixture to stir  
   for 10 min. 
 9)  Transfer the boronic acid solution from the drying tube to the  
  reaction tube over 120 min., washing the solids with 
  THF (3 x 1.0 mL) 
 10)  Stir the reaction mixture at 600 rpm for 22 hours. 
Purification 11) Add hexanes (12 mL) to the ppt. chamber, then add a portion of  
  the reaction solution (3 mL) to the ppt. chamber. 
 12) Withdraw the solution in the ppt. chamber through the SiO2 plug  
  and send to the waste can 
 13) Repeat steps 11 and 12 until all of the reaction solution has been 
transferred 
 14) Add Et2O w/ MeOH (1.5 % v/v) (7.5 mL) to the ppt. chamber, 
  withdraw the solution through the SiO2 plug, and send to waste. 
  Repeat an additional four times. 
 15) Add Et2O (7.5 mL) to the ppt. chamber, withdraw the solution  
  through the SiO2 plug, and send to waste. Repeat an additional  
  two times. 
 16) Flow Ar gas through the SiO2 plug for three minutes to evaporate  
  residual solvent. 
 17) Backflow THF (11 mL) through the SiO2 column out to the ppt. 
chamber. 
 18) Stir the THF mixture for 30 minutes in the ppt. chamber. 
 19) Withdraw the THF solution into the main pump. The next coupling 
sequence begins at step 1. 
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Aqueous coupling modification: 
Note: This sequence begins after step 19 from the general automation script (above). 
 1) Sparge the THF solution derived from the purification of the  
  previous cross-coupling with Ar gas for 15 minutes. 
 2) Transfer the THF solution to the reaction tube in one portion. 
 3) Stir the mixture for 5 minutes. 
 4) Add degassed H2O (2 mL) to the reaction tube 
 5) Stir the reaction mixture at room temperature for 12 hours. 
 6) Add aq. NH4Cl (2.5 mL), mix for 5 minutes, then withdraw the 
entirety of the mixture and transfer it to the product test tube.  
 
 
 
 
β-parinaric acid (5.30) 
All steps were performed according to the general procedure. The machine was equipped 
with reagent tubes as follows: 
 
Step 1. The machine was equipped with a deprotection tube charged with Amberlyst resin 
(2.0 g) and MIDA boronate 5.24 (211 mg, 1.0 mmol); a drying tube charged with mol. 
sieves (2.0 g), K2CO3 (2.0 g) and Celite (0.2 g); and a reaction tube charged with the Pd-
mixture (488 mg), the SPhos-mixture (488 mg) and boronate 5.26 (103 mg, 0.333 mmol). 
 
Step 2. The machine was equipped with a deprotection tube charged with Amberlyst resin 
(1.0 g); a drying tube charged with mol. sieves (1.0 g), K2CO3 (1.0 g) and Celite (0.1 g); 
and a reaction tube charged with the Pd-mixture (244 mg), the SPhos-mixture (244 mg), 
and boronate 5.26 (34 mg, 0.11 mmol). 
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Step 3. The machine was equipped with a deprotection tube (empty, but used for sparging 
the MIDA boronate solution) and a reaction tube charged with the Pd-mixture (60 mg), 
the SPhos-mixture (60 mg), KOH (75 mg, 1.7 mmol) and halide 5.29 (11 mg, 0.037 
mmol). 
 
Automation. The synthesis was performed in a fully automated fashion with no operator 
intervention. Step 1 and step 2 were performed following the standard script and step 3 
was performed following the aqueous coupling modification of the standard script. The 
aqueous mixture that was outputted from the machine was manually purified as follows: 
The mixture was transferred to a 60 mL separatory funnel and was diluted with sat. aq. 
NH4Cl (10 mL). The mixture was extracted twice with Et2O (20 mL) and the combined 
organics were washed with brine (20 mL); dried over MgSO4; filtered, then concentrated 
in vacuo. The 1H-NMR (CDCl3) spectrum of the crude product was consistent with the 
literature data.3 The yield of the product was not determined. 
 
Step 1 was repeated and the MIDA boronate solution generated in line 19 of the standard 
script was diverted into a test tube and then concentrated to afford pure intermediate 5.27 
as a colorless solid (40 mg, 52%). 
 
 
 
1H-NMR (500 MHz, acetone-d6): δ 6.53 (dd, J = 17.0, 10 Hz, 1H), 6.11 (dd, J = 15.5, 
10.0 Hz, 1H), 5.82 (dt, J = 15.5, 6.5 Hz, 1H), 5.54 (d, J = 17.5 Hz, 1H), 4.20 (d, J = 17.0 
Hz, 2H), 4.01 (d, J = 17.0 Hz, 2H), 2.98 (s, 3H), 2.10 (quint, J = 7.5 Hz, 2H), 0.99 (t, J = 
7.5 Hz, 3H). 13C-NMR (125 MHz, acetone-d6): δ 196.1, 143.7, 137.8, 132.6, 62.2, 47.2, 
26.1, 13.7. 
 
Step 1 and step 2 were repeated and the MIDA boronate solution generated during the 
second coupling (line 19 of the standard script) was diverted into a test tube and then 
concentrated to afford pure intermediate 5.28 as a colorless solid (22 mg, 76%). 
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1H-NMR (500 MHz, acetone-d6): δ 6.58 (dd, J = 18.0, 10.5 Hz, 1H), 6.28 (dd, J = 15.0, 
10.0 Hz, 1H), 6.20 (dd, J = 15.0, 10.0 Hz, 1H), 6.11 (ddt, J = 15.5, 10.5, 1.5 Hz, 1H), 
5.82 (dt, J = 15.0, 6.5 Hz, 1H), 5.64 (d, J = 17.5 Hz, 1H), 4.21 (d, J = 17.0 Hz, 2H), 4.03 
(d, J = 17.0 Hz, 2H), 2.99 (s, 3H), 2.12 (quint, J = 7.5 Hz, 2H), 0.99 (t, J = 7.5 Hz, 3H). 
13C-NMR (125 MHz, acetone-d6): δ 169.0, 143.5, 138.3, 134.8, 133.5, 130.3, 62.2, 47.3, 
26.4, 13.8. 
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all-trans-retinal (5.33) 
All steps were performed according to the general procedure. The machine was equipped 
with reagent tubes as follows: 
 
Step 1. The machine was equipped with a deprotection tube charged with Amberlyst resin 
(1.0 g) and MIDA boronate 5.31 (173 mg, 0.500 mmol); a drying tube charged with mol. 
sieves (1.0 g), K2CO3 (1.0 g) and Celite (0.1 g); and a reaction tube charged with the Pd-
mixture (244 mg), the SPhos-mixture (244 mg) and boronate 5.26 (52 mg, 0.111 mmol). 
 
Step 2. The machine was equipped with a deprotection tube charged with Amberlyst resin 
(0.5 g); a drying tube charged with mol. sieves (0.5 g), K2CO3 (0.5 g) and Celite (50 mg); 
and a reaction tube charged with the Pd-mixture (82 mg), the SPhos-mixture (82 mg). A 
separate polypropylene tube was charged with a solution of halide 5.32 (0.056 mmol) in 
degassed THF (3 mL). 
 
Automation. The synthesis was performed in a fully automated fashion with no operator 
intervention. Step 1 was performed following the standard script. Step 2 was performed 
following the standard script with the modification that the THF used in line 8 of the 
standard script was the entirety of the solution containing halide 7. Further, the script for 
step 2 was stopped after line 10 and the reaction solution was outputted to a test tube. The 
product was manually purified as follows: The reaction solution was concentrated in 
vacuo and the solid yellow residue was purified by SiO2 chromatography using an Isco-
Teledyne CombiFlash system to afford all-trans-retinal as a yellow solid (3.3 mg, 20%). 
The 1H-NMR (CDCl3) spectrum of the product was consistent with the literature data.3 
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APPENDIX A 
SCRIPTING COMMANDS USED TO PROGRAM THE MACHINE 
 
 This appendix describes the commands that are used in the custom scripting 
language that is interpreted by the software that runs the machine. All automated iterative 
cross-coupling procedures are written using only these fifteen commands. Each command 
that is described below is also accompanied by an example on the usage of the command. 
The scripting language is not case-sensitive. 
 
' (apostrophe) 
 
Description: 
Used to designate a comment. The text following an apostrophe is not interpreted by the 
program as a command. 
 
Usage: 
' [enter comment text following the apostrophe] 
 
Example: 
valve 1a 2b  ' This is a comment on the same line as a command 
'This is a comment on its own line. 
  
 
[ ] (brackets) 
 
Description: 
Used to designate a variable. A variable is a place-holder for a value that can be 
specified with a define command. Using variables allows the code to be more flexible. 
 
Usage: 
command [variableName] 
 
Executes a command, represented here generically as command, for which the variable 
variableName contains the instructions to be interpreted by the command. The value of 
variableName would be defined earlier in the code using the define command. 
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Example: 
valve [Tube] 
pump 5 in=[THF] out=a rate=[StdRate] 
 
In the above code the variables are [Tube], [THF] and [StdRate]. Using the define 
command the values could be set at the beginning of the code, and could be changed 
easily before the file is executed. For example: 
 
Define Tube=4a THF=b StdRate=45 
 
valve [Tube] 
pump 5 in=[THF] out=a rate=[StdRate] 
pump 2 in=[THF] out=a 
valve 2b [Tube] 
 
In this way the code is more flexible. This same routine could be called for a number of 
different tube locations, and using just one line or code the entire routine could be 
modified for a new tube location. Also, if the location of the THF bottle changed, it would 
be easy to specify a new location using just one line of code, even though the routine 
accesses the THF bottle on several lines. 
 
 
DEFINE 
 
Description: 
Used to set the value of a variable within a script. 
 
NOTE: Due to current code limitations, each variable should only be defined once in a 
procedure. 
 
Usage: 
define variable_name=variable_value 
 
variable_name represents the name of the variable to define 
variable_value is the data which will now stand in the place of all instances of the variable 
defined by variable_name 
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Example: 
define pumpnum=a 
valve 4[pumpnum] 
valve 5[pumpnum] 8[pumpnum] 
 
All instances of [pumpnum] (the variable) will be replaced with the value a at runtime. 
That is, the program will interpret the script as follows: 
 
define pumpnum=a 
valve 4a 
valve 5a 8a 
 
Variables allow flexible code since with a few uses of the define command, a general 
script can be mapped onto any number of equipment combinations. 
 
 
PAUSE 
 
Description: 
Pauses the script for a specified period of time before executing the next line. 
 
Usage: 
pause [# of seconds to pause] 
 
Example: 
pause 5  This pauses the script for 5 seconds 
 
 
LOG 
 
Description: 
Writes a user comment to the file "MachineLog.txt" with a time and date stamp. The 
comment is added to the end of the file without affecting the previous text in the log file. 
The command is useful in logging the time and date when specific portions of code are 
executed or completed. 
 
Usage: 
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log "Text Here" 
 
Any text can be entered between the two quote marks. 
 
Example: 
log "Program Start" 
 
Writes "5/22/09 8:32:12 AM: Program Start" to the file "cMachineLog.txt", where the 
system date is 5/22/09 and the system time is 8:32 AM and 12 seconds. 
 
 
SUB 
END SUB 
 
Description: 
The SUB and END SUB commands enclose scripting commands that can be executed as 
a sub routine. That is, a particular sequence of code can be designated as a sub routine 
and given a unique identifying name. Rather than retyping the code each time the routine 
needs to be run, the code can be executed using the RUN command. Additionally, using 
the BACKGROUND command sub routines can be executed as background processes 
(although care needs to taken in how the code is scripted). 
 
Usage: 
sub SubName 
   enter lines of code here 
end sub 
 
Define a sub routine with the identifier SubName. The code contained within the sub and 
end sub lines can be executed by using the run command followed by the identifier. 
 
NOTE: Every sub routine within a script must have a unique identifier. If two sub routines 
with the same identifier are used, an error will result. 
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Example: 
sub test 
  log “Start time” 
  pause 30 
  log “End time” 
end sub 
 
Defines the sub routine test. At this point the machine will not actually do anything. 
Rather, it has saved the instruction defined by the test routine for later use. To execute 
the test script the run command is used: 
 
run test  ‘ Run the script once 
run test  ‘ Run the script again 
 
The test sub routine is run twice. Each time the sub routine is run it writes the line “Start 
time” to the log file, waits 30 seconds, and writes the line “End time” to the log file. After 
the above script has executed, the log file will contain four new lines. 
 
For information on the RUN command, see below. 
 
 
RUN 
 
Description: 
Runs a sub routine that has been specified by the SUB command structure. 
 
Usage: 
run SubName 
 
Executes the code contained within the sub routine represented by the identifier 
SubName. The identifier SubName can refer to any sub routine defined earlier in the 
script using the sub, end sub commands. 
 
Example: 
See the above example for the sub, end sub command. 
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BACKGROUND 
 
Description: 
Begins the execution of a sub routine as a background process. After processing this 
initial event, the script will immediately read the next line of the main as the background 
process continues. 
 
NOTE: There are important consequences to running a process in the background. It is 
the script writer's responsibility to ensure that the background process will not conflict 
with the foreground process. Specifically, appropriate use of the lock/unlock 
commands is encouraged to make sure that the same equipment is not being accessed 
at the same time. Additionally, the program cannot display the progress of the 
background process, nor can it save the progress of the background process if the code 
is halted. Thus, the background command should be used sparingly. 
 
NOTE: Only one instance of a sub routine per pump is allowed to execute as background 
process at any given time. 
 
Usage 
background SubName 
 
Begins background execution of the sub routine with the identifier SubName. 
 
Example: 
sub TestPause 
  pause 15 
end sub 
 
background TestPause 
 
pause 10 
 
The sub TestPause portion defines a sub routine that will have the machine pause for 
15 seconds. The background command then calls the TestPause routine to execute in 
the background while it then immediately processes the next command: pause 10. Thus, 
the total execution time for this script will be 15 seconds, since the machine will 
simultaneously pause for both 15 and 10 seconds. 
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WAIT 
 
Description: 
Halts program execution until a condition is met. Specifically, the WAIT command allows 
other machine processes to catch up to the script before executing the next command 
line. This is particularly useful in coordinating background-executed sub routines. 
 
Usage: 
wait SubRoutineName 
 
SubRoutineName is the identifier of a sub routine that was previously executed using the 
background command. The system will wait until the process for SubRoutineName is 
complete before proceeding to the next line. 
 
Example: 
sub TestPause 
  pause 15 
end sub 
 
background TestPause 
 
pause 5 
wait TestPause 
 
log “Script complete” 
 
Similar to the example of the background command, the sub TestPause portion 
defines a sub routine that will have the machine pause for 15 seconds. The background 
command then calls the TestPause routine to execute in the background while it then 
immediately processes the next command: pause 5. After the pause 5 command 
completes (5 seconds later), the machine pauses and waits for the TestPause sub that is 
running in the background to complete. Thus, the line “Script complete” is not written to 
the log file until 15 seconds after the background TestPause command is executed. If 
the wait TestPause command was omitted, the log command would execute 5 
seconds after the background TestPause command was executed 
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VALVE 
 
Description: 
Used to change to port position of an 8-port valve. The  command can also be used to 
turn a selenoid valve on or off. Multiple  valves can be manipulated secquentially in a 
single VALVE call. 
 
Usage: 
valve command1 command2 commmand3  
 
command1, command2, commmand3, etc. describes the # of the valve being 
manipulated and the new state for the valve. Multiple valves can be manipulated using a 
single valve command. In fact, there is no limit to the number of manipulations that can 
be performed with a single valve command. Changes to the valves of the system are 
executed in the order command1, then command2, then command3, etc. 
 
Example: 
valve 1a  This moves valve #1 to position A 
 
valve 1b 2b  This moves valve #1 to position A, then moves valve #2 to 
position B 
 
valve x1on  This turns selenoid #1 on 
 
valve x2on x1off This turns selenoid #2 on, then turns selenoid #1 off 
 
 
PUMP 
 
Description: 
Used to control the syringe pump. This command is used to move specific volumes of 
liquid from one port to another, at a rate specified by the user. 
 
Usage: 
pump volume in=PortIn out=PortOut rate=RateOfWithdrawl/Infusion  
rateIn=RateOfWithdrawl rateOut=RateOfInjection 
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volume specifies the amount of reagent that is to be moved by the syringe pump. The 
volume specified can be greater than the capacity of the syringe only if the syringe is both 
withdrawing and injecting the reagent during the same command. The volume is 
expressed as a number representing mL. That is, do not include the unit when specifying 
the volume--it is assumed. 
PortIn (optional), specifies the port from which the reagent will be withdrawn. If [port in] is 
not specified the program will use whatever port the syringe pump is already set to. Note: 
if [port out] is not specified, an equal sign does not need to follow the in parameter. 
RateOfWithdrawl/Infusion (optional), specifies the port to which the reagent will be 
delivered. If [port out] is not specified the program will use whatever port the syringe 
pump is already set to. Note: if [port out] is not specified, an equal sign does not need to 
follow the in parameter. 
RateOfWithdrawl/Infusion (optional), allows the user to specify how fast the syringe pump 
will handle the reagent transfer. The rate is specified as a number representing the 
mL/min. That is, do not include the units when specifying the rate--they are assumed. 
RateOfWithdrawl (optional) (similiar to above). This implementation allows the rate of 
withdrawn of the syringe to be set independently of the rate of injection. 
RateOfInjection (optional). Same as RateOfWithdrawl, but specifies the rate of injection. 
Note: if the rate of withdrawal is specified but the rate of injection is omitted, the default 
rate of injection will be used. This applies vice-versa when only the rate of injection is 
specified. 
 
Excluding an out port will cause the pump to only inject the reagent already present in the 
syringe. If an in port is excluded, the pump will only fill the syringe with reagent. 
 
Example: 
pump 5 in=A out=B rate=5 
 
Pumps 5 mL of reagent from port A to port B at a rate of 5 mL/min for both withdrawl and 
injection. 
 
pump 3 in=B out=B rateIn=10 rateOut=2 
 
Pumps 3 mL of reagent from port A to port B. The reagent is drawn into the syringe at 10 
mL/min and is injected out at a rate of 2 mL/min. 
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pump 5 in=B out=C 
 
Pumps 5 mL of reagent from port B to port C at the default rate for withdrawl & injection. 
 
pump 4 in=A 
 
Withdraws 4 mL of reagent from port A into the syringe and then waits for the next 
command. It is the programmer's responsibility to account for the fate of the reagent in 
the syringe. Note: no more than 10 mL of reagent can be withdrawn into the syringe with 
this command (since the syringe has a capacity of 10 mL). 
 
pump 2 out=B 
 
Injects 2 mL of the contents of the syringe through port B. This command assumes that 
the syringe contains reagent that was withdrawn with a previous command. 
 
pump out=B 
 
Injects the entire contents of the syringe through port B. This command assumes that the 
syringe contains reagents that was withdrawn with a previous command. If the syringe 
does not contain reagent, this command with do nothing. Note: this command can be 
used to ensure that the syringe is empty before executing addition code. 
 
pump out 
 
Similiar to above, however a port is not specified. The syringe pump injects the entire 
contents of the syring through the currently selected port on the syringe pump. 
 
pump 0.5 in out 
 
Withdraws 0.5 mL of reagent from the default port and then injects it back through this 
same port. This command is useful for priming the reagent lines or mixing a solution in 
the syringe pump. 
 
pump 1 in out=C rate=2 
 
Withdraws 1 mL of reagent from the currently selected port on the syringe pump and then 
injects the reagent through port C at a rate of 2 mL/min. 
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AUX 
 
Description: 
This command follows the same structure as the pump command, but sends its 
instructions to the auxiliary pump. 
 
Usage: 
Same as the pump command 
 
Example: 
aux 3 in=B out=B rateIn=10 rateOut=2 
 
Uses the auxiliary pump to transfer 3 mL of reagent from port A to port B. The reagent is 
drawn into the syringe at 10 mL/min and is injected out at a rate of 2 mL/min. 
 
 
WETPUMP 
 
Description: 
This command follows the same structure as the pump command, but sends its 
instructions to the water-handling pump. 
 
Usage: 
Same as the pump command 
 
Example: 
wetpump 3 in=B out=B rateIn=10 rateOut=2 
 
Uses the water-handling pump to transfer 3 mL of reagent from port A to port B. The 
reagent is drawn into the syringe at 10 mL/min and is injected out at a rate of 2 mL/min. 
 
 
LOCK 
 
Description: 
Used to claim a pump or valve for exclusive access by a particular module. This 
command is used on machines for which there are several autonomous processes that 
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share a common resource (a common valve or pump). Other processes that try to access 
the shared valve or pump while it is locked will get a busy signal, and will wait until the 
resource becomes available. The resource is freed with the UNLOCK command. 
 
Usage: 
lock # 
lock aux 
lock wetpump 
 
# indicates the number of the valve that should be locked. To use a single lock 
command to lock many valves, separate each valve name with a space. 
aux indicates the auxiliary pump should be locked 
wetpump indicates that the water-handling pump should be locked 
 
Example: 
lock 3 5 aux 
 
Locks valve #3, valve #5 and the auxiliary pump for exclusive access by the calling 
module. 
 
 
UNLOCK 
 
Description: 
Used to release a pump or valve from exclusive access by a particular module (see LOCK 
command above). 
 
Usage: 
unlock # 
unlock aux 
unlock wetpump 
unlock all 
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# indicates the number of the valve that should be unlocked. To use a single unlock 
command to unlock many valves, separate each valve number with a space. 
aux indicates the auxiliary pump should be unlocked 
wetpump indicates that the water-handling pump should be unlocked 
all indicates that all resources locked by the calling module should be released 
 
Example: 
unlock 3 5 aux 
 
Releases valve #3, valve #5 and the auxiliary pump from exclusive access by the calling 
module. 
 
unlock all 
 
Releases all resources from exclusive access by the calling module. 
 
 
